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RIASSUNTO 
Durante questo progetto di dottorato sono stati condotti studi per comprendere la capacità 
delle cellule mesenchimali amniotiche (AMCs) di agire attraverso meccanismi paracrini. La 
prima fase del disegno sperimentale ha valutato l’efficacia delle AMCs sulla proliferazione delle 
cellule endometriali (EDCs) in assenza di un contatto cellula-cellula. Le EDCs sono state co-
coltivate in un sistema trans-well con le AMCs o sono state coltivate in presenza del loro 
medium condizionato (CM). In entrambe le condizioni sperimentali è stato osservato un 
aumento del tasso di proliferazione delle EDCs definendo, così, il ruolo cruciale dei fattori 
secreti dalle AMCs come mediatori dell'azione delle cellule staminali. Il CM è composto da 
fattori solubili e non-solubili rappresentati da microvescicole (MVs). Per capire il ruolo delle 
MVs e del loro contenuto nell’azione paracrina, la seconda fase del disegno sperimentale è 
stata incentrata sull’individuazione del tipo di MVs secrete dalle AMCs e sulla loro efficacia in 
processi infiammatori in vitro su due importanti modelli sperimentali nella specie equina quali 
l’endometrio ed il tendine. La produzione di MVs è stata ottimizzata attraverso 
un’ultracentrifugazione del CM a 100.000 g per 1 ora. Attraverso lo strumento Nanosight è 
stato calcolato che la produzione di MVs da AMCs equine è di circa 2550±71 particelle/cellula, 
con una dimensione media di 258±55 nm. La microscopia elettronica a trasmissione ha 
confermato la presenza di vescicole cellulari che per dimensioni e modalità di secrezione sono 
state classificate come shedding vesicles. Per capire se le cellule endometriali (EDCs) e tendinee 
(TNCs) fossero target delle MVs secrete dalle AMCs, è stata studiata l’incorporazione delle 
medesime dopo marcatura con un fluorocromo lipofilico quale il PKH-26. Dopo uno studio di 
una curva dose-risposta è stato osservato che la dose ottimale per l'incorporazione di MVs in 
EDCs è stata di 50x106 MVs/ml a 72 h e per le TNCs di 50x106 MVs/ml a 24-48h. Per esaminare 
l'abilità delle MVs nel contrastare un processo infiammatorio, entrambe le linee cellulari sono 
state stressate in vitro con LPS e trattate con MVs. La vitalità cellulare, l'espressione di alcuni 
geni pro-infiammatori ed il rilascio delle rispettive citochine sono stati i parametri impiegati per 
valutare l’efficacia delle MVs. Per entrambe le linee cellulari, il tasso di apoptosi è 
drammaticamente salito nelle cellule trattate con LPS, rispetto al controllo (CTR). LPS ha indotto 
un aumento significativo dell'espressione di TNF-α, IL-6 e IL-1β in EDCs e di MMP-1, MMP-9, 
MMP-13 e TNF-α in TNCs. Le MVs sono state in grado di contrastare l'effetto di LPS, 
diminuendo il tasso di apoptosi in entrambe le linee cellulari e riducendo il livello di espressione 
dei geni pro-infiammatori. Una conferma di questi dati è stata ottenuta attraverso l'analisi delle 
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citochine pro-infiammatorie (TNF-β and IL-6) ed anti-infiammatorie (TGF-α) rilasciate dalle EDCs 
nel terreno di coltura, confermando l'abilità delle MVs di trasportare molecole capaci di 
contrastare la risposta infiammatoria in cellule stressate con LPS. 
Data l'importanza del contenuto in miRNA delle MVs, sia nelle AMCs sia nelle loro MVs è stata 
studiata la presenza di tre miRNA (miR-335, miR-146a, and miR-26a-2) coinvolti nella 
regolazione dei processi infiammatori. Questi tre miRNA sono stati identificati sia nelle AMCs 
sia nelle MVs, di conseguenza, è possibile ipotizzare che l'espressione genica dopo 
infiammazione con LPS e trattamento con MVs possa essere stato modulato dal trasferimento 
di miRNAs dalle MVs alle cellule target. 
Successivamente a questi studi, si è tentato di capire quanto in un processo rigenerativo possa 
essere imputato alle MVs e quanto ai fattori solubili presenti nel CM e, a questo proposito, è 
stata valutata l’abilità delle MVs di inibire la proliferazione delle cellule periferiche 
mononucleate del sangue (PBMC). La loro azione è stata comparata a quello del CM e del 
sovranatante (SN) ottenuto dal CM dopo scorporazione delle MVs. Il CM ed il SN hanno 
manifestato capacità immunosoppressiva ma, anche dopo un trattamento di sonicazione al fine 
del rilascio del loro contenuto, le MVs non hanno dimostrato quest’abilità. Questi risultati 
portano a dedurre che le MVs sono in grado di trasportare informazioni alle cellule target 
attraverso molecole capaci di contrastare l'effetto infiammatorio dovuto all'uso di LPS ma, 
tenendo in considerazione la mancanza di effetto immunomodulatorio, probabilmente in vivo 
la loro azione è integrata anche dalla presenza dei fattori solubili presenti nel CM. 
I meccanismi paracrini materno-fetali sono di vitale importanza ai fini dell’instaurarsi di una 
gravidanza, per cui si è ritenuto interessante studiare questi meccanismi durante la produzione 
in vitro di embrioni bovini. Le differenti componenti del secretoma (CM, SN e MVs) ottenute da 
AMCs ed EDCs bovine sono state aggiunte al terreno di coltura embrionale a differenti giorni di 
coltura. I risultati hanno dimostrato che il giorno 5 è il migliore momento per la 
supplementazione e che le MVs di AMCs portano a migliori risultati qualitativi. Questi dati sono 
stati confermati dalla valutazione di alcuni geni coinvolti nell'apoptosi e nella protezione contro 
specie reattive dell'ossigeno. I motivi per i quali le MVs di AMCs si siano dimostrate migliori di 
quelle secrete dalle EDCs non sono ancora conosciuti ma è probabile che le EDCs coltivate in 
monostrato in vitro vadano incontro a de-differenziamento che altera la qualità del loro 
secreto.  
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In conclusione, è possibile affermare che le AMCs sono una linea cellulare affascinante in 
quanto derivano da materiale di scarto biologico, e quindi a basso costo, e possono essere 
impiegate in medicina rigenerativa per la loro capacità di trasportare informazioni alle cellule 
target. Le MVs possono offrire un nuovo strumento terapeutico privo di cellule nell’ambito 
della nanomedicina. 
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ABSTRACT 
During this PhD project, studies were carried out to understand the ability of amniotic 
mesenchymal cells (AMCs) to act by paracrine mechanism. At first, AMCs and their conditioned 
medium (CM) were investigated in an in vitro model using equine endometrial cells (EDCs) as 
target. Proliferation of EDCs was studied co-culturing them with AMCs in a trans-well system or 
in presence of AMC-CM. In both conditions, there was a significant increase in EDC proliferation 
rate, defining the crucial role of factors secreted by AMCs in stem cells action. CM is composed 
of soluble factors and no-soluble factors as microvesicles (MVs). In this context, in the second 
step of this project, the presence and the type of AMC-MVs were identified to understand their 
role in regenerative medicine. The production of MVs was optimized through a CM 
ultracentrifugation at 100.000 g for 1 hour. Microvesicle production from equine AMCs was 
2550±71 particles/cell, with a mean dimension of 258±55 nm. The transmission electron 
microscopy confirmed the presence of extra-cellular vesicles that were classified as shedding 
vesicles for their size and modality of secretion. In order to understand if endometrial cells 
(EDCs) tendon cells (TNCs) were target of these MVs, an incorporation study was performed 
labelling MVs with a lipophilic fluorochrome such as PKH-26. By a dose-response curve, the 
optimal conditions of incorporation were at 72 h at a concentration of 50x106 MVs/ml for EDCs, 
and at 24-72 h at a concentration of 50x106 MVs/ml for TNCs. In order to study MVs ability to 
counteract an in vitro inflammation, EDCs and TNCs challenged with LPS and treated with MVs 
were evaluated by viability cell tests, by expression of some pro-inflammatory genes, and by 
release of respective cytokines. For both cell types, the apoptosis rate increased dramatically in 
cells treated with LPS if compared to the control (CTR). LPS significantly upregulated the 
expression of TNF-α, IL-6 and IL-1β in EDCs and of MMP-1, MMP-9, MMP-13 and TNF-α in TNCs. 
MVs were able to counteract the action of LPS, decreasing the apoptosis rate and reducing in 
the expression levels of the pro-inflammatory genes in both cell lines. Coherent results were 
obtained through the analysis of pro-inflammatory (TNF-β and IL-6) and anti-inflammatory 
(TGF-α) cytokines released by EDCs in the culture medium, confirming the ability of MVs to 
transport molecules able to counteract the stress induced by LPS.  
Since MVs contain various active molecules, the presence of three miRNAs (miR-335, miR-146a, 
and miR-26a-2) was investigated, as they are involved in the regulation of inflammation. The 
selected miRNAs have been found in both AMCs and their MVs, so the previously observed 
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downregulation of gene expression could be correlated to miRNA transfer from MVs to target 
cells. Moreover, the ability of MVs to inhibit peripheral blood mononuclear cell (PBMC) was 
evaluated, but MVs, also after lysis by sonication to release their content, were not able to 
inhibit PBMC proliferation despite to CM and SN. These results led to hypothesize that MVs 
brought to the target cells some molecules able to counteract the inflammatory situation due 
to the LPS but, taking into account the lack of their immunomodulatory action, probably, for an 
in vivo healing, soluble factor of CM are necessary too. 
Paracrine mechanism are essential also in maternal-fetal communication. In this context, we 
studied these mechanisms during bovine in vitro embryo production. Different components of 
secretome (CM, SN and MVs) from bovine AMCs and EDCs were supplemented to the embryo 
culture media at different days of culture. The results demonstrated that the day 5 of culture is 
the best time point for the supplementation of these components and that AMCs-MVs 
provided the best environment for the embryo concerning the blastocyst quality. These data 
were confirmed by the evaluation of genes involved in apoptosis and reactive oxygen species 
protection. The reasons for which the MVs of AMCs have proved better than those secreted by 
EDCs are not yet known but it is likely that in vitro culture of EDCs in monolayer may induce a 
de-differentiation that alters the quality of their secretion. 
As conclusion of this project, it is possible to speculate that AMCs are fascinating in view of 
producing off-the-shelf products, at low cost, and their use in regenerative medicine for their 
capacity to carry information to the target cells. The MVs may offer a new therapeutic cell-free 
tool in nanomedicine.  
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Structure of the work - The first section of this thesis gives a brief overview of the literature 
about the regenerative medicine, focusing the attention on the paracrine communication 
between cells. More details are provided on the description of extracellular vesicles that are 
supposed to be mainly involved in this paracrine action. The second section concerns some 
models for the study of the paracrine communication in regenerative veterinary medicine such 
as equine tendinitis and endometritis, and, furthermore, in bovine embryo production. Lastly, a 
list of the publications realized during my PhD project follows, within which it is possible to find 
the protocols used to study the mechanisms involved in these communications and the original 
results of the research of the 3-academic-year–period (2014-2016).  
This thesis is based on the following papers: 
I. Corradetti B, Correani A, Romaldini A, Marini MG, Bizzaro D, Perrini C, Cremonesi F, Lange-
Consiglio A. Amniotic membrane-derived mesenchymal cells and their conditioned media: 
potential candidates for uterine regenerative therapy in the horse. 2014 PLoS One. 
9(10):e111324. 
II. Perrini C, Strillacci MG, Bagnato A, Esposti P, Marini MG, Corraddetti B, Bizzaro D, Idda A, 
Ledda S, Capra E, Pizzi F, Lange-Consiglio A, Cremonesi F. Microvesicles secreted from 
equine amniotic-derived cells and their potential role in reducing inflammation in 
endometrial cells in an in vitro model. 2016 Stem Cell Res Ther doi: 10.1186/s13287-016-
0429-6 
III. Lange-Consiglio A, Perrini C, Tasquier R, Deregibus MC, Camussi G, Pascucci L, Marini MG, 
Corradetti B, Bizzaro D, De Vita B, Romele P, Parolini O, Cremonesi F. Equine amniotic 
microvesicles and their anti-inflammatory potential in a tenocyte model in vitro. 2016 
Stem Cell Dev 15;25(8):610-21.  
IV. Perrini C, Esposti P, Compagnoni D, Treglia S, Cremonesi F, Lange Consiglio A. Secretome 
derived from different cell lines in bovine in vitro embryo production. 2016 Submitted to 
PlosOne 
 
Other papers published during the PhD project include the following: 
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Bosi G, Belloli A, Pravettoni D, Locatelli V, Cremonesi F, Bizzaro D. Peculiarity of porcine 
amniotic membrane and its derived cells: a contribution to the study of cell therapy from a 
large animal model. 2015 Cell Reprogram 17(6):472-83. 
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LIST OF ABREVIATION 
AKI: acute kidney inflammation 
AMC-MVs: amniotic mesenchymal cells derived microvesicles 
AMCs: amniotic mesenchymal cells 
bp: base pair 
CD: cluster of differentiation 
CM: conditioned medium 
c-MYC: v-myc avian myelocytomatosis viral oncogene homolog 
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miRNA: micro RNA 
MMP: metalloprotease 
mRNA: messenger RNA 
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RISC: RNA-induced silencing complex 
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rRNA: ribosomal RNA 
RT-qPCR: quantitative reverse transcription polimerase chain reaction 
SCF: stem cell factor 
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snoRNA: smal nucleolar RNA 
snRNA: small nuclear RNA 
TGFβ1: transforming growth factor beta-1 
TEM: transmission electron microscopy 
TNCs: tendon cells 
TNF- α : tumor necros factor α 
tRNA: transfer RNA 
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1. INTRODUCTION 
Regenerative medicine is a newly emerging and multidisciplinary field based on biology, 
medicine and genetic manipulation for the development of strategies aimed to restore, 
maintain, or enhancing the function of tissues or organs that have been compromised through 
disease, pathology or injury. Many treatments have been proposed for the regenerative 
medicine, but stem cell based therapies, nowadays, represent promising opportunities to repair 
or replace diseased or damaged tissues otherwise not treatable by conventional pharmaceutical 
remedies. 
The use of adult stem cells, such as mesenchymal stromal cells (MSCs), have represented a good 
therapeutic approach to the study and the treatment of many injuries. Unfortunately, stem cells 
derived from adult tissues are considered more limited in their potential and growth as 
compared to embryonic stem cells (Paris and Stout, 2010). Moreover, the risk of the 
immunological rejection of the transplanted cells by the recipient is another important limiting 
factor. For the effective application of stem cells in regenerative medicine, a large number of 
cells should be non-invasively collected without risk for the donor and with the ability to 
cryogenically bank and expand the cells. In human medicine, placenta-derived amniotic 
mesenchymal cells (AMCs) have been reported as an alternative and novel class of stem cells 
with intermediate characteristics between embryonic and adult stem cells. Firstly, placental 
tissues are generally discarded after parturition overcoming any ethical issues. Secondly, the 
amount of the tissue is so abundant that a large number of cells can be easily collected. The 
origin of these tissues supports the possibility that they may contain cells with the plasticity 
typical of the early embryonic cells. Lastly, since placenta is involved in the maintenance of 
fetal-maternal immune tolerance during pregnancy, AMCs should have higher 
immunomodulatory capacities than adult MSCs (Arnhold et al., 2007). 
After isolation, stem cell can be administered into the organism intravenously, or directly into 
the lesioned tissue. This last route, when possible, allows to use a lower amount of cells with 
the highest concentration into the area of interest. In any case, recently, it has been 
demonstrated that the inhospitable environment of the lesion, due to the presence of 
inflammation cells and molecules, could lead to a premature cell death of the injected cells 
(Leung et al., 2006). For these reasons, researchers hypothesized that cells could not directly be 
responsible of the healing, but products released from the cells themselves could intervene in 
the regenerative process, instead. Conditioned medium (CM) is defined as the culture medium 
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enriched of soluble factors and microvesicles (MVs) released by the cultured cells. CM has been 
already demonstrated to have the same in vivo effect of the administration of the stem cells of 
origin, when injected into spontaneous equine tendon lesions (Lange-Consiglio et al., 2013a). 
For this reason, recently, the paracrine effect involving CM and MVs is subject of further studies. 
This PhD work aimed to better understand the mechanism of paracrine communication 
involving MVs derived from amniotic progenitor cells in two in vitro model studies: tendon 
lesion and endometritis in the equine species. In addition, paracrine mechanisms of 
communication between bovine embryos and amniotic and endometrial cells secretome were 
studied. 
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2. SOURCE OF STEM CELLS 
Stem cells are primitive cells with the capacity of self-renewal and the ability to give rise to 
other cell types in a process known as differentiation. Differentiation can be toward specific 
lineage progenitors, which have the capacity to grow, or toward a terminal and highly 
specialized state no longer capable to grow (Morrison et al., 1997; Lovell-Badge, 2010). Stem 
cells have been isolated from all stages of life, from preimplantation embryos to adulthood. 
Categories of stem cells have been described based on their tissue of origin (Igura et al., 2004; 
Zhang et al., 2006) 
 embryonic stem cells (ESCs) derived from in the inner cell mass (ICM) of the early 
preimplantation embryo  (Evans and Kaufman, 1981; Martin, 1981) 
 fetal stem cells isolated from fetal tissues (Guillot et al., 2006) 
 extra-fetal cells isolated from extra-fetal tissues, such as amniotic membranes (Marcus and 
Woodbury, 2008; Lange-Consiglio et al., 2012) 
 adult stem cells isolated from mature tissues such as, for example, bone marrow (Pittenger 
et al., 1999), adipose tissue (Zuk et al.,2001), periosteum (Hanada et al., 2001), brain 
(Mackay et al., 1998), muscle (Williams et al., 1999).  
 induced pluripotent stem cells (iPS) that represent a newest category, since they are stem 
cells obtained by reprogramming of adult cells into ESC-like cells. 
According to their differentiation potential, stem cells have been classified mainly into four 
categories: totipotent, pluripotent, multipotent and unipotent. The best known totipotent cell is 
the zygote that has the ability to give rise to an entire living organism. Once the blastocyst stage 
is reached, embryonic stem cells isolated from the ICM lose the totipotency of the zygote but 
are still able to differentiate into the three germ layers, so they are pluripotent. Based on their 
self-renewal and differentiation abilities, ESCs are hierarchically higher than other cell types that 
have more restricted properties, but it is important to take into account potential problems in 
clinical applications aroused by their high tumorigenic rate after transplantation (Kooreman and 
Wu, 2010) and ethical issues. Adult stem cells represent a population with more restricted 
differentiation potential respect to ESCs, because they are considered multipotent. Multipotent 
progenitors exist in a variety of tissues, including fetal, extra-fetal and adult tissues. Among 
stem cells, there are mature cells committed only for a single cell line and for this reason are 
defined unipotent (Mathur and Martin, 2004). 
The international society for cellular therapy (ISCT) has proposed the following minimum 
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criteria for the definition of the MSCs (Dominici et al., 2006): 
- adherence to plastic surfaces under standard cell culture conditions 
- expression of cell surface markers, such as cluster of differentation (CD) CD90, CD73 and 
CD105, and lack of expression of CD14, CD34, CD45, CD79, CD19 and human leukocyte 
antigen - D related, HLA-DR 
- capability to differentiate into chondrocytes, osteoblasts and adipocytes 
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3. AMNIOTIC MESENCHYMAL CELLS: THE HUMAN LESSON 
The requirement for extended self-renewal capacity becomes less important when, as in fetal 
and extra-fetal tissues, abundant multipotent cells can be obtained from the starting material 
for regenerative medicine applications. Extra-fetal tissues, such as amniotic membranes, are 
routinely discarded at parturition, so there is less ethical controversy attending the harvest of 
the resident stem cell populations. Amnion is a thin avascular membrane composed of an inner 
epithelial layer and an outer connective tissue layer. To obtain cells from term delivered amnion, 
this membrane is separated from allantois by peeling them apart. The elastin lamina in the 
loose connective tissue of the amnion facilitates the separation of the membranes. Typically, 
human amnion stromal cells, called amniotic mesenchymal cells (AMCs), are obtained after 
complete removal of the epithelial layer using trypsin followed by digestion in collagenase 
(Donofrio et al., 2005). Because human amniotic membrane differentiates from the epiblast at a 
time when it retains pluripotency, it is reasonable to speculate that AMCs may have escaped the 
specification that accompanies gastrulation and that these cells may preserve some or all of the 
characteristics of the epiblast such as pluripotency (Miki and Strom, 2006). 
Immunohistochemical and quantitative PCR analysis demonstrated that AMCs express typical 
MSC phenotypical markers (CD105, CD90 and CD73) and stem cell marker (octamer-binding 
transcription factor 4, OCT4; Nanog homebox, NANOG; stem cell factor, SCF; v-myc avian 
myelocytomatosis viral oncogene homolog, c-MYC; keratinocyte marker 19 and 8; and β1-
integrin) (Bilic et al., 2008; Yu et al., 2015; Kwon et al., 2016). These data, taken together, 
indicate that some stem cell marker-positive cells are conserved over the course of pregnancy. 
These cells possess immune suppressive activity on T-lymphocytes (Magatti et al., 2008; 
Alikarami et al., 2015), multipotent differentiation ability (Barzilay et al., 2008; Carraro et al., 
2008; Sun and Ji, 2009; Connell et al., 2013; Moussavou et al., 2013; Jiawen et al., 2014) low 
immunogenicity (Kubo et al., 2001) and anti-inflammatory activity (Toda et al., 2007). 
Several clinical trials demonstrated prolonged survival of human amniotic membrane or human 
AMCs after xenogeneic transplantation into immunocompetent animals, including rabbits (Avila 
et al., 2001) and rats (Kubo et al., 2001), suggesting active migration and integration into 
specific organs, and indicating active tolerance of the xenogeneic cells (Evangelista et al., 2008).  
Amniotic membrane has been used in ocular surface reconstruction for substrate 
transplantation to promote the development of normal corneal or conjunctival epithelium 
without acute rejection in absence of immunosuppressive treatment (Gomes et al., 2005). 
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Amniotic membrane transplantation is an effective clinical therapy for reconstruction of the 
ocular surface also in veterinary patients such as horses (Lassaline et al., 2005; Ollivier et al., 
2006; Plummer, 2009) and dogs (Arcelli et al., 2009) because it is avascular and strong, 
promotes re-epithelialization, decreases inflammation and fibrosis (Solomon et al., 2005) and 
modulates angiogenesis (Dua et al., 2004). Several growth factors, such as transforming growth 
factor, keratinocyte growth factor and hepatocyte growth factors, produced from amniotic 
membrane are involved in these processes (Koizumi et al., 2000).   
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4. PARACRINE MECHANISMS OF COMMUNICATION 
Communication between cells is required for proper development and functioning of tissues, 
either via direct interactions or via secreted factors (Tetta et al., 2013). In the past, these 
secreted factors included small soluble molecules (neurotransmitters, chemokines, cytokines 
and hormones) that could behave in a paracrine manner (short distances) or in an endocrine 
manner (long distances) (Morhayim et al., 2014). Nowadays, the molecules and vesicles 
produced and secreted from a cell are commonly defined “secretome”. This concept born from 
the hypothesis that after the administration of stem cells into the damaged area, the 
regeneration is due to secretome rather than to the presence of the cells themselves. In fact, 
some studies reported beneficial effects of stem cell therapy in degenerative diseases or lesions 
and revealed that stem cells led to tissue repair due to their ability to secrete trophic factors 
that exert beneficial impact on the damaged tissue, rather than their capacity to differentiate 
into the needed cells (Lange-Consiglio et al., 2013a; Yang et al., 2013). Various studies on stem 
cell-derived secreted factors showed that these products alone without the stem cells 
themselves might led to tissue repair in various conditions that involved tissue/organ damage. 
Secretome can be identified as the culture medium, called conditioned medium (CM) (Kim and 
Choi, 2013) where the stem cells are cultured. 
 
4.1 CONDITIONED MEDIUM 
The use of CM has several advantages compared to the use of stem cells, as it can be 
manufactured, freeze-dried, packaged and transported more easily. Moreover, as it is a cell free 
product, there is no need to match the donor and the recipient to avoid rejection problems. 
Therefore, CM have a promising prospect to be produced as pharmaceuticals for regenerative 
medicine. So far, CM has been produced from several cells type, such as mesenchymal stem 
cells (derived from adipose tissue, bone marrow), embryonic and extra-fetal stem cells and iPS. 
The process to produce CM is easy: cells need to be cultured in their typical culture medium 
added or not with supplements. Some authors add fetal bovine serum to the medium, while 
others use serum-free media. Culture medium represents a microenvironment that mimic the in 
vivo conditions and may determine cell fate and thus cell secretion (Goswami and Kaplan, 
2011). The timing for the CM production varies in culture duration from sixteen hours to five 
days (Mirabella et al., 2011; Ho et al., 2012). The production of CM can also differ from cell 
culture in normoxia (oxygen level of 20-21%) and variable oxygen deprived (hypoxia with 
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oxygen level from 0.5% to 2%) condition. Conditioned medium contains various growth factors 
and tissue regenerative agents, which are secreted by the stem cells. Each stem cell type, 
depending on its very typical nature, can secrete different factors. Some anti-inflammatory 
cytokines that have been described to be secreted by stem cells are transforming growth factor 
beta-1 (TGFβ1), interleukine (IL) 6, 10, 27, 17E, 13, while the secreted pro-inflammatory 
cytokines are IL-8, IL-9, and IL-1β (Mirabella et al., 2011). In CM, various factors may be present 
and act in concert to promote regeneration in several pathological conditions. Most of the stem 
cells secrete vascular endothelial growth factor (VEGF) that plays a role on angiogenesis that is 
important in regeneration of injured/damaged tissues/organs (Sadat et al., 2007). In addition, 
VEGF may prevent apoptosis in hypoxic condition, preventing further damage. Other growth 
factors contribute in the regeneration of injured/damaged tissue organs, with special emphasis 
on proliferation, such as platelet derived growth factor (PDGF) for connective tissue, glial and 
other cells, epidermal growth factor (EGF) for mesenchymal, glial and epithelial cells, and 
insulin-like growth factor (IGF) I and II for various kinds of cells (Litwack, 2008). Pro-
inflammatory cytokines that play a role in regeneration are IL-1β due to its liver protective role, 
IL-8 due to its angiogenic activity, and IL-9 due to wound healing promotion activity (di Santo et 
al., 2009). In addition, anti-inflammatory cytokines prevent inflammation, promote liver 
regeneration, promote tissue repair, prevent apoptosis, induce vasodilatation, reduce cellular 
oxidative stress and apoptosis and induce bone marrow stem cell proliferation (Zagoura et al., 
2012). 
The use of CM for therapy is very appealing and may be booming in the near future, as studies 
on the use of CM for various diseases are accumulating. Conditioned medium have already 
been tested in various kinds of human diseases/conditions, for example alopecia (Fukuoka et 
al., 2012), acute and chronic hind limb ischemia (Mirabella et al, 2011), acute and chronic 
wound healing (Lee et al., 2011), myocardial infarct (Yang et al., 2013), acute liver injury/failure 
(Zagoura et al., 2012), cerebral injury/ischemia/stroke (Inoue et al., 2013), spinal cord injury 
(Cantinieaux et al., 2013), and showed improvement of these conditions. A study in mice 
demonstrated that dental pulp-derived stem cell CM protects the heart from injury in response 
to ischemia/reperfusion through at least two mechanisms, improvements in myocardial cell 
viability and suppression of inflammatory cytokines (Yamaguchi et al., 2015). Another example 
is the application of implants treated with CM secreted by human deciduous teeth stem cells to 
promote bone morphogenesis during the early stages of osseo-integration, facilitating the bone 
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regeneration around dental implants (Omori et al., 2015). Concerning other stem cell source, 
CM secreted by human notochordal cells restored chondrocyte cartilage matrix production to 
healthy chondrocyte baseline levels in a model of osteoarthritic articular, significantly 
counteracts by the production of potent pro-inflammatory cytokines (Müller et al., 2016). Again, 
human bone marrow MSCs-CM has been reported to have partly protective effects against 
induced nephrotoxicity in a model of rat acute kidney injury (Abedi et al., 2016). 
In veterinary medicine, CM has only been tested in vivo in spontaneous tendon lesions in 
sportive horses with results, in term of relapses, overlapping those obtained by the use of stem 
cells of origin (Lange-Consiglio et al., 2013a,b). 
 
4.2 EXTRACELLULAR VESICLES 
A specific route of cell-to-cell communication that has gained more and more attention is the 
communication via extracellular vesicles, also called microvesicles (MVs). They have been 
studied in several biological processes and are discovered now as novel mediators of 
intercellular communication both in health system and during disease evolution (Yoon et al., 
2014). Extracellular vesicles are membrane-bound vesicles that transfer information such as 
lipids, proteins and nucleic acids from one cell to another, thereby influencing the recipient cell 
function (Raposo and Stoorvogel, 2013; Yanez-Mo et al., 2015). They form a heterogeneous 
group of small particles commonly categorized in three main classes (Hristov et al., 2004; 
Cocucci et al., 2009; Simons and Raposo, 2009; Morhayim et al., 2014; Yanez-Mo et al., 2015):  
 exosomes, formed within the endosomal network and released after the fusion of 
multivesicular bodies with the plasma membrane (10–100 nm dimension) 
 microvesicles/microparticles/ectosomes/shedding vesicles/matrix vesicles produced by 
outward budding of the plasma membrane (100–1000 nm dimension) 
 apoptotic bodies that are released when dying cells fragment (0.8–5 μm dimension)  
Unfortunately, the terminology in the literature is a bit confounding, because the term 
“microvesicles” identify either the whole vesicles group or the specific 100-1000 nm dimension 
category. For this reason, in order to simplify the comprehension of the reader, from now on, 
the term “microvesicles” will be used as synonymous of “extracellular vesicles”.  
 
4.3 ISOLATION AND CHARACTERIZATION METHODS OF MICROVESICLES 
One major challenge in the expanding field of MV research is to improve and standardize 
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methods for MV isolation and characterization. Currently, differential centrifugation is the “gold 
standard” procedure for this purpose (Thery et al., 2006). In this method, biological fluids or 
supernatants of cultured cells undergo multiple sequential centrifugations, starting from low 
speed to remove cellular debris, followed by increasing speeds to isolate smaller particles. 
Apoptotic bodies and big microvesicles are commonly pelleted at around 10.000 g, whereas 
small shedding vesicles and exosomes require high-speed centrifugation (≥100.000 g) (Thery et 
al., 2006). Microvesicles-depleted serum and/or serum-free medium incubation before MVs 
collection are essential for cell cultures to eliminate MVs and protein contaminants from bovine 
fetal calf serum (Morhayim et al., 2014). Other isolation methods for MVs, which have been 
developed to date, include ultrafiltration, sucrose density gradient, size-exclusion 
chromatography and immune-affinity capture (Taylor and Shah, 2015). The most used methods 
to characterize MVs include biochemical, fluidic and imaging analyses. Western blot and flow 
cytometry are also used to study MVs with known vesicle markers (Wubbolts et al., 2003). The 
analysis of smaller sized MVs is difficult with conventional flow cytometry as it cannot 
distinguish particles <250 nm. This led to the recent development of a high-resolution flow 
cytometry that could quantify immune-labeled MVs in the range of 100–200 nm (van der Vlist 
et al., 2012). Nanoparticle tracking analysis is another method that allows quantification and 
determination of size distribution of MVs as small as 50 nm, based on their Brownian motion in 
fluids (van der Pol et al., 2010; Zheng et al., 2013).  
 
4.4 MOLECULAR COMPOSITION OF MICROVESICLES 
Microvesicles contain a specific composition of nucleic acids, proteins, as well as lipids in a 
functionally active form. Because of the increasing interest in MV research, public online 
databases that document the molecular content of MVs are available. These include 
Vesiclepedia (www.microvesicle.org) (Kalra et al., 2012), Evpedia (www.evpedia.info) (Kim et al., 
2013) and ExoCarta (www.exocarta.org) (Simpson et al., 2012) which are based on proteomic, 
lipidomic, microarray and deep sequencing analyses of different MV populations described in 
literature. Knowledge on the molecular composition of MVs is pivotal to understand the relation 
with cellular origin, biogenesis and interactions with target cells. The role of MVs in intercellular 
communication is supported by the fact that nucleic acids are found to be enriched in MVs. In 
2006, the presence of functional ribonucleic acid (RNA) in murine stem cell derived-MVs was 
described for the first time (Ratajczak et al., 2006). Microvesicles do not only contain messenger 
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RNA (mRNA) (Baj-Krzyworzeka et al., 2006) but also micro RNA (miRNA), long noncoding RNA 
(lncRNA), piwi-interacting RNA (piRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), small 
nuclear RNA (snRNA), and small nucleolar RNA (snoRNA) (Huang et al., 2013). The presence or 
absence of genomic deoxyribonucleic acid (DNA) fragments into MVs is still debated. In addition 
to nucleic acids, MVs are also highly abundant in proteins. Most predominantly, MVs are 
enriched in cytoskeletal, cytosolic, heat shock, plasma membrane, and vesicular trafficking 
proteins (Mathivanan and Simpson, 2009; Morhayim et al., 2014). These proteins are involved 
in a broad range of function including MV biogenesis, selection of cargo, as well as binding and 
uptake by target cells (Hemler, 2003; Perez-Hernandez et al., 2013). Among MV protein, 
tetraspanins are the best described proteins and have been widely used as markers for MVs 
(Andreu and Yanez-Mo, 2014). Tetraspanins may be coupled to chaperones such as heat shock 
proteins that aid in the sorting machineries of vesicular cargo (Hegmans et al., 2004). Markers, 
such as CD9, CD63, CD81, CD82 and CD151 are shared among MV groups from various cellular 
sources, while others are restricted to particular cells. For instance, CD37 and CD53 are 
characteristic for hematopoietic cells-derived MVs (Andreu and Yanez-Mo, 2014). The bilayer 
membrane of MVs is formed by lipids, which provide structure and protect MV cargo from 
degradation before they reach their targets. MVs are generally enriched in cholesterol, 
sphingomyelin, phosphatidylserine and glycosphingolipids, compared to their parent cells 
(Record et al., 2014). Besides providing structure, MV lipids play pivotal role in vesicular 
formation, release and intercellular communication (Llorente et al., 2007; Subra et al., 2010; 
Record et al., 2014).  
 
4.5 BIOGENESIS AND UPTAKE MECHANISMS OF MICROVESICLES 
At least three distinct mechanisms of MV biogenesis are known: 1) exocytosis, 2) direct budding 
from the plasma membrane and 3) fragmentation of dying cells, each leading to the release of 
the three different MV groups described above. Exosomes, which are the smallest-sized MV 
class, are released from exocytosis of multivesicular bodies (de Gassart et al., 2004). However, 
the process by which these bodies fuse with plasma membrane and release of exosomes in the 
extracellular environment is still unknown. It has been proposed that cytoskeleton and tumor 
protein p53 (p53) play an important role in these processes, as well as guanosine triphosphate 
(GTP) hydrolase enzymes (GTPases) (Yu et al., 2006; Simpson et al., 2009). On the other hand, 
shedding vesicles direct bud from the plasma membrane. Apoptotic bodies are formed from 
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cellular degradation of dying cells and are immediately phagocytosed in order to prevent their 
contents spilling out and cause damage to the surrounding cells. However, they can also escape 
phagocytosis and target specific cells, but the function of apoptotic body targeting is still under 
investigation (Bergsmedh et al., 2001). MV uptake by recipient cells generally depends on the 
type of target cells. In most cases, MV internalization appears to occur via endocytosis including 
phagocytosis, micropinocytosis, clathrin-dependent, caveolin-dependent, and lipid raft-
mediated endocytosis (Mulcahy et al., 2014). Besides endocytosis, MVs uptake can also occur 
via membrane fusion. However, direct fusion of MVs with the plasma membrane may be limited 
to acidic environments, such as those found in tumor microenvironments, because at neutral 
pH, the rigidity of the membraneprevents fusion (Parolini et al., 2009).  
 
4.6 MICROVESICLES IN REGENERATIVE MEDICINE 
Recent findings indicate a pro-regenerative role for MVs released by MSCs in several models of 
tissue regeneration, including regeneration of kidney, heart, liver and nervous tissues. 
Kidney regeneration mediated by MVs produced by human bone marrow-derived stem cells has 
been studied in an acute kidney inflammation (AKI) models induced by cisplatin. The injury of 
cultured renal tubular epithelial cells is mitigated after the addition of MVs, increasing the 
amount of proliferation, while decreasing the number of apoptotic cells (Camussi et al., 2010). 
In addition, microarray analysis of the MV mRNA detected 239 species of mRNA molecules, with 
specific enrichment of mRNAs involved in cell proliferation, transcription and immune 
regulation, providing another example of selective uptake of RNA species into MVs. These 
processes appear to be mediated, at least in part, by the transfer of RNA by MSC-MVs, as 
indicated by the loss of regenerative effects after RNase treatment of the MVs. In addition to 
mRNAs, the transfer of miRNAs by MVs is important in the context of kidney regeneration. In a 
rat model of AKI, intravenously injected endothelial progenitor cells-MVs localize mainly in the 
peritubular capillaries and renal tubular cells, and subsequently promote tissue repair and 
reduce functional impairment (Cantaluppi et al., 2012). Their protective effects can be inhibited 
by the knockdown of Dicer, essential for the processing of miRNA. These data indicate an 
important and potential role of MVs transferred miRNA in stimulating tissue regeneration. 
Concerning the heart tissue, the intravenous injection of MVs in a mouse model reduces the 
infarct size caused by ischemia and reperfusion and improves left ventricular function drastically 
observed as early as 4 hours after reperfusion (Lai et al., 2010).  
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For the hepatic tissue, an example is represented by the ability of MVs to reduce tetrachloride-
induced liver fibrosis, by inhibiting the epithelial-to-mesenchymal transition of hepatocytes and 
the collagen production (Li et al., 2013). In another study, human liver stem cells have been 
used as a MV source to stimulate liver regeneration after physical and chemical injury in a rat 
model. These stem cells produce MVs that protect cultured hepatocytes from D-galactosamine-
induced apoptosis. In parallel with the in vitro data, administration of these MVs to 
hepatectomized rats contributed significantly to structural and functional hepatic recovery. 
Specifically, the amounts of the hepatic enzymes aspartate aminotransferase and alanine 
aminotransferase in the serum diminished, and the production of albumin increased (Herrera et 
al., 2010). 
A role for MVs has also been proposed in an ischemic model of neural regeneration. Treatment 
of healthy primary rat cortical neurons with MVs derived from the brain extract-treated MSCs 
increases the total number of neurites and the neurite length. The changes in neurite number 
and length seem to result from the targeting and inhibition, by specific transported miRNAs, of 
ras homolog family member A (Rho-A), a small GTPase, suppressor of neurite growth (Xin et al., 
2012). 
Many other studies have been already performed on the ability of MVs to carry information 
between cells, with the result to ameliorate a pathological situation. Eventually, some studies 
demonstrated that MVs from different cell source have immunological activity, since they are 
able to differentially modulate T, B and natural killer (NK) cell functions (Di Trapani et al., 2016). 
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5. MICROVESICLES AND NON CODING RNAs: miRNAs AND piRNAs 
Micro RNA (miRNA) sequences are distributed all throughout the genome, being localized in 
exonic or intronic regions, as well as intergenic locations. The biogenesis of miRNAs starts with 
their transcription by RNA polymerase II, although some other miRNAs are transcribed by RNA 
polymerase III, resulting in a primary transcript known as primordial mi-RNA (pri-miRNA) which 
contains a 33 base pair (bp) hairpin stem, a terminal loop and a flanking single stranded 
sequence of hundreds of bases. In general, pri-miRNAs are capped at the 5’ end and 
polyadenylated at the 3’ end. After transcription, a specific RNase III, called Drosha, processes 
the pri-miRNA by cleaving. Drosha digestion can occur co-transcriptionally or before splicing, 
and the product of this digestion is an intermediary RNA molecule known as precursor miRNA 
(pre-miRNA). Following pre-miRNA generation, Exportin-5, a double strand RNA (dsRNA) 
binding protein, transports the pre-miRNAs to the cytoplasm in a GTP dependent process. Once 
in the cytoplasm, Dicer, another RNase III, digests the pre-miRNA into a 22 bp mature duplex 
miRNA (miRNA:miRNA*, where miRNA* is called passenger strand). Dicer is an essential 
protein of miRNA maturation and its down-regulation decreases the mature miRNA levels. 
After generation of the miRNA duplex, the strands are unwound: one strand (the miRNA-guide 
strand) is loaded onto the RNA-induced silencing complex (RISC), formed by Dicer and its 
cofactors. The resultant complex between mature miRNA and RISC is denominated miRISC. The 
remaining passenger strand is excluded and generally degraded. Finally, miRISC acts as a guide 
to recognize the mRNA targets, based on complementarity rules, to negatively regulate mRNAs. 
There are at least three possible mechanisms by which miRNA mediate repression of gene 
expression: 1) mRNA target hybridization and degradation, 2) inhibition during the mRNA 
initiation or elongation phases and 3) mRNA decay by its recruitment to P bodies (Romero-
Cordoba et al., 2014). As a result, mRNA molecule target is set to silent. 
Recently, noncoding RNAs able to associate with P-element Induced WImpy testis (Piwi) 
proteins have been discovered and named piRNAs (Piwi-interacting RNAs). First identified in 
germ cells and more recently in somatic cells, piRNAs differ greatly from miRNA and small-
interfering RNA in their structure and origin. piRNAs are considerably longer than mature 
miRNA and are derived from single stranded precursors that originate largely from repetitive 
sequences in the genome. piRNAs are believed to act as sequence-specific guides for Piwi 
protein complexes to mediate what seems to be their primary function: transcriptional gene 
silencing of retrotransposons and other genetic elements. Extensive analyses of piRNAs 
28 
 
associated with Piwi proteins have identified the genomic origins of piRNAs and led to the 
proposal of two biogenesis pathways: the primary processing pathway and the ping-pong 
amplification loop. Both mechanisms are important for mounting an effective defense against 
transposable elements. First, the primary piRNA biogenesis pathway results in production of 
primary piRNA. Next, the ping-pong cycle further shapes the piRNA population by using the 
initial pool of piRNAs, which associate with specific Piwi proteins, to target and cleave multiple 
transposable elements transcripts thereby further amplifying production of piRNAs (Bamezai et 
al., 2012). 
Recently, researchers demonstrated that MVs can be carrier of small non coding RNAs, and that 
these MVs can ameliorate situation in different pathology models, such as myocardium 
ischemia (Wang et al., 2015), or atherosclerotic lesion (Hergenreider et al., 2011). These finding 
support the hypothesis that MVs carry information into the target cells, which can capture the 
miRNA content in order to reduce the stress induced by the pathological environment. 
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6. MODELS FOR THE STUDY OF PARACRINE COMMUNICATION 
While the predominant interest in this field is normally focused on human application, stem 
cells can benefit high value animal species. Investigations in these species also provide 
opportunities for preclinical optimization of therapeutic strategies in humans.  
 
6.1 IMPORTANT PATHOLOGIES IN EQUINE SPECIES: ENDOMETRITIS AND TENDON LESIONS 
Endometritis is an important cause of reduced fertility in large animals, also in mares in which 
artificial insemination by fresh or frozen semen may induce acute endometrial inflammatory 
reactions. If these conditions are not promptly resolved, infections become chronic mainly in 
old mares that, if pregnant, show a pregnancy loss rate higher than expected (Hurtgen, 2006). 
The regular uterine environment promotes normal embryo development but clinical or 
subclinical disorders could contribute to pregnancy failure. Cytological endometritis emerged as 
a problem of remarkable importance for equine reproduction because animals suffering of this 
disorder present a persistent inflammatory uterine environment leading to reduced conception 
rate and increased foaling-to-conception intervals. Equine endometritis is characterized by the 
expression of pro-inflammatory cytokines and an influx of polymorphnuclear neutrophils 
(PMNs) into the uterus. Mares resistant to persistent endometritis clear the inflammation 
within hours after exposure to microorganisms or semen. In contrast, mares that are 
susceptible to persistent endometritis fail to clear the inflammation in a timely fashion. They 
have an imbalanced of pro- and anti- inflammatory cytokine and, consequently, these mares 
establish a chronic inflammation, which interferes with the establishment of pregnancy 
(Troedsson and Woodward, 2016). Many treatments have been proposed to treat or prevent 
endometritis. In mares, post-mating endometritis is treated with uterine irrigation and ecbolics, 
and acute endometritis with systemic or intrauterine antibiotics but these therapies are not 
always effective for resolving chronic uterine inflammation. The prevention include nutritional 
supplements and hygienic conditions during parturition. Commonly, therapies in use include 
hormonal treatments with GnRH, exogenous gonadotrophins and prostaglandins (Perez-Marin 
et al., 2011). However, in view of the enhancement of embryo-maternal interactions, a different 
approach to restore or ameliorate uterine receptivity in case of infertility due to endometrial 
damages could be represented by regenerative medicine. One example of new treatment for 
equine endometritis is represented by the use of platelet-rich plasma (PRP). The latter has an 
effect in modulating the exacerbated uterine inflammatory response to semen in mares with 
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chronic degenerative endometritis (Reghini et al., 2016) and also in vitro study on endometrial 
cells stressed by lipopolysaccharide (LPS) confirmed the effect of PRP (Marini et al., 2016). The 
following and more innovative step is the use of stem cells. Researchers already demonstrated 
that the endometrial hysteroscopy injection of autologous bone marrow-MSCs in mares is a safe 
procedure (Alvarenga et al., 2016). 
In addition to endometritis, also the tendon lesion is an important disease in equine species. In 
this large animal, injuries affecting tendons are the most common causes of lost training days or 
premature retirement in the equine athlete. Standard treatments are not effective and the 
tendon healing is a prolonged process, with a high risk of re-injury during athletic performance.  
Tendons and ligaments heal slowly after injury and rarely regain their original strength and 
elastic qualities. Suboptimal healing, prolonged rehabilitation time and a high incidence of 
recurrence make degenerative injuries difficult to treat successfully. The prognosis for patients 
with tendon or joint injuries is often poor (Lange-Consiglio et al., 2013b). Despite a short 
inflammatory phase after the injury incident, the healing process is dominated by fibroplasia 
and can be referred to repair rather than regeneration, with the formation of hyper-cellular scar 
tissue with poor extracellular matrix organization, in which stiffness is increased but elasticity is 
decreased compared with the original tendon tissue (Richardson et al., 2007). Standard 
treatment for orthopaedic injuries are not effective, and tendons require a long healing time, 
with high risk of re-injury during athletic performances. For this reason, a regenerative medicine 
could bring to a regeneration of the original tissue, restoring the functionality of the system. 
Researchers demonstrated that PRP treatment in some cases leads to the formation of tendon 
with normal morphology and functionality, which translate in the resumption of the agonistic 
activity (Scala et al., 2015). 
 
6.2. BOVINE IN VITRO EMBRYO PRODUCTION 
It is known that, usually, in vitro produced (IVP) embryos are of a poorer quality when 
compared with in vivo ones (Wrenzycki and Stinshoff, 2013). Fertilization of eutherian animals 
occurs in the maternal oviduct, which is the natural and unique environment to achieve the 
necessary requirements for embryo life in its early and late development. The in vitro conceived 
embryo is manipulated and cultured in very different conditions and today a huge amount of 
information point out the alterations that can occur in IVP embryos because of the 
manipulation and artificial environmental conditions associated with these techniques (Lucas, 
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2013). Some researchers reported that the culture system and the medium composition can 
affect the embryo quality (Abe et al., 2002; Rizos et al., 2002) and that the in vitro culture (IVC) 
of embryo is probably the most relevant factor in the alterations of epigenetic reprogramming 
and development of IVP embryos. In fact, while the innate feature of the oocyte is the major 
factor determining the blastocyst yield, it is evident that post-fertilization culture environment is 
critical in defining the quality of the blastocyst (Costa Pereira et al., 2005; Lonergan et al., 2006). 
This underline the key effect of the maternal microenvironment on the success of early 
embryonic development in terms of viability (Schmaltz-Panneauet al., 2015). In mammals, 
during the pre-implantation stage, the exchange of different types of signals between the 
mother and the embryo is thought to be critical for embryo development and implantation 
(Fazeli, 2008). In cattle, it has been considered that the absence of communication between a 
receptive endometrium and a viable embryo could be an important cause of the low efficiency 
of pregnancies (Thatcher et al., 2001). These considerations led to the hypothesis that paracrine 
communication between the mother and the embryo/fetus must exists. 
 
6.2.1. BOVINE MATERNAL-FETAL COMMUNICATION 
A myriad of locally produced factors into the microenvironment of the reproductive tract is 
regulated not one-way but, rather, through embryonic–maternal cross talk. Both embryonic and 
maternal counterpart have been described to secrete MVs involved in paracrine 
communication.  
Microvesicles can be secreted from maternal side and bioinformatics of endometrium-derived 
MVs miRNAs revealed that these miRNAs have potential targets in biological pathways highly 
relevant for embryo implantation (Ng et al., 2013). On the other hand, it has been revealed that 
IVP embryos release MVs whose amount increase with developmental stage and whose size 
correlates with embryo quality (Gardiner et al., 2013). These considerations led the hypothesis 
that a successful implantation is dependent on coordination between the embryo and the 
endometrium, and MVs may participate in this required cross-talk. Endometrial epithelium 
release MVs involved in the transfer of signaling miRNAs and of adhesion molecules to the 
blastocyst that in turn can affect endometrial receptivity and implantation. Analysis of these 
vesicles revealed miRNAs and proteins expressed both by the conceptus trophectoderm and by 
the endometrial epithelium. In human studies, MVs have been isolated from uterine fluid from 
women in different phases of the menstrual cycle. Both the luminal and glandular apical 
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surfaces of endometrial epithelial cells express CD9 and CD63 exosomal markers, thereby 
showing that the endometrial epithelium is a possible source of the exosomes found in the 
uterine cavity (Ng et al., 2013). The identification of MVs in the uterine fluid suggests a possible 
role of MVs in transferring information from the endometrium during implantation. 
 
6.2.2. CO-CULTURE SYSTEMS IN BOVINE EMBRYO PRODUCTION 
To mimic the in vivo cross-talk environment, co-culture systems are largely used in IVP embryos 
in different species and, in some mammalian species, somatic cell co-cultures improved the 
development of IVP embryos (Li et al., 2001). Indeed, co-culture system with bovine oviduct 
epithelial cells, used for the development of bovine zygotes, enhanced blastocyst formation and 
quality of the resulting embryos, inducing also specific transcriptomic changes (Schmaltz-
Panneau et al., 2015). This suggests that paracrine mechanisms of communication exist 
between “helper” cells and embryos. In fact, various growth factors, receptors and binding 
proteins are secreted by cells in the medium, but the embryos themselves produce them too. 
Conditioned media were already developed and used in bovine embryo IVP. Some of these cell-
free media, produced, for example, by culturing granulosa, cumulus or oviduct cells, 
demonstrated a similar effect in development of embryos produced by co-culture systems 
(Rieger et al., 1995). In addition to the reputation of CM, as already said in this thesis, the 
existence of MVs inside CM could be assumed as key factor for the beneficial effect of the use of 
cell-free media. 
 
6.2.3 EMBRYONIC BI-DIRECTIONAL COMMUNICATION: AMNIOTIC MESENCHYMAL CELLS 
AND ENDOMETRIAL CELLS 
Placenta is a transient organ that mediates not only hormonal, nutritional and oxygen support 
to the fetus but also actively secretes signal substances and immune regulatory factors that 
modulate maternal immune response during pregnancy. For the first time, Sabapatha et al.  
(2006) described circulating placental exosomes and studied their role in the down regulation 
of T-cell responses of pregnant women. Successful implantation is dependent on coordination 
between the embryo and the endometrium, so it has been suggested that the endometrial 
epithelium releases MVs that are involved in the transfer of signaling miRNAs and adhesion 
molecules to the blastocyst, which in turn can affect endometrial receptivity and implantation 
(Burns et al., 2014). Further experiments have shown that these MVs can pass through the zona 
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pellucida and can be internalized by blastomeres (Saadeldin et al., 2014). In vitro studies have 
shown that MVs isolated from the uterine fluid of pregnant sheep can transfer RNAs to other 
cells. These findings indicate that these MVs likely have a biological role in the interaction 
between the embryo and the endometrium (Burns et al., 2014). A fundamental study described 
that syncytiotrophoblast secretes miRNAs in the maternal circulation by exosomes (Chim et al., 
2008) supporting the opposite direction of communication, from embryos to maternal 
environment, by microvesicles. 
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7. SUMMARY OF THE PROJECT 
During my PhD project, studies were carried out to understand the already known ability of 
MSCs to ameliorate pathological situation in animal models in in vitro studies. Results of these 
studies produced during the 3-year project are described in some publications that are attached 
in the following chapter. 
The first paper, entitled “Amniotic membrane-derived mesenchymal cells and their conditioned 
media: potential candidates for uterine regenerative therapy in the horse” by Corradetti et al. 
(2014) was aimed to investigate if AMCs and their CM could be a potential tool for the 
regeneration of damaged uteri in a vitro model. The paracrine action of the AMCs was 
investigated comparing the potential of AMCs in toto and AMC-conditioned medium (AMC-CM) 
in an in vitro model using endometrial cells (EDCs) as target. The experiment was designed to 
study the endometrial regeneration, analyzing EDC proliferation by co-culturing them with 
AMCs in a trans-well system or in presence of AMC-CM. In both conditions, there was a 
significant increase in EDC proliferation rate, defining the crucial role of soluble factors as 
mediators of stem cells action. These preliminary findings revealed that AMCs, via their derived 
CM, have the potential to improve endometrial cell replenishment. It is possible to speculate 
that the beneficial effects in tissue regeneration is due to the release of soluble factors 
indicating CM as a novel therapeutic cell-free product for regenerative medicine applications 
(Corradetti et al., 2014).  
 
The second study, published in the paper entitled “Microvesicles secreted from equine 
amniotic-derived cells and their potential role in reducing inflammation in endometrial cells in 
an in vitro model” by Perrini et al. (2016), aimed to study MVs as anti-inflammatory tool in an in 
vitro model of equine endometritis. The production of CM and MVs from cultures of equine 
AMCs was optimized. Conditioned media were produced by culturing AMCs in a serum-free 
medium for 5 days, collecting the culture medium and centrifuging it to remove cell debris. 
From the CM, it was possible to obtain MVs through an ultracentrifugation at 100.000 g for 1 
hour. The supernatant (SN) obtained after this step can be considered as the ensemble of 
soluble factors of the CM deprived of MVs. Microvesicle production from equine AMCs was 
2550±71 particles/cell. Next step was the characterization of AMC-derived MVs by Nanosight 
Instrument: the size of MVs ranged from 50 nm to 670 nm, with a mean size of 258±55 nm for 
three samples. The transmission electron microscopy (TEM) revealed the presence of variably-
35 
 
sized extra-cellular membranous roughly spherical vesicles, budding from or lying near AMCs, 
characterized by an electron-lucent or moderately electron-dense content. The size of MVs 
varied from about 100 nm to 1000 nm, with a predominance of vesicles between 100 and 200 
nm. Because of the size and morphological characteristics, the vesicles observed were 
considered mainly shedding vesicles, rather than exosomes.  
Then, some experiments of incorporation and action of MVs into LPS challenged-target cells, 
represented by EDCs, as model of equine endometrial injury, were performed. In order to 
obtain the optimal concentration of MVs for their application in the following experiments, a 
dose/response curve at different concentrations of MVs and different exposure times was 
studied. Endometrial cell internalization and accumulation of MVs peaked at 72 h at a 
concentration of 50x106 MVs. At this point, the effect of LPS and MVs on EDCs was evaluated by 
viability cell tests (apoptotic and prolificacy tests), by expression of some pro-inflammatory 
genes, studied by quantitative reverse transcription polimerase chain reaction (RT-qPCR), and 
by release of respective cytokines.  
Considering that the MV uptake by EDCs was visible by fluorescence signal only after 6 hours, 
MVs were used simultaneously to LPS or three hours after the treatments by LPS or 24 hours 
before the LPS. The rate of apoptosis increased dramatically in cells treated with LPS if 
compared to the EDCs CTR. The results of prolificacy test had the opposite trend. MVs were able 
to counteract the action of LPS either when used simultaneously to LPS or when incorporated 
by endometrial cells 24 h before the treatment with LPS, because cells pre-treated with MVs or 
treated with MVs and LPS together had an apoptotic rate lower than the EDCs CTR. LPS 
upregulated significantly the expression of TNF-α, IL-6 and IL-1β. In the condition where LPS and 
MVs were used simultaneously, the action of LPS was counteracted by MVs, indeed, the 
expression of IL-6 and IL-1β fell significantly. The expression of TNF-α was independent by 
presence of MVs. Coherent results were obtained through the analysis of pro-inflammatory 
(TNF-β and IL-6) and anti-inflammatory (TGF-α) cytokines released by EDCs in the culture 
medium, confirming the ability of MVs to transport molecules capable to counteract the 
inflammatory response of cell stressed with LPS.  
Since MVs contain various active molecules, such as lipids, proteins, mRNA, and miRNA, we 
studied the presence of three miRNAs in MVs involved in the regulation of pro-inflammatory 
genes (miR-335, miR-146a, and miR-26a-2) that have been demonstrated to regulate the 
expression of some pro-inflammatory genes in human and bovine species. We found the 
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presence of these three miRNAs in both AMCs and their MVs, so the downregulation of gene 
expression shown in this study could be correlated to miRNA transfer from MVs to EDCs (Perrini 
et al., 2016). 
 
After these results, a similar experimental design was performed to study the ability of MVs to 
counteract an in vitro inflammation, leading to the third publication entitled “Equine amniotic 
microvesicles and their anti-inflammatory potential in a tenocyte model in vitro” by Lange-
Consiglio et al. (2016). Also for tendon cells (TNCs), in order to obtain the optimal concentration 
of MVs for their application in the following experiments, a dose/response curve at different 
concentrations of MVs and different exposure times was studied. For TNCs, internalization and 
accumulation of MVs suddenly increased at 24-72 h at a concentration of 50x106 MVs/ml.  At 
this point, knowing the optimal dose of MVs, their ability to counteract an in vitro inflammation 
was studied in TNCs challenged with LPS. After exposure to LPS, a moderate but significant 
increased gene expression of metalloproteinase (MMP) 1 and 9 was observed if compared to 
TNCs CTR. Expression of MMP-13 and tumor necrosis factor α (TNF-α) were noticed significantly 
higher after LPS exposure if compared to TNCs CTR. The presence of MVs had a significant effect 
on gene expression, with a striking reduction in the expression levels for MMP-1, MMP-9, MMP-
13, and TNF-α, when compared to TNCs CTR.  
Moreover, in this study, the ability of MVs to inhibit peripheral blood mononuclear cell (PBMC) 
proliferation when stimulated with phytohemagglutinin (PHA) was evaluated, but MVs, also 
after lysis by sonication to release their content, were not able to inhibit PBMC proliferation.  
These results led to conclude that MVs brought to the target cells some molecules able to 
counteract the inflammatory situation due to the LPS but, taking into account the lack of their 
immunomodulatory action, probably, for an in vivo tendon lesions healing, soluble factor of CM 
are necessary too (Lange-Consiglio et al., 2016). 
 
Since paracrine communication seems to be regulated by cell secretome represented by CM, SN 
and MVs, we thought it could be interesting to study these mechanisms during in vitro embryo 
production, considering that usually the in vitro production rate is lower than in vivo one. The 
results of this study are collected in the fourth paper entitled “Secretome derived from different 
cell lines in bovine in vitro embryo production” by Perrini et al. that has been submitted to Plos 
One (November 2016). Different components of secretome from bovine AMCs and EDCs were 
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supplemented to the embryo culture media at different days of culture. Endometrium and 
amnion were studied because they have a role in the establishment of pregnancy. Endometrial 
cells were evaluated at the early luteal phase, which correspond to the period when these cells, 
in vivo, interact with early stage embryos. Amnion was chosen because Lange-Consiglio et al. 
(2010) used a monolayer of equine amniotic epithelial cells as feeder to culture bovine embryos 
with good results in term of blastocyst rate, compared to the bone marrow derived cells and 
cumulus cells. These authors suggested that EGF, produced by monolayer of amniotic epithelial 
cells, could have been one of most representative candidate to play a positive role in the 
embryonic development as it happens in vivo for the endometrium. Indeed, EGF is produced in 
vivo by endometrial cells and the embryo possesses receptors for it. In this context, in our study, 
the amniotic cells were further investigated and compared to endometrial cells through the 
effect of their secretome. The results demonstrated that the day 5 of culture is the best time 
point for the supplementation of these components and that AMCs-MVs provided the best 
environment for the embryo concerning the blastocyst quality, rather than blastocyst rate, since 
the number of alive blastomeres and the ICM/trophoblast ratio were higher than in the CTR 
condition. These data were confirmed by the evaluation of genes involved in apoptosis and 
reactive oxygen species protection. Probably, AMC-MVs bring information that led to the 
production of embryos with better qualities respect to the standard embryo production.  
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Abstract
Amniotic membrane-derived mesenchymal cells (AMCs) are considered suitable candidates for a variety of cell-based
applications. In view of cell therapy application in uterine pathologies, we studied AMCs in comparison to cells isolated from
the endometrium of mares at diestrus (EDCs) being the endometrium during diestrus and early pregnancy similar from a
hormonal standpoint. In particular, we demonstrated that amnion tissue fragments (AM) shares the same transcriptional
profile with endometrial tissue fragments (ED), expressing genes involved in early pregnancy (AbdB-like Hoxa genes), pre-
implantantion conceptus development (Era, PR, PGRMC1 and mPR) and their regulators (Wnt7a, Wnt4a). Soon after the
isolation, only AMCs express Wnt4a and Wnt7a. Interestingly, the expression levels of prostaglandin-endoperoxide synthase
2 (PTGS2) were found greater in AM and AMCs than their endometrial counterparts thus confirming the role of AMCs as
mediators of inflammation. The expression of nuclear progesterone receptor (PR), membrane-bound intracellular
progesterone receptor component 1 (PGRMC1) and membrane-bound intracellular progesterone receptor (mPR), known
to lead to improved endometrial receptivity, was maintained in AMCs over 5 passages in vitro when the media was
supplemented with progesterone. To further explore the potential of AMCs in endometrial regeneration, their capacity to
support resident cell proliferation was assessed by co-culturing them with EDCs in a transwell system or culturing in the
presence of AMC-conditioned medium (AMC-CM). A significant increase in EDC proliferation rate exhibited the crucial role
of soluble factors as mediators of stem cells action. The present investigation revealed that AMCs, as well as their derived
conditioned media, have the potential to improve endometrial cell replenishment when low proliferation is associated to
pregnancy failure. These findings make AMCs suitable candidates for the treatment of endometrosis in mares.
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Introduction
Embryo-maternal communication is a pre-requisite for success-
ful implantation that facilitates the establishment, recognition, and
maintenance of pregnancy. Studies of early pregnancy in different
mammalian species have shown that the majority of embryo losses
occurs during the pre-implantation phase: in the horse, this phase
is very critical [1,2]. During this period, the conceptus (the embryo
and the associated extra-embryonic membranes) interacts with the
uterine environment via paracrine signaling to coordinate
attachment and implantation. Disruption of the integrity of the
endometrial tissue and of the capacity to support its functions are
the responsible factors in determining a subfertile phenotype [3].
As such, the development of chronic endometritis followed by
degenerative and abnormal changes of the endometrium, like
fibrosis (scarring) around the glands, might inhibit the regeneration
of traumatized endometrium. The damage then leads to an
impairment of the progenitor cell ratio that reduces the
endometrial tissue’s ability to regenerate and thus future foaling
rates as well. This mainly results in the inability of the tissue to
support embryo implantation.
Given the potential role of these cells have in remodeling the
endometrium, it may be reasonable to suggest cell therapies based
on mesenchymal stem cells (MSCs) as suitable strategies to restore
and maintain normal function in damaged reproductive tissues.
With this in mind, we recently retrieved MSCs from extra-fetal
tissues in the equine species [4]. For the first time, we compared
the proliferative and differentiative potential of amniotic mem-
brane-derived MSCs (AMCs) with bone marrow derived MSCs
(BM-MSCs). together with their possible application in the
treatment of horse tendon injuries [5,6]. We next demonstrated
the potential immunomodulatory properties of AMCs and their
conditioned medium (AMC-CM) in vitro, and proved the efficacy
of AMC-CM in the treatment of spontaneous horse tendon and
ligament injuries in vivo [7]. Data obtained in this study
demonstrated the crucial role of soluble factors in inhibiting
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peripheral blood mononucleated cell proliferation in vitro and in
improving healing in vivo. Taken together, the AMCs features
described so far by our group suggest this cell type as the most
suitable for regenerative medicine approaches [5] and its derived
conditioned media (CM) as a novel, cell-free therapeutic product
in regenerative medicine.
For these reasons, the aim of the present study was to better
understand the nature of AMCs, so that we may exploit their
potential role in uterine replacement therapy. AMCs were further
characterized for the expression of early pregnancy-associated
genes in view of their potential application in endometrial
regeneration or in stimulating the proper preparation of the
endometrium for embryo implantation.
The AbdB-like Hoxa gene (Hoxa9) and the wingless type genes
(Wnt7a, Wnt4a), which influence pre-implantantion conceptus
development, the classical oestrogen (ERa and ERb) and
progesterone (PR) receptors, and the more recently characterized
membrane-bound intracellular progesterone receptors (PGRMC1
and mPR), were evaluated on amniotic membrane fragment (AM)
or AMCs (at different passages) in comparison to endometrial
tissue fragments (ED) or isolated endometrial cells (EDCs) at
diestrus. We also looked at the expression of other genes, including
the cyclooxygenase prostaglandin E2 synthase (PTGS2), forkhead
box 01 (FOXO1), serum/glucocorticoid regulated kinase 1
(SGK1), and tumor protein p53 inducible protein3 (TP53) whose
transcriptional activity has been associated with luteo-protective
action [8], protection of the feto-maternal unit against oxidative
damage [9], improved reproductive outcome [10], and epithelial
ion transport and cell survival responses [11] during early
pregnancy, respectively. Since the endometrial stromal and
epithelial cells proliferation and differentiation through the period
of embryo preimplantation are controlled by ovarian steroid
hormones (progesterone and estrogen) [12,13], we aimed to
recreate the endometrial environment, thus culturing AMCs for
different passages in the presence of progesterone.
We further hypothesized that AMCs might induce tissue-
resident endometrial cells to proliferate or, alternatively, to
modulate the local immune response and promote endometrial
regeneration. MSCs, in general, are believed to play their role as
mediators of tissue repair through the release of paracrine factors
[14]. To test this hypothesis EDCs were cultured either with
AMCs in a transwell system or with their conditioned media, in
order to evaluate the capability of AMCs to increase the
proliferative potential of endometrial cells.
Materials and Methods
Materials
Samples were collected from horses slaughtered in a national
slaughterhouse (Titbit Srl, Bagnolo in Piano, Reggio Emilia, Italy)
with legal regulations.
Chemicals were obtained from Sigma-Aldrich Chemical (Milan,
Italy) unless otherwise specified, and tissue culture plastic dishes
were purchased from Euroclone (Milan, Italy).
Tissue collection and isolation
Three amniotic membranes were obtained at term of normal
pregnancies after vaginal delivery from three mares. Clean
collected portions of allanto-amnion were kept at 4uC in PBS
with 100 U/ml penicillin, 100 mg/ml streptomycin and 4 mg/ml
amphotericin B and were processed within 8 h. The amniotic
membrane was stripped from the overlying allantois and cut into
small pieces (about 9 cm2 each) before starting the enzymatic
digestion. Endometrial tissues were collected from 3 different
horses aged between 8 and 10 years, after euthanasia unrelated to
our experiments. Endometrial samples were obtained during the
reproductive season from normal-cycling mares at diestrus (early-
mid luteal phase). Before euthanasia, 5 ml of blood were collected
in heparinized tubes from all mares. After centrifugation, plasma
was separated, kept refrigerated and immediately transported to
the laboratory for progesterone determination by a quantitative
Enzyme Linked Fluorescent Assay (ELFA) based on the MiniVidas
(Biomerieux, Firenze, Italy) technology. According to the manu-
facturer, the measurement range of the assay varied from 0.25 to
80 ng/ml with an intra-assay variability of 4.12% and an inter-
assay variability of 6.32%.
Only uteri belonging to mares with an obvious corpus luteum
on the ovary and progesterone levels between 6 to 20 ng/ml,
indicative of the early/mid diestral phase of the estrous cycle [15],
were used for endometrial fragment collection and ensuing cell
culture.
Tissue fragments for RNA isolation were immediately immersed
in RNA Later solution, whereas those destined for cell isolation
and expansion procedure were kept at 4uC in saline solution
supplemented with 4 mg/ml amphotericin B, 100 IU/ml penicillin
and 100 mg/ml streptomycin and were processed within 8 h.
Cell isolation
Amniotic membrane-derived mesenchymal cells were isolated
as previously reported [4]. Briefly, amnion fragments were
incubated for 9 min at 38.5uC in PBS containing 2.4 U/mL
dispase (Becton Dickinson, Milan, Italy). After a resting period (5–
10 min) at room temperature in high-glucose Dulbecco’s modified
Eagle’s medium (HG-DMEM; EuroClone, Milan, Italy), supple-
mented with 10% heat inactivated fetal bovine serum (FBS) and
2 mM L-glutamine, the fragments were digested with 0.93 mg/
mL collagenase type I and 20 mg/mL DNAse (Roche, Mann-
heim, Germany) for approximately 3 h at 37uC. The amnion
fragments were then removed, and mobilized cells were passed
through a 100 mm cell strainer before being collected by
centrifugation at 2006g for 10 min.
Endometrial cells from diestrus mare’s uteri were obtained
according to the protocol described by Donofrio et al. [16] and
slightly modified for equine cells. Briefly, the endometrium was
digested in sterile filtered Hank’s buffered salt solution supple-
mented with 2 mg/ml collagenase II, 4 mg/ml bovine serum
albumine, and 0.4 mg/ml DNase I for 90 minutes at 38.5uC in a
shaking bath. Cells were then filtered through a membrane with a
pore size of 80 mm, centrifuged at 2006g for 10 minutes, and then
washed twice in PBS. This protocol allowed for the isolation of the
endometrial stromal portion.
Fibroblasts (used as a control for AMCs) were isolated from skin
specimens collected from three horses after euthanasia unrelated
to our experiments. Samples (2 mm3) were taken by excision and
fragments of approximately 1 mm were incubated with 40 mg/ml
collagenase IV for 3 h at 38.5uC. After digestion, cells were
washed and allowed to grow to confluence in 60-mm culture
dishes.
Before seeding, the primary cultures (P0) obtained from the
amnion, endometrium and skin were counted using a Burker
chamber with the trypan blue dye exclusion assay.
Cell expansion
Endometrial and fibroblast cells cultures were established in
HG-DMEM supplemented with 10% FBS, penicillin (100 UI/
ml)-streptomycin (100 mg/ml), 0.25 mg/ml amphotericin B and
2 mM L-glutamine. Medium was supplemented with 10 ng/ml
epidermal growth factor (EGF) for AMC cultures.
Amnion-Derived Cells and Andometrial Regeneration
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To remove non-adherent cells, the medium was replaced for the
first time after 72 h, and then changed either twice per week
thereafter or according to the experiment requirements. For
maintenance of cultures, cells were plated in flasks of 25 cm2 at the
density of 16105 cells/cm2 and incubated at 38.5uC in a
humidified atmosphere with 5% CO2. Adherent cells were
detached with 0.05% trypsin-EDTA just prior to reaching
confluence (80%) and then reseeded for culture maintenance at
the density of 16104 cells/cm2.
Molecular characterization of EDCs was performed only at P0
as de facto control for gene expression, whereas AMCs were
studied from P0 to P5.
Preparation of conditioned medium
AMCs and fibroblasts, at P3, were plated in 24-well plates at a
density of 16105 cells/well in DMEM standard complete medium.
To obtain AMC-CM and fibroblast-CM, cells were cultured for 5
days at 38.5uC in a humidified atmosphere with 5% CO2.
Supernatants from each plate were then collected, pooled,
centrifuged at 7006g, filtered (0.2 mm), and stored at 280uC.
This procedure was performed for cells obtained from three
different placentas and from three different samples of skin.
The collected supernatants were lyophilized and stored at 4uC
until use, at which point they were dissolved in sterile cell culture
water to one-quarter of the initial volume.
Molecular characterization
Total RNA was extracted from tissues (AM and ED) and cells
(AMCs and EDCs) immediately after isolation (P0) using TRI
ReagentH Solution (Life Technologies, Monza, Italy). Total RNA
was also extracted from AMCs at different passages (P1, P3 and
P5) and after culture in the presence of progesterone. Samples
were then treated with DNase in order to avoid DNA
contamination. RNA concentration and purity were measured
by Nanodrop Spectrophotometer (NanodropH ND1000). The
cDNA was synthesized from total RNA (500 ng) using a Taqman
Reverse Transcription reagents kit (Applied Biosystems, Branch-
burg, NJ). The gene expression evaluation was performed using
specific sequences; equine-specific oligonucleotide primers were
designed using open source PerlPrimer software v. 1.1.17, based
on available NCBI Equus caballus sequences or on mammal
multi-aligned sequences. Primers were designed across an exon–
exon junction in order to avoid genomic DNA amplification and
their sequence conditions and the references used are shown in
Table 1. Equine glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was employed as a reference gene in each sample in
order to standardize the results by eliminating variation in mRNA
and cDNA quantity and quality.
Conventional RT-PCR was performed in a 25 ml final volume
with RBC Taq DNA Polymerase (RBC Bioscience) under the
following conditions: initial denaturation at 95uC for 2 minutes, 32
cycles at 95uC for 30 seconds (denaturation), 55–60uC for 30
seconds (annealing), 72uC for 1 minute (elongation) and final
elongation at 72uC for 7 minutes. For conventional PCR, primers
were used at 300 nM final concentrations.
Quantitative PCRs were performed with SYBR green method
in a MyiQ iCycler thermal cycler (Biorad). Triplicate PCR
reactions were carried out for each sample analyzed. The reactions
were set on a strip in a final volume of 25 ml by mixing, for each
sample, 1 ml of cDNA, 12.5 ml of 2X concentrated Power
SybrHGreen PCR Master Mix (Applied Biosystems) containing
SYBR Green as a fluorescent intercalating agent, 0.2 mm forward
primer, 0.2 mm of reverse primer and MQ water. PCR efficiencies
were tested and found to be close to 1. The thermal profile for all
reactions was 10 minutes at 95uC and then 40 cycles of 15 seconds
at 95uC, 1 minute at 60uC. Fluorescence monitoring occurred at
the end of each cycle. Additional dissociation curve analysis was
per- formed and in all cases showed one single peak. The data thus
obtained were analyzed using the iQ5 optical system software
version 2.0 (BioRad). Gene expression levels found in AM and
AMCs were normalized and represented with respect to ED and
EDCs, respectively.
Proliferation studies
Growth curves. To obtain growth curves at P1 and P5,
AMCs and EDCs were plated at the density of 96103 cells into
six-well tissue culture plates. Every three days, over the 15 days of
culture, cells from one well of each plate were detached and
counted.
Doubling time (DT). Cell proliferation was determined as
previously reported [4]. DT for passages 1–5 was assessed plating
96103 cells into six-well tissue culture plates. Every 4 days cells
were trypsinized, counted and reseeded at the same density. Mean
DT was calculated from day 0 to day 4. The DT value was
obtained for each passage according to the formula DT = CT/
CD, where CT represents the culture time and CD = log(Nc/No)/
log2 represents the number of cell generations (Nc represents the
number of cells at confluence, No represents the number of seeded
cells). Data representative of three independent experiments are
reported.
EDC proliferation in presence of AMCs or AMC-CM. To
assess the potential of AMCs to increase EDCs proliferation
(evaluated as growth curves and DT) 24-well plates with 0.4 mm-
pore transwell inserts were used to physically separate the two cell
populations. EDCs were plated at 16104 cells/well in standard
complete medium and AMCs were added at the same density on
top of the inserts.
To evaluate the effect of AMC-CM on EDCs proliferation,
growth and DT were studied plating 96103 cells into six-well
tissue culture plates. For this experiment, cultures were established
in standard complete medium supplemented with 10% AMC-CM.
As a control group, EDCs were studied in the presence of either
fibroblasts separated with a transwell system or fibroblast-derived
CM.
AMCs culture in the presence of progesterone
To determine whether AMCs would be effective in replacement
therapy we cultured them in the presence of progesterone.
Cultures at P1 were established in HG-DMEM supplemented
with 10% FBS, 10 ng/ml EGF, 1% penicillin (100 UI/ml)/
streptomycin (100 mg/ml), 0.25 mg/ml amphotericin B, 2 mM L-
glutamine (standard complete medium) and 20 ng/ml of proges-
terone. For maintenance of the cultures, cells were plated at 16104
cells/cm2 and incubated at 38.5uC in a humidified atmosphere
with 5% CO2. Just prior to reaching confluence (80%), adherent
cells were detached with 0.05% trypsin-EDTA and then reseeded
for culture maintenance at the density of 16104 cells/cm2. The
medium was changed twice per week. Cells at P5 were the last
time point included for the molecular characterization studies.
Statistical analysis
For proliferation data, statistical analysis was performed using
GraphPad Instat Software version 3.00 for Windows (La Jolla, CA,
US). Three replicates for each experiment were performed.
Results are reported as mean 6 standard deviation (SD). One-
way analysis of variance (ANOVA) for multiple comparisons by
Student-Newman-Keuls multiple comparison tests was used.
Differences were considered statistically significant for P values
Amnion-Derived Cells and Andometrial Regeneration
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,0.05. For quantitative PCR data, non-parametric tests were
used. The Kruskal-Wallis test was used for comparison between
multiple groups whereas Mann-Whitney U-test was employed to
compare two groups. P,0.05 was considered significant.
Results
Cells isolation and expansion
Cells were selected purely on their ability to adhere to plastic.
For AMCs, initial viability was .90%, whereas for EDCs it was
.80%. All cell lines displayed the typical fibroblast-like morphol-
ogy (Figs 1A and 1B). AMCs observed at the early stages of culture
organised as tridimensional clusters (Fig 1C).
Molecular characterization
As previously reported, molecular studies demonstrated that at
P3 AMCs display a typical mesenchymal stromal phenotype,
expressing pluripotent and MSC-specific markers [4]. For further
information, see Supplementary Information. When the expres-
sion of genes associated to pre-implantantion conceptus develop-
ment was investigated, conventional RT-PCR analysis demon-
Table 1. Oligonucleotide sequences used for RT-PCR analysis.
REF SEQ Markers Forward (59R39) Reverse (59R39) TAnnealing bp
XM_001498494.3 Progesteron Receptor (PR) GTCAGTGGACAGATGCTGTA CGCCTTGATGAGCTCTCTAA 55uC 255
NM_001081772.1 Estrogen receptor a (ERa) TCCATGATCAGGTCCACCTTCT GGTGTCTGTCATCTTGTCCA 55uC 341
XM_001915519.2 Estrogen receptor b (ERb) TCAGCCTGTTCGACCAAGTG CCTTGAAGTCGTTGCCAGGA 60uC 194
NM_001256979.1 Membrane-associated progesterone receptor (MPR) GCCAAGTATCGTTACCGGAG AAGAGGATCTGGAGCGTGTG 55uC 173
XM_001914705.2 Membrane-associated progesterone receptor (PGRMC1) TCAACGGCAAGGTGTTCGAC GGCTCTTCCTCATCTGAGTA 58uC 280
XM_003364827.1 Homeobox protein Hox-A9-like (Hoxa9) ACGCTGGAACTGGAGAAAGA CTTTCGCTCGGTCCTTATTG 55uC 160
NM_001163856.1 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) AGATCAAGAAGGTGGTGAAG TTGTCATACCAGGAAATGAGC 59uC 178
XM_001501510.2 Wingless-type MMTV integration site family, member 4
(Wnt7a)
TTTCGGATTCCCGCAGTCTC CATCTGCACCTGCCTCTGAA 55uC 177
XM_001489623.2 Wingless-type MMTV integration site family, member
7A(Wnt7a)
CATGGTCTACCTCCGGATCG TATGACGATGATGGCGTCGG 55uC 134
XM_005600181.1 Tumor protein p53 inducible protein3 (TP53) TCGCATTTCAAGCCAAACCG CTTCCTTCTCCTTCCCGTCG 60uC 110
XM_005601179.1 Forkhead box 01 (FOX01) ATTGAGCGCTTGGACTGTG CGTTGTCTTGACACTGTGC 60uC 126
XM_005609749.1 Prostaglandin-endoperoxide synthase 2 (PTGS2) GATCCTAAGCGAGGTCCAGC AGGCGCAGTTTATGCTGTCT 60uC 101
XM_001504377 Serum/glucocorticoid regulated kinase 1 (SGK1) CTGCACTCCCTGAACATCGT ATGTTCTCCTTGCAGAGCCC 60uC 107
doi:10.1371/journal.pone.0111324.t001
Figure 1. Cell morphology. Monolayer of AMCs (A) and EDCs (B); tridimensional cluster of AMCs (C). Magnification, x 20; scale bar
= 20 mm.
doi:10.1371/journal.pone.0111324.g001
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strated that PR, mPR, PGRMC1, Hoxa9, Wnt7a, Wnt4a, as well
as PTGS2, FOXO1, SGK1 and TP53 were expressed in ED and
AM. While ERa was expressed by AM and ED, ERß was not
detected in both tissues.
Quantitative RT-PCR showed a statistically significant increase
in the expression of mPR (4.0860.37; P,0.01), PGRCM1
(1.5260.3; P,0.05), Wnt7a (105.41613.27), Wnt4a (1.6660.11;
P,0.05), and PTGS2 (1.5560.23; P,0.05) in the comparison of
AM to ED (Fig 2A). Although ERa expression was demonstrated
by conventional RT-PCR, when quantitatively analyzed it was
found to be statistically lower when comparing AM to ED.
At P0, right after cell isolation, AMCs expressed all the genes
studied with only the exception of ERa and ERß. When cells from
the amniotic membrane and endometrial tissue were quantita-
tively compared, data showed a significant upregulation in the
expression of PR (1.360.11; P,0.05), PGRCM1 (260.07; P,
0.01), Hoxa9 (1.7460.17; P,0.05), Wnt7a (3.1660.7; P,0.01),
and PTGS2 (5.6660.015) in AMCs (Fig 2B).
Despite being qualitatively detected in ED and AM and in cells
derived from both sources, the levels of FOXO1, SGK1 and TP53
found in AM and AMCs were significantly lower in comparison to
those observed in ED and EDCs (Fig 2B). No expression for the
genes of interest was detected in further passages with only the
exception of Hoxa9 whose mRNA was found at P1 (data not
shown). AMCs cultured in the presence of supplemented
progesterone, expressed Hoxa-9, PGRMC1 and mPR until the
last passage studied (Fig 3).
Proliferation studies
Growth curve and DT. At P1, EDCs and AMCs demon-
strated a growth curve with an initial lag phase of 3 days that
decreased at P5 with AMCs growing more rapidly than EDCs
during this phase (Figs 4A and 4B). The proliferative potential of
EDCs was higher at P1 than at P5 in contrast with the results of
AMCs.
The DT values at P1 were similar between the two cell lines
(Fig 4C). In EDCs, it significantly increased (P,0.05) toward P5.
On the contrary, the greater proliferative ability associated to
AMCs was found between P3 and P5, and was further confirmed
by the growth curve at passage 5. At each passage, the differences
observed between the DT values observed for AMCs and EDCs
was statistically significant (P,0.05). The mean DT value for the
EDCs was 2.1960.65 days, while it was 0.8860.22 days for
AMCs.
EDCs proliferation in presence of AMCs or AMC-
CM. In vitro studies demonstrated that co-culture with AMCs
significantly increased EDCs proliferation in all passages studied
(Figs 4 A, B, C). The mean DT value for EDCs in the transwell
experiment (1.78 days) had a decrease of ,1.23-fold in
comparison to baseline EDCs proliferation in standard complete
medium (2.19 days; P,0.05 for all comparisons). The culture in
the presence of AMC-CM was able to stimulate EDCs prolifer-
ation to the same level of that obtained when cells were grown in
the transwell system (DT value of 1.63 days with a decrease of
,1.34-fold). Co-culture with fibroblasts, physically separated
through a transwell system or in presence of their CM, did not
induce any change in the proliferative potential of EDCs (Figs 4 D,
E, F).
Discussion
As in humans, equine fetal adnexa have been recently suggested
as appealing candidates for the derivation of MSCs to be used in
cell-based therapies [4,17–26] due to their higher proliferation
capacity, longer telomeres, broader differentiation, and extensive
proliferative potential in comparison to cells obtained from adult
tissues [5,17,27].
We previously isolated AMCs from the equine amniotic
membranes confirming that these cells share specific characteris-
tics with embryonic and adult stem cells; they express represen-
tative mesenchymal (CD105, CD44, CD29, CD166) and plurip-
otent (Tra-1-60, SSEA-4, Oct-4) markers, are highly proliferative
and retain high plasticity [4,5]. We also provided evidence of their
superior efficacy in tendon regeneration compared to their bone
marrow counterparts when allogeneically transplanted in vivo
[4,6].
Taken together, these characteristics make AMCs suitable
candidates for endometrial regeneration. To test this hypothesis
we further characterized AMCs comparing them to uterine
stromal cells collected at diestrus, due to the similarities found in
the hormonal profile between early pregnancy and the diestrous
stage. Both stages are characterized by high blood progesterone
level [28].
Our data demonstrates that at P0, AM and AMCs are similar to
ED and EDCs, respectively, for the expression of some endome-
trial-specific genes. Although our study only assayed a few genes,
we selected the ones that are crucial in the process of conceptus-
endometrium interaction. In particular, we found the expression of
Wnt4a statistically higher in AM than ED and with similar results
between AMCs and EDCs. This data can be explained with the
role that the wingless type genes play in reproductive events:
Figure 2. Molecular characterization of endometrial tissue (ED) and amnion (AM) (A), and endometrial cells at diestrus stage (EDCs)
and amniotic-derived stem cells (AMCs) (B). Qualitative and quantitative RT–PCR analysis for the expression of genes associated to
differentiation of uterine stromal cells during early pregnancy (Hoxa9), those influencing pre-implantantion conceptus development (ERa, ERb, PR,
PGRMC1 and mPR) and their regulators (Wnt7a,Wnt4a), and prostaglandin E2 synthase (PTGS2), FOXO1, SGK1, and TP53. GAPDH was used as reference
gene.
doi:10.1371/journal.pone.0111324.g002
Figure 3. Molecular characterization of AMCs. Conventional
RT-PCR analysis of evaluated genes in AMCs after culture with
progesterone from passage 1 (P1) to passage (P5).
doi:10.1371/journal.pone.0111324.g003
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including the establishment and maintenance of pregnancy,
implantation, proliferation, and secretion activity of endometrium
during the estrous cycle and pregnancy [29–32].
According to this, we can hypothesize that in horses Wnt7a and
Wnt4a regulation allows the synchronization of the uterus and
embryo development during the pre-implantation period of the
mare as proposed in sheep and mice [28,33,34].
The AbdB-like Hoxa family includes a second class of genes
differentially expressed during early pregnancy and primarily
confined to the mesenchymal cell compartment during in utero
Figure 4. Proliferation studies. Growth curve at P1 (A) and P5 (B) for AMCs and EDCs alone or in co-culture with AMCs by transwell
system or by AMC-conditioned medium (AMC-CM). Doubling times at different passages during cell culture for both AMCs and EDCs (C) in
different culture conditions. Asterisks represent statistically different doubling times with respect to P1 (P,0.01). Growth curve at P1 (D) and P5 (E) for
EDCs alone or in co-culture with fibroblast by transwell system or by fibroblast-conditioned medium. Doubling times at different passages during cell
culture for EDCs (E) in different culture conditions with fibroblast. Asterisks represent statistically different doubling times with respect to P1 (P,0.01).
doi:10.1371/journal.pone.0111324.g004
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development [35,36]. Among these genes, AMCs and EDCs share
the expression of Hoxa-9, which is specifically involved in the
Mu¨llerian duct cell patterning into oviducts, uterus, and vagina
[35], as well as uterine function during early pregnancy [36,37]. In
particular, this gene is considered as one of the primary steroid
hormone-responsive genes in the uterine stroma of humans and
mice [35]. Its expression is regulated by factors such as ovarian
steroids, interferons, and embryonic oestrogen in human [38],
mouse [31], sheep [39], pig [40], and recently in equine
endometrium [28]. As in humans, equine proliferation and
secretion of endometrial cells, implantation of embryo, renewal
of endometrial layers, and configuration of endometrial gland
morphogenesis [29,33,41] are essential processes for the establish-
ment of pregnancy [42] controlled by ovarian steroid hormones
and local growth factors [43]. Among these, progesterone and
estrogens are at the forefront of the cascade that could play a
critical role in endometrial maturation and receptivity [44] and are
thought to influence pre-implantation conceptus development
[45,46]. These hormones are thought to act indirectly via the
endometrium. As mentioned above, progesterone mediates
endometrial maturity and receptivity through specific nuclear
receptors [47]. Data obtained herein demonstrate that the levels of
expression of mPR and PGRMC1 detected in AM and AMCs
respectively, are even higher than those found in ED and EDCs.
These findings may indicate the differential biological effect
exerted by progesterone on the amniotic membrane and on the
cells derived from it. While in ED it acts through a relatively slow
‘genomic pathway’ [45,46], in the amniotic tissues progesterone
seems to work via ligand-specific steroid receptors, including the
non-classical membrane-associated receptors we analysed
(PGRMC1 and mPR) [48,49].
The co-expression of Wnt and Hoxa9 as well as the
progesterone receptors in AMCs, suggests that these cells share
similar cellular and molecular characteristics with uterine stromal
cells. For some of the genes studied, our results confirm those
obtained in humans, showing the same pattern of expression [50].
The loss of expression of some markers observed soon after AMCs
isolation, as well as in EDCs, could depend on the culture
conditions employed in this study with the consequent changes
induced during the expansion.
When the expression of FOXO1, SGK1, and TP53 was
investigated the levels found in AM and AMCs were significantly
lower than those observed in ED and EDCs. So far, no data has
been published regarding these markers as crucial players in the
process of conceptus-endometrium interaction in the equine
species, and only one paper reports the link between TP53
transcriptional activity and cattle reproduction (10). Further
studies are required to elucidate the role of FOXO1, SGK1, and
TP53 regulation in horses. At a molecular level, this study
reinforces our previous findings regarding the immunomodulatory
potential of the amniotic membrane and the cells derived from
them (7) and further highlights their potential use in cell-based
therapies. This observation comes from the higher levels of
PTGS2 expression found in AM and AMCs compared to their
endometrial counterparts. It is important to point out that
prostaglandin E2 not only exerts a crucial role as immunosup-
pressive molecules during pro-inflammatory events, but are also
known to be actively involved at the onset of pregnancy as
temporary luteo-protective factors [51].
To recreate the biochemical cues found during gestation,
characterized by high progesterone levels, we optimized the AMCs
culture system supplementing the media with progesterone. The
presence of progesterone in the culture media was sufficient to
preserve the expression of membrane-bound intracellular proges-
terone receptors and Hoxa-9 along the 5 passages in vitro. Since
endometrial receptivity depends on the number of progesterone
receptors in epithelial and stromal cells [52], our data provide an
intriguing indication of the possible application of AMCs in
endometrial regeneration.
Whether the major contribution of AMCs to the healing process
depends on their ability to differentiate, the immunomodulatory
and trophic factors they release, or is a combination of the two
mechanisms is still under debate [53,54]. The present study also
provides evidence of the role that soluble signals produced by
AMCs may have in promoting EDC proliferation. Indeed, the
presence of AMCs by transwell system or the effect of AMC-CM
increased the EDCs proliferation.
In conclusions, the present work lays the foundation for in vivo
studies on the potential application of AMCs in the treatment of
horse uterine diseases. A substantial overlap was found between
equine amnion and endometrium based on gene expression
profiling, indicating that AMCs are ideal therapeutic candidates
for uterine cells replenishment when scarcity or low proliferation
of uterine endometrial cells is associated with pregnancy failure.
Besides this, our data reinforce the idea that MSCs obtained from
gestational tissues exert their beneficial effects in tissue regener-
ation through the release of soluble factors and indicates the
conditioned media as novel therapeutic cell-free products for
regenerative medicine applications.
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Microvesicles secreted from equine
amniotic-derived cells and their potential
role in reducing inflammation in
endometrial cells in an in-vitro model
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Bruna Corradetti3, Davide Bizzaro3, Antonella Idda4, Sergio Ledda4, Emanuele Capra5, Flavia Pizzi5,
Anna Lange-Consiglio1* and Fausto Cremonesi1,2
Abstract
Background: It is known that a paracrine mechanism exists between mesenchymal stem cells and target cells. This
process may involve microvesicles (MVs) as an integral component of cell-to-cell communication.
Methods: In this context, this study aims to understand the efficacy of MVs in in-vitro endometrial stressed cells in view
of potential healing in in-vivo studies. For this purpose, the presence and type of MVs secreted by amniotic mesenchymal
stem cells (AMCs) were investigated and the response of endometrial cells to MVs was studied using a dose-response
curve at different concentrations and times. Moreover, the ability of MVs to counteract the in vitro stress in endometrial
cells induced by lipopolysaccharide was studied by measuring the rate of apoptosis and cell proliferation, the expression
of some pro-inflammatory genes such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin 1β (IL-1β), and
metalloproteinases (MMP) 1 and 13, and the release of some pro- or anti-inflammatory cytokines.
Results: MVs secreted by the AMCs ranged in size from 100 to 200 nm. The incorporation of MVs was gradual over time
and peaked at 72 h. MVs reduced the apoptosis rate, increased cell proliferation values, downregulated pro-inflammatory
gene expression, and decreased the secretion of pro-inflammatory cytokines.
Conclusion: Our data suggest that some microRNAs could contribute to counteracting in-vivo inflammation of
endometrial tissue.
Keywords: Microvesicles, Endometrium, Inflammation, LPS, Regenerative medicine
Background
The regular uterine environment promotes normal em-
bryo development, but clinical or subclinical disorders
could contribute to pregnancy failure. As reviewed by
Hurtgen [1], endometritis is an important cause of re-
duced fertility in mares in which artificial insemination
by fresh or frozen semen may induce acute endometrial
inflammatory reactions. If these conditions are not
promptly resolved, infections become chronic and, in
old pregnant mares, often result in higher pregnancy
loss. A similar clinical endometritis also occurs in dairy
cows following parturition [2, 3]. Furthermore, cyto-
logical endometritis emerged as a problem of remarkable
importance for dairy cattle reproduction because ani-
mals suffering from this disorder present a persistent
inflammatory uterine environment even in the absence
of clinical symptoms. A reduced conception rate and
increased calving-to-conception intervals are conse-
quences of these uterine diseases [4–7].
Successful implantation requires a complex sequence
of signaling events that are crucial to the establishment
of pregnancy, and a large number of molecular media-
tors, influenced by the level of ovarian hormones, have
been involved in this early embryo-maternal interaction.
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These mediators include adhesion molecules, cytokines,
growth factors, lipids, and others [8, 9]. Koot et al. [10]
underlined that infertility could occur after the early phases
of implantation as a malfunction of the endometrium-
embryo ‘dialogue’. The degree of endometrial production
of these mediators could be impaired by persistent endo-
metritis. Indeed, pro-inflammatory factors transcripted in
bovine endometrial epithelial cells are elevated in cases of
subclinical or clinical endometritis [11]. Repeat-breeding
cows (animals that after three or more inseminations do
not get pregnant because of fertilization failure or early
embryonic death) show abnormalities in the growth factor-
cytokine network, specifically in endometrial epidermal
growth factor (EGF) concentration [12]. The EGF family
acts on the trophectoderm, promoting cell attachment and
embryo development [13], and its impairment could
explain the pregnancy failure in these animals.
Many therapies have been proposed to treat or prevent
mare endometritis. Post-mating endometritis is usually
treated with uterine irrigation and ecbolic, while the
acute endometritis treatment is performed with systemic
or intra-uterine antibiotics. However, these therapies are
not always effective for resolving chronic uterine inflam-
mation. The prevention, mainly in cattle, includes nutri-
tional supplements and hygienic conditions during
parturition. Commonly, therapies in use include hormo-
nal treatments with GnRH, exogenous gonadotrophins,
and prostaglandins [14], or the exploitation of assisted
reproductive techniques, such as in vitro embryo pro-
duction and embryo transfer. However, in case of infer-
tility due to endometrial damage, the embryo-maternal
interaction and the restoration of uterine receptivity
could be improved by regenerative medicine treatment.
Regenerative medicine has several applications in the
treatment of many pathologies in both human and veter-
inary medicine. Treatments are based on mesenchymal
stem cell (MSC) transplantation but, although engraft-
ment of the transplanted MSCs has been documented in
some cases [15–17], only a small percentage of the
injected MSCs engraft successfully in various disease
models [18–21]. In an irradiated murine model, endo-
metrial regeneration by bone marrow-derived MSCs has
been studied showing a low number of cells engrafted in
the regenerating endometrium [22]. Consistent with
these findings, some studies recently showed that the
regenerative ability of MSCs could be attributed to the
production of molecules and mediators capable of acti-
vating the intrinsic repair processes in the damaged
tissues. To date, the conditioned medium (CM) obtained
from in vitro cultured MSCs has been proven to be
sufficient to stimulate the structural and functional re-
generation of cardiac [20, 23], renal [19, 24], spinal cord
[25], and tendon [26] tissues. These results indicate that
the beneficial effects of MSCs can be attributed to the
activation of paracrine mechanisms enabling stimula-
tion of endogenous stem cells. These cells are respon-
sible for the bioactive soluble factors (lipids, growth
factors, and cytokines) known to inhibit apoptosis and
fibrosis, enhance angiogenesis, stimulate mitosis and/or
differentiation of tissue-resident progenitor cells, and
modulate the immune response [27]. In addition to sol-
uble factors, recent findings indicate that extracellular
vesicles are released from MSCs inside the CM and that
these can be involved as important mediators in cell-
to-cell communication [28]. Microvesicles (MVs) have
been categorized into exosomes (EXs), released from
the endosomal compartment, and shedding vesicles
(SVs), which bud directly from the cell membrane. MVs
contain various active molecules such as lipids, pro-
teins, mRNA, and microRNA (miRNA) [29]. It has
been demonstrated that CM and MVs can be used in
vitro and in vivo to repair tissue damage, increasing the
healing rate [26, 29, 30]. MVs are involved in a dynamic
mutual paracrine communication between the embry-
onic and the maternal environment at the early stage of
pre-implantation embryo development [31]. Equine
embryos at day 8 are thought to secrete MVs that can
modulate the functions of the oviduct epithelium
through transfer of early pregnancy factor (HSP10) and
miRNAs [32]. On the other hand, MVs can be secreted
from the maternal side, and endometrium-derived MV
miRNAs are revealed to have potential targets in bio-
logical pathways highly relevant for embryo implant-
ation [33]. Uterine miRNAs are suggested to play a
potential regulatory role in the development and pro-
gression of bovine subclinical endometritis. Indeed,
Hailemariam et al. [34] demonstrated that there is an
aberrant expression of 23 miRNAs in cows with
subclinical endometritis compared with healthy cows.
Furthermore, they observed a similar expression of
miRNA patterns in cytobrush samples from sick cows
and in vitro cultured endometrial cells challenged by
lipopolysaccharide (LPS). This suggests that in vitro
endometrial cell culture, treated with LPS, could
be an excellent model to test potential regenerative
medicine treatments for endometritis. In human medicine,
the different pattern of miRNAs between women
with and without endometriotic disease have been
proposed as biomarkers that could underpin the de-
velopment of a noninvasive diagnostic test for endo-
metriosis [35].
In this context, the aims of this study were to identify
the presence and type of MVs secreted by amniotic mes-
enchymal progenitor cells (AMCs), and to elucidate
whether equine endometrial cells could be targeted by
MVs in vitro. In addition, we considered whether MVs
are able to counteract an in vitro endometrial cell in-
flammatory process induced by LPS.
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Methods
Materials
Uteri samples were collected from horses slaughtered in
a national slaughterhouse under legal regulation. Chemi-
cals were obtained from Sigma-Aldrich Chemical (Milan,
Italy) unless otherwise specified, and tissue culture plas-
tic dishes were purchased from Euroclone (Milan, Italy).
Study design
Initially, amniotic cells were isolated and cultured to
produce MVs that were characterized using a Nanosight
instrument (Nanoparticle tracking analysis, NTA; Nano-
Sight Ltd., Amesbuty, UK). Endometrial cells were iso-
lated, and specific endometrial genes were identified by
qualitative reverse transcription polymerase chain reac-
tion (RT-PCR). Isolated endometrial cells were used as
the target for different concentrations of MVs. Further-
more, the effect of MVs on endometrial cells treated by
LPS was analyzed by quantitative RT-PCR (qRT-PCR)
expression of inflammatory genes, evaluation of the re-
lease of different cytokines, and viability cell tests. Fi-
nally, the presence of some miRNAs, regulating
inflammation, inside the MVs was evaluated.
Tissue collection
Allanto-amniotic membranes were obtained at term
from normal pregnancies in three mares. Samples of
allanto-amnion were transported at 4 °C in calcium- and
magnesium-free phosphate-buffered saline (PBS; Euro-
clone, Milan, Italy) supplemented with 4 mg/mL ampho-
tericin (Euroclone), 100 UI/mL penicillin and 100 mg/
mL streptomycin (Euroclone), and were processed
within 12 h of collection. The amniotic membrane was
mechanically separated from the allantois and the isola-
tion of AMCs was performed as previously reported by
Lange-Consiglio et al. [36].
Endometrial samples were obtained during the repro-
ductive season from normal-cycling mares at diestrus
stage (early-mid luteal phase). Before slaughtering, 5 ml
of blood was collected in heparinized tubes from all
mares. After centrifugation, plasma was separated, kept
refrigerated, and immediately transported to the labora-
tory for progesterone determination by a quantitative
enzyme linked fluorescent assay (ELFA) based on the
MiniVidas (Biomerieux, Firenze, Italy) technology. Ac-
cording to the manufacturer, the measurement range of
the assay varied from 0.25 to 80 ng/ml with an intra-
assay variation of 4.12 % and an inter-assay variability of
6.32 %.
Only uteri belonging to mares with an obvious corpus
luteum on the ovary and progesterone levels between 6
and 20 ng/ml, indicative of the early/mid diestral phase
of the estrous cycle [37], were used for endometrial frag-
ment collection and ensuing cell culture.
Tissue fragments for RNA isolation were immediately
immersed in RNA Later solution, whereas those des-
tined for cell isolation and the expansion procedure were
kept at 4 °C in saline solution supplemented with 4 μg/
ml amphotericin B, 100 IU/ml penicillin, and 100 μg/ml
streptomycin and processed within 8 h.
Cell isolation
Amniotic membrane-derived mesenchymal cells were
isolated as recently reported by Lange-Consiglio et al.
[36]. Briefly, amnion fragments were incubated for
9 min at 38.5 °C in PBS containing 2.4 U/mL dispase
(Becton Dickinson, Milan, Italy). After a resting period
(5–10 min) at room temperature in high-glucose Dul-
becco’s modified Eagle’s medium (HG-DMEM; Euro-
Clone, Milan, Italy), supplemented with 10 % heat-
inactivated fetal bovine serum (FBS) and 2 mM L-glu-
tamine, the fragments were digested with 0.93 mg/mL
collagenase type I and 20 mg/mL DNAse (Roche, Mann-
heim, Germany) for approximately 3 h at 37 °C. The am-
nion fragments were then removed, and mobilized cells
were passed through a 100-μm cell strainer before being
collected by centrifugation at 200 × g for 10 min.
Endometrial cells from diestrum uteri of mares were
obtained according to the protocol described by Dono-
frio et al. [38] and slightly modified for equine cells.
Briefly, the endometrium was digested in sterile filtered
Hank's buffered salt solution supplemented with 2 mg/
ml collagenase II, 4 mg/ml bovine serum albumin, and
0.4 mg/ml DNase I for 90 min at 38.5 °C in a shaking
bath. Cells were then filtered through a membrane with
a pore size of 80 μm and centrifuged at 200 × g for
10 min, then washed twice in PBS. This protocol allowed
for the isolation of the endometrial stromal portion. Be-
fore seeding, cells were counted using a Burker chamber
with the Trypan Blue dye exclusion assay.
Cell expansion
Endometrial cell (EDC) cultures were established in HG-
DMEM supplemented with 10 % FBS, penicillin (100
UI/ml), streptomycin (100 μg/ml), 0.25 μg/ml amphoter-
icin B, and 2 mM L-glutamine. Medium was supple-
mented with 10 ng/ml EGF for AMC cultures.
To remove non-adherent cells for both cell lines the
medium was replaced for the first time after 72 h, and
then changed either twice per week thereafter or accord-
ing to the experiment requirements. For maintenance of
cultures, cells were plated in flasks of 25 cm2 at a density
of 1 × 105 cells/cm2 and incubated at 38.5 °C in a hu-
midified atmosphere with 5 % CO2. Adherent cells were
detached with 0.05 % trypsin-EDTA just prior to reach-
ing confluence (80 %) and then reseeded for culture
maintenance at a density of 1 × 104 cells/cm2.
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A detailed characterization of these cells was per-
formed in the paper of Corradetti et al. [39]. In this
study, a molecular characterization of EDCs was per-
formed only at passage (P)0 as a de facto control for
gene expression.
Isolation and measurements of MVs
MVs were obtained from the culture media of AMCs de-
rived from three different placentas, cultured for 1 week
with HG-DMEM supplemented with 10 % MV-deprived
FCS and overnight in HG-DMEM deprived of FCS and
supplemented with 0.5 % BSA (Sigma). The overnight
culture media were pooled and centrifuged at 2000 × g
for 20 min to remove debris, then at 100,000 × g (Beck-
man Coulter Optima L-100 K ultracentrifuge) for 1 h at
4 °C, washed in serum-free medium 199 containing N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES;
25 mM) and submitted to a second ultracentrifugation
under the same conditions. After ultracentrifugation, the
pellet was immediately resuspended in HG-DMEM, and
a fraction of the resuspended pellet was taken for mea-
surements of MV size and concentration. A second frac-
tion was labeled with fluorochrome PKH-26 and the
remaining part of the pellet was cryopreserved with 1 %
dimethylsulfoxide at –80 °C and used for the in vitro
test. The size and concentration of MVs were evaluated
by the Nanosight LM10 instrument, which permits dis-
crimination of microparticles less than 1 μm in diam-
eter. The software (NTA 2.0 analytic software) allows
the analysis of video images of particle movement
under Brownian motion and the calculation of diffusion
coefficient, sphere equivalent, and hydrodynamic radius
of particles by using the Strokes–Einstein equation.
This instrument was configured with a 405-nm laser
and a high-sensitivity sCMOS camera (OrcaFlash2.8,
Hamamatsu C11440, NanoSight Ltd). Videos were
collected and analyzed using the NTA software with
the minimal expected particle size, minimum track
length, and blur setting all set to automatic. Ambient
temperature was recorded manually and did not exceed
25 °C. Each sample (5 μl) was diluted in sterile physio-
logical solution to a final volume of 1 ml. Samples were
analyzed within 15 min of the initial dilution with a
delay of 10 s between sample introduction and the start
of the measurement. For each sample, multiple videos
of 30 s duration were recorded generating replicate his-
tograms that were averaged.
MVs labeling with PKH-26
To trace in vitro MVs by fluorescence microscopy, MVs
from AMCs were labeled with the red fluorescence ali-
phatic chromophore intercalating into lipid bilayers
PKH26 dye (Sigma). Briefly, after ultra-centrifugation,
the MV pellet was diluted to 1 ml with PKH-26 kit and
2 μl of fluorochrome was added to this suspension and
incubated for 30 min at 38.5 °C. At the end of the reac-
tion, 7 ml of serum-free DMEM was added to the sus-
pension that was ultra-centrifuged again at 100,000 g for
1 h at 4 °C. The final pellet was immediately resus-
pended in HG-DMEM.
Incorporation of MVs in endometrial cells
To study the incorporation capacity of MVs into endo-
metrial cells, a dose-response growth was performed in
three replicates. Endometrial cells were seeded at a
density of 60 × 103 on culture slides (13 mm; Nalgen
Nunc International, Rochester, NY, USA) in 24 wells
and co-cultured with 10, 20, 30, 40, and 50 × 106 MVs/
ml labeled with PKH-26 dye, and pre-incubated or not
with trypsin (0.5 mM) for 24, 48, and 72 h at 38.5 °C.
At the end of each experimental condition, cells were
nuclear stained with 10 μg/ml Hoechst 33343 for
15 min at 38 °C. The uptake of MVs was evaluated by
an Olympus BX51 microscope equipped with a Scion
Corporation 1394 video camera interfaced with a
computer provided with software for image acquisition
and analysis (Image-Pro Plus 5.1-Media Cybernetics,
Immagini & Computer, Bareggio, Italy). Excitation
wavelength was positioned at 550 nm while emission
wavelength was set at 567 nm. Hoechst 33342 dye
(Sigma) was excited at 353–365 nm while the emission
wavelength was set at 460 nm. To detect the intensity
of fluorescence, a semi-quantitative analysis was per-
formed. Different images were acquired for each condi-
tion and then, for each image, the area of interest (AOI;
where the signal was present) was manually defined by
the user. Inside the AOI, up to three different back-
ground signals were sampled. The background areas
were positioned by the user only where the fluorescent
signal was not specific. The maximum value collected
from the background areas was then used to define the
threshold. Only fluorescence with an intensity above
the threshold was considered to indicate fluorescence
due to labeled MVs. Finally, the program measured the
signal intensity expressed in arbitrary units (a.u.).
Confocal microscopy analysis to assess internalization
of MVs was performed using a Leica SP2 laser scanning
confocal microscope (Leica Microsystems Srl, Italy)
equipped with a PL Fluotar 20× AN 0.5 Dry objective.
In vitro effect of MVs on endometrial cells treated with LPS
The dose-response curve of LPS on endometrial cells
was studied showing that 10 ng/ml and 12–24 h were
the dose and the times most effective in inducing cellu-
lar stress evaluated by an apoptotic study (data not
shown). Sixty thousand cells were incubated at the
same time with LPS 10 ng/ml and 40 × 106 MVs/ml for
3, 12, and 24 h. In another experimental condition,
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endometrial cells were treated first for 3 h with LPS
and then with MVs at the same concentrations and
times. In the last experiment, endometrial cells were
treated first for 24 h with MVs and then with LPS
10 ng/ml. Endometrial cells alone or endometrial cells
with LPS or MVs only were used as controls at different
times. At the end of each experimental condition, the
MTT reduction assay method and apoptotic test were
used to analyze cell proliferation and viability of cells
on some samples. Cells from other samples were de-
tached with 0.05 % trypsin-EDTA, centrifuged, and
cryopreserved for molecular biology studies in liquid
nitrogen using standard cryopreservation protocols.
The supernatants were destined for the evaluation of
cytokines released from endometrial cells. All experi-
ments were performed in three replicates.
Viability cell tests
Cell proliferation test by MTT reduction assay method
The MTT reduction assay method (Chemicon, Temecula,
CA, USA) estimates the activity of the enzyme
dehydrogenase by converting the MTTcompound (3-(4,5-
dimethylthiazol- 2-yl)-2,5-diphenyletrazolium bromide)
into formazan by the mitochondria. The measurement
was performed with a spectrophotometer (Perking
Elmer HTS 700 plus; Boston, MA, USA) at the absorb-
ance reading of 570 nm for each sample. Briefly, at each
experimental condition of in vitro effect of MVs on
endometrial cells treated with LPS, cells were washed
twice in PBS, and 1 ml of 5 mg/l MTT solution was
added to each well. Avoiding light, plates were then
placed in a humidified incubator at 37 °C for 4 h. The
supernatant was discarded, 1 ml of dimethylsulfoxide
was added as an extracting solution, and plates were in-
cubated for 2 h until the precipitations were resolved
completely for spectrophotometric reading. This test
was performed in three replicates.
Apoptotic test
The percentage of apoptotic cells was assessed using an
Annexin-V-FITC Apoptosis Detection KIT (Sigma) fol-
lowing the manufacturers’ instructions; 500 μl of cells
(5 × 105 cells) were incubated with 5 μl of Annexin V so-
lution and with 10 μl propidium iodide for 1 h at room
temperature while protected from light. Apoptosis rates
were evaluated by conventional fluorescence analysis
using a BX 51 microscope (Olympus) equipped with a
DMU filter set. One hundred cells were analyzed using
a combination of 488/560 nm emission. Cells at the
early stage of apoptosis stained with the annexin V-
FITC alone. Live cells showed no staining with either
propidium iodide or Annexin V-FITC. Cells dead for
apoptosis were stained by both propidium iodide and
Annexin V-FITC, and cells dead for necrosis were
stained by propidium iodide alone. The apoptotic test
was performed in three replicates.
Molecular biology studies
Characterization of endometrial cells
After isolation from endometrial tissue, cells were ana-
lyzed to detect the expression of specific endometrial
genes as previously reported [39]. Total RNA was ex-
tracted from endometrial cells immediately after isola-
tion (P0) using TRI Reagent Solution (Life Technologies,
Monza, Italy) and conventional RT-PCR was performed
with RBC Taq DNA Polymerase (RBC Bioscience) using
previously optimized primers [39]. The primer se-
quences and conditions are shown in Tables 1 and 2.
Glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH)
was employed as a reference gene.
Gene expression of pro-inflammatory cytokines
Genes involved in the inflammatory process, such as
interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor
necrosis factor α (TNF-α), were analyzed by qRT-PCR
under all experimental conditions. The mRNA expres-
sion levels of all genes were measured in three samples
(biological replicates). Total RNA was isolated using the
mirVana™ miRNA isolation Kit (Life Technologies) ac-
cording to the manufacturer’s protocol and stored at
−20 °C. The concentration and purity of RNAs were
evaluated three times by the NanoQuant spectropho-
tometer (Thermo Scientific, USA) and, in order to verify
the integrity of extracted RNA, eight samples that were
randomly chosen were analyzed on a Bioanalyzer 2100
using the Agilent RNA 6000 Pico Kit (Agilent). Accord-
ing to the RNA quantity, each sample was normalized to
the final RNA concentration of 10 ng/μl.
RT-PCRs were performed with the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems/
Life Technologies, Carlsbad, CA, USA) using 100 ng of
RNA per reaction.
All the qPCR experiments were run in triplicates (tech-
nical replicates) using the qPCR protocol described by
TaqMan Fast Gene Expression Assays (Life Technologies™)
on a 7500 Fast Real-time PCR System instrument (Applied
Biosystems by Life Technologies™). To assess gene expres-
sion, each target gene and the GAPDH, as the housekeep-
ing control gene, were co-amplified. The assay primers
were available and synthesized by Life Technologies™.
Average target gene threshold cycle (ΔCtg) for each
sample (calculated using the CT values of the technical
replicates within each experimental conditions) were
normalized to the average GAPDH values (ΔCtGAPDH)
of the same cDNA sample. Then the expression varia-
tions calculated were normalized to the internal control
(i.e., control cell at 3 h) using the ΔΔCt method.
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Finally, the fold-change expression of each gene was
calculated as 2−ΔΔCT [40].
Gene expression of metalloproteinases
Matrix metalloproteinase 1 (MMP-1) and matrix metal-
loproteinase 13 (MMP-13) were selected to evaluate the
effect of MVs to contrast LPS activity. Gene expression
was performed with the SYBR green method in a MyiQ
iCycler thermal cycler (Biorad). Triplicate PCR reac-
tions were carried out for each sample, analyzed using
primer sequences reported in Table 1. The reactions
were set on a strip in a final volume of 25 μl by mixing,
for each sample, 1 μl of cDNA, 12.5 μl of 2× concen-
trated SYBR Premix Ex Taq II (Takara Bio) containing
SYBR Green as a fluorescent intercalating agent,
0.2 μM forward primer, 0.2 μM of reverse primer, and
MQ water. PCR efficiencies were tested and found to
be close to 1. The thermal profile for all reactions was
30 s at 95 °C and then 40 cycles of 5 s at 95 °C, and
30 s at 60 °C. Fluorescence monitoring occurred at the
end of each cycle. The efficiency of amplification for
each primer was monitored through the analysis of ser-
ial dilution. Additional dissociation curve analysis was
performed, and in all cases showed a single peak. The
data thus obtained were analyzed using the iQ5 optical
system software version 2.0 (BioRad). The expression of
each gene was normalized to the reference gene
GAPDH in order to standardize the results by eliminat-
ing variation in cDNA quantity. Sequences used are
listed in Table 1.
miRNA analyses by RNA extraction and PCR amplification
The MV pellet was subjected to RNase digestion to re-
move extraneous ribonucleic acids [41]. Total RNA was
isolated from a pool of different MVs and amniotic-
derived cell preparations using the NucleoSpin® mRNA
kit (Macherey-Nagel, Germany), in combination with
TRIzol® lysis and purification of small and large RNA in
one fraction (total RNA). RNAs were quantified using a
NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA). RNA quality was
checked using the Agilent Bioanalyser 2100 (Agilent,
Santa Clara, CA, USA), where the presence of small
RNAs was verified in both MV and cell samples.
RNAs from all samples were reverse transcribed with
the miScript Reverse Transcription Kit and the cDNA
was then pre-amplified using the miScript PreAMP
PCR Kit (all from Qiagen, Valencia, CA, USA), follow-
ing the manufacturer’s instruction with some modifica-
tion: miScript PreAMP Primer Mix was replaced with
miR-specific primers: hsa-miR-26a-2, -335, -146a, and
SNORD95 as forward primer, and miScript Universal
Primer as reverse primer in separate reactions. Homo
sapiens hsa miRNA were perfectly homologous with
Equus caballus eca miRNA sequence. PCR was per-
formed on pre-amplified products using the PCR Mas-
ter Mix (2×) (Thermo Fisher Scientific Inc., Waltham,
MA, USA), with the same primer couple: hsa-miR-26a-
2, -335, -146a, SNORD95 in combination with miScript
Universal Primer. The small nucleolar snoRNA, C/D
Box 95 SNORD95 was used as the positive control.
Table 1 Oligonucleotide sequences used for reverse transcription polymerase chain reaction analysis
Reference
sequence
Markers Forward Reverse Annealing
temperature
bp
XM_001498494.3 Progesteron Receptor (PR) GTCAGTGGACAGATGCTGTA CGCCTTGATGAGCTCTCTAA 55 °C 255
NM_001256979.1 Membrane-associated progesterone
receptor (MPR)
GCCAAGTATCGTTACCGGAG AAGAGGATCTGGAGCGTGTG 55 °C 173
XM_001914705.2 Progester one receptor membrane
component 1 (PGRMC1)
TCAACGGCAAGGTGTTCGAC GGCTCTTCCTCATCTGAGTA 58 °C 280
XM_003364827.1 Homeobox protein Hox-A9-like
(Hoxa9)
ACGCTGGAACTGGAGAAAGA CTTTCGCTCGGTCCTTATTG 55 °C 160
NM_001163856.1 Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
AGATCAAGAAGGTGGTGAAG TTGTCATACCAGGAAATGAGC 59 °C 178
NM_001081847.2 Matrix metallopeptidase 1 (MMP-1) ACTGCCAAATGGACTTCAAGCTGC TCTTCACAGTGCTAGGAAAGCCG 60 °C 158
NM_001081804.1 Matrix metallopeptidase 13
(MMP-13)
CTCTGGTCTGCTGGCTCACGC CCAAACTCGTGTGCAGCGAC 60 °C 132
Table 2 Oligonucleotide sequences synthesized by Life Technologies
Assay ID Gene
symbol
Entrez gene
ID
NCBI
assembly
CHR Location on NCBI genome
assembly
Location on transcript or
gene
Ec03467871_m1 TNF 100033834 2.1 20 31359792 318
Ec03468680_m1 IL-6 100034196 2.1 4 54424314 468
Ec04260298_s1 IL-1B 100034237 2.1 Un|NW_001871813.1 5795 254
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Negative controls using water in place of the pre-Amp
product were performed alongside each reaction. The
cycling conditions were 3 min at 95 °C, followed by
35 cycles of 30 s at 95 °C, 30 s at 58 °C, 1 min at 72 °C,
and finally 7 min at 72 °C. The amplified PCR products
were separated electrophoretically on 2.5 % agarose
gels, and visualized under UV, using the GeneRuler
50 bp as a DNA ladder (Thermo Fisher Scientific Inc.).
Cytokines
Cytokine release (IL-6, transforming growth factor
(TGF)-β, and TNF-α) was measured in cell-free super-
natants obtained by centrifugation at 1200 rpm for
5 min and stored at −80 °C until measurement. Cyto-
kine production was assessed by commercially available
sandwich ELISAs (Bioptis SA, Liege, Belgium). ELISAs
were performed according to the supplier’s instructions.
Results are expressed in pg/ml. The limit of detection
was 15.6 pg/ml for all cytokines tested.
Statistical analysis
For quantitative PCR experiments, data were analyzed
by one-way analysis of variance (ANOVA). Also, cell via-
bility data were analyzed by one-way ANOVA applying a
Bonferroni correction.
For cytokines, statistical differences were determined
using ANOVA followed by Dunnett’s multiple compari-
son test, the Tukey–Kramer multiple comparisons test
or unpaired t test.
Differences were considered statistically significant if
the value of P was <0.05.
Results
Tissue collection and cell isolation
Cells were selected for their ability to adhere to plas-
tic. For AMCs, the initial viability was >90 %, whereas
for EDCs it was >85 %. EDCs (Fig. 1a) and AMCs
(Fig. 1b) displayed fibroblast-like morphology. Mo-
lecular biology analyses at P3 showed that AMCs
showed a typical mesenchymal stromal phenotype,
with the expression of markers such as CD29, CD44,
CD106, CD105, and MHCI, but not CD34 and MHCII.
Moreover, AMCs showed differentiative potential in
mesenchymal (osteogenic, adipogenic, and chondro-
genic) and ectodermic lines (neurogenic) as reported
by Lange-Consiglio et al. [36].
The molecular biology study on endometrial cells at
P0 confirmed that these cells were endometrial cells
because of the expression of PR, MPR, PGRMC1,
HOXA-9 (Fig. 1c).
Isolation and measurement of MVs
In all the studied samples, the viability of AMCs at the
time of MV collection was 99 % as detected by trypan
blue exclusion. By Nanosight, the size of MVs ranged
from 50 to 670 nm, with a mean size of 258 ± 55 nm for
three samples. The number of MVs ranged from 800 to
4700 particles/cell, with a mean value of 2550 ± 71 parti-
cles/cell (corresponding to 540 × 106 particles/ml of
medium). In a previous study [42], transmission electron
microscopy (TEM) analysis revealed the presence of
variably sized extracellular membranous vesicles bud-
ding from, or lying near, the cell of origin. The size of
MVs ranged from 100 nm to 1000 nm, with a predomin-
ance of vesicles between 100 and 200 nm. Because of
the size, by Nanosight and TEM, and morphological
characteristics, the vesicles observed were mainly con-
sidered as shedding vesicles.
Incorporation of MVs in endometrial cells
As seen by fluorescence microscopy, in all the studied
samples no fluorescence signal was detectable up to the
sixth hour of co-incubation of MVs with endometrial
cells, and only nuclei stained with Hoechst 33342 were
visible (Fig. 2a). The increase in uptake of 40 × 106 MVs/
ml by endometrial cells between 24 h and 72 h is
showed in Fig. 2b, c, d and e. No signal was detected
after treatment of MVs with trypsin. The incorporation
of MVs is gradual and constant at 24 h with a concentra-
tion of 40 × 106 MVs/ml, and suddenly increases at a
concentration of 50 × 106 MVs/ml. The uptake of MVs
drastically increased at 48 h at a concentration of 40 ×
106 MVs/ml and decreased at a concentration of 50 ×
106 MVs/ml. The internalization and accumulation of
MVs peaked at 72 h for all the different concentrations
but, once again, decreased at a concentration of 50 × 106
MVs/ml (Fig. 3a).
As seen by confocal microscopy, after 24 h of incuba-
tion with MVs, endometrial cells showed a fine granular
fluorescent pattern within their cytoplasm, indicating in-
corporation of MVs (Fig. 3b and c).
In vitro effect of MVs on endometrial cells treated with LPS
Viability cell tests The effect of LPS and MVs was eval-
uated by apoptotic and cell proliferation tests. The
rate of cells at the early stage of apoptosis increased
dramatically on treatment with LPS; indeed, the per-
centage of apoptotic cells reached 55 ± 4.1 % at 12 h of
stress, decreasing to 40.48 ± 4.82 % at 24 h. The rate
of apoptosis due to MVs is not statistically different
from endometrial cells alone (Fig. 4a). The results of
the cell proliferation test showed the opposite trend to
the apoptotic test, confirming the effect of LPS and
MVs (Fig. 4b).
MVs were able to counteract the action of LPS either
when used simultaneously with LPS or when incorpo-
rated from endometrial cells 24 h before the treatment
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with LPS. In this condition, cells previously treated with
MVs and after being exposed to LPS had a lower apop-
totic rate (P < 0.05) than the control cells, at both 12 and
24 h of experiment (12.01 ± 1.38 % vs 18.05 ± 1.34 % at
12 h and 15.56 ± 1.5 % vs 24.5 ± 2.78 % at 24 h). On the
other hand, the stress induced by LPS exposure before
the treatment with MVs was not contrasted by MVs and
the apoptotic rate increased up to 63.16 ± 6.8 % at 24 h
(Fig. 4c). The results of the cell proliferation test showed
the opposite trend to the apoptotic test (Fig. 4d).
Fig. 1 Morphology of a endometrial (EDCs) and b amniotic cells. c Expression of specific endometrial markers revealed by qualitative PCR on
endometrial cells at passage 0 (P0). GAPDH glyceraldehyde-3-phosphate dehydrogenase, HOXA9 homeobox protein Hox-A9-like, MPR membrane-
associated progesterone receptor, NC negative control, PGRMC1 progesterone receptor membrane component 1, PR progesterone receptor
Fig. 2 Representative micrographs of internalization by endometrial cells of MVs labeled with PKH-26. Under a fluorescent microscope, the
endometrial cell nuclei are blue and the MVs are red. a No incorporation of MVs pre-incubated with trypsin. Incorporation of 40× 106 MVs/ml into the
target cells from b 24 h, c 36 h, d 48 h, and e 72 h, respectively
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Molecular biology study
The expression of some pro-inflammatory genes was
evaluated by qRT-PCR. Endometrial cells, LPS, and
MVS were tested alone. Data were obtained from three
samples and are shown in Fig. 5. LPS at 3 h significantly
upregulated (P < 0.05) the expression of TNF-α and IL-6
(0.0019 ± 0.317E–6 and 10.54 ± 0.014, respectively) and of
ILβ-1 at 24 h (9.91 ± 0.017). Endometrial cells used as
controls (CTR) and MVs did not induce expression of
pro-inflammatory genes. In the experiment with simul-
taneous use of LPS and MVs, the action of LPS was
counteracted by MVs; indeed, the expression of IL-6 at
first increased significantly (P < 0.05) at 3 h by LPS and
then fell significantly in the presence of MVs either at
12 h (2.41 ± 0.039) or at 24 h (1.15 ± 0.081). IL-1β at
24 h was completely and significantly (P < 0.05) down-
regulated (0.22 ± 0.0008). The expression of TNF-α is
not dependent on the presence of MVs.
When LPS was used for 3 h before adding the MVs, the
action of LPS was neutralized by the presence of MVs.
Indeed, the expression of IL-6 at 3 h, 12 h, and 24 h was
2.08 ± 0.0019, 1.75 ± 0.0033, and 2.65 ± 0.0013, respectively,
compared to the treatment with LPS only. In addition, the
expression of IL-1β was significantly (P < 0.05) downregu-
lated at 24 h (0.21 ± 0.0016).
Under the final condition of MVs for 24 h and then
LPS, the expression of all genes was downregulated.
TNF-α expression at 3 h fell 0.0002-fold compared to
the treatment with LPS. IL-6 expression was statistically
(P < 0.05) downregulated at each time point, and IL-1β
was statistically (P < 0.05) downregulated at 24 h.
A moderate but significant (P < 0.05) increase in the
expression was observed for MMP-1 (5.18 ± 0.44) and
MMP-13 (2.69 ± 0.19) compared to untreated cells
when endometrial cells were exposed to LPS for 24 h
(Fig. 5d and e). The presence of MVs, simultaneously
to LPS, significantly counteracted the effect of LPS on
the expression of metalloproteinases as shown by the
striking reduction in the expression levels for MMP-1
(1.67 ± 0.14) and MMP-13 (0.36 ± 0.11).
miRNA analyses by RNA extraction and PCR amplification
Expression of specific miRNA was determined by PCR
assay that showed the presence of miR-26a-2, miR-335,
and miR-146a in both MVs and cells isolated from the
amniotic membrane (Fig. 5f ).
Cytokines
The results of the release over time (3, 12, and 24 h) of
pro-inflammatory (TNF-α and IL-6) and anti-inflammatory
Fig. 3 MV uptake. a Graph of dose/exposure time for microvesicle (MV) incorporation. The uptake of MVs drastically increased at 72 h for
all concentration but decreased at 50 × 106/ml MVs. Data represent the mean and SD of three independent experiments. b, c Representative z-stack
orthogonal projection micrographs showing the internalization of MVs as detected by confocal microscopy in two group of endometrial cells
co-cultured with MVs for 24 h. The images were taken at different plans scanned every 0.5 μm from top to bottom of the nucleus and showed at
different magnification. a.u. arbitratry units
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(TGF-β) cytokines by endometrial cells stimulated with
10 ng/ml of LPS and treated with MVs are shown
graphically in Fig. 6.
Cells stressed with LPS secreted significantly (P < 0.05)
more TNF-α and IL-6 at 3 h and 12 h, respectively,
when compared to control cells and cells treated by
MVs. The MVs, used simultaneously or incorporated
from endometrial cells 24 h before the treatment with
LPS, were able to counteract the action of LPS and sig-
nificantly (P < 0.05) and equally decreased the produc-
tion of TNF-α and IL-6, mainly between 12 h and 24 h.
Cells incubated with LPS for 3 h before the treatment
with MVs secreted significantly more TNF-α and IL-6
when compared to all the other experimental conditions.
TGF-β was constitutively produced by control cells
but the treatment with MVs induced a higher release
(P < 0.05) of TGF-β, mainly when used simultaneously
with LPS or incorporated from endometrial cells 24 h
before the treatment with LPS. No efficacy of MVs was
evident after LPS-induced stress of cells for 3 h before
the addition of MVs.
Discussion
MVs are secreted by MSCs. Although bone marrow rep-
resents the most widely investigated source of MSCs,
cells harvested from bone marrow have limited potential
in terms of in vitro proliferation capability [43, 44] and
do not appear to noticeably improve long-term function-
ality [45] compared to those from extra-fetal tissues.
AMCs have already been demonstrated to be an excel-
lent source for the treatment of tendon diseases in horse
[26]. Furthermore, Lange-Consiglio et al. [46] used the con-
ditioned medium derived from AMCs for the treatment of
horse tendon diseases and showed that the positive evolu-
tion of spontaneous tendon injuries in competition
horses was comparable to that achieved with AMCs,
thereby showing that AMC-CM had angiogenic and
immunomodulatory properties mediated by paracrine
mechanisms. Corradetti et al. [39] demonstrated that
equine AMCs share the same transcriptional profile as
endometrial cells and express genes that are involved in
early pregnancy, pre-implantation, and conceptus de-
velopment. In addition, co-culture of endometrial cells
by transwell in the presence of AMCs, or incubated
with CM, showed a significant increase in the prolifera-
tion rate of endometrial cells compared to fibroblasts
and the CM secreted by them. All these preliminary
data suggest that AMCs and CM exert regenerative ef-
fects through paracrine mechanisms, and that AMCs
and their CM may have the potential to improve endo-
metrial cell replenishment. Since MVs are contained in
the CM, the aim of the present study was to investigate
the role of MVs produced by AMCs in in-vitro cell-to-
cell communication that could ultimately lead to endo-
metrium repair. We ultimately aim to demonstrate that
they could be used as effective tools for regenerative
medicine purposes, especially in the reproduction field.
Our results show that AMCs secrete MVs (with a mean
size of 258 nm) as detected by a Nanosight instrument,
and this size allows us to categorize them as shedding
vesicles. Moreover, we found that MVs are easily internal-
ized by endometrial cells. Fluorescent microscopy analysis
Fig. 4 Results of viability and proliferation. The rate of cells at a the early stage of apoptosis and b absorbance values of the cell proliferation test in
control cells. c Early apoptosis rate and d absorbance values of the cell proliferation test in treated cells. Data represent the mean and SD of three
independent experiments. Values labeled with different letters are statistically different within each time point (3 h, 12 h and 24 h) (P < 0.05). MV
microvesicle, LPS lipopolysaccharide
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suggests that the uptake of MVs by endometrial cells starts
at 6 h after co-culture and increases gradually at 24 h, ris-
ing to the maximum internalization at 72 h at all different
concentrations. At a concentration of 50 × 106 MVs/ml, a
decrease at 48 h and 72 h was detected. We hypothesize
that after 48 h and 72 h of exposure at 40 × 106/ml, the
cells are saturated and phagocytosis of MVs, for the re-
lease of their contents into the cell cytoplasm, begins. This
phagocytosis probably results in the destruction of the
MV membranes and, consequently, in the loss of fluores-
cence signal. Cocucci et al. [47] demonstrated that the in-
ternalization of MVs is the result of the direct fusion or
endocytic uptake by target cells. Once internalized, the
MVs fuse their membrane with that of endosomes, mak-
ing a horizontal transfer of their contents into the cyto-
plasm of the recipient cells. Alternatively, MVs can remain
segregated inside the endosomes and be phagocytized by
lysosomes or eliminated from the cells after fusion with
the plasma membrane through a mechanism of transcyto-
sis [47]. Our data show that horizontal transfer of the con-
tents of MVs within endometrial cells could be one of the
mechanisms of action of MVs, although other methods of
interaction may occur simultaneously. The process of up-
take and internalization of MVs by the endometrial cells
could also be facilitated by the presence of surface cell re-
ceptors. This hypothesis is confirmed by the results of
Fig. 5 Quantitative RT-PCR analysis for the expression of a TNF-α, b IL-6, and c IL-1β in endometrial cells in different experimental conditions.
Expression of d MMP-1 and e MMP-13 in endometrial cells exposed to 10 ng/ml LPS (LPS10 24h) and simultaneously to 10 ng/ml LPS and MVs
(LPS10 24h + MV). Expression levels have been normalized to the reference gene (GAPDH). Data are represented as fold-change compared with
the expression observed in endometrial cells (control, CTR). Values are mean ± SD (n = 3). P values of expression levels in respect to control are
shown above groups when significant in panels a–c, and the values labeled with different letters are statistically different (P < 0.05) in panels
d and e. f PCR assays to determine the presence of different miRNA (miR-26a-2, miR-335, miR146a), and small nucleolar snoRNA, C/D Box 95
(SNORD95; positive control) in MVs and cells (C) isolated from amniotic membrane. CTR control, IL interleukin, L molecular weight ladder, LPS
lipopolysaccharide, MMP matrix metalloproteinase, MV microvesicle, NC negative control, ns not significant, TNF tumor necrosis factor
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experiments in which MVs were treated with trypsin be-
fore being incubated with endometrial cells. Having identi-
fied that the endometrial cells represent target cells for
MVs secreted by equine AMCs, a further aim of this study
was to understand whether MVs might be involved in the
regeneration of endometrial diseases. Obviously, due to the
difficulty of studying the repair systems of endometritis in
vivo, we recapitulated in vitro the inflammatory process by
stimulating cells with LPS.
The inflammatory response is a complex process in-
volving many signaling cascades and cytokines have a
significant role in the recruitment of inflammatory
cells [48]. In the genital tract, the initial response of
the endometrium against infection is dependent on in-
nate immunity and mucosal defense systems [49, 50].
The uterine immune response is generated not only by
professional immune cells but also by endometrial epi-
thelial and stromal cells, which can respond to LPS
through the Toll-like receptors (TLRs) [51]. Activated
TLRs subsequently stimulate the production of pro-
inflammatory cytokines and chemokines [52].
To understand the mechanism of action of MVs, a
single concentration of 40 × 106 MVs/ml was used after
stress induced with LPS. This concentration was chosen
because, during the study of internalization, endomet-
rial cells at 24 h of culture were not saturated with
MVs and no MV degradation started.
In these experiments, we used LPS and MVs under
different conditions. In control cells, even if the apop-
tosis is higher than expected, the cell proliferation of
80 % remaining cells was very high during the 24 h of
experimentation, as proven by MTT values. Indeed,
Fig. 6 Effect of LPS and MVs under different experimental conditions on the release of TNF-α, IL-6, and TGF-β in endometrial cells. Each value
represents the mean ± SD of three samples. Values labeled with different letters are statistically different within each time point (3 h, 12 h and
24 h) (P < 0.05) CTR control, IL interleukin, LPS lipopolysaccharide, MV microvesicle, TGF transforming growth factor, TNF tumor necrosis factor
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viability was constantly high over the different times of
culture, and values of absorbance also did not statisti-
cally change in the presence of MVs. When the cells
were stressed with LPS, the viability decreased with re-
spect to control cells and cells cultured in the presence
of MVs. Indeed, apoptosis increased drastically after
treatment with LPS and, vice versa, the proliferation de-
clined to the same intensity. The dose of LPS (10 ng/ml)
was chosen on the basis of data obtained by Herath et
al. [53]. These authors found that this value is present in
cows with clinical endometritis. Also, over a short time,
this dose of LPS is probably also deleterious for endo-
metrial cells in a static system in vitro if compared to in
vivo environments, where this effect can be modulated.
These results underscored the stressor effect of LPS that
has been reduced by the beneficial effect of MVs on the
vitality of cells. When LPS and MVs were used at the
same time, the viability of cells was high without signifi-
cant differences compared to control cells. These results
confirm the anti-inflammatory properties of MVs. How-
ever, the beneficial effect of MVs is time-dependent. In
fact, MVs did not counteract the action of LPS if the
cells were previously exposed to LPS (3 h LPS exposure).
On the other hand, LPS does not show any detrimental
effect if the internalization of MVs in the endometrial
cells occurred 24 h before LPS treatment.
The expression of pro-inflammatory genes supports
these data. LPS induces overexpression of IL-1β at 24 h
and MVs are able to counteract this action. Indeed, at
24 h this expression is downregulated in all three experi-
mental conditions (LPS and MVs simultaneously, LPS
for 3 h and then MVs, MVs for 24 h and then LPS). This
downregulation is observed even in the experiment
where cells were previously exposed to LPS. The cells
surviving the apoptotic process are probably able to in-
corporate MVs that, at 24 h, are capable of counteract-
ing the action of LPS. The overexpression of IL-6 and
TNF-α induced by LPS occurs at 3 h and, at this time,
MVs used either simultaneously or added after the ac-
tion of LPS are not able to block the action of LPS. This
seems to indicate that the downregulation of these genes
could occur only when the cells are incubated with MVs
for a longer time to guarantee the necessary incorpor-
ation of MVs. Indeed, we found that MVs were visible
only after 6 h and increased up to 24 h.
In parallel with gene expression, the release of cyto-
kines was studied, confirming the observations regarding
gene regulation. LPS was demonstrated to be capable of
inducing the release of TNF-α the peak of which was ob-
tained 24 h after stimulation with LPS. The release of
IL-6 appeared earlier and reached the highest level 12 h
after stimulation with LPS, and then gradually decreased
over the subsequent observation period. MVs reduce the
release of these pro-inflammatory cytokines and the
maximum modulatory activity was observed between
12 h and 24 h, both when MVs were used simultan-
eously or 24 h before LPS treatment. In both cases, no
contrasting action of MVs was obtained within the first
3 h, confirming that the internalization had yet to begin.
MMP-1 and MMP-13 expression is induced by IL-1β,
so the expression of these two genes was investigated at
24 h after treatment with 10 ng/ml LPS, taking into ac-
count the higher expression of IL-1β at this time. MMP-
1 and MMP-13 expression was statistically higher com-
pared to the control, confirming the inflammatory effect
induced by LPS. Matrix metalloproteinases (MMPs) are
a family of structurally related zinc/calcium-dependent
proteinases with a pivotal role in the extracellular matrix
degradation during both normal and pathological tissue
remodeling processes [54, 55]. In addition, the MMP
collagenases are key participants in extracellular matrix
remodeling and are important for the separation of bo-
vine placental tissues from the endometrium at term
[56]. MMP-1, -2, -3, -9, and -13 are all highly expressed
in the bovine endometrium in late gestation [57], while
MMP-1 and MMP-13 expression levels are downregu-
lated in postpartum endometrium. Our study demon-
strated that MVs downregulated the expression of
MMP-1 and MMP-13 at 24 h of LPS treatment.
It is well known that miRNA-containing microvesicles
can regulate the inflammation process [58]. In this con-
text, from our results it is possible to assume that the
cargo of MVs contributed to the anti-inflammatory ef-
fect. Since MVs contain various active molecules, such
as lipids, proteins, mRNA, and miRNA [29], we studied
the presence of three miRNAs in MVs involved in the
regulation of pro-inflammatory genes in our in vitro
model (miR-335, miR-146a, and miR-26a-2). miR-335
has been demonstrated to regulate the expression of
TNF-a and IL-6 during human adipose cell inflammation
[59]. miR-146a has been demonstrated to decrease the
expression of IL-1β and, as an indirect effect, to suppress
the level of MMP in intervertebral discs in bovine spe-
cies [60]. miR-26a-2 has been widely studied and it has
been correlated with human inflammation, cell prolifera-
tion, and apoptosis [61]. The DIANA tool confirmed
that these miRNAs have predicted targets also in horse
inflammation. The downregulation of gene expression
shown in this study could be correlated to miRNA trans-
fer from MVs to endometrial cells.
Conclusion
These data provide a critical starting point for beginning
to dissect how equine amniotic MVs respond to and
alter an inflammatory situation, shown to be a promising
approach for the treatment of endometritis. Much re-
search is still needed to establish the true biological role
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of miRNAs in endometrial disease with a view to trans-
lating this knowledge into clinically effective outcomes.
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Equine Amniotic Microvesicles
and Their Anti-Inflammatory Potential
in a Tenocyte Model In Vitro
Anna Lange-Consiglio,1 Claudia Perrini,1 Riccardo Tasquier,1 Maria Chiara Deregibus,2
Giovanni Camussi,2 Luisa Pascucci,3 Maria Giovanna Marini,4 Bruna Corradetti,4
Davide Bizzaro,4 Bruna De Vita,5 Pietro Romele,6 Ornella Parolini,6 and Fausto Cremonesi1,7
Administration of horse amniotic mesenchymal cells (AMCs) and their conditioned medium (AMC-CM)
improves the in vivo recovery of spontaneous equine tendon lesions and inhibits in vitro proliferation of
peripheral blood mononuclear cells (PBMC). This process may involve microvesicles (MVs) as an integral
component of cell-to-cell communication during tissue regeneration. In this study, the presence and type of
MVs secreted by AMCs were investigated and the response of equine tendon cells to MVs was studied using a
dose–response curve at different concentrations and times. Moreover, the ability of MVs to counteract in vitro
inflammation of tendon cells induced by lipopolysaccharide was studied through the expression of some
proinflammatory genes such as metallopeptidase (MPP) 1, 9, and 13 and tumor necrosis factor-a (TNFa), and
expression of transforming growth factor-b (TGF-b). Lastly, the immunomodulatory potential of MVs was
investigated. Results show that AMCs secrete MVs ranging in size from 100 to 200 nm. An inverse relationship
between concentration and time was found in their uptake by tendon cells: the maximal uptake occurred after
72 h at a concentration of 40 · 106 MVs/mL. MVs induced a downregulation of MMP1, MMP9, MMP13, and
TNFa expression without affecting PBMC proliferation, contrary to CM and supernatant. Our data suggest that
MVs contribute to in vivo healing of tendon lesions, alongside soluble factors in AMC-CM.
Introduction
There are three regenerative mechanisms ascribed tomesenchymal stem cells (MSCs): (i) differentiation to-
ward reparative or replacement cell types, (ii) enhancement
of the nutrient supply, and (iii) improvement of the survival
and function of endogenous cells through paracrine actions
[1–3]. It is known that the inhospitable microenvironment of
injured or degenerating tissues may result in the death or
apoptosis of a large proportion of implanted MSCs in the
short period immediately posttransplantation [4]. This raises
the need to identify other mechanisms than differentiation of
transplanted cells for the promotion of regeneration. This
notion is supported by a recent study of Lange-Consiglio
et al. [5] in which a conditioned medium (CM), derived
from amniotic mesenchymal cells (AMCs), was injected into
spontaneous injuries of equine tendons and ligaments and
produced results consistent, and overlapping (in terms of time
to complete healing), with the beneficial effects of trans-
planted AMCs as observed in the same animal model [6].
These results suggest that it may be possible to substitute
cell treatment with the use of CM derived from the culture
of these cells as the in vivo effects are mainly exerted by
factors released from cells rather than through the direct
cell-to-cell contact. This hypothesis was further supported
by the evaluation of the immunosuppressive properties of
AMC-CM, as peripheral blood mononuclear cell (PBMC)
proliferation was inhibited by AMC-CM [5].
Secreted bioactive molecules may act as paracrine or
endocrine mediators directly activating target cells and/or
causing neighboring cells to secrete functionally active
agents [7]. However, little is known about how the MSCs
might release these secretions. Many of the secreted mol-
ecules cannot freely cross cell membranes, and a carrier is
needed to facilitate the crossing [8]. It has recently been
demonstrated that extracellular vesicles, or microvesicles
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(MVs), released from cells are an integral component of
cell-to-cell communication in tissue regeneration [9,10]
and therefore may contribute to the paracrine action of MSCs.
These vesicles can be categorized into exosomes and shed-
ding vesicles. Exosomes arise from the endosomal membrane
cell compartment and are released into the extracellular space
after fusion of multivesicular bodies with the plasma mem-
brane [11–13]. Shedding vesicles, also known as ectosomes
or microparticles, originate from direct budding and ‘bleb-
bing’ of the plasma membrane of many different cell types
[11–13]. Exosomes tend to be homogeneous in size (30–
120 nm), while shedding vesicles are more heterogeneous
(ranging from 100 nm to 1mm). MVs express surface recep-
tors and contain biologically active molecules such as pro-
teins and lipids, as well as mRNA and microRNA [14].
Some in vivo studies have indicated that MVs could ac-
celerate the recovery from acute kidney injury induced by
glycerol in SCID mice [15], or significantly improve the
recovery of blood flow in a rat hind limb ischemia model
[16] suggesting that the therapeutic potential of MSC-derived
MVs was similar to that of MSCs. Considering the in vivo
results in spontaneous equine tendon lesions treated with
AMC-CM and the in vitro results on inhibition of PBMC
proliferation [5], it appears reasonable to assume that MSC-
derived MVs act as mediators in the repair of tendon lesions.
In this context, the aims of this study were to identify the
presence and type of MVs secreted by AMCs and elucidate
whether equine tendon cells can be the target of MVs in vitro.
In addition, in an explorative study, we considered whether
MVs are able to counteract an in vitro equine tendon cell
inflammatory process induced by lipopolysaccharide (LPS)
and their effect on inhibition of PBMC proliferation.
Materials and Methods
Materials
Tendon samples were collected from horses slaughtered
in a national slaughterhouse under legal regulation. Che-
micals were obtained from Sigma-Aldrich Chemical unless
otherwise specified, and tissue culture plastic dishes were
purchased from Euroclone.
Study design
Initially, amniotic cells were isolated and cultured to
produce MVs that were characterized using Nanosight and
transmission electron microscopy (TEM). Tendon cells were
then isolated and specific tendon genes were identified by
qualitative PCR. Isolated tendon cells were used as the
target for different concentrations of MVs. Furthermore, the
effect of MVs was analyzed by quantitative PCR expression
of inflammatory genes on tendon cells treated by LPS and,
last, the effect of MVs on inhibition of PBMC proliferation
was also investigated.
Tissues collection and cell isolation
This study was approved by the Ethics Committee of the
University of Milan and written owner consent was ob-
tained. All procedures were conducted following standard
veterinary practice and in accordance with 2010/63 EU di-
rective on animal protection and Italian Law (D.L. No. 116/
1992). Allanto-amniotic membranes were obtained at term
from normal pregnancies in three mares. Samples of allanto-
amnion were transported at 4C in calcium- and magnesium-
free phosphate-buffered saline (Euroclone) supplemented with
4 mg/mL amphotericin (Euroclone), 100 UI/mL penicillin–
100 mg/mL streptomycin (Euroclone), and were processed
within 12 h of collection. The amniotic membrane was me-
chanically separated from the allantois and the isolation
of AMCs was performed as previously reported by Lange-
Consiglio et al. [17].
Superficial digital flexor tendon samples were aseptically
collected from the mid-metacarpal region from three horses
within 2 h of slaughtering (mean age: 7 – 3 years). Tendon
cells were isolated by stripping off the sheath and paratenon
from tendon samples to obtain 2–3 g of trimmed tissue cut
into small pieces with scalpel and scissors and then digested
in HG-DMEM supplemented with 0.075% collagenase
type I at 37.5C overnight (about 16–20 h). The digested
suspension was filtered on an 80 mm strainer, centrifuged at
400 g for 10 min, and washed twice in PBS. Before seed-
ing, cells were counted using a Burker chamber with the
Trypan Blue dye exclusion assay.
Cell culture and expansion
Amniotic and tendon cell cultures were established in
the HG-DMEM standard medium composed of 10% fe-
tal calf serum (FCS), penicillin (100 UI/mL)–streptomycin
(100 mg/mL), 0.25 mg/mL amphotericin B, and 2 mM glu-
tamine. The medium was supplemented with 10 ng/mL
epidermal growth factor for AMC cultures. Cultures were
established at a density of 1 · 105 cells/cm2 in T75 culture
flasks. The flasks were incubated at 38.5C with 5% CO2
and 90% humidity. The medium was replaced after 72 h to
remove nonadherent cells and then replaced twice weekly
until cells reached approximately 80% confluence. Cells were
then detached with 0.05% trypsin-EDTA (Euroclone), coun-
ted, and redistributed at a density of 1 · 104 cells/cm2 into
new culture flasks to maintain and expand the culture for
three passages (P). Previous molecular biology analyses at
P3 showed that these AMCs display a typical mesenchymal
stromal phenotype, with the expression of markers such as
CD29, CD44, CD106, CD105, and MHCI, but not of CD34
and MHCII, as reported by Lange-Consiglio et al. [17]. At
P3, AMCs were used to obtain the CM or MVs and for the
TEM analysis. At P3, tendon cells were used for the in
vitro experiment with MVs and LPS, or cryopreserved in
liquid nitrogen, using standard cryopreservation protocols,
for the molecular biology study to confirm the character-
istics of isolated cells.
Preparation of AMC-CM
AMCs at P3 were plated into 24-well plates at a density
of 5 · 104 cells/mL/well in DMEM standard medium. To
generate AMC-CM, cells were cultured for 5 days at 37C
in a humidified atmosphere of 5% CO2. Supernatants (SN)
from each plate were then collected, pooled, centrifuged at
700 g, and stored at +4C until use. This procedure was
performed for cells obtained from three different placentas.
The final AMC-CM was obtained pooling the media ob-
tained from different amniotic samples.
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Isolation and measurements of MVs
MVs were obtained from the culture media of AMCs de-
rived from three different placentas, cultured for a week with
HG-DMEM supplemented with 10% MV-deprived FCS and
overnight in HG-DMEM deprived of FCS, and supplemented
with 0.5% of BSA (Sigma). The overnight culture media
were centrifuged at 2,000 g for 20 min to remove debris, then
at 100,000 g (Beckman Coulter Optima L-100K ultracen-
trifuge) for 1 h at 4C, washed in serum-free medium 199
containing N-2-hydroxyethylpiperazine-N-2-ethanesulfonic
acid (HEPES) 25 mM (Sigma), and submitted to a second
ultracentrifugation under the same conditions. After ul-
tracentrifugation, SN were stored at +4C until use for
lymphocyte proliferation test, while the pellets were im-
mediately resuspended in HG-DMEM, and a sample of the
resuspended pellet was taken for measurements of MV size
and concentration. A second fraction was labeled with
fluorochrome PKH-26 and the remaining part of pellet was
cryopreserved with 1% of dimethylsulfoxide at -80C and
used for the in vitro test. Size and concentration of MVs
were evaluated by the Nanosight LM10 instrument (Nano-
particle tracking analysis, NTA; Nano-Sight Ltd.), which
permits discrimination of microparticles less than 1mm in
diameter. The software (NTA 2.0 analytic software) allows
the analysis of video images of particle movement under
Brownian motion and the calculation of diffusion coeffi-
cient, sphere equivalent, and hydrodynamic radius of particles
by using the Strokes–Einstein equation. This instrument was
configured with a 405 nm laser and a high-sensitivity sCMOS
camera (OrcaFlash2.8, Hamamatsu C11440; NanoSight Ltd.).
Videos were collected and analysed using the NTA soft-
ware with the minimal expected particle size, minimum track
length, and blur setting, all set to automatic. Ambient tem-
perature was recorded manually and did not exceed 25C. Five
microliters of each sample was diluted in sterile physiological
solution to a final volume of 1 mL. Samples were analyzed
within 15 min of the initial dilution with a delay of 10 s be-
tween sample introduction and the start of the measurement.
For each sample, multiple videos of 30 s duration were re-
corded generating replicate histograms that were averaged.
TEM of MVs
For TEM analysis, AMCs were detached from the well
by trypsin-EDTA and centrifuged at 600 g for 10 min to
remove the culture medium. Cells were then fixed with 2.5%
glutaraldehyde in 0.1 M cacodylate buffer (CB) pH 7.3, for
1 h at 4C. The pellet was subsequently washed twice in CB,
postfixed in 2% osmium tetroxide, dehydrated in a graded
series of ethanol up to absolute, preinfiltrated, and embed-
ded in Epon 812. Ultrathin sections (90 nm) were sectioned
and mounted on 200-mesh copper grids, stained with uranyl
acetate and lead citrate, and examined under a Philips EM
208 transmission electron microscope (TEM) equipped with
a digital camera [University Centre for Electron Microscopy
(CUME)—Perugia].
MV labeling with PKH-26
To trace in vitro MVs by fluorescence microscopy, MVs
from AMCs were labeled with the red fluorescence aliphatic
chromophore intercalating into lipid bilayers PKH26 dye
(Sigma). Briefly: after ultracentrifugation, the MV pellet was
diluted to 1 mL with the PKH-26 kit, and 2mL of fluoro-
chrome were added to this suspension and incubated for
30 min at 38.5C. Thereafter, 7 mL of serum-free DMEM
were added to the suspension that was ultracentrifuged again
at 100,000 g for 1 h at 4C. The final pellet was immediately
resuspended in HG-DMEM.
Incorporation of MVs in tendon cells
To study the capacity of MVs to be incorporated into
tendon cells, a dose–response growth was performed in three
replicates. Tendon cells were seeded at a density of 60· 103
on culture slides (13 mm; Nalgen Nunc International) in
24 wells and cocultured with 10-20-30-40-50· 106 MVs/mL
labeled with PKH-26 dye, and preincubated or not with
trypsin (0.5 mM) for 24, 48, and 72 h at 38.5C. At the end of
each experimental condition, cells were nuclear stained with
10mg/mL of Hoechst 33343 for 15 min at 38C. The uptake
of MVs was evaluated by an Olympus BX51 microscope
equipped with a Scion Corporation 1394 video camera in-
terfaced with a computer provided with software for image
acquisition and analysis (Image-Pro Plus 5.1-Media Cyber-
netics; Immagini & Computer). Excitation wavelength was
positioned at 550 nm, while emission wavelength was set at
567 nm. Hoechst 33342 dye (Sigma) was excited at 353–
365 nm, while the emission wavelength was set at 460 nm.
To detect the intensity of fluorescence, a semiquantitative
analysis was performed. Different images were acquired for
each condition then, for each image, the area of interest (AOI;
where the signal was present) was manually defined by the
user. Inside the AOI, up to three different background signals
were sampled. The background areas were positioned by
the user only where the fluorescent signal was not specific.
The maximum value collected from the background areas
was then used to define the threshold. Only fluorescence with
an intensity above the threshold was considered to indicate
fluorescence due to labeled MVs. Finally, the program mea-
sured the signal intensity expressed in arbitrary unit (a.u.).
Confocal microscopy analysis to assess internalization of
MVs was performed using a Leica SP2 laser scanning
confocal microscope (Leica Microsystems Srl) equipped
with a PL Fluotar 20x AN 0.5 Dry objective.
In vitro effect of MVs on tendon cells
treated with LPS
Dose/response curve of LPS on tendon cells was studied
showing that 100 ng/mL and 48 h were the dose and the time
most effective in inducing cellular stress evaluated by ap-
optotic study (data not shown). Sixty thousand cells were
incubated with and without LPS (100 ng/mL) in the pres-
ence or absence of 40· 106 MVs/mL for 24 and 48 h.
Tendon cells at different times were used as control. At the
end of each experimental condition, cells were detached
with 0.05% trypsin-EDTA, centrifuged, and cryopreserved,
for molecular biology studies, in liquid nitrogen using
standard cryopreservation protocols.
Molecular biology study
After isolation from tendon tissue, cells were analyzed to
detect the expression of specific tendon genes. Total RNA
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was extracted from tendon cells immediately after isolation (P0)
using TRI Reagent Solution (Life Technologies). Samples were
then treated with DNase to avoid DNA contamination. RNA
concentration and purity were measured by Nanodrop Spec-
trophotometry (NanodropH ND1000). The cDNA was synthe-
sized from total RNA (500 ng) using the PrimeScript RT
reagent Kit (Takara Bio). The gene expression evaluation was
performed using specific sequences; equine-specific oligonu-
cleotide primers were designed using open source PerlPrimer
software v. 1.1.17 based on available NCBI Equus caballus
sequences or on mammal multialigned sequences. Primers
were designed across an exon–exon junction to avoid ge-
nomic DNA amplification and their sequence conditions
and the references used are shown in Table 1.
Conventional reverse transcription-PCR (RT-PCR) on ten-
don genes as tenascin (TN), tenomodulin (TNDT), decorin
(DCN), and collagen type I (COL1A1) was performed in a
25mL final volume with RBC Taq DNA Polymerase (RBC
Bioscience) under the following conditions: initial denaturation
at 95C for 2 min, 32 cycles at 95C for 30 s (denaturation),
55–60C for 30 s (annealing), 72C for 1 min (elongation), and
final elongation at 72C for 7 min. For conventional PCR,
primers were used at 300 nM final concentrations.
After treatment of cells with LPS and MVs or CM, some
specific genes involved in the inflammatory process were
analyzed by RT-quantitative PCR (RT-qPCR) that was per-
formed with SYBR green method in a MyiQ iCycler thermal
cycler (Biorad). Matrix metallopeptidase 1 (MMP1), ma-
trix metallopeptidase 9 (MMP9), matrix metallopeptidase 13
(MMP13), and tumor necrosis factor-a (TNFa) were proin-
flammatory genes selected for this study. Transforming
growth factor-b (TGFb) was evaluated as anti-inflammatory
gene. Triplicate PCR reactions were carried out for each
sample analyzed. The reactions were set on a strip in a
final volume of 25 mL by mixing, for each sample, 1 mL of
cDNA, 12.5 mL of 2X concentrated SYBR Premix Ex Taq II
(Takara Bio) containing SYBR Green as a fluorescent in-
tercalating agent, 0.2 mm forward primer, 0.2 mm of reverse
primer, and MQ water. PCR efficiencies were tested and
found to be close to 1. The thermal profile for all reactions
was 30 s at 95C and then 40 cycles of 5 s at 95C and 30 s
at 60C. Fluorescence monitoring occurred at the end of
each cycle. Efficiency of amplification for each primer was
monitored through the analysis of serial dilution. Additional
dissociation curve analysis was performed and in all cases
showed a single peak. The data thus obtained were analyzed
using the iQ5 optical system software version 2.0 (BioRad).
The expression of each gene was normalized to the reference
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(internal control) to standardize the results by eliminating
variation in cDNA quantity.
PBMC isolation
Horse PBMCs were obtained from heparinized whole blood
samples, after informed consent was obtained from the owners,
using density gradient centrifugation (Lymphoprep; Axis-
Shield) at 500 g without brakes for 20 min at room temperature.
PBMC proliferation test
Proliferation was induced by stimulating PBMC (2 · 105
horse PBMC/well in a 96-well flat-bottomed plate) through
the addition of phytohemagglutinin (PHA; Sigma) at a final
concentration of 2mg/mL in a final volume of 200 mL/well
of RPMI complete medium. To study the effects of MVs on
PBMC proliferation, MVs were used in different amounts:
100· 106, 50· 106, and 5 · 106 in 100 mL of DMEM sup-
plemented with 0.1% penicillin/streptomycin and 10% FCS.
The same concentrations of MVs were tested after sonica-
tion by Soniprep 150 instrument (MSE). PBMC prolifera-
tion was tested also with 170, 120, and 80 mL/well of CM in
its entirety and its SN obtained after centrifugation to sep-
arate the MVs.
All cultures were carried out in triplicate.
In all cases, PBMC proliferation was assessed after 3 days
of culture by adding 0.67 mCi per well (96-well tissue cul-
ture plates) of [3H]-thymidine (INC Biomedicals) for 16–
18 h. Cells were then harvested with a Filtermate Harvester
(PerkinElmer), and thymidine incorporation was measured
using a microplate scintillation and luminescence counter
(Top Count NXT; PerkinElmer).
Table 1. Primer Sequences and Characteristics
Markers Forward Reverse bp
Decorin (DEC) CCAATGTTCTGATTTGGGTCTG GTTGTTGACAAGAATCAACGC 152
Tenomodulin (TNMD) CCATGCTGGATGAGAGAGGT GTTGCAAGGCATGATGACAC 152
Tenascin-C (TEN) CAAGTTCACAACAGACCTC AGGTCGTGTCTCCATTCAG 184
Collagen type I (COL1A1) CTACGATGGCTGCACGAGTC GACAGGGCCAATGTCGATGC 151
Matrix metallopeptidase 1
(MMP1)
ACTGCCAAATGGACTTCAAGCTGC TCTTCACAGTGCTAGGAAAGCCG 158
Matrix metallopeptidase 9
(MMP9)
CGACGAAGAGTTGTGGTCTCTGG GCGGTCGGTGTCATAGTAGGC 184
Matrix metallopeptidase 13
(MMP13)
CTCTGGTCTGCTGGCTCACGC CCAAACTCGTGTGCAGCGAC 132
Tumor necrosis factor-a
(TNFa)
GCCTCAGCCTCTTCTCCTTC GGCTTGTCACTTGGGGTTC 172
Transforming growth factor-b
(TGFb)
GGAATGGCTGTCCTTTGATG CGGAGTGTGTTATCTTTGCTGTC 120
glyceraldehyde-3-phosphate
dehydrogenase (GAPDH)
TAACGTGTCAGTCGTGGATC TTGTCATACCAGGAAATGAGC 234
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Statistical analysis
For quantitative PCR data, nonparametric tests were used.
The Mann–Whitney U-test was employed to compare two
groups (treated vs. untreated). Results were considered sta-
tistically significant if the value of P was <0.05.
For PBMC proliferation test, paired t-test, baseline cor-
rected unpaired t-test, and ANOVA plus Tukey’s test were
used with GraphPad Prism software, version 6. Results were
considered statistically significant if the value of P was <0.05.
Results
Tissue collection and cell isolation
Cells were selected purely on their ability to adhere
to plastic. For AMCs, initial viability was >90%, whereas
for tendon cells it was >80%. Amniotic cells (Fig. 1A) and
tendon cells (Fig. 1B) displayed typical fibroblast-like
morphology. AMCs observed at the early stages of culture
were organized as three-dimensional clusters (Fig. 1C).
The molecular biology study on tendon cells confirmed
that these cells were tendon cells because of the expression
of TN, TNMD, DCN, and COL1A1.
Isolation and measurements of MVs
In all studied samples, the viability of AMCs at the time of
MV collection was 99% as detected by trypan blue exclusion.
By Nanosight, the size of MVs ranged from 50 to 670 nm,
with a mean size of 258 – 55 nm for three samples. The
number of MVs ranged from 800 to 4,700 particles/cell,
with a mean value of 2,550– 71 particles/cell (corresponding
to 540· 106 particles/mL of medium).
TEM of MVs
TEM revealed the presence of variably sized, extracellu-
lar membranous vesicles budding from or lying near the
source cell and characterized by an electron-lucent or mod-
erately electron-dense content (Fig. 2A, B). The size of MVs
varied from about 100 to 1,000 nm, with a predominance of
vesicles between 100 and 200 nm. The vesicles were roughly
spherical.
Although active budding was not frequently observed, it is
believed that, because of size and morphological character-
istics, the vesicles observed were mainly shedding vesicles
(microvesicles), rather than exosomes. Multivesicular bodies
in the early stages of maturation were occasionally detected
(Fig. 2C). This suggests that the production of exosomes by
these cells is less relevant compared with shedding vesicles.
Incorporation of MVs in tendon cells
As seen by fluorescence microscopy, in all studied sam-
ples, no fluorescence signal was detectable up to the sixth
hour of coincubation of MVs, and tendon cells and only
FIG. 1. Morphology of amniotic (A)
and tendon cells (B). AMCs observed
at the early stages of culture organized
as three-dimensional clusters (C). Re-
sults of molecular biology study on
tendon cells (D). AMC, amniotic
mesenchymal cell.
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nuclei stained with Hoechst 33342 were visible (Fig. 3A).
Neither was any signal detected after treatment of MVs with
trypsin. When MVs were incorporated into cells, a fine
granular fluorescent pattern was detectable within the cy-
toplasm, indicating the incorporation of labeled MVs. Under
a fluorescent microscope, the tendon cell nuclei (blue), the
MVs (red), and the merged image, show the incorporation of
MVs into the target cells (Fig. 3B–D). The internalization
and accumulation of MVs peaked between 24 (Fig. 3E) and
72 (Fig. 3F) h.
As seen by confocal microscopy, after 24 h of incubation
with MVs, tendon cells showed a fine granular fluorescent
pattern within their cytoplasm, indicating incorporation of
MVs (Fig. 4).
At higher concentrations, uptake rate was faster: 50· 106
MVs were incorporated in 24 h, 40· 106 MVs in 48 h, and
30 · 106 MVs in 72 h (Fig. 5). Moreover, the uptake of MVs
drastically increased at 72 h at a concentration of 40· 106
MVs and decreased at the concentration of 50· 106 MVs
(Fig. 6).
In vitro effect of MVs on tendon cells treated
with LPS
The expression of some proinflammatory genes was eval-
uated by RT-qPCR and nonstimulated tendon cells were used
as a control. Data were obtained from three samples. A
moderate, but significantly (P< 0.05) increased gene expres-
sion of MMP1 (1.6– 0.14) and MMP9 (4.4– 0.14) was ob-
served compared to tendon cells 48 h after exposure to LPS
(Fig. 6). A significantly higher expression of MMP13 (16.7–
0.12) and TNFa (8.47– 0.42) were noticed 48 h after LPS
exposure compared to baseline levels (Fig. 7). The pres-
ence of MVs had a significant effect on the gene expression
of metallopeptidases when compared to expression levels
of control. In particular, a striking reduction in the ex-
pression levels for MMP1 (0.77 – 0.2), MMP9 (2.4 – 0.18),
MMP13 (7.22 – 0.18), and TNFa (3.42 – 0.21) was found at
48 h after addition of MVs. At 24 h, the combination of
LPS and MVs increased the expression of MMP9. Tendon
cells constitutively express TGFb that decreased after LPS
treatment, but it is restored from MVs.
PBMC proliferation test
Through in vitro studies, we demonstrated that MVs did
not inhibit PBMC proliferation after activation with PHA
even after sonication of them (Fig. 8). The only inhibitor
effect was evident with CM in its entirety and its SN ob-
tained after centrifugation to isolate MVs (Fig. 8), without a
statistical difference between them. The inhibitory effect
was dose dependent either with the CM or its SN with
significant effect at 170 and 120mL, but not with 80mL.
Discussion
AMCs are the focus of great interest in veterinary re-
generative medicine for their in vitro multilineage differ-
entiation potential, their great in vitro expansion, and for
their potential therapeutic applications in vivo in spontane-
ous equine tendon lesions [5]. Their paracrine effects have
been demonstrated in in vitro and in vivo [6] studies, sug-
gesting that soluble factors are implicated in the AMC ef-
fects and cell-cell contact is not necessary for their action.
Cell-derived MVs were described as a new mechanism for
cell-to-cell communication [18], indeed, MVs are released
by a variety of cell types, [18,19] including stem cells and
progenitor cells [9,20]. In this study, we investigated whe-
ther equine AMCs produce MVs and if tendon cells could be
targeted by them. Our results show that AMCs secret MVs
FIG. 2. Electron micro-
scopy analysis of MVs. (A–
C) Arrows show the release
of MVs from the surface of
an AMC. Asterisk shows a
multivesicular body in the
early stage of maturation (D).
Scale bar: 500 nm for (A, C,
and D), 200 nm for (B). MV,
microvesicle.
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FIG. 4. Representative z-
stack micrographs showing
the internalization of MVs as
detected by confocal micros-
copy in tendon cells co-
cultured with MVs for 24 h.
(A) The images were taken at
different plans scanned every
0.5 mm from top to bottom of
the nucleus. (B) Orthogonal
projection of the same group
of cells. Color images avail-
able online at www.liebertpub
.com/scd
FIG. 3. Representative micrographs of internalization by tendon cells of MVs labeled with PKH-26. Under a fluorescent
microscope, the tendon cell nuclei (blue), the MVs (red), and the merged image, which show incorporation of MVs into the
target cells. (A) No incorporation of MVs preincubated with trypsin. MVs (B), tendon cell nuclei (C) and merged image (D)
show the incorporation of MVs into the target cells. (E) Internalization in tendon cell at 24 h and (F) 72 h. Color images
available online at www.liebertpub.com/scd
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(with a mean size of 258 nm) as detected by a Nanosight
instrument. The TEM analysis confirmed this size, under-
lining that the vesicles observed are mainly shedding vesi-
cles or MVs. Indeed, the production of exosomes by these
cells was more rarely detected. An interesting finding is the
number of MVs that these cells are capable of secreting. In
our experimental conditions, each amniotic cell, plated at a
density of 1 · 104 cells/cm2, is able to secrete approximately
2,550 MVs, corresponding to about 540· 106 particles/mL
of SN. Moreover, we found that MVs are easily internalized
by tendon cells. Fluorescent microscopy analysis suggests
that the uptake of MVs by tendon cells shows an inverse
relationship between concentration and time. Indeed, the
highest concentrations are internalized in a shorter time and,
vice versa. The behavior of the cells stimulated with MVs
for 72 h is surprising. More MVs (determined by semi-
quantitative analysis) are incorporated at 72 h when com-
pared to other studied times, but after a peak of
internalization with 40 · 106 MVs/mL, there is an abrupt
decrease of fluorescence intensity detected at 50· 106 MVs/
mL. Obviously, the target cell is able to incorporate MVs,
but it must be able to use their contents too. We hypothesize
that after 72 h of exposure at 40 · 106/mL, the cells are
saturated and phagocytosis of MVs, for the release of their
contents into the cell cytoplasm, begins. This phagocytosis
probably results in the destruction of the MV membranes
and, consequently, in the loss of fluorescence signal. A
mechanism for internalization as a result of the direct fusion
or endocytic uptake by target cells was demonstrated by
Cocucci et al. [21]. Once internalized, the MVs can fuse
their membrane with that of endosomes, making a hori-
zontal transfer of their contents into the cytoplasm of the
recipient cells. Alternatively, MVs can remain segregated
inside the endosomes and be phagocytized by lysosomes or
eliminated from the cells after fusion with the plasma
membrane through a mechanism of transcytosis [21]. Our
data show that horizontal transfer of the contents of MVs
within tendon cells could be one of the mechanisms of ac-
tion of MVs, although other methods of interaction may
occur simultaneously. Indeed, the lack of MV internaliza-
tion by tenocytes after treatment with trypsin is interesting.
Presumably, the interaction between membrane receptors of
FIG. 5. Micrographs of
dose/exposition time for MV
incorporation. No fluores-
cence signal was detectable
up to the sixth hour of coin-
cubation of MVs and tendon
cells. At higher concentra-
tions, the uptake rate was
higher: 50 · 106 MVs were
incorporated in 24 h, 40 · 106
MVs in 48 h, and 30 · 106
MVs in 72 h. Color images
available online at www
.liebertpub.com/scd
FIG. 6. Graph of dose/ex-
position time for MV incorpo-
ration. The uptake of MVs
drastically increased at 72 h at
40·106 MVs and decreased at
50·106 MVs. Data represent
the mean and SD of at least
three independent experiments.
In the curve of 72 h, values la-
beled with different letters are
statistically different (P<0.05).
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the MVs and target cell surface receptors is required for the
process of internalization. The removal of surface molecules
by trypsin treatment inhibits their incorporation, confirming
the importance of surface molecules in the internalization of
MVs. Bruno et al. [15] found that MSC-derived MVs ex-
pressed several adhesion molecules of MSCs such as CD44,
CD29 (a1-integrin), a4- and a5 integrins, and CD73, but not
a6 integrin. Some of these molecules, namely CD44 and
CD29, were found to be instrumental in MV internalization
into tubular endothelial cells, as treatment with anti-CD44
and anti-CD29 blocking antibodies prevented MV incorpo-
ration. In our study, the simple treatment with trypsin and
the subsequent failure of incorporation of MVs into tendon
cells confirm a process of interaction between the receptor
and the target cells before internalization of MVs.
Having identified that the tendon cells represent target
cells for MVs secreted by equine AMCs, a further aim
of this study was to understand whether or not these MVs
might be involved in the regeneration of tendon injuries
previously treated in vivo with AMC-CM [6]. Obviously,
due to the difficulty of studying the repair systems of spon-
taneous tendon pathology in vivo, we recapitulated in vitro
the inflammatory process by stimulating cells with LPS. The
inflammatory process is essential because the activation of
the inflammatory cascade is an important stimulus for tendon
healing, although persistent inflammation is believed to be the
FIG. 7. Quantitative RT-PCR analysis for the expression of MMP1, MMP9, MMP13, TNFa, and TGFb genes. Cells were
cultured in presence of 100 ng/mL LPS with or without MVs at 24 and 48 h. Expression levels have been normalized to the
reference gene (GAPDH). Data are represented as fold change compared with the expression observed in tendon cells
(control). Values are mean – SD (n = 3). Asterisks depict significant (*P < 0.05) differences. LPS, lipopolysaccharide; RT-
PCR, reverse transcription-PCR.
618 LANGE-CONSIGLIO ET AL.
cause of fibrosis that is counterproductive to achieve a suc-
cessful healing [22]. In physiological conditions, inflammation
becomes self-regulating within the first 24–48 h following an
insult [23]. For this reason, the in vitro experiment was set at
48 h. In this explorative study, we analyzed TNF-a, which it is
a proinflammatory cytokine that mediates inflammation [24]
and genes involved in tendon extracellular matrix degradation.
In addition, expression of TGFb was assessed. Following 48 h
treatment with LPS at 100 ng/mL, MMP1 and MMP9 ex-
pression increased moderately, while MMP13 and TNFa ex-
pression increased more than control. The MMPs are a family
of structurally related zinc-/calcium-dependent proteinases
that play a central role in the extracellular matrix degradation
during both normal and pathological tissue remodeling pro-
cesses [25,26]. Nomura et al. [27] demonstrated that in equine
superficial digital flexor tendinitis, MMP1 was not detected at
mRNA level, while MMP13 was upregulated in the tendinitis
compared to normal tendon, suggesting that MMP13 plays an
important role in tendon injuries in the racehorse. Although the
origin of these MMP13-expressing cells in the tendinitis is still
not clear, we hypothesize that this enzyme could be involved in
the process of superficial digital flexor tendinitis development.
Expression of MMP9 has been reported to increase in horses
with insulin-induced laminitis compared with control horses
[28], so it is plausible that in our static in vitro system, with LPS
treatment, the MMP9 is moderately expressed. These data
confirm our results regarding the moderate increase of MMP1
and MMP9 compared to MMP13 in the LPS treatment.
Since treatment with LPS induced an inflammatory re-
sponse, an explorative study to understand the mechanism
of action by MVs was performed. The single concentration
of 40 · 106 MVs/mL was used because, during the study of
internalization, neither were tendon cells saturated with MVs
at this concentration at 48 h of culture nor did MV degrada-
tion start. In this experiment, MVs downregulated the ex-
pression of MMP1, MMP9, MMP13, and TNFa genes at
48 h of LPS treatment and restored the expression of TGFb
that is constitutively expressed by tendon cells. At 24 h, the
combination of LPS and MVs increased unexpectedly the
expression of MMP9. This behavior was consistent in all
three experiment replicates. From our data not shown, MVs
alone do not induce an upregulation of the genes studied at
different time, but apparently, the combination of LPS and
MVs induced an inflammatory process. In tendon lesion,
the presence of MMP9 is remarkable, but its presence is
probably related to invading cells and their factors [29]. In
our in vitro context at 24 h, MVs could have introduced
factors (such as miRNA) that, acting as an inflammatory
process, temporarily enhanced the expression of MMP9
that is reinstated at 48 h by MVs themselves.
The last study was the PBMC proliferation inhibition by
MVs to confirm that the inhibition obtained by AMC-CM
[5] was due to the paracrine factors that communicate with
immune cells. However, the finding that inhibition of PBMC
proliferation was induced only by whole CM or by its SN
and not by MVs suggests that this competence is imputable
to factors (growth factors) not contained in MVs. This hy-
pothesis was further supported by our findings that PBMC
proliferation was not inhibited by the sonicated or lysed
MVs. A similar effect was recently reported by Del Fattore
et al. [30] with bone marrow-derived extravesicle (EV) that
induced T-cell apoptosis without significantly suppressing
T-cell proliferation, even if EV treatment increased the
Treg/Teff ratio and the immunosuppressive cytokine IL-10
concentration in the culture medium. The divergent effects
of AMC-CM and MVs on PBMC stimulated with PHA are
at present unexplained. Even though it is generally accepted
that MSCs from amniotic membrane or other sources act in
a paracrine manner (for review [31–33]), from our study, it
is possible to hypothesize that the effect of these mecha-
nisms is mainly due to soluble factors and not the cargo of
MVs. Although many studies failed to detect those cyto-
kines and growth factors that are present in low concentra-
tions [34], TGF-b1, hepatocyte growth factor, prostaglandin
E2, interleukin-10, haem oxygenase-1, interleukin-6, and
human leukocyte antigen-G5 are all known to be constitu-
tively produced by MSCs [35–37]. Recently, Rossi et al.
[38] suggested that prostaglandins as one of the key effector
FIG. 8. Lymphocyte pro-
liferation test. Effects of dif-
ferent amounts (100-50-
5· 106) of MVs per mL and
different amount of CM and
SN on the proliferation of
PHA-stimulated lymphocytes
(PBMC + PHA). Data repre-
sent the mean and SD of at
least three independent ex-
periments. *P< 0.05 versus
Control (PBMC + PHA). CM,
conditioned medium; PBMC,
peripheral blood mononuclear
cell; SN, supernatant.
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molecules of the antiproliferative activity of human amni-
otic membrane-derived cells. However, the divergent effects
of AMC-CM and MVs on PBMC stimulated with PHA are
at present unexplained and, as demonstrated by Del Fattore
et al. [30], appear to be different from those exhibited by
their cells of origin. In this context, the immunosuppressive
effects of MVs cannot be ruled out since more studies are
required regarding MVs and lysed MV influence on the
different lymphocytic subpopulations.
Conclusion
Our preliminary results demonstrate that AMCs produce
MVs that are able to target tendon cells. Moreover, these
MVs, in our explorative experimental conditions, exerted
anti-inflammatory effects although they were not able to
suppress immune cell activity in vitro. This let us assume
that in therapeutic in vivo administration of CM, for the
treatment of spontaneous equine tendon injuries [6], both
MVs’ cargo and soluble factors contributed to the regener-
ative effect. Additional works will be needed to better un-
derstand both, the efficacy and the mechanisms of action of
this novel potential tool, which will change the perspective
of the therapeutic use of MSCs in tendon lesions, or in
inflammatory process-based diseases, considering the MVs
as a cell-free therapy.
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ABBREVIATIONS 31 
AMCs: amniotic epithelial derived cells 32 
BAX: Bcl-2–associated X protein 33 
BSA: bovine serum albumin 34 
CM: conditioned medium 35 
COCs: cumulus–oocyte complexes 36 
CTR: control 37 
EDCs: epithelial endometrial cells 38 
EGF: epidermal growth factor 39 
FCS: fetal calf serum 40 
GPX1: glutathione peroxidase 1 41 
HEPES: N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid 42 
HG-DMEM: high-glucose Dulbecco’s modified Eagle’s medium 43 
ICM: inner cell mass 44 
IVC: in vitro culture 45 
IVF: in vitro fertilization 46 
IVM: in vitro maturation 47 
IVP: in vitro embryo production 48 
miRNA: microRNA 49 
MVs: microvesicles 50 
No-CM: no-conditioned medium 51 
PBS: phosphate-buffered saline 52 
ROS: reactive oxygen species 53 
SN: supernantant 54 
SOFaa: synthetic oviductal fluid with aminoacids 55 
TALP: Tyrode’s-albumin-lactate-pyruvate 56 
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ABSTRACT 57 
Conditioned media (CM), secreted by cells during their culture, brings to results similar to co-58 
culture systems in in vitro embryo production. CM is composed of microvesicles (MVs) and soluble 59 
factors that are present in supernatant (SN) after removal of MVs. The effect of different component 60 
of CM has not been studied yet, so we tried to study these interactions in vitro. Secretome of bovine 61 
endometrial and amniotic cells on embryo rate and quality was investigated. Presumptive zygotes 62 
were randomly transferred in SOFaa (control, CTR) or cultivated by adding 20% endometrial or 63 
amniotic CM or SN or 100x106 MVs/ml on day 1, 3 and 5 post fertilization. Embryos were 64 
evaluated on day 7. Results showed that on day 1, only MVs of both cell lines allowed embryo 65 
development but with rate lower than CTR. On day 3, amniotic and endometrial CM and MVs 66 
provided blastocyst, but the rate of CM is statistically lower than those obtained by MVs in both 67 
cell lines. On day 5, all the fractions of secretome of both cell lines provided embryos but only 68 
amniotic MVs gave a rate of embryos comparable to CTR. Qualitatively, only amniotic CM and 69 
MVs on day 5 provided values statistically higher of inner cell mass than CTR. These data were 70 
confirmed by evaluation of genes involved in apoptosis and reactive oxygen species protection. In 71 
conclusion, MVs gave results equivalent or better than CM, and amniotic CM and MVs resulted in 72 
a blastocyst rate comparable to CTR, but with a better embryo quality.  73 
 74 
Key words: embryo quality, bovine, microvesiscles, amniotic cells, endometrial cells 75 
 76 
INTRODUCTION 77 
It is known that, usually, embryos produced in vitro are of a poorer quality when compared with in 78 
vivo ones [1]. Fertilization of eutherian animals occurs in the maternal oviduct. This is the natural 79 
and unique environment to achieve the necessary requirements for embryo life in its early and late 80 
development. The embryo conceived in vitro is manipulated and cultured in very different 81 
conditions and today a huge amount of information, mostly derived from animals, point out the 82 
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alterations that can occur in embryos produced in vitro because of the manipulation and artificial 83 
environmental conditions associated with these techniques [2]. It is quite difficult to define the 84 
degree of influence of the different factors implicated in the in vitro embryo production technique, 85 
such as superovulation, gametes and embryo culture and absence of maternal embryo-signaling [3]. 86 
Some researchers reported that the culture system and the medium composition can affect embryo 87 
quality [4,5] and that the in vitro culture (IVC) of embryo is probably the most relevant factor in the 88 
alterations of epigenetic reprogramming and development of animal embryos produced in vitro. As 89 
a direct result embryo physiology, gene expression and development are compromised [6]. In fact, 90 
while the innate feature of the oocyte is the major factor determining the blastocyst yield, it is 91 
evident that post-fertilization culture environment is critical in defining the quality of the blastocyst 92 
[5,7-9]. This underline the key effect of the maternal microenvironment on the success of early 93 
embryonic development in terms of viability [10]. In mammals, during the pre-implantation stage, 94 
the exchange of different types of signals between the mother and the embryo is thought to be 95 
critical for embryo development and implantation [11].  96 
Thus, successful pregnancy in mammals involves synchronization between a receptive 97 
endometrium and a viable embryo [11-13]. In cattle, it has been considered that the absence of these 98 
signals could be an important cause of the low efficiency of IVF [14].  99 
To mimic the in vivo cross-talk environment, co-culture systems are largely used in in vitro embryo 100 
production (IVP) in different species and, in some mammalian species, somatic cell co-cultures 101 
improved the in vitro development of embryos [15-18]. Indeed, co-culture system with bovine 102 
oviduct epithelial cells used for the development of bovine zygotes produced in vitro enhanced 103 
blastocyst formation and quality of the resulting embryos, inducing also specific transcriptomic 104 
changes [10]. This suggests that paracrine mechanisms of communication exist between “helper” 105 
cells and embryos. In fact, various growth factors, receptors and binding proteins are secreted by 106 
cells in the medium, but the embryos themselves also produce them. Conditioned media (CM), 107 
composed of factors secreted by cells during their culture, were developed and used in bovine 108 
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embryo IVP. Some of these cell-free media, produced, for example, by culturing granulosa, cumulus 109 
or oviductal cells demonstrated a similar effect in development of embryos produced by co-culture 110 
systems [19]. In addition to the reputation of CM, recent studies have uncovered the existence of 111 
MVs, which are released by cells into the extracellular environment. As consequence, we can define 112 
the CM as a composition of soluble factors plus MVs. These MVs have been shown to contain 113 
proteins, lipids (specifically high levels of sphingomyelins), a variety of RNA species, including 114 
microRNAs (miRNAs) and mRNA fragments [20], but researchers are still debating the 115 
presence/absence of DNA inside them. MVs could serve as vehicles for the transfer of these 116 
molecules between cells both locally (autocrine and paracrine) and remotely [21,22]. MVs are 117 
secreted by most of the cells and can be found in organic fluids, for example, MVs have been 118 
isolated from the uterine luminal fluid of cyclic and pregnant sheep [23]. Analysis of these vesicles 119 
revealed miRNAs and proteins expressed both by the conceptus trophectoderm and by the 120 
endometrial epithelium, such as cathepsin L1 and prostaglandin synthase 2. In vitro studies have 121 
shown that these MVs, isolated in pregnant sheep, can transfer RNAs to other cells [23]. These 122 
findings indicate that these MVs likely have a biological role in the interaction between the embryo 123 
and the endometrium, transferring information from the latter supporting early embryo 124 
development, although this hypothesis still needs to be proven. The successful ontogenesis is 125 
dependent on coordination between the embryo and the microenvironments that in vivo is 126 
represented by endometrium, and in vitro by different culture conditions. The in vitro use of feeder 127 
cell or CM probably involve MVs that may participate in this required cross-talk. The effect of 128 
different component of feeder cells secretome has never been studied and, since it is difficult to 129 
study these communications in vivo, we tested these interactions in vitro. Endometrium and amnion 130 
have a role in the establishment of pregnancy, then, their secretome, composed of CM in toto, MVs 131 
and supernatant (SN), composed of CM soluble factors after removal of MVs, was investigated to 132 
know which of these components, if not all, have effects on embryo production, in terms of 133 
blastocyst rate and quality.  134 
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 135 
MATERIALS AND METHODS 136 
Chemicals were obtained from Sigma-Aldrich Chemical (Milan, Italy) unless otherwise specified, 137 
and tissue culture plastic dishes were purchased from Euroclone (Milan, Italy). 138 
Samples of endometrial tissue and ovaries were collected from bovine slaughtered in a 139 
slaughterhouse (INALCA, Ospedaletto Lodigiano, Lodi, Italy) under legal regulations.  140 
Allanto-amniotic membranes were obtained at term of normal pregnancies and after vaginal 141 
delivery from three cows (bos taurus). All procedures were performed according to approved 142 
animal care and use protocols of the institutional ethics committee and to good veterinary practice 143 
for animal welfare as to European directive 2010/63/UE. Moreover, written farmers’ consent was 144 
obtained at the beginning of the study. 145 
 146 
Cell isolation and culture 147 
Portions of allanto-amnion were kept at 4 °C in phosphate-buffered saline (PBS; EuroClone, Milan, 148 
Italy) with 100 U/ml penicillin-100 mg/ml streptomycin and amphotericin B and were processed 149 
within 12 h. The amniotic membrane was stripped from the overlying allantois and cut into small 150 
pieces (about 9 cm2 each) before enzymatic digestion. 151 
Amniotic epithelial derived cells (AMCs) were isolated and characterized as previously reported 152 
[24]. Briefly, amnion fragments were incubated for 9 min at 38.5 °C in PBS containing 2.4 U/mL 153 
dispase (Becton Dickinson, Milan, Italy). After a resting period (5-10 min) at room temperature in 154 
high-glucose Dulbecco’s modified Eagle’s medium (HG-DMEM; EuroClone, Milan, Italy), 155 
supplemented with 10% heat inactivated fetal calf serum and 2 mM L-glutamine, the fragments 156 
were digested with 0.05% trypsin/EDTA for 45 min at 38.5 °C for approximately 45 min. Then, the 157 
amnion fragments were removed and mobilized cells were passed through a 100 µm cell strainer 158 
before being collected by centrifugation at 250 g for 10 min.  159 
Epithelial endometrial cells (EDCs) at early luteal phase (day 4-8, considering day 0 = estrus) were 160 
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isolated according to Donofrio et al. [25]. Shortly, the endometrium was digested in sterile filtered 161 
Hank’s buffered salt solution supplemented with 2 mg/ml collagenase II, 2 mg/ml trypsin III 162 
(Roche), 4 mg/ml bovine serum albumine, and 0.4 mg/ml DNase I for 90 minutes at 38.5 °C in a 163 
shaking bath. Then, cells were filtered through a membrane with a pore size of 80 µm, centrifuged 164 
at 250 g for 10 minutes, and washed twice in PBS. To obtain separate stromal and epithelial cell 165 
populations, the cell suspension was removed 18 h after plating, which allowed selective attachment 166 
of stromal cells. The removed cell suspension was then reseeded and incubated allowing epithelial 167 
cells to adhere. Stromal and epithelial cell populations were distinguished by cell morphology. 168 
Both cell lines were cultured in a medium composed of HG-DMEM supplemented with 10% fetal 169 
calf serum (FCS), 1% penicillin (100 UI/ml)–streptomycin (100 mg/ml), 0.25 mg/ml amphotericin 170 
B and 2 mM L-glutamine. In AMCs culture medium, 10 ng/ml epidermal growth factor (EGF) was 171 
also added. Both cell lines were incubated at 38.5 °C in a humidified atmosphere of 5% CO2, until 172 
they reached passage (P) 3. 173 
 174 
Conditioned medium, microvesicles and supernatant production 175 
For CM production, cells at P3 at confluence were cultured for 5 days in a serum-free medium. 176 
Conditioned media of three samples from each cell line were collected, pooled, centrifuged at 3500 177 
g for 20 min to remove cellular debris. Control medium, no-conditioned medium (no-CM), was 178 
generated in the same way as above, except that no cells were cultured in the plates. 179 
A portion of CM in toto was stored at -80 °C. To obtain MVs and SN, another portion of CM was 180 
ultra-centrifuged (Beckman Coulter Optima L - 100K) at 100,000 g for 1h at 4 °C. SN was collected 181 
and stored at – 80 °C for later use. The pellet was washed in serum-free medium 199 containing N-182 
2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES) 25 mM and submitted to a second 183 
ultra-centrifugation under the same conditions. The resulting pellet, composed of MVs, was 184 
fractionated for MVs analysis or used for the in vitro test. 185 
 186 
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Measurements of MVs 187 
Size and concentration of MVs were evaluated by Nanosight LM10 instrument (Nanoparticle 188 
tracking analysis, NTA, Nano-Sight Ltd., Amesbuty, U.K.), which permits discrimination of 189 
microparticles less than 1 µm in diameter. The software (NTA 2.0 analytic software) allows the 190 
analysis of video images of particle movement under Brownian motion and the calculation of 191 
diffusion coefficient, sphere equivalent and hydrodynamic radius of particles by using the Strokes–192 
Einstein equation. This instrument is equipped with a 405 nm laser and a high-sensitivity sCMOS 193 
camera (OrcaFlash2.8, Hamamatsu C11440, NanoSight Ltd). Videos were collected and analysed 194 
using the NTA software with the minimal expected particle size, minimum track length and blur 195 
setting, all set to automatic. Ambient temperature was recorded manually and did not exceed 25 °C. 196 
Five µl of each sample were diluted in sterile physiological solution to a final volume of 1 ml. 197 
Samples were analyzed within 15 min of the initial dilution with a delay of 10 seconds between 198 
sample introduction and the start of the measurement. For each sample, multiple videos of 30 199 
seconds duration were recorded generating replicate histograms that were averaged.  200 
 201 
MVs labeling with PKH-26 202 
To trace MVs in vitro by fluorescence microscopy, MVs from AMCs and ECs were labeled with the 203 
red fluorescence aliphatic chromophore intercalating into lipid bilayers PKH-26 dye. Briefly, after 204 
ultra-centrifugation, the MV pellet was diluted to 1 ml with PKH-26 kit solution and 2 µl of 205 
fluorochrome were added to this suspension and incubated for 30 min at 38.5 °C. Thereafter, 7 ml 206 
of serum free DMEM were added to the suspension that was ultra-centrifuged again at 100,000 g 207 
for 1 h at 4 °C. The final pellet was immediately resuspended in HG-DMEM and cryopreserved 208 
with 1% of dimethylsulfoxide at -80 °C.  209 
 210 
In vitro embryo production in different IVC media 211 
Collection of oocytes and in vitro maturation (IVM) 212 
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Ovaries were collected from slaughtered Holstein-Fresian cows (bos taurus) whose age, genealogy, 213 
and physiological status were unknown. Ovaries were transported in sterile saline solution (0.9% 214 
NaCl) supplemented with 150 mg/l kanamycin and maintained at 30 °C. About 5940 oocytes were 215 
used to produce embryos to submit to IVC with different culture system. Oocytes were retrieved by 216 
aspiration of 3-5 mm diameter follicles with 18 G needle. Cumulus–oocyte complexes (COCs) were 217 
selected and washed tree times in pre-incubated TCM 199-Hepes buffered supplemented with 10% 218 
FCS.  219 
IVM was performed for 24 h in TCM 199 Earl’s Salt medium supplemented with 10% FCS, 5 220 
μg/ml LH (Lutropin, Vetoquinol, France), 0.5 μg/ml FSH (Folltropin, Vetoquinol) 0.2 mM sodium 221 
pyruvate, 5 μl/ml gentamycin and 1 mg/ml estradiol 17β. Cultures were performed in 70 μl droplets 222 
(up to 20 oocytes/droplet) of the medium under mineral oil, at 38.5 °C in 5% CO2. 223 
 224 
In vitro fertilization (IVF) 225 
IVF was performed in Tyrode’s-albumin-lactate-pyruvate (TALP) medium containing 2 mM 226 
penicillamine, 1 mM hypotaurine, 250 mM epinephrine, 20 μg/ml heparin, 114 mM NaCl, 3.2 mM 227 
KCl, 0.4 mM NaH2PO4, 10mM sodium lactate, 25mM NaHCO3, 0.5mM MgCl2-6H20, 2.0 mM 228 
CaCl2-2H2O, 6mg/ml bovine serum albumin (BSA, Sigma), 5 μl /ml gentamicin, 0.2mM sodium 229 
pyruvate. Frozen-thawed semen of only one bull of proved fertility was prepared by Percoll density 230 
gradient (Amersham Pharmacia Biotec) (45/90%). Semen was thawed at 37 °C for 30 s, placed on 231 
the top of the Percoll gradient and centrifuged for 30 min at 300 g. Semen suspension was diluted in 232 
the appropriate volume of fertilization medium to obtain a final concentration of 107 spermatozoa 233 
per ml. An aliquot of 10 µl of semen was co-incubated with matured oocytes for 18 h at 38.5 °C in 234 
5% CO2. At the end of gamete co-culture, cumulus cells were completely removed and cumulus-235 
free presumptive zygotes were randomly transferred into different culture system and cultured up to 236 
day 7. 237 
 238 
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In vitro culture (IVC) 239 
The standard medium for IVC was synthetic oviductal fluid with aminoacids (SOFaa) composed of 240 
1.1 M NaCl, 72 mM KCl, 12 mM KH2PO4, 7.4 mM MgSO4, 50 mM DL-lactate, 250 mM NaHCO3, 241 
260 mM fenol red, 100 mM sodium pyruvate, 178 mM CaCl2-2H2O, 125 mM Hepes sodium salt, 242 
125 mM Hepes, 30.8 mM glutamine, 500 mM glycine, 84.2 mM alanine, 100X MEM non essential, 243 
100X BME, 2.8 mM Myo-Inositol, 340 mM trisodium citrate, 2% FCS, 0.005 gr/ml BSA, 0.2mM 244 
sodium pyruvate, 5 µl/ml gentamicin.  245 
At the beginning of the culture in SOFaa, presumptive zygotes were randomly assigned to a control 246 
group (CTR, no supplementation), or to one of the experimental groups in which SOFaa was 247 
supplemented with one of the a-cellular extracts on day 1 or 3 or 5. Experimental groups were as 248 
follows: 249 
SOFaa supplemented with 20% of CM obtained by AMCs or EDCs (SOF+CM) added on day 1, 3 250 
or 5;  251 
SOFaa supplemented with 20% of no-CM (SOF+ no-CM) added on day 1, 3 or 5;  252 
SOFaa supplementd with 20% of SN obtained by AMCs or EDCs (SOF+SN) added on day 1, 3 or 253 
5;  254 
SOFaa additioned of 100x106 MVs obtained by AMCs or EDCs (SOF+MVs) added on day 1, 3 or 255 
5. 256 
In every culture condition, IVC was performed for 7 days in 5% O2, 5% CO2 and 90% N2 in 257 
humidified atmosphere at 38.5 °C. Usually, the half of the medium is renewed on day 3 and 6 258 
during culture period. In this study, to avoid stress to the embryo and to allow the action of 259 
secretome, the medium was renewed on day 3 and 5 and these time points (includind day 1 as 260 
culture starting) were chosen to add different components of secretoma to SOF. 261 
 262 
Evaluation of MVs uptake by blastocysts 263 
To confirm MVs incorporation into blastocyst, a group of IVC embryos was cultured in SOF 264 
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supplemented with AMCs- and EDCs-MVs previously stained with PKH-26. A dose–response 265 
curve was studied with different concentration of MVs (10-20-40-60-80-100-150 x106 MVs/ml). 266 
On day 7, blastocysts were stained with Hoechst 33343 (10 μg/mL) and MVs incorporation was 267 
evaluated under fluorescent microscopy BX71 (Olympus). Labeled MVs were excited at 550 nm 268 
while emission wavelength was set at 567 nm. Hoechst 33342 dye was excited at 353-365 nm while 269 
the emission wavelength was set at 460 nm. In addition, confocal microscopy analysis to assess 270 
internalization of MVs was performed using a Leica SP2 laser scanning confocal microscope (Leica 271 
Microsystems Srl, Italy) equipped with a PL Fluotar 20x AN 0.5 Dry objective.  272 
 273 
Blastocyst production rate and viability evaluation 274 
On day 7, embryos of control and experimental groups were counted out of the initial oocytes, for 275 
the evaluation of blastocyst rate. A portion of the blastocyst was used for the analysis of viability, 276 
which was assessed by Hoechst 33342 and propidium iodide staining. Blastocyst were retrieved 277 
from the IVC drops, washed with PBS supplemented with 2% BSA and incubated with Hoechst 278 
33342 (10 µg/ml) and propidium iodide (1 µg/ml) for 15 min at 38.5 °C. Then, they were observed 279 
under fluorescent Olympus BX51 microscope at a magnification of 40x, analyzing the images with 280 
Image-Pro Plus 5.1-Media Cybernetics software. Hoechst 33342 dye was excited at 353-365 nm 281 
while the emission wavelength was set at 460 nm. Propidium iodide was excited at 535 nm while 282 
the emission wavelength was set at 617 nm. 283 
 284 
Differential staining 285 
Another portion of the cultured embryos of control and experimental groups was used for 286 
differential staining. The latter was performed with propidium iodide and Hoechst 33342 after 287 
disrupting the membrane integrity of the surface trophectoderm cells with detergent (Triton X-100), 288 
which permits penetration of propidium iodide into the trophectoderm cells, but not into the inner 289 
cell mass cells. Since all the cells were stained with Hoechst 33342, in this way, the inner cell mass 290 
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(ICM) stained blue and the trophectoderm purple. The staining was performed according to Thouas 291 
et al. [26] with some modifications. Briefly, prior to differential staining, embryo were washed in 292 
PBS supplemented with 5% FCS, then were permeabilised for 30 seconds in PBS containing 0.04% 293 
Triton X-100 and 0.1 mg/ml of propidium iodide. After that, embryos were staining with 10 µg/ml 294 
of Hoechst for 15 min at 38.5 °C and mounted on a glass slide in a small drop of PBS. Four small 295 
pillars of wax were applied and a cover glass was laid over the drop applying a suitable pressure to 296 
visualize cell for counting. Cell counting was performed from digital photographs obtained by a 297 
fluorescent Olympus BX51 microscope at a magnification of 40x at the wavelength previously 298 
described. The images were analysed, using Image Pro-Plus software, by a single operator in a 299 
blinded manner. 300 
 301 
Gene expression assessment in IVP bovine embryos on day 5 of treatment 302 
Genes involved in apoptosis (BAX; Bcl-2–associated X protein) and reactive oxygen species (ROS) 303 
protection (GPX1; glutathione peroxidase 1) were analyzed by reverse transcription-quantitative 304 
PCR (RT-qPCR) in embryos treated on day 5 with CM, MVs, and SN of both cell lines. The mRNA 305 
expression levels of all genes were measured in three samples (biological replicates). Fifteen 306 
blastocyst for each group on day 7 of culture were collected, washed in sterile PBS and immediately 307 
placed in sterile RNAse DNAse–free eppendorf tubes. Samples were kept at -80 °C until RNA 308 
extraction. RNA extraction was performed using Trizol and the concentration of RNAs were 309 
evaluated three times using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, 310 
Wilmington, DE, USA). RNAs quality was checked using the Agilent Bioanalyser 2100 (Agilent, 311 
Santa Clara, CA). RT-PCRs were performed with the High Capacity cDNA Reverse Trascription 312 
Kit (Applied Biosystems/Life Technologies, Carlsbad, CA, USA) using 100 ng of RNA per 313 
reaction. All the qPCR experiments were run in triplicates (technical replicates) using the qPCR 314 
protocol described by TaqMan Fast Gene Expression Assays (Life Tecnologies™) on 7500 Fast 315 
Real-time PCR System instrument (Applied Biosystems by Life Technologies™). To assess gene 316 
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expression, each target gene and the GAPDH, as the housekeeping control gene, were co-amplified. 317 
Conditions of amplifications were an initial step of 95 °C (3 minutes), followed by 40 cycles of 95 318 
°C (30 seconds), 60 °C (30 seconds), and 72 °C (20 seconds), followed by the acquisition of the 319 
melting curve (fluorescence acquisition every 0.5 °C). PCR efficiencies were tested and found to be 320 
close to 1. Efficiency of amplification for each primer was monitored through the analysis of serial 321 
dilution. Additional dissociation curve analysis was performed and in all cases showed a single 322 
peak. 323 
Average target gene threshold cycle (ΔCtg) for each sample (calculated using the CT values of the 324 
technical replicates within each experimental conditions), were normalised to the average GAPDH 325 
values (ΔCtGAPDH) of the same cDNA sample. Then, the expression variations calculated were 326 
normalized to internal control (i.e. CTR) using the ΔΔCt method. Finally, the fold change 327 
expression of each gene was calculated as 2− ΔΔCT [27] Primers from each gene were designed using 328 
Primer3 web interface (www. primer3plus.com). The assay primers were available and synthesized 329 
by Life technologies™. 330 
BAX: Forward AGAGGATGATCGCAGCTGTGGA;  331 
Reverse CAAAGATGGTCACTGTCTGCCATGT; (bp = 300); Gene Bank access NM_173894.1 332 
GPX1: Forward GCAACCAGTTTGGGCATCA; Reverse CTCGCACTTTTCGAAGAGCATA; 333 
(bp = 116); Gene Bank access NM_174076.3. 334 
 335 
Statistical analysis 336 
Development on day 7 was assessed using Chi-square test. Cell counts were compared using one-337 
way ANOVA and the non-parametric Kruskall-Wallis test with Dunn’s pairwise multiple 338 
comparison.  339 
For quantitative PCR expression, Kruskal–Wallis and Mann–Whitney nonparametric tests were 340 
performed to analyze relative mRNA abundance. Differences were considered statistically 341 
significant at the 95% confidence level and P<0.05. Data were analyzed with GraphPad Instat 3.00 342 
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for Windows (GraphPad software, Inc. La Jolla, CA, USA). 343 
 344 
RESULTS 345 
Cell isolation 346 
Cells were selected purely on their ability to adhere to plastic. The initial viability of EDCs and 347 
AMCs was >90%. EDCs and AMCs show typical polygonal epithelial morphology (Figure 1 A,B). 348 
Previous molecular biological analyses on AMCs at P3 showed that these cells display a typical 349 
stem cell phenotype, with the expression of markers, such as CD29, CD44, CD106, CD105, and 350 
MHCI, but not CD34 and MHCII, as reported by Corradetti et al. [24]. 351 
Previously molecular biology study on EDCs confirmed their endometrial nature due to the 352 
expression of ER-A, ER-B, PR and TP53 [28]. 353 
 354 
MVs identification and uptake in bovine blastocyst 355 
The 100,000 g fractions isolated in this study measured using Nanosight Instruments, showed a 356 
major peak in each preparation between 226-363 nm for EDCs (Fig 2A) and 220-295 for AMCs 357 
(Fig 2B). NanoSight analysis determined that amniotic MVs had a dimension between 50 nm and 358 
670 nm, with a mean of 258±55 nm. Considering the seeding density and the amount of MVs 359 
obtained it possible to speculate that AMCs produced about 800 to 4700 MVs/cell, with a mean of 360 
2550±71 MVs/cell, corresponding to 540x106 MVs/ml of CM. Endometrial cell instead produced 361 
MVs with a dimension between 199 nm and 337 nm with a mean of 238±40 nm. Endometrial cells 362 
produced about 2762 to 3414 MVs/cell with a mean of 3166±329 MVs/cell, corresponding to 363 
670x106 MVs/ml of CM. 364 
Fluorescent microscope analysis demonstrated that both amniotic and endometrial MVs were 365 
internalized into blastomeres. Blastomers nuclei were stained in blue by Hoechst 33342 (Fig 3A) 366 
and MVs in red by PKH-26 (Fig 3B). MVs incorporation is better evaluable by the merging of blue 367 
and red images (Fig 3C). A dose–response curve showed that the concentration of 100x106 MVs/ml 368 
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provided the more intense fluorescence signal (data not shown). We calculated that 100x106 MVs 369 
are present in about 20% of CM of both cell lines and, for this reason, SOF was supplemented with 370 
20% of CM or SN.  371 
As seen by confocal microscopy, after incubation with labeled MVs, blastomeres showed a fine 372 
granular fluorescent pattern within their cytoplasm at the same plane of nuclei, indicating 373 
incorporation of MVs (Figure 3D). 374 
 375 
Blastocyst rate 376 
A total of 2820 oocytes were fertilized over the course of this experiment that consisted of three 377 
replicates. 378 
Embryo morphology was evaluated on day 7 after fertilization under a stereomicroscope (Leica) 379 
and the embryos were grouped according to stage (morula, compact morula and blastocyst). Poor 380 
quality morulas/compact morulas were classified as degenerate if there was loss of plasma 381 
membrane integrity (lysis) and/or generalized loss of cell forms. 382 
Blastocyst rate obtained from the different fractions of secretome are showed in Fig 4. In CTR, 383 
blastocyst rate was 35.45±2.53%.  384 
The use of no-CM (control medium) on different days did not provide blastocyst. 385 
CM and SN of both cell lines on day 1 did not provide blastocysts. Amniotic and endometrial MVs 386 
on day 1 gave 24.24±2.75% and 26.19±2.82% of blastocysts, respectively, that were not statistically 387 
different (P>0.05) between them but different (P<0.05) compared to the CTR. 388 
On day 3, CM and MVs, but not SN, of both cell lines provided embryos. Only amniotic MVs gave 389 
a rate comparable to CTR, while the other experimental conditions provided lower results 390 
statistically different (P<0.05) compared to CTR. 391 
On day 5, amniotic CM and MVs provided respectively 34.17±3.29% and 34.85±3.66% of 392 
blastocyst, without statistical difference (P<0.05) between them and CTR. The 25.80±2.83% rate 393 
obtained by amniotic SN on day 5 was statistically lower (P<0.05) than the other groups previously 394 
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described. All the blastocyst rates obtained by endometrial CM, SN or MVs used on day 5 were 395 
statistically lower than amniotic secretome and CTR (21.69±1.87, 13.70±2.05 and 29.27±2.44%, 396 
respectively).  397 
 398 
Embryo viability evaluation 399 
Results of embryo viability by different fractions of secretome are showed in Fig 5. The Fig. 6 A,B 400 
point out an embryo on day 7 and the corresponding viability staining. 401 
The rate of blastomeres viability in CTR was 92.36±4.48%.  402 
Almost all experimental conditions that gave embryos provided a rate of viability not statistically 403 
different (P<0.05) compared to the CTR. Three conditions, namely endometrial CM added on day 404 
3, (83.61±5.18), endometrial SN added on day 5 (84.29±2.71) and endometrial MVs added  on day 405 
5 (85.98±2.77) provided statistically significant lower values of vitality compared to CTR. The only 406 
treatments that gave a statistically significant (P<0.05) higher rate of viable blastomeres than the 407 
CTR were amniotic CM and MVs added on day 5 (99.4±4.83and 98.56±3.27% respectively). 408 
 409 
Embryo quality evaluation 410 
Results of embryo quality by different fractions of secretome are showed in Table 1, 2, 3. The Fig. 6 411 
C shows the differential staining in an embryo on day 7, while the Fig 7 display the number of ICM.  412 
The rate of ICM/trophoblast in CTR was 29.65±2.03. 413 
When blastocysts were differentially stained to permit the cell counting of inner cell mass and 414 
trophectoderm, the rate of ICM/trophoblast was statistically similar (P>0.05) to CTR for all the 415 
experimental condition with two exceptions. Namely, amniotic and endometrial MVs, added on day 416 
1, gave a lower rate (P<0.05) than the CTR, while amniotic CM and MVs added on day 5, provided 417 
a quality of embryos that was statistically better (P<0.05) than the control and the other groups. This 418 
increase is due to the statistically higher number (P<0.05) of ICM cells of the amniotic CM and 419 
MVs treated embryos compared to the CTR (33.66±1.93 and 34.42±1.27 vs 27.6±1.44, 420 
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respectively). On the contrary, the number of trophoblast cell in these experimental conditions was 421 
similar.  422 
 423 
Table 1: Effect of conditioned medium secreted by amniotic or endometrial cells on embryo quality 424 
evaluated by differential staining 425 
 426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
 434 
 435 
 436 
 437 
 438 
 439 
 440 
Different small letters superscripts (a,b,c) indicate statistically different comparisons (P<0.05). 441 
 442 
 443 
 444 
 445 
 446 
 447 
 448 
 449 
 450 
Conditioned 
media 
(CM) 
day Total cells 
Differential staining 
Inner cell 
mass 
Troph Ratio 
ICM:troph 
SOF (CTR)  120.69±5.43 27.6±1.44a 93.09±5.62 29.65±2.03a 
SOF + no-CM 1 - - - - 
SOF + no-CM  3 - - - - 
SOF + no-CM  5 - - - - 
SOF + CM-AMCs  1 - - - - 
SOF + CM-AMCs  3 115.43±8.82 25.6±2.72a 86.12±4.55 29.75±3.48a 
SOF + CM-AMCs  5 128.66±3.52 32.4±1.83b 96.26±5.82 33.66±1.93b 
SOF + CM-EDCs   1 - - - - 
SOF + CM-EDCs   3 101.66±7.55 20.82±2.98c 76.44±8.37 26.7±5.67b 
SOF + CM-EDCs   5 102.91±3.58 25.41±1.03a 87.5±7.54 29.04±2.88a 
19 
 
 
 
Table 2: Effect of supernatant secreted by amniotic or endometrial cells on embryo quality 451 
evaluated by differential staining 452 
 453 
 454 
 455 
 456 
 457 
 458 
 459 
 460 
 461 
 462 
 463 
Different small letters superscripts (a,b,c) indicate statistically different comparisons (P<0.05). 464 
 465 
Table 3: Effect of microvesicles secreted by amniotic or endometrial cells on embryo quality 466 
evaluated by differential staining  467 
 468 
 469 
 470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
 478 
Different small letters superscripts (a,b,c) indicate statistically different comparisons (P<0.05). 479 
 480 
 481 
 482 
Supernatant 
(SN) 
day Total cells 
Differential staining 
Inner cell 
mass 
Troph Ratio 
ICM:troph 
SOF (CTR)  120.69±5.43 27.6±1.44a 93.09±5.62 29.65±2.03 a 
SOF + SN-AMCs  1 - - - - 
SOF + SN-AMCs  3 - - - - 
SOF + SN-AMCs  5 105.54±2.51 22.33±2.58b 83.21±5.86 26.84±2.89 b 
SOF + SN-EDCs   1 - - - - 
SOF + SN-EDCs   3 - - - - 
SOF + SN-EDCs   5 98.98±2.26 20.29±1.17b 78.69±5.56 25.78±2.83 b 
Microvesicles 
(MVs) 
day Total cells 
Differential staining 
Inner cell 
mass 
Troph Ratio 
ICM:troph 
SOF (CTR)  120.69±5.43 27.6±1.44 a 93.09±5.62 29.65±2.03a 
SOF + MVs-AMCs  1 108.15±8.49 20.87±1.64 b 87.28±3.23 23.91±2.41b 
SOF + MVs-AMCs  3 107.83±8.41 25.71±2.16 a 82.12±4.37 31.31±3.33a 
SOF + MVs-AMCs  5 132.98±8.42 34.42±1.27 c 98.56±4.66 34.92±2.98c 
SOF + MVs-EDCs   1 115.72±7.55 23.92±2.66 a 91.78±3.95 26.06±2.37a 
SOF + MVs-EDCs   3 105.77±8.57 20.98±1.14 b 84.79±6.12 24.74±2.85b 
SOF + MVs-EDCs   5 104.42±7.21 23.18±2.83 a 81.22±6.65 28.54±2.51a 
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Embryo gene expression 483 
Regarding gene related to apoptosis, BAX was significantly (P<0.05) downregulated in groups 484 
treated with CM and MVs secreted by AMCs (0.5±0.12 and 0.5±0.13, respectively) but up-485 
regulated with SN of both cell lines compared to CTR group (P<0.05, Fig 8A). GPX1 (Fig 8B), was 486 
significantly upregulated (P<0.05) for treatments with CM and MVs secreted by AMCs compared 487 
to CTR group (3.2±0.27 and 4.0±0.37). GPX1 expression in AMC-MVs was statistically different 488 
(P<0.05) compared to AMC-CM. 489 
 490 
DISCUSSION  491 
As already stated, IVP embryos have a lower development, a lower number of blastomeres and a 492 
higher apoptosis rate compared to the ones produced in vivo in various animal species [29-31]. In 493 
addition, it is known that their implantation rate after transfer is low [32-34]. 494 
To date, to improve embryo quality, the in vitro  blastocysts production is still based on using feeder 495 
cells, mainly oviduct and uterine epithelia cells, to mimic in vivo conditions. This suggests that 496 
paracrine or autocrine trafficking between helper cells and embryos is present. Many growth 497 
factors, receptors and binding proteins are secreted into the culture medium by helpers cells [35,36] 498 
and the potential of these medium, called CM, is already known for a long time. Ijaz et al. [37] and 499 
Zhu et al. [38] defined the CM as a complex matrix of secreted products from cells, in particular 500 
growth factors, cytokines and glycoproteins that may influence the development of early embryos 501 
pre-implantation. Some experiments have shown that the use of CM provides embryo 502 
developmental rates similar to those obtained in the co-culture systems [39-41], with the benefit of 503 
not having animal cells in the embryo culture. To date, the effect of all  components of CM on in 504 
vitro embryo development has not been investigated. Lopera-Vásquez et al. [42] evaluated the 505 
effect of conditioned media (CM) and extracellular vesicles (EVs) derived from bovine oviduct 506 
epithelial cell but they did not studied the effect of soluble factors (SN) only and the incorporation 507 
of MVs inside the blastomeres. Since the embryo interacts with the uterus for implantation and with 508 
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the placenta, this study investigated the effect of different components of endometrial and amniotic 509 
cell secretome on the IVP embryos development. 510 
Endometrial cells were isolated at early luteal face (day 4-8, considering day 0 = estrus) because 511 
only in this case these cells are in contact with the early embryo in vivo up to the blastocyst stage. 512 
The amnion was chosen because Lange-Consiglio et al. [43] used the monolayer of equine amniotic 513 
epithelial cells as feeder to culture bovine embryos with good results, in term of blastocyst rate, 514 
compared to the bone marrow derived cells and control cells, represented by monolayer of cumulus 515 
cells. These authors suggested that EGF, produced by monolayer of amniotic epithelial cells, could 516 
have been one of most representative candidate to play a positive role in the embryonic 517 
development as it happens in vivo for the endometrium. Indeed, EGF is produced in vivo by 518 
endometrial cells and the embryo possesses receptors for it. In this context, in our study, the 519 
amniotic cells were further investigated and compared to endometrial cells through the effect of 520 
their secretoma 521 
In this study, at first, we identified the presence of MVs in CM produced by both amniotic and 522 
endometrial cell culture. By their size it is possible to classify these MVs as shedding vesicles, also 523 
known as ectosomes or microparticles, that originate from direct budding and ‘blebbing’ of the 524 
plasma membrane. These shedding vesicles are different from exosomes that arise from the cell 525 
membrane endosomal compartment and are released into the extracellular space after fusion of 526 
multivesicular bodies with the plasma membrane. Exosomes tend to be homogeneous in size (30-527 
120 nm) while shedding vesicles are more heterogeneous (ranging from 100 nm to 1 μm). MVs 528 
found in amniotic and endometrial CM are similar in size (258±55 nm for AMCs and 238±40 nm 529 
for EDCs) even if, in the same culture conditions and density of seeding, the EDCs produced more 530 
MVs than AMCs (670x106 MVs/ml vs 540x106 MVs/ml). Obviously, these data refer to in vitro 531 
study and no information about their production in in vivo conditions are available. 532 
In this study, at first, the control medium (no-CM) was tested to verify that components of the 533 
original medium used to culture had no effect on in vitro embryo production. No embryos were 534 
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obtained, probably for dilution of SOF with medium no containing growth factors.  535 
After that, the CM in toto and its different components, MVs and SN, were used on different days 536 
during the embryo culture to study the temporal effect, considering the changing nutritional 537 
requirements of the embryo during its development. 538 
The results of our study suggest that the exposition of bovine embryos at different time of culture to 539 
the various fractions of secretome of both cell lines provide dissimilar rates of blastocysts. Among 540 
the different experimental conditions, the best results were obtained when supplementation started 541 
on day 5, corresponding also, in the case of amniotic CM and MVs, to the better culture conditions 542 
for embryo quality. Indeed, this condition did not improve the blastocyst rate compared to the CTR 543 
but enhanced the quality of embryos as observed by the increase of ICM/trophoblast rate and by the 544 
rate of blastomere vitality. In all the other conditions, the rate of blastocysts was lower than CTR 545 
and, mostly, all the results obtained by endometrial CM, SN or MVs used on day 5 were lower than 546 
those obtained by amniotic secretome and CTR groups. In almost all the experimental conditions 547 
that reduced the total number of cells, or that of the inner mass cells, a decrease in embryo viability 548 
was noted. Moreover, the data obtained by addition of amniotic CM in toto or MVs were equivalent 549 
while blastocysts number and quality provided by SN were always scarce or insignificant.  550 
These data were confirmed by gene expression evaluation performed on day five of treatment. 551 
Studies are still not completely in accordance regarding the set of genes capable of reflecting 552 
accurately the effect of different culture conditions on embryo quality [44]. Therefore, we selected 553 
two genes related to apoptosis and ROS protection, respectively. Melka et al. [45] reported that Bax 554 
pro-apoptotic gene expression could be a potential quality marker as they found an upregulation of 555 
this gene in poor quality 4-cell preimplantation embryos with a higher DNA fragmentation, 556 
compared with morphologically good quality embryos at the same stage. Our study, indeed, found a 557 
downregulation of this gene in groups treated by CM and MVs secreted by AMCs compared to 558 
CTR group (P<0.05) and up-regulation in groups treated by SN of both cell lines. 559 
Because embryo protection against oxidative stress relies on the activity of certain antioxidant 560 
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enzymes [46], we have evaluated mRNA expression of GPX1 gene to investigate the effect of 561 
different components of secretome on embryo defense mechanisms against ROS. GPX1 562 
deficiencies can have an effect on the cells, making them more susceptible to possible stressors 563 
leading to an increase in apoptosis. In accordance with this study, our CTR group has less abundant 564 
GPX1 mRNA compared to groups treated by CM and MVs secreted by AMCs, suggesting its 565 
susceptibility to ROS damage. Moreover, the expression of GPX1 in amniotic MVs is higher 566 
compared to amniotic CM 567 
The reasons of the good result on day 5 of supplementation are not clear, and can only be 568 
hypothesized. The beginning of the activation of the genome takes place, in the bovine, between the 569 
8 and 16 cell stage, corresponding, to the embryonic stage attained, in vitro, between day 2 and 4 of 570 
culture. The embryo at this stage may be more susceptible to the influence of culture conditions 571 
compared to other developmental stages [47]. Environmental changes at this stage could unsettle 572 
the activation of the embryonic genome and this would explain why amniotic and endometrial 573 
secretome have not favored embryonic development. On the contrary, the supplementations on the 574 
5th day increased the development of blastocysts. Moreover, probably as in the mouse, two periods, 575 
during which embryos are more responsive to the culture conditions, are recognized which coincide 576 
with the time elapsing between 48 and 72 hours, and between 72 and 120 hours [47]. Furthermore, 577 
day 5 mimics the time of the bovine embryo entrance into the uterus following fertilization and this 578 
would confirm the positive results obtained by supplementation on day 5. It is important to 579 
underline that amniotic secretome appears more suitable than the endometrial one. This might 580 
indicate that the amniotic and endometrial secretome contain different components and that these 581 
differences cause different degrees of development. At this stage of the experiment we did not 582 
investigated the composition of secretome but it is known that CM contain many factors secreted by 583 
the somatic cells. Indeed, some studies have shown that many factors, such as EGF, PDGF, LIF, 584 
IL6, IL1, bFGF, VEGF [39,48,49], and embryotrofic factors [47] are secreted from the cells in co-585 
culture and, therefore, are consequently also present in the CM. Up to our knowledge, as indicated 586 
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in the present study, it is our believe that soluble factors should not be called up for the better 587 
embryo development compared to CTR, because we do not obtained the same results by the use of 588 
SN that is only constituted by soluble factors. As a matter of fact, MVs were able to produce best 589 
results when, added either alone or as components of CM in toto, while the only soluble factors in 590 
CM deprived of MVs did not provide positive results. Moreover, our study evidenced the ability of 591 
embryos to uptake labeled MVs and this could suggests that there may be a mechanism of transfer 592 
of the MVs contents within the blastomeres. 593 
To date, no works in the literature relating to the incorporation of MVs of any origin into the 594 
blastocyst have been traced. A question of particular interest relates to what kind of molecules 595 
contained in MVs is involved in this communication. Recently, several studies have focused on 596 
miRNAs. These small non-coding RNA molecules are present in many biological fluids such as in 597 
follicular fluid or culture media [50]. While total miRNAs in human biofluids or supernatants from 598 
cell cultures may be released from apoptotic cells or cell debris, MVs miRNAs are actively released 599 
by viable cells and are expected to represent an active means of communication between cells and 600 
tissues locally or systemically. MV-encapsulated miRNAs, in particular, are shielded from 601 
degradation and are remarkably stable in biological fluids. Specifically, miRNAs that are 602 
encapsulated by MVs might have a different role compared with miRNAs in biofluids as they 603 
transfer biological information to recipient cells [51]. 604 
Certainly, amniotic MVs induced improvement of embryo quality, compared to endometrial MVs, 605 
by transfer of specific amniotic progenitor cell signals or material. At this stage, we could not 606 
investigate the different expression profile of miRNAs between amniotic and endometrial MVs. In 607 
our study, we can only see their functional influence on embryo development. MiRNAs play an 608 
essential regulatory role during development, indeed, aberration of blastocyst miRNA expression is 609 
associated with human infertility [52]. It could be that miRNAs, transferred by MVs route within 610 
the blastocyst, contribute to the miRNA content of the blastocyst itself promoting their development 611 
and quality. Moreover, it is likely that amniotic secretome promote embryo development in a more 612 
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physiological way than endometrial one, but further experiments are planned to better explain these 613 
data and to better understand MVs cargo of both cell lines. 614 
In conclusion, it is known that co-culture systems improved the in vitro development of embryos, 615 
but after our results, we suggest that in this system, probably, MVs along with their miRNA 616 
contents are involved in this effect. Indeed, the present study demonstrated that the brief in vitro 617 
exposition of embryo to amniotic CM and MVs, but not to soluble factors (SN), improved embryo 618 
quality. Blastocyst rate from IVP is essential and, in this study, culture with amniotic MVs gave 619 
similar rate to CTR. On the other hand, it is mandatory that IVP embryos at the blastocyst stage 620 
should be of the highest possible quality to ensure optimal pregnancy rates after transfer, especially 621 
after freezing and thawing. Amniotic MVs induced increase of ICM and changes in the profile of 622 
expression of some genes known to be related to embryo quality, suggesting reduced apoptosis and 623 
increased capacity to struggle against oxidative stress. Once that relevant miRNAs and functional 624 
targets will identified, a possible clinical use for these molecules will represent the next front line 625 
and may lead to novel strategies for better enhancing or manipulating reproductive efficiency. 626 
Moreover, this study may provide a useful starting point for further studies related to paracrine 627 
mechanisms of communications between embryo and culture medium. 628 
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FIGURE LEGENDS 783 
 784 
Figure 1. Cell morphology. Monolayer of epithelial endometrial (A) and amniotic epithelial cells 785 
(B). Scale bar  = 20µm. Original magnification x20. 786 
 787 
Figure 2. Nanosight analysis. Results of MVs purified from endometrial (A) and amniotic epithelial 788 
cells (B). The mean size and particle concentration values are calculated by the Nanoparticle 789 
Tracking Analysis software that allows the analysis of video images of the particle movement. The 790 
curve describes the relationship between particle number distribution (left Y-axis) and particle size 791 
(X-axis). 792 
 793 
Figure 3. Incorporation of MVs. Representative micrographs of internalization by blastomeres of 794 
MVs labeled with PKH-26. Under a fluorescent microscope, the blastomeric nuclei are blue (A) and 795 
the MVs are red (B). Merge image (C). Representative z-stack orthogonal projection micrographs 796 
showing the internalization of MVs as detected by confocal microscopy in blastocyst co-cultured 797 
with MVs for 24 h (D). The images were taken at different plans scanned every 5 µm from top to 798 
bottom of the blastocyst.  799 
 800 
Figure 4. Graphic representation of effect of secretome produced by amniotic or endometrial cells 801 
on blastocyst rate. Different small letters superscripts (a,b,c) indicate statistically different 802 
comparisons (P<0.05). 803 
 804 
Figure 5. Graphic representation of effect of secretome produced by amniotic or endometrial cells 805 
on embryo viability. Different small letters superscripts (a,b,c) indicate statistically different 806 
comparisons (P<0.05). 807 
 808 
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Figure 6. Evaluation of blastocyst. Blastocyst at 7 day of culture observed at optical microscopy 809 
(A). Vitality staining (B) and differential staining (C).  810 
 811 
Figure 7. Graphic representation of effect of secretome produced by amniotic or endometrial cells 812 
on inner cell mass. Different small letters superscripts (a,b,c) indicate statistically different 813 
comparisons (P<0.05). 814 
 815 
Figure 8. Quantitative PCR analysis for the expression BAX and GPX1 in blastocysts treated on day 816 
5 with secretome of both cell lines. Expression levels normalized to the reference gene GAPDH. 817 
Data are represented as fold-change compared with expression observed in CTR blastocysts. Values 818 
are mean ± SD (n=3). Different letters depict significant (P<0.05) differences between treatments. 819 
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8. DISCUSSIONS 
In veterinary, as in human medicine, fetal adnexa have been recently suggested as appealing 
candidates for the derivation of MSCs to be used in cell-based therapies (Kern et al., 2006; 
Lange-Consiglio et al., 2012) due to their higher proliferation capacity, longer telomeres, 
broader differentiation, and extensive proliferative potential in comparison to cells obtained 
from adult tissues (Lange-Consiglio et al., 2013c). Amniotic mesenchymal cells isolated from the 
equine amniotic membranes share specific characteristics with embryonic and adult stem cells. 
They express representative mesenchymal and pluripotent markers, are highly proliferative and 
retain high plasticity. Taken together, these characteristics make AMCs suitable candidates as 
tool for regenerative medicine, as previously demonstrated by my research group in the 
treatments of equine spontaneous tendon lesions (Lange-Consiglio et al., 2012; Lange-Consiglio 
et al., 2013b).  
In the context of paracrine communication between cells, and considering the inhospitable 
environment of the lesion, due to the presence of inflammation cells and molecules, that lead 
to a premature cell death of the injected cells (Leung et al., 2006), our previous studies tested 
the effect of CM in in vivo equine spontaneous tendon lesions (Lange-Consiglio et al., 2013a). 
The results showed the same effect, in term of rate of relapses, compared to the administration 
of the original stem cells (Lange-Consiglio et al., 2013b). For this reason, in our laboratory, 
recently, the paracrine effect involving CM and MVs in tendon lesions and other pathologies, or 
in paracrine mechanism of cell communication, has been subjected to further studies. All data 
presented in the appended publications provided evidence of the role of the soluble signals 
produced by AMCs.  
At first, we found that AMC-CM promoted in vitro EDCs proliferation demonstrating the 
potential application of this secretome to improve endometrial cell replenishment when low 
endometrial regenerationis associated to pregnancy failure. The cell-cell contact was not 
necessary for the action of AMCs on EDCs proliferation and, since cell-derived MVs have been 
recently described as a new mechanism for cell-to-cell communication (Schorey and Bhatnagar, 
2008), we investigated their presence inside the AMC-CM. We found that AMCs secrete MVs, 
mainly shedding vesicles, and that these MVs are incorporated in both cell lines studied (TNCs 
and EDCs). An interesting finding is the number of MVs that these cells are capable of secreting. 
In our experimental conditions, each amniotic cell, plated at a density of 1x104 cells/cm2, is able 
to secrete approximately 2.550 MVs, corresponding to about 540x106 particles/mL of CM. 
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These values are important in the perspective of MVs application  in the in vivo treatment of 
diseases.  
Moreover, we demonstrate that TNCs and EDCs are in vitro target of MVs because these MVs 
are incorporated in both studied cell lines and their fluorescence signal (after labeling by PKH-
26) is visible inside the cells at the same plane of the nucleus. We do not know the mechanism 
for their internalization by target cells but the hypothesis is that, once internalized, MVs can 
fuse their membrane with that of endosomes or, alternatively, MVs can remain segregated 
inside the endosomes and be phagocytized by lysosomes (Cocucci et al., 2007). In any case, 
their contents is transferred into the cytoplasm of the target cells. We observed the effect of 
MV cargo on cells stressed by LPS. It is known that the stimulation with LPS leads to a 
modification of gene expression of various cytokines and interleukins (TNF-α, IL-1β, IL-8, and IL-
6) revealing, thus, the ability of LPS to contribute to inflammation during the early acute stages 
(Vèzina-Audette et al., 2013). In our explorative study, the expression of TGF-β, TNF-α, MMP-1, 
MMP-9 and MMP-13 genes were investigated for the study on TNCs, whereas TNF-α, IL-6, IL-
1β, MMP-1 and MMP-13 genes were investigated for endometrial studies. Our results showed 
that, in TNCs, a concentration of 40x106 MVs/mL downregulates the expression of MMP-1, 
MMP-9, MMP-13, and TNF-α genes, and restores the expression of TGF-β that is constitutively 
expressed by TCs. 
Considering that inside target cells the fluorescence signal of labeled MVs was visible only after 
the 6th hours of incubation, our question was if the time required by the MVs to transfer the 
signal after their incorporation was enough to counteract the stress effect of LPS. In this 
context, three different experimental conditions were used for EDCs: 1) LPS and MVs were 
administered simultaneously, 2) LPS was administered for 3 h and then MVs were added, 3) 
MVs were administered for 24 h and then LPS was added. Results showed that LPS induced an 
over-expression of IL-6 and TNF-α, and MVs were able to counteract this action when they 
were used either simultaneously or 24 h before the action of LPS. MVs added 3 h after LPS were 
not able to neutralize the action of this stressor. In parallel with gene expression, the release of 
cytokines studied by ELISA confirmed the observations about gene regulation. Indeed, LPS 
induced the release of TNF-α and IL-6, whereas, MVs reduced the release of these pro-
inflammatory cytokines, both when used simultaneously or 24 h before LPS treatment. In both 
cases, no contrasting action of MVs was obtained when MVs were added after LPS. In addition, 
MVs were not able to counteract the action of LPS within the first 3 h, confirming that their 
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internalization has yet to begin. This seems to indicate that the downregulation of these genes 
could occur only when the cells are incubated with MVs for enough time to guarantee their 
necessary incorporation.  
Another important aim of our study was to understand the efficacy of MVs on PBMC 
proliferation inhibition, in order to confirm the presence of paracrine factors as mediators for 
communication with immune cells. However, compared to the data of Lange-Consiglio et al. 
(2013a), where equine AMC-CM showed this potential, MVs were not able to inhibit the PBMC 
proliferation even after their sonication to release their content. Since the whole CM or its SN, 
composed of soluble factor after removal of MVs, showed this competence, we hypothesize 
that this ability is imputable to soluble factors and not to molecules contained in MVs. This let 
us assume that in therapeutic in vivo administration of CM for the treatment of spontaneous 
equine tendon injuries (Lange-Consiglio et al., 2013a), both MVs cargo and soluble factors had 
contributed to the regenerative effect.  
Our results are promising despite the limits just described, that are the time of MVs uptake and 
the lack of immunomodulatory effect. Our studies were performed in in vitro systems which are 
static and, to confirm or not these data, we need to test the effect of these MVs in vivo. Indeed, 
increasing numbers of reports in human medicine indicate that MVs show therapeutic effects 
similar to those that can be achieved by the MSCs themselves. Recently, Zhang et al. (2014) 
elegantly demonstrated that MVs induce recovery from skin burns, promoting skin cell 
proliferation. Katsuda and Ochiya (2015) investigated the in vivo therapeutic potential of MVs 
using animal models of Alzheimer’s disease. These findings, as well as ours, suggest a novel 
therapeutic strategy using MVs as drugs for future regenerative medicine. 
However, MVs and their cargo may play key roles in numerous aspects of biology, including 
reproduction. Gametogenesis, fertilization, implantation and early embryo development are 
complex processes that are highly dependent on communication between cells and organs. 
After the development, embryo migrates into the uterus, and the subsequent adherence of the 
blastocyst to the endometrial luminal epithelium must occur to result in a successful 
implantation (Cuman et al., 2014). Detection of MVs in the reproductive biofluids, including 
plasmastic, seminal, follicular and uterine luminal fluids, points to possible roles of MVs in the 
intercellular communication necessary for and after the conception. In this context, we tried to 
study the effect of amniotic and endometrial secretome on in vitro embryo production. MVs 
were able to produce better results when added either alone or as components of CM in toto 
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during the bovine embryo culture. On the other hand, the soluble factors in CM deprived of 
MVs, which is SN, did not provide positive results. Moreover, our study evidenced the ability of 
embryos to uptake labeled MVs and this could suggests that there may be a mechanism of 
transfer of the MV content within the blastomeres. Surprisingly, amniotic MVs induced 
improvement of embryo quality but further experiments will be needed to better explain these 
data. 
The main question to explain all our data is “how do MVs act?” One of the most attractive 
characteristics of MVs is their ability to transfer RNAs (mRNA, miRNA, piRNA) from one cell to 
another, thereby allowing the transferred RNAs to affect the target cells. Between 2006 and 
2007, a sensational finding demonstrated that MV-contained mRNAs could be transferred in 
recipient cells and translated to proteins (Ratajczak et al., 2006; Valadi et al., 2007). 
Furthermore, in 2010, MVs were shown to transfer miRNAs between cells, and these miRNAs 
displayed RNA interference (RNAi) effects in the recipient cells (Pegtel et al., 2010; Kosaka et 
al., 2010; Zhang et al., 2010). In recent years, MVs containing RNAs have been shown to be 
transferred from MSCs to injured cells and to contribute to tissue recovery (Katsuda and 
Ochiya, 2015). 
MicroRNAs are also proposed to be key molecules responsible for MSC-MVs-mediated 
therapeutic potential. For example, miR-335 has been demonstrated to regulate the expression 
of TNF-α and IL-6 during human adipose cell inflammation (Zhu et al., 2014). MiR-146a has 
been demonstrated to decrease the expression of IL-1β and, as an indirect effect, to suppress 
the level of MMP in intervertebral discs in bovine species (Gu et al., 2015) while miR-26a-2 has 
been widely studied and it has been correlated with human inflammation, cell proliferation, 
and apoptosis (Gao and Liu, 2011). In my PhD project, we investigated the presence of these 
three miRNA and we found their presencein both equine AMCs and their derived MVs. The 
miRBase tool (http://www.mirbase.org/) confirmed that these miRNAs have predicted targets 
also in horse inflammation. The downregulation of pro-inflammatory gene expression showed 
in our studies could be correlated to miRNA transfer from MVs to target cells. 
It is important to say that we expanded the miRNAs cargo of equine amniotic cells and their 
MVs (unpublished data). RNA was extracted from three different samples of AMCs and their 
respective AMC-MVs using Trizol® and purified by NucleoSpin® miRNA kit. RNA concentration 
and quality were determined by Agilent 2100. MicroRNA libraries were generated using the 
TruSeq Small RNA Library Preparation kits. The libraries were pooled and purified on a Pippin 
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Prep system to recover the fractions containing mature miRNAs. The libraries obtained were 
quantified by RT-PCR with KAPA Library Quantification Kits. MicroRNA detection and discovery 
was carried out with Mirdeep2. Equuss caballus miRNAs available at miRBase 
(http://www.mirbase.org/) were used to accomplish known miRNA detection on the trimmed 
sequences. The Mirdeep2 quantifier module was used to quantify expression and retrieve 
counts for the detected miRNAs. Fold change in miRNA expression was calculated based on the 
normalized mean differences between cells, cells and MVs or between cells and the 
corresponding MVs. Statistical analysis were performed by using the t test or ANOVA with 
Newman-Keuls multicomparison test, where appropriate. A p value < 0.05 was considered 
significant. 
Table 1 shows the list of miRNAs presents in the AMC-MVs and their abundancy is referred as 
the average number of the count of the sequences in three samples. 
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Table 1. List of all the miRNAs present in AMC-MVs listed in ascending order referring to the 
average number of counts of the sequences in three samples. 
miRNA Count miRNA Count miRNA Count 
eca-miR-22 299833 eca-miR-130a 2064 eca-miR-107b 464 
eca-miR-21 178114 eca-miR-381 1851 eca-miR-148b-3p 445 
eca-miR-10b 62999 eca-miR-25 1805 eca-miR-323-3p 436 
eca-miR-143 41528 eca-let-7d 1771 eca-miR-451 433 
eca-miR-127 30627 eca-miR-23a 1609 eca-miR-1388 432 
eca-miR-27b 21340 eca-miR-125b-5p 1482 eca-miR-188-5p 411 
eca-miR-24 20906 eca-miR-28-5p 1466 eca-miR-19b 391 
eca-miR-26a 17766 eca-miR-432 1425 eca-miR-1379 369 
eca-miR-16 15046 eca-miR-423-3p 1378 eca-miR-301a 363 
eca-let-7a 14543 eca-miR-146b-5p 1162 eca-miR-193a-3p 352 
eca-let-7f 13408 eca-miR-31 1104 eca-miR-370 328 
eca-miR-411 10592 eca-let-7g 1101 eca-miR-342-3p 322 
eca-miR-221 10497 eca-miR-23b 1097 eca-miR-450b-5p 269 
eca-miR-423-5p 10019 eca-miR-196b 1061 eca-miR-503 255 
eca-miR-186 9874 eca-miR-660 1036 eca-miR-361-5p 246 
eca-miR-30d 9665 eca-miR-486-5p 1010 eca-miR-34a 246 
eca-miR-148a 7823 eca-miR-146a 1007 eca-miR-101 243 
eca-miR-92a 7744 eca-miR-199a-5p 970 eca-miR-132 243 
eca-miR-28-3p 7585 eca-miR-424 961 eca-miR-502-3p 241 
eca-miR-181a 6611 eca-miR-3958 921 eca-miR-134 235 
eca-let-7c 6310 eca-miR-532-5p 921 eca-miR-130b 228 
eca-miR-199a-3p 5456 eca-miR-487b 910 eca-miR-656 226 
eca-miR-199b-3p 5302 eca-miR-30b 890 eca-miR-145 221 
eca-miR-27a 4761 eca-miR-103 822 eca-miR-340-5p 218 
eca-miR-99b 4473 eca-miR-379 808 eca-miR-15b 206 
eca-miR-30e 4104 eca-miR-193b 741 eca-miR-450c 203 
eca-miR-29a 4004 eca-miR-380 738 eca-miR-744 202 
eca-miR-10a 3820 eca-miR-107a 737 eca-miR-125a-3p 201 
eca-miR-100 3531 eca-miR-155 702 eca-miR-122 196 
eca-miR-191a 3361 eca-miR-214 664 eca-miR-99a 196 
eca-miR-378 3254 eca-miR-93 649 eca-miR-485-3p 190 
eca-miR-222 3041 eca-miR-181b 636 eca-miR-17 183 
eca-miR-199b-5p 3032 eca-miR-128 625 eca-miR-487a 180 
eca-miR-125a-5p 2816 eca-miR-369-3p 597 eca-miR-1271a 179 
eca-miR-494 2692 eca-miR-15a 520 eca-miR-485-5p 179 
eca-miR-409-3p 2674 eca-miR-98 520 eca-miR-204b 176 
eca-let-7e 2442 eca-miR-382 520 eca-miR-3548 160 
eca-miR-410 2225 eca-miR-889 509 eca-miR-431 160 
eca-miR-151-5p 2096 eca-miR-30c 490 eca-miR-376c 145 
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miRNA Count miRNA Count miRNA Count 
eca-miR-126-5p 142 eca-miR-18a 56 eca-miR-582-3p 22 
eca-miR-433 139 eca-miR-708 56 eca-miR-140-5p 21 
eca-miR-1307 136 eca-miR-138 52 eca-miR-324-3p 21 
eca-miR-330 136 eca-miR-324-5p 52 eca-miR-331 21 
eca-miR-106a 128 eca-miR-192 50 eca-miR-140-3p 20 
eca-miR-758 127 eca-miR-193a-5p 46 eca-miR-144 19 
eca-miR-20a 122 eca-miR-542-5p 46 eca-miR-676 19 
eca-miR-329b 122 eca-miR-671-5p 46 eca-miR-1468 17 
eca-miR-542-3p 122 eca-miR-532-3p 45 eca-miR-9055 17 
eca-miR-425 118 eca-miR-301b-3p 44 eca-miR-628a 17 
eca-miR-502-5p 117 eca-miR-126-3p 43 eca-miR-34c 17 
eca-miR-1180 115 eca-miR-362-5p 41 eca-miR-142-3p 15 
eca-miR-7 115 eca-miR-377 41 eca-miR-490-5p 15 
eca-miR-454 114 eca-miR-182 39 eca-miR-545 15 
eca-miR-299 112 eca-miR-1 38 eca-miR-340-3p 14 
eca-miR-29b 92 eca-miR-3200 38 eca-miR-872 14 
eca-miR-495 92 eca-miR-500 38 eca-miR-218 14 
eca-miR-374a 91 eca-miR-450a 36 eca-miR-342-5p 14 
eca-miR-505 88 eca-miR-345-3p 35 eca-miR-329a 14 
eca-miR-9021 88 eca-miR-369-5p 35 eca-miR-374b 13 
eca-miR-543 87 eca-miR-148b-5p 34 eca-miR-8946 13 
eca-miR-196a 86 eca-miR-361-3p 33 eca-miR-9080 13 
eca-miR-133a 84 eca-miR-363 33 eca-miR-376a 12 
eca-miR-136 83 eca-miR-296 32 eca-miR-6529 12 
eca-miR-142-5p 83 eca-miR-335 32 eca-miR-150 11 
eca-miR-3959 81 eca-miR-493b 30 eca-miR-671-3p 11 
eca-miR-106b 77 eca-miR-32 28 eca-miR-9163 10 
eca-miR-365 77 eca-miR-1296 27 eca-miR-190a 10 
eca-miR-652 77 eca-miR-501-5p 27 eca-miR-1842 10 
eca-miR-154a 76 eca-miR-409-5p 25 eca-miR-7177b 10 
eca-miR-497 76 eca-miR-539 25 eca-miR-1197 9 
eca-miR-19a 72 eca-miR-184 24 eca-miR-1193 8 
eca-miR-376b 70 eca-miR-350 24 eca-miR-483 8 
eca-miR-1839 68 eca-miR-655 24 eca-miR-185 7 
eca-miR-195 61 eca-miR-194 23 eca-miR-590-3p 6 
eca-miR-197 61 eca-miR-496 23 eca-miR-190b 6 
eca-miR-29c 60 eca-miR-8992 23 eca-miR-8917 6 
eca-miR-92b 59 eca-miR-328 22 eca-miR-1185 6 
eca-miR-149 57 eca-miR-345-5p 22 eca-miR-183 5 
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miRNA Sample miRNA Sample 
eca-miR-615-3p 5 eca-miR-9174 3 
eca-miR-215 5 eca-miR-9180 3 
eca-miR-3065 5 eca-miR-337-5p 2 
eca-miR-874 5 eca-miR-3613 2 
eca-miR-223 4 eca-miR-188-3p 2 
eca-miR-490-3p 4 eca-miR-205 2 
eca-miR-154b 4 eca-miR-212 2 
eca-miR-187 4 eca-miR-491-5p 2 
eca-miR-326 4 eca-miR-541 2 
eca-miR-8986b 4 eca-miR-8920 2 
eca-miR-9060 4 eca-miR-9a 2 
eca-miR-139-5p 4 eca-miR-34b-5p 2 
eca-miR-362-3p 3 eca-miR-323-5p 1 
eca-miR-582-5p 3 eca-miR-1249 1 
eca-miR-8951 3 eca-miR-33b 1 
eca-miR-9178 3 eca-miR-9159 1 
eca-miR-1301 3 eca-miR-8986a 1 
eca-miR-449a 3 eca-miR-129a-5p 1 
eca-miR-504 3 eca-miR-129b-3p 1 
eca-miR-450b-3p 3 eca-miR-129b-5p 1 
eca-miR-873 3 eca-miR-8914 1 
eca-miR-9182 3 eca-miR-8977 1 
eca-miR-200a 3 eca-miR-9126 1 
eca-miR-200b 3 eca-miR-95 1 
eca-miR-675 3 
   
 
  
47 
 
Surprisingly, we found 24 miRNAs enriched in the MVs respect to the original AMCs. Table 2 
shows these miRNA, referred as average of fold change in three samples. 
 
Table 2. List of the 24 top miRNAs differentially expressed in the MVs versus the original AMCs 
expressed as logarithm of fold change (Log FC). The p value is p <0.002 for all the data. 
miRNA Log FC 
eca-miR-144 11,48 
eca-miR-490-5p 10 
eca-miR-223 9,41 
eca-miR-150 9,04 
eca-miR-451 8,37 
eca-miR-486-5p 6,37 
eca-miR-142-3p 5,39 
eca-miR-142-5p 5,39 
eca-miR-146a 4,07 
eca-miR-126-3p 4,02 
eca-miR-122 4,02 
eca-miR-423-5p 3,21 
eca-miR-126-5p 3,2 
eca-miR-125a-3p 3,07 
eca-miR-132 2,94 
eca-miR-9055 2,79 
eca-miR-1468 2,35 
eca-miR-140-3p 2,06 
eca-miR-1180 1,83 
eca-miR-22 1,67 
eca-miR-342-5p 1,53 
eca-miR-323-3p 1,46 
eca-miR-188-5p 1,42 
eca-miR-370 1,05 
 
These results demonstrated that AMCs-MVs contain miRNAs specific of the origin cell that may 
serve as a signature when MVs are administrated to target cells. Twenty-four miRNAs were 
found to be selectively accumulated inside the AMC-MVs suggesting a dynamic regulation of 
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miRNA compartmentalization in the MVs released from amniotic stem cells. These selective 
miRNAs may be transferred and accumulated into target cells where they may downregulate 
specific genes. 
For this reason, through Ingenuity software (http://www.ingenuity.com/products/ipa/ 
microrna-regulatory-analysis) we studied the pathways in which these 24 miRNAs could be 
involved, showing that these pathways are mainly those involved in the inflammatory and 
immune response (table 3). 
 
Table 3. Functional enrichments in the network of the 24 selected miRNAs 
BIOLOGICAL PROCESS (GO) 
pathway ID pathway description count in gene set 
GO:0006952 defense response 62 
GO:0006955 immune response 59 
GO:0045087 innate response 51 
GO:0002376 immune system precess 67 
GO:0051707 response to other organism 39 
 
 
 
  MOLECULAR FUNCTION (GO) 
pathway ID pathway description count in gene set 
GO:0005126 cytokine receptor binding 22 
GO:0005515 protein binding 90 
GO:0005102 receptor binding 38 
GO:0070851 growth factor receptor binding 13 
GO:0005149 interleukin-1 receptor binding 7 
 
The recent finding that MVs may carry selected patterns of mRNAs and miRNAs suggests that 
MVs may represent a new mechanism of genetic exchange between cells. Ratajczak et al. (2006) 
demonstrated that MVs released from embryonic stem cells may reprogram hematopoietic 
progenitors by delivering mRNAs and proteins. The mechanism of mRNA and miRNA 
compartmentalization and in particular whether RNAs are accumulated into MVs in a random or 
organized manner, remain to be defined. However, some studies (Collino et al., 2010; Chen et 
al., 2010), as well as the present results, suggest a selective mechanism of RNA packaging into 
MVs. 
Obviously, the work is in progress because it will be necessary to monitor the 
ribonucleoproteins involved in the intracellular traffic of RNAs and to compare the species of 
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miRNAs contained in the MVs and in the origin cells to obtain information on the mechanism of 
RNA accumulation within MVs. Moreover, it should be demonstrated that the miRNAs 
contained inside MVs are transferred to target cells. This will require the study of miRNAs cargo 
inside the target cells to find the presence of transferred miRNAs and to understand if these 
miRNAs are functional. 
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9. CONCLUSIONS 
Microvesicles display a cell-free approach to regenerative medicine overlapping the potential of 
origin cells, but limiting concerns of using active replicating cells that may undergo mal-
differentiation or mutation. Mesenchymal derived MVs have beneficial effects on the recovery 
from a variety of tissue injuries mainly tested in human medicine. Our results are the first 
indication of their importance also in veterinary medicine. Amniotic derived MVs showed ability 
to down-regulated pro-inflammatory genes expression and apoptosis on cells stressed by LPS. 
Probably, the MSC-MVs content of molecules, including proteins and non coding RNAs, such 
miRNAs and piRNA, are able to mediate these effects, and elucidations on the mechanisms of 
these actions are now in progress. For the realization of clinical applications of MSC-MVs, two 
concerns are important. At first, for future considerations, it will be necessary to improve the 
standardization of the protocols used for their isolation and storage, and to define the criteria 
for characterization and quality control. Moreover, it is important to underline that, in addition 
to preliminary in vitro studies (as in this PhD project), whenever possible, representative animal 
models should be identified and applied in advance of clinical studies investigating MV-based 
therapeutics. Safety, toxicity and immunogenicity need to be monitored in the course of early 
phase clinical trials. Reliable information concerning efficacy and long-term side effects of 
autologous or allogeneic MVs must be obtained before their clinical application. 
Lastly, it is important to underline that our study was performed with amniotic cells that 
represent an alternative and promising source of MSCs. The amniotic membrane, as a MSC 
source, is fascinating in view of producing off-the-shelf products from biological waste. If the 
safety and efficacy of these cells can be proven comparable, or better than MSC from other 
sources, the amnion could become an important and unforeseen cell source of MSCs and their 
secretome. 
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10. FUTURE PERSPECTIVES 
In the next few years, the therapeutic effects of MSC-MVs should be explore and better 
understand. Specifically, proteome analysis of MSC-MVs, and proposed signalling pathways that 
are expected, could predict a single MV molecule as therapeutic effector. 
In our context, once that relevant miRNAs contents in equine and bovine AMC-MVs and 
functional targets are identified, a possible clinical use for these molecules may represent the 
next front line and may lead to novel strategies, for example, for tendon and endometrial 
diseases or for better enhancing or manipulating reproductive efficiency. In this respect, MVs, as 
endogenous carriers of biomolecules, may be particularly advantageous. MVs are naturally 
present in human biofluids, but may also be engineered for tissue-specific transfers. MVs could 
be loaded with a range of molecules and serve as drug delivery vesicles, which provide new 
options in antitumor and immune therapy for targeted drug delivery, for example, or to transfer 
selected compounds into gametes and embryos to increase reproductive success. In this regard, 
the application of synthetic or semisynthetic MVs for therapeutic drug delivery is still in its 
infancy. Issues regarding the understanding of MVs biogenesis, large-scale production, and in 
vivo interactions need to be addressed to develop successful and cost-effective MVs-based drug 
delivery systems. Given their reduced size, their potential to express targeting ligands in native 
conformations, and their deformable structure, MVs offer a logical biological vesicle platform 
for adapting and producing semisynthetic vesicles with excellent potential for nanomedicine 
applications. Undoubtedly, progress in synthetic biology to harnessing MVs for therapeutic 
nucleic acid delivery is crucial to mimic the physicochemical properties of naturally occurring 
MVs to overcome delivery challenges and to establish robust technology platforms. If 
successful, MVs could then transport nucleic acids into a subsequent population of cells, 
including embryos, to obtain the desired effect. 
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12. APPENDIX: OTHER PUBLICATIONS 
During the 3 year-project, the work performed in the laboratory was not only focused on 
the experiments designed for the present thesis. Some hours were spent also working on 
side projects. In this contest, since the laboratory investigates on the biology of the 
reproduction, a paper entitled “Leptin and leptin receptor are detectable in equine 
spermatozoa but are not involved in in vitro fertilization” was published. 
Then, in the field of the regenerative medicine, some experiments were performed on the 
use of PRP as tool for the regeneration. On this basis, two papers entitled “Platelet 
concentrate in bovine reproduction: effects on in vitro embryo production and after 
intrauterine administration in repeat breeder cows” and “Effects of platelet-rich plasma in a 
model of bovine endometrial inflammation in vitro” emerged from the experiments. 
In parallel with the characterization of equine and bovine AMCs, also the porcine ones were 
object of study; from that, a paper entitled “Peculiarity of porcine amniotic membrane and 
its derived cells: a contribution to the study of cell therapy from a large animal model” 
developed from the experiments. 
Alongside the AMCs, other sources of stem cells were investigated and the paper entitled 
“Does the bovine pre-ovulatory follicle harbor progenitor stem cells?” is about the study of 
a potential niche of stem cells in the ovary, whereas the paper titled “Isolation, molecular 
characterization and in vitro differentiation of bovine Wharton's jelly-derived multipotent 
mesenchymal cells” is about the study of stem cells obtained from the Wharton's jelly. 
Finally, during a project developed in Brazil with the team headed by Prof. Felipe Perecin, a 
study on the miRNA differential expression of cumulus-oocyte complexes and their derived 
extracellular vesicles was conducted. The article that emerged, entitled “MicroRNA 
mediated regulation and role of PI3K-Akt pathway in bovine oocyte developmental 
competence” has been submitted to Scientific Report on December, 2016. In this study, we 
tested the hypothesis that oocyte competence is associated with alterations of regulatory 
miRNAs during follicle development, then 348 miRNAs were screened in granulosa cells and 
cumulus-oocyte complexes and their derived MVs. Bioinformatics analyses revealed that 
PI3K-Akt pathway was highly regulated by exclusive miRNAs. Indeed, PI3K-Akt signalling 
pathway had different levels in follicular cells correlating with oocyte competence. This 
miRNA-modulated pathway was downregulated in follicular cells of lower quality oocytes, 
indicated by increased levels of phosphatase and tensin homolog (PTEN) and decreased 
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levels of PTEN regulators bta-miR-494 and bta-miR-20a. In conclusion, it was possible to 
assume that the miRNA expression profiles can be used as tool to identify molecular 
pathways involved in oocyte competence. 
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Abstract. In human and swine, leptin (OB) has been identified in seminal plasma and leptin receptors (OB-R) on the cell
surface of spermatozoa, indicating that spermatozoa are a target for OB. This hormone has also been detected in follicular
fluid (FF) in women and mares, although its role requires further study. The aims of this study were to investigate the
immunolocalisation and the expression of OB and OB-R in equine spermatozoa and to evaluate the involvement of OB in
equine in vitro fertilisation (IVF). Since progesterone (P) andOB are both found in FF, the individual and combined effects
of these two hormones were studied in equine IVF and compared with the results obtained from the use of FF for in vitro
sperm preparation. For the first time, we were able to identify OB and OB-R mRNA and their corresponding proteins in
equine spermatozoa.When spermatozoa were treated with OB, there was a decrease in the three motility parameters VSL,
STR and LIN, commonly associated with hyperactivation, whilst the acrosome reaction rate increased (P, 0.05). The
fertilisation rate was 51% with FF, 46.15% with P, 43.64% with PþOB and 0% with OB alone. The percentage of eight-
cell stage embryos was 18.7%with FF, 17.1%with P and 16.7%with OBþP. OB alone did not permit oocyte fertilisation,
indicating that, in the horse, OB is involved in capacitation and hyperactivation but not in sperm penetration.
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Introduction
In equine species, in vitro assisted reproduction techniques are
challenging. Only two papers report the birth of foals from
in vitro fertilisation (IVF). In both cases, in vivo-matured
oocytes collected by ovum pick-up were used (Palmer et al.
1991; Bezard 1992). The main limiting factors appear to be the
reliance on the zona pellucida for hardening of oocytes and
reduced in vitro capacitation of stallion spermatozoa. Heparin,
equine proteins present in zona pellucida (also called zona
proteins), caffeine and lysophospholipids have been shown to
increase the percentage of capacitated and acrosome-reacted
spermatozoa, although they do not facilitate sperm penetration
into in vitro-matured oocytes (Graham 1996). Following incu-
bation of sperm–oocyte complexes for 1 h there is a low inci-
dence (20%) of the acrosomal reaction (AR) in stallion
spermatozoa bound to the zona pellucida (Ellington et al. 1993;
Cheng et al. 1996; Meyers et al. 1996). The reported low inci-
dence of AR in zona-bound spermatozoa suggests that several
other localised biological agents contribute to induction of the
AR required for successful fertilisation in vivo. Follicular fluid
(FF) represents one of these agents as, at ovulation, it is trans-
ported, together with the cumulus–oocyte complex, from the
follicle to the oviductal ampulla, where fertilisation occurs.
Progesterone (P) has been suggested to be the main active
component in FF responsible for the induction of the AR. When
charcoal treatment is used to remove steroid hormones from FF
it becomes inactive; efficacy is restored when the charcoal-
treated FF is supplemented with P (Cheng et al. 1998). Fur-
thermore, progesterone receptors have been detected on the
surface of spermatozoa in different species including man
(Kirkman-Brown et al. 2002) and horse (Cheng et al. 1998).
Another hormone found in the FF is leptin (OB). This
hormone is the 167-amino acid product of Ob gene expression
(Zhang et al. 1994) and is involved in the regulation of energy
metabolism. OB is synthesised predominantly by adipocytes
and has been shown to be involved in the regulation of various
reproductive functions (Chehab et al. 1996). OB has been
quantitatively assayed in human (De Placido et al. 2006), pig
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(Lackey et al. 2002) and mare FF (Lange-Consiglio et al. 2013).
Both P andOB have been reported to be involved in capacitation
and acrosome reactions of spermatozoa. Many studies confirm
that the effects of P on human spermatozoa are mediated by the
increase of intracellular calcium concentrations (Blackmore
et al. 1990), the stimulation of phospholipase activity (Murase
andRoldan 1996), the phosphorylation of proteins (Tesarik et al.
1993; Luconi et al. 1995; Emiliozzi et al. 1996) and the efflux of
chloride (Meizel 1997). It is known that OB is also involved in
protein phosphorylation. Tyrosine phosphorylation of sperm
proteins during capacitation has been reported in mice, human,
bulls, hamsters (Visconti et al. 1995; Leclerc et al. 1996;
Galantino-Homer et al. 1997), pigs (Kala´b et al. 1998; Flesch
et al. 1999; Tardif et al. 2003) and horses (Gonza´lez-Ferna´ndez
et al. 2013). Furthermore, the Janus kinases and signal transdu-
cers and activators of transcription pathways (JAK/STAT)
represent themain signalling cascades activated byOB (Thomas
2004). The binding between OB and OB receptors (OB-R)
activates JAK2 kinase, causing phosphorylation of several
tyrosine residues including those on the functional OB-R. These
phosphorylative mechanisms provide binding sites for STAT3
protein, which, following activation, is translocated to the
nucleus where transcription of target genes is stimulated.
By this mechanism it is conceivable that OB increases
protein tyrosine phosphorylation and affects both the capacita-
tion and the acrosome reactions (Lampiao and du Plessis 2008).
In pigs and horses, as inman, OB has been found in seminiferous
tubules and in seminal plasma (Lackey et al. 2002; Aquila et al.
2005a). OB-R were detected on the cell surface of human
spermatozoa, indicating that these may be a possible target for
OB in the male genital tract (Jope et al. 2003). In the horse, there
are as yet no reports of the presence of OB-R on the surface of
spermatozoa, nor any on the effects of OB on capacitation and
fertilisation. In this context, we investigated whether OB and
OB-R are detectable at a molecular level and by immunocyto-
chemistry in equine spermatozoa. Since OB and P are found in
FF, we also aimed to assess the individual and combined effect
of OB and P in comparison to FF to better understand the role of
OB in equine IVF.
Materials and methods
Materials and animals
All reagents were purchased from Sigma Aldrich Chemical
(Milano, Italy) unless otherwise specified.
Fresh semen was collected by means of an artificial vagina
from three adult stallions of proven fertility. All collectionswere
performed according to approved animal care and following
protocols of the Bioethics Committee of Milan University.
Equine epididymides (n¼ 6) and ovaries (n¼ 375) were
collected at a local abattoir from horses slaughtered for reasons
other than the present study.
Experimental design
There were three parts to this study: in the first, OB andOB-R on
equine spermatozoa were assessed by immunocytochemistry,
western blot analysis and molecular biology; in the second, the
effect of OB on capacitation and hyperactivation of equine
spermatozoa was studied by motility assessment, fluorescent
staining and detection of apoptosis. In this step, the individual
effect of OB was compared with that induced by P or by the
combination of OB and P (OBþP), or by FF. In the third part,
IVF was performed using media supplemented with OB, P,
OBþP or FF.
Experiment 1: detection of OB and OB-R on equine
spermatozoa by immunocytochemistry, western
blot analysis and molecular biology
Immunocytochemistry
Immunocytochemical detection of OB and OB-R was per-
formed on fresh ejaculated spermatozoa selected by a swim-up
procedure and on spermatozoa collected from the caput epidi-
dymidis of three different stallions, pooled and washed three
times with Tris-buffered saline (TBS; 0.05M Tris/HCl, 0.15M
NaCl; pH 7.5). Ten mL of concentrated cell suspension were
smeared onto clean glass slides. The smearswere dried and fixed
in cold absolute methanol for 7min at 208C. After methanol
removal, spermatozoa were washed in TBS and placed in a
blocking solution overnight. The blocking solution consisted of
0.1M glycine, 1% goat serum, 0.01% Triton X-100, 1% pow-
dered non-fat dry milk, 0.5% bovine serum albumin (BSA) and
0.02% sodium azide in phosphate-buffered saline (PBS; Euro-
clone,Milan, Italy). After blocking, OB andOB-R stainingwere
carried out overnight using anti-OB (A-20) and anti-OB-R
(M-18) affinity-purified rabbit polyclonal antibodies (Santa
Cruz Biotechnology Inc., Santa Cruz, CA, USA) diluted
1 : 100 in PBS containing 1% Triton X-100 (PBS-T).
The specificity of the immunostaining was proven using non-
immune rabbit serum (DakoCytomation, Glostrup, Denmark)
instead of specific antiserumor omission of the primary antibody.
Spermatozoa were then washed four times for 15min in
PBS-T and incubated for 4 h with goat anti-rabbit fluorescein
isothiocyanate (FITC)-conjugated secondary antibody (Santa
Cruz Biotechnology Inc.), diluted 1 : 100 in PBS-T. Slides
were examined by conventional fluorescence analysis using a
BX 51 microscope (Olympus, Sintak S.r.l., Corsico, Mi, Italy)
equipped with dichroic mirror ultraviolet (DMU) filter set.
Three hundred spermatozoa per slide were analysed by a
combination of 488/650 nm emission wavelength (100 objec-
tive). Similar staining on histological slides of equine adipose
tissue was used as positive control.
Western blot analysis
Swim-up purified spermatozoa were washed and centrifuged
for 5min at 5000g at room temperature and the pellet was
shaken in lysis buffer (60mM Tris-HCl (pH 6.8), 50mM
dithiothreitol (DTT), 2% sodium dodecyl sulfate (SDS), 10%
glycerol, 1mM of phenylmethylsulfonyl fluoride (PMSF) for
15min. Protein concentration was evaluated using Bradford’s
assay and an equal quantity of proteins (20 mg) were diluted and
boiled for 10min in 2 Laemmli SDS buffer. Samples were
electrophoresed on 10% SDS polyacrylamide gels and electro-
blotted onto 0.2mm Bio-Rad nitrocellulose membranes using a
Bio-Rad trans-blot electrophoretic cell and reagents (Bio-Rad
Life Science, Segrate, Italy). The primary antibodies (anti-OB
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(A-20) and anti-OB-R (M-18) affinity-purified rabbit polyclon-
al antibodies; Santa Cruz Biotechnology Inc.) were diluted
1 : 1000 in a solution containing 2% BSA, 0.01% NaN3 in
PBS and were incubated for 2 h at,208C and rinsed three times
with PBS plus 0.05%Tween 20. Anti-b-actin antibody (ab8226;
ABCAM, Cambridge, UK) was used to normalise the sample
loading. The secondary antibody reactions were performed
using Immun-Star goat anti-rabbit or goat anti-mouse AP
Detection Kit reagents for western blot and ChemiDoc MP
imager (Bio-Rad). Adipose tissue lysate was used as a positive
sample and the negative control was swim-up sperm lysate
immunodepleted with anti-OB or anti-OB-R after immunopre-
cipitation with protein A-G agarose.
Ob and Ob-R mRNA detection
Total RNA from equine adipose tissue, ejaculated spermato-
zoa after swim-up and immature spermatozoa from epididy-
mides was isolated using TRIZOL reagent (Invitrogen Life
Technologies Italia, Monza, Italy) following the manufacturer’s
protocol and according to Das et al. (2010). After treating the
samples with DNase, RNA concentration and purity were
measured using a NanoDrop Spectrophotometer (NanoDrop
ND1000; Thermo scientific, Wilmington, DE, USA). Comple-
mentary DNA was synthesised from 500 ng of total RNA using
TaqMan reverse transcription reagents (Applied Biosystems
Italia, Monza, Italy). Conditions used were 258C for 5min,
428C for 30min and 858C for 5min. Qualitative PCR was
performed using 1mL of the obtained cDNA in 25 mL final
volume with Jumpstart Taq ReadyMix under the following
conditions: initial denaturation at 948C for 2min, 35 cycles
at 948C for 30 s (denaturation), 608C for 30 s (annealing), 728C
for 2min (elongation) and final elongation at 728C for 5min.
PCR products were analysed by gel electrophoresis and
visualised using an UV Gel Doc trans-illuminator (Bio-Rad).
Equine-specific oligonucleotide primerswere designed based on
NCBI Equus caballus available sequences or on mammal multi-
aligned sequences. Primers were used at 300 nM final concen-
tration and their sequences are as follows: glycerhaldehyde-
3-phosphate dehydrogenase (GAPDH): forward 50-AGATC
AAGAAGGTGGTGAAG-30 and reverse 50-TTGTCATACC
AGGAAATGAGC-30 (product size: 170 bp); leptin receptor
(Ob-R): forward 50-TCCAAGTCACATCTGGTGGA-30 and
reverse 50-GGTAAAAGTGTTGGGCTGGA-30 (product size:
154 bp); leptin (Ob): forward 50-GCACTGTGGACCCCTG
TGC-30 and reverse 50-TGGAGGAGACTGACTGCGTG-30
(product size: 180 bp). Equine adipose tissue was employed as
a positive control.
Experiment 2: capacitation and hyperactivation of equine
spermatozoa assessed by motility, fluorescent staining
and apoptosis
Sperm culture media
In this study, modified Whittens non-capacitating medium
(MW; 100mM NaCl, 4.7mM KCl, 1.2mM MgCl2, 5.5mM
glucose anhydrous, 22mM 2-[4-(2-hydroxyethyl)piperazin-1-
yl]ethanesulfonic acid buffer (HEPES), 4.8mM lactic acid
hemicalcium salt and 1.0mM pyruvic acid; Travis et al. 2004)
was used. To obtain capacitating conditions, non-capacitating
MWbase mediumwas supplemented with 25mMNaHCO3 and
7mgmL1 BSA. This medium was called capacitating medium
(CM). For both media the final pH was 7.25.
Another medium used in this study was FF. Follicular fluid
was drawn from preovulatory follicles of mares’ ovaries during
oestrus collected at the local abattoir. Assessment of the diameter
of the follicle (,4.5 cm) along with visual analysis of the
presence of uterine endometrial folds and the value of circulating
progesterone (,1 ngmL1) confirmed that mares were in oes-
trus. Pooled FF was centrifuged (1300g, 10min, room tempera-
ture) to remove cells and then frozen at 808C until P assays
were performed. Progesterone concentration was determined on
pooled FF using a quantitative test based on the enzyme-linked
fluorescent assay (ELFA) technique (Mini-Vidas; bioMe´rieux
Italia S.p.A., Florence, Italy; Anckaert et al. 2002).
Other media employed in this study were: CM supplemented
with 10 ngmL1 recombinant human OB (Sigma), CM supple-
mented with 200 ngmL1 P (Sigma) and CM supplemented
with 10 ngmL1 OB and 200 ngmL1 P.
Recombinant human OB was used because, after multiple
sequence alignment studies, this OB was most similar to
horse OB.
Semen preparation
Preparation of fresh semen was performed as previously
reported (McPartlin et al. 2009) with somemodifications. Sperm
motility and concentration of each sample diluted in pre-warmed
non-capacitating MW and kept at 378C were analysed by com-
puter-assisted semen analysis (CASA). A customised CASA
systemwas assembledwith anOlympus BX51microscope fitted
with a warming stage, negative-phase contrast optics (20
objective and 10 ocular) and a Basler (model A6021–2; Sintak
S.r.l., Corsico,Mi, Italy) video camera interfacedwith a computer
to digitise and analyse the image. The software used for image
acquisition and analysis was Image-Pro Plus 5.1-Media Cyber-
netics (Immagini and Computer, Bareggio, Milano, Italy).
The instrument setting for computerised semen analysis is
reported in Table 1.
An aliquot of 5mL of diluted semen was pipetted into a pre-
warmed 20-mm depth counting chamber (Cell-Vu Chambers;
Fertility Technologies Inc., IMV,Piacenza, Italy). Spermmotility
Table 1. Instrument setting for computerised semen analysis
Parameter Value
Number of frames to analyse 20 frames
Sampling frequency 30 frames s1
Minimum sampling points for motility 1 point
Minimum sampling points for velocity 3 points
Maximum velocity 150mm s1
Threshold velocity 8mm s1
Minimum sampling points for calculating AHL 7 points
Minimum velocity for calculating AHL 20mm s1
Minimum linearity for calculating AHL 3.5 mm
Pixel scale 0.688mm per pixel
Cell size range 4–15 pixel
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was assessed within 20 s. For each sample, 10 microscope fields
were analysed. Some parameters were measured directly on the
digital images (velocity parameters and movements of the head)
whilst others were calculated from the measurements, e.g.
straightness of movement and the percentage of motile or pro-
gressively motile spermatozoa. The cell track was reconstructed
on sequential digital images by the accompanying software.
Apoptotic rate
The percentage of apoptotic spermatozoa was assessed using
an annexin-V-FITC apoptosis detection kit (Sigma Aldrich
Chemical, Milano, Italy) following the manufacturers’ instruc-
tions. Samples were analysed every 2 h from 0 h to 6 h of
incubation under capacitating conditions: (1) CM, (2) FF,
(3) CM supplemented with OB (10 ngmL1), (4) CM supple-
mented with P (200 ngmL1) or (5) CM supplemented with
OBþP (10 ngmL1 and 200 ngmL1, respectively). Reactions
were performed on 500mLof semen. Three hundred spermatozoa
were analysed using a combination of 488/560 nm emission.
Spermatozoa at the early stage of apoptosis stained positively
only for the annexin V-FITC, necrotic spermatozoa for propi-
dium iodide (PI) and annexin V-FITC and live spermatozoa did
not stain positively for either PI or annexin V-FITC.
Capacitation of spermatozoa
Pooled samples of ejaculated spermatozoa from three stal-
lions, in triplicate, were centrifuged in 15-mL conical tubes at
100g for 1min at 378C to remove particulate matter and dead
spermatozoa. The supernatant was transferred to a 14-mL round-
bottomcentrifuge tubes and centrifuged at 600g for 5min at 378C.
The pellet of pooled spermatozoa was resuspended in CM to a
final concentration of 10 106 spermatozoa mL1 and 500-mL
aliquots were incubated for 6 h in polyvinyl alcohol-coated 5-mL
round-bottom tubes (Holmquist 1982) at 378C in a humidified air
atmosphere.
Hyperactivation of spermatozoa
Hyperactivation of spermatozoa resuspended in CM was
induced by incubation for an additional 6 h in different media:
(1) CM (control, CTR), (2) FF, (3) CM supplemented with OB
(10 ngmL1), (4) CM supplemented with P (200 ngmL1) or
(5)CMsupplementedwithOBþP (10 ngmL1 and 200 ngmL1,
respectively). For each condition the final cell concentration was
standardised to 1 106 spermatozoa mL1 and sperm motility
was analysed by CASA every 2 h from 0h to 6 h of incubation.
In addition to the percentage of motile spermatozoa, five
motility parameters were evaluated: the average path velocity
(VAP, mm s1; the average velocity of the smoothed cell path),
the straight-line velocity (VSL, mm s1; the average velocity
measured in a straight line from beginning to end of the track), the
amplitude of lateral head displacement (ALH, mm; the mean
width of head oscillations), the straightness (STR, %; the average
value of the ratio VSL/VAP 100) and the linearity index (LIN,
%; the average value of the ratio VSL/VCL 100).
First, a dose-response study on the effects of recombinant
humanOBon spermatozoawas performed in order to identify the
best concentration of this hormone to be used for the subsequent
experiments. Spermatozoa were incubated in CM supplemented
with OB at different concentrations, from 0 to 50 ngmL1 at
5 ngmL1 increments. Sperm motility assessment, fluorescent
staining (FITC-conjugated peanut agglutinin and propidium
iodide (FITC–PNA/PI)) for viability and acrosome reaction and
apoptotic rate evaluation were performed every 2 h from 0 h to
6 h after treatments.
The following experiments were performed using OB at
10 ngmL1 based on the optimal results obtained for motility,
viability, acrosome reaction and the lower response of apoptotic
rate (data not shown).
Fluorescent staining (FITC–PNA/PI) for viability
and acrosome reaction
FITC-conjugated peanut agglutinin (FITC–PNA) was used to
determine the acrosome status of viable spermatozoa under all the
conditions of hyperactivation tested: (1) CM, (2) FF, (3) CM
supplemented with OB (10 ngmL1), (4) CM supplemented
with P (200 ngmL1) and (5) CM supplemented with OBþP
(10 ngmL1 and 200 ngmL1, respectively). Propidium iodide
staining was used to detect apoptotic spermatozoa. FITC–PNA
intensely labelled the acrosome region of acrosome-reacted
spermatozoa (green), whereas PI stained the head of dead
spermatozoa (red). Evaluation was performed every 2 h from
0 h to 6 h of incubation. Briefly, 500mL of semen were diluted in
HEPES–BSAsolution (130mMNaCl, 4mMpotassiumchloride,
14mM fructose, 10mM HEPES, 1mM calcium chloride,
0.5mMmagnesium chloride, 0.1% BSA) to reach the concentra-
tion of 15 106 spermatozoa mL1. Samples were then incu-
bated with 2.5mL propidium iodide (1mgmL1) and 2.5mL
FITC–PNA (1mgmL1) at 378C for 5min under light-proof
conditions. Spermatozoa were fixed in 10% formalin solution.
Three hundred spermatozoa per slide were immediately exam-
ined using an Olympus BX 51 microscope equipped with DMU
filter set using a simultaneous combination of excitation and
emission filters at 488/650 nm at 100 magnification.
Experiment 3: in vitro fertilisation
Recovery and maturation of oocytes
Ovaries were obtained during the natural reproductive season
(fromMarch to August) immediately after slaughter, maintained
at 308C in PBS supplemented with antibiotics (100 IUmL1
penicillin and 100mgmL1 streptomycin sulfate) and processed
within 6 h of slaughtering. Cumulus–oocyte complexes (COCs)
were harvested by scraping the surface of obvious follicles. Only
compact cumulus oocytes (CCOs) with at least three layers of
cumulus cells were assigned for in vitromaturation (IVM). CCOs
were washed three times in basic TCM199 medium with Earle’s
salts, buffered with 4.43mM HEPES, supplemented with 10%
fetal bovine serum and 25mgmL1 gentamicin (M199). IVM
was performed following the method previously described
(Dell’Aquila et al. 2003). Medium TCM-199 with Earle’s salts,
buffered with 4.43mM HEPES and 33.9mM sodium bicarbo-
nate and supplemented with 0.1 gL1 L-glutamine, 2mM
sodium pyruvate, 2.92mM calcium-L-lactate pentahydrate
(Fluka 21175 Serva Feinbiochem GmbH and Co, Milano, Italy)
and 50mgmL1 gentamicin was used. pH was adjusted to 7.18
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and the medium was filtered through 0.22-mm filters (Lida
Manufacturing Corp, Dix Hills, NY, USA) and stored at 48C
until use (for a maximum of 1 week). On the day of IVM, the
medium was further supplemented with 20% (v/v) fetal calf
serum. Then, gonadotrophins (10 mgmL1 ovine FSH and
20 mgmL1 ovine LH) and 1 mgmL1 17b-oestradiol were
added. The medium was re-filtered and equilibrated for 1 h
under 5% CO2 in air before use. Compact COCs were washed
three times in the culture medium and groups of up to 10 COCs
were placed in 400 mL of medium per well of a four-well dish
(Nunc Intermed, Euroclone, Milano, Italy), covered with pre-
equilibrated lightweight paraffin oil and cultured for 29 h at
38.58C under 5% CO2.
The protocol for oocyte maturation was standardised in our
laboratory and, as reported by Lange-Consiglio et al. (2009), the
maturation rate of compact cumulus oocytes reached 43–45%.
In vitro fertilisation
Spermatozoa (10 106mL1) were pre-incubated for 6 h in
CM, then diluted to 1 106 spermatozoa mL1 with: (1) CM,
(2) FF, (3) CM supplemented with OB (10 ngmL1), (4) CM
supplemented with P (200 ngmL1) or (5) CM supplemented
with OBþP (10 ngmL1 and 200 ngmL1, respectively). A
sample of semenwas pre-incubated in non-capacitatingmedium
for 6 h and then diluted in each of the five media mentioned
above and used for IVF.
Five mature mare oocytes were transferred into droplets of
100mL of each sperm suspension and incubated for 18 h at
38.58C in 5% CO2. Oocytes were then transferred into
Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12
(DMEM/F-12) for three days to evaluate the rate of embryo
development. For each experimental condition, a sperm-free
control was performed to assess parthenogenesis. The presence
of two pronuclei and a sperm tail before cleavage were evalu-
ated, on a sample of oocytes, at the end of IVF by aceto–orcein
stain (1% orcein in 45% acetic acid, followed by aceto-glycerol
(glycerol 20%, acid acetic 20%, distilled water 60%)). More-
over, cleavage was evaluated by Hoechst staining on a sample
of oocytes after 24 h of co-incubation with spermatozoa.
Oocytes were considered fertilised if one or more deconden-
sing sperm heads or pronuclei were observed, or if they cleaved
to the two-cell stage. Degenerating oocytes containing no
chromatin or fragmented chromatin, and oocytes that failed to
mature to metaphase II were not counted in the assessment of
fertilisation rates.
Statistical analysis
The experiments on semen were repeated three times on pooled
ejaculates from three stallions. The values reported represent the
mean values. The IVF study was repeated four times. Data were
analysed by one-way ANOVA with post-test using standard
parametric methods through a system of linearmodel analysis of
variance. When significant differences (P, 0.05) were detec-
ted, the Student–Newman–Keuls method was applied to assess
all pair-wise multiple comparisons.
The statistical analyseswere carried out usingGraphPad Instat
3.00 for Windows (GraphPad Software, La Jolla, CA, USA).
Results
Experiment 1: detection of OB and OB-R on equine
spermatozoa by immunocytochemistry, western blot
analysis and molecular biology
Leptin OB and OB-R localisation and expression
in equine spermatozoa
OB and OB-R were weakly detected in ejaculated spermato-
zoa in the post-acrosomal region and in the middle piece of
equine spermatozoa (Fig. 1a). The adipose tissue, used as positive
control, stained positively for both OB and OB-R (Fig. 1b). The
negative controls demonstrated no immunoreactivity.
At mRNA level, Ob was detected in ejaculated spermatozoa
but reverse transcription–polymerase chain reaction (RT-PCR)
failed to detect signal for the Ob-R transcripts in the same
samples (Fig. 1c). Ob and Ob-R expression was confirmed in
immature spermatozoa collected from the head of the epididy-
mis (Fig. 1d ).
Western blot analysis
The presence of OB protein in equine spermatozoa was also
investigated by western blotting. A single band at 16 kDa was
observed in the lysate obtained from equine sperm samples,
corresponding to that observed in the adipocyte extract used as
positive control (Fig. 2a). Some weakly immunoreactive bands
associated with different isoforms were obtained for OB-R. For
this protein, one main band corresponding to the molecular
weight of 90 kDa was also found (Fig. 2b).
Experiment 2: capacitation and hyperactivation of equine
spermatozoa assessed by motility, fluorescent staining
and apoptosis
To evaluate the effects of P in our experimental settings, we
measured the levels of P in FF. The mean concentration of P
evaluated by quantitative test was 200 ngmL1.
Apoptotic rate
There was no effect on the apoptotic rate of spermatozoa
after 6 h of incubation in FF, OB or P when compared with those
in CM, demonstrating no cytotoxic effect (Table 2).
Hyperactivation of spermatozoa
The addition of different media to stallion spermatozoa at 0 h
induced an immediate change in motility. This change was
characterised by the decrease (P, 0.05) of VSL, STR and LIN,
increase of AHL (P, 0.05) and onset of circling motion. After
6 h incubation in the tested media, spermatozoa were slower
compared with those incubated in CM medium, showing a
further decrease (P, 0.05) in VSL, STR and LIN. (Table 3).
Fluorescent staining (FITC–PNA/PI) for viability
and acrosome reaction and apoptosis
Immunofluorescent patterns of vitality and acrosome reac-
tion staining of equine spermatozoa are shown in Table 4. As
determined by FITC–PNA/PI staining, at the beginning of
incubation on average 66.1%, 61.6%, 61.11%, 60.3% and
60.8% of viable spermatozoa were detected in CM, FF, CM
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with OB, CMwith P and CMwith OBþP, respectively, with no
significant difference between media. Following 6 h incubation,
sperm viability progressively decreased to 48.8%, 26.3%,
14.3%, 29.7% and 25.5%, respectively. The effects in each
sample differed significantly from the control.
The initial percentage of AR in live equine spermatozoa at
Time 0 of incubation was 10.7%, 11.4%, 9.2%, 10.5% and
12.7% inCM, FF, CMwithOB, CMwith P andCMwithOBþP,
respectively. No significant difference was found between the
different culture conditions. After 6 h of incubation, the number
of capacitated spermatozoa, expressed as live acrosome-reacted
(AR), increased significantly (P, 0.05) reaching the percen-
tages of 44.6%, 35.3%, 46.1% and 44.8% respectively in FF,
CM with OB, CM with P and CM with OBþP. In CM, the
percentage of AR spermatozoa remained constant until the last
time point. In FF the highest percentage of live AR spermatozoa
was achieved after 4 h of incubation, when the percentage of
dead spermatozoa was lower. The incidence of AR spermatozoa
in the OB-treated sample was lower and significantly different
from FF, P and OB combined with P.
Experiment 3: in vitro fertilisation
Fertilisation was confirmed by either pronuclear formation
(Fig. 3) or cleavage to the two-cell stage. The fertilisation rates
obtained were 51%  4.83% (26/51 oocytes) for IVF with FF,
46.15%  3.18% (24/52) with P and 43.64%  3.63% (24/55)
with OBþP. No fertilisation was achieved using OB (0/55) or
CM (0/42). Our IVF setting only allowed for the attainment of
eight-cell stage embryos, which were obtained when combining
the capacitating conditions with the induction of hyperactiva-
tion. The eight-cell stage embryos were produced in four inde-
pendent replicates at the following rates: 18.7 1.9% using FF,
17.1%  1.15 with P and 16.7%  0.51 with OBþP. Sperma-
tozoa incubated in OB alone and in the other conditions (in CM
Leptin(a)
(b)
(c) (d )
Leptin receptor
GA
PD
H
Ob Ob
-R
100 μm 100 μm
GAPDH Ob
A B C D E A B C D E A B C D E
Ob-R
Fig. 1. Immunocytochemistry and molecular expression of leptin (OB) and leptin receptor (OB-R).
(a) Immunolocalisation in the post-acrosomal region and in the tail in equine ejaculated spermatozoa.
(b) Immunolocalisation of OB and OB-R in equine adipose tissue used as control. Magnification 20. (c) Ob and
Ob-R expression at mRNA level in equine spermatozoa. Signal forGAPDH (employed as reference gene) and leptin
transcripts observed in: A, adipose tissue (positive control); B, total ejaculate; C, spermatozoa after swim-up;
D, spermatozoa after swim-up and following 6 h of incubationwith exogenous leptin; E, blank. (d )GAPDH,OB and
OB-R transcripts observed in immature spermatozoa from head of epididymis. Marker: 100 bp.
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alone, or in non-capacitating medium supplemented with FF,
OB, P or OBþP), did not fertilise oocytes (Table 5, Fig. 4) as
demonstrated by the Hoechst staining. These data are net of
the rate of parthenogenesis that was,6% in each experimental
condition, as calculated on test sample oocytes.
Discussion
In this study, we investigated whether OB and OB-R were
detectable in equine spermatozoa. Immunocytochemical anal-
ysis detected the presence of OB and OB-R in the post-
acrosomal region, as well as in the middle piece of equine
spermatozoa. Antibody specificity was supported by the posi-
tive controls on equine adipose tissues. The western blot anal-
ysis supported this result. At the molecular level, however, the
expression of Ob-R was only confirmed in ejaculated sperma-
tozoa, leading us to speculate that Ob-R transcription stops
during sperm maturation. This suggests that the presence of
protein is mainly due to the translation process occurring during
the earlier stages of spermatogenesis. The expression of Ob-R
found in immature spermatozoa collected from the head of the
epididymis confirmed our hypothesis.
The expression pattern of one isoform at 90 kDa, observed in
this study, is different from that reported for pig spermatozoa by
Aquila et al. (2008), who observed different isoforms, and byDe
Ambrogi et al. (2007), who demonstrated one isoform at 382 bp,
although Aquila et al. (2008) claim that the pattern of OB-R
expression is species-specific.
To our knowledge, this is the first study reporting the
presence of OB and OB-R mRNA in equine ejaculated sperma-
tozoa. Aquila et al. (2005b) were the first to demonstrate direct
production of OB by human ejaculated spermatozoa, indicating
that spermatozoa are effective in secreting OB, despite their
supposed inability to translate transcripts. In contrast to
Grunewald et al. (2005), Aquila et al. (2005a) proposed that
some of these transcripts could encode for proteins that are
essential in early embryo development. More recently, the
presence of OB mRNA was also detected in bull spermatozoa
(Abavisani et al. 2011), supporting the idea that spermatozoa are
able to transcribe Ob and translate it.
As demonstrated in pig spermatozoa, OB affects both the
capacitation and acrosome reactions through its receptor
(Aquila et al. 2008). After detecting OB and OB-R in ejaculated
spermatozoa by immunocytochemistry and gene expression, we
investigated its effect alone or in combination with P in the
challenging settings of equine IVF to gain a deeper understand-
ing of the involvement of OB in equine IVF. Results were then
compared with those obtained when in vitro capacitation was
induced using FF conditions.
Based on analysis of the motion parameters currently used to
define hyperactivated motility in other species (Mortimer and
AT
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40
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120
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Fig. 2. Western blot to assess the presence of (a) OB and (b) OB-R on two horse sperm samples (S1,
S2). Adipose tissue (AT) lysate was used as positive control and sperm lysate immunodepleted of OB
or OB-R was employed as negative control (ctrl). b-actin represents the reference marker.
Table 2. Percentage of apoptotic spermatozoa after exposure to
different capacitation media
Data are expressed as mean s.e.m. Different small letter superscripts (a,b,c)
indicate statistically significant differences (P, 0.05) between rows.
Different capital letter superscripts (A,B,C,D) indicate statistically significant
differences (P, 0.05) between columns. CM, capacitating medium; FF,
follicular fluid; P, progesterone; OB, leptin
Time of
exposure (h)
CM CM þ FF CM þ P CM þ OB CM þ
OBþP
0 16 0.6acA 18 0.4bA 16 0.6acA 15 0.3aA 17 0.6cA
2 17 0.5aAB 16 1.1aA 16 0.3aA 18 1.7aA 17 0.7aA
4 18 0.8aB 17 1.3aA 18.  1.7aA 23 2.3bB 19 0.6aB
6 21 0.7aC 18 0.4aA 17 0.8bcA 25 2.9dB 20 0.5abB
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Mortimer 1990; Suarez et al. 1992; Ho and Suarez 2001;
Marquez and Suarez 2004, 2007; Baumber and Meyers 2006;
Marquez et al. 2007), incubation with FF, OB, P or OBþP
significantly affected stallion sperm motility. Stallion sperma-
tozoa can be defined as hyperactivatedwhenVSL,46.5mms1,
STR ,46.6% and LIN ,20.2% are detected (McPartlin et al.
2009). As shown in this study, sperm tracks shortened, became
more curved and the decrease in VSL, LIN and STR was
consistent with the acquisition of hyperactivation.
Although the ability of FF to induce capacitation andmotility
changes has already been established, as well as the potential of
P to increase the permeability of the plasma membrane to
calcium (The´rien and Manjunath 2003), there is no evidence
of the involvement of OB in equine sperm hyperactivation and
fertilisation. Despite a claim by Li et al. (2009) that OB had no
significant effect on ejaculated human spermmotility, our study
suggests a regulatory role of OB signalling in sperm motility.
This hypothesis comes from the expression of OB-R observed in
the middle piece of equine spermatozoa, which is the region that
mainly contributes to sperm motility.
Table 3. Stallion sperm hyperactivation in different capacitation media at two set times
Data are expressed as mean s.e.m. Different small letter superscripts (a,b) indicate statistically significant differences (P, 0.05) between 0 h and 6 h in each
medium. Different capital letter superscripts (A,B) indicate statistically significant differences (P, 0.05) at 6 h between CM and other media. CM, capacitat-
ing medium; FF, follicular fluid; P, progesterone; OB, leptin; VAP, average path velocity; VSL, straight-line velocity; AHL, average lateral head;
STR, straightness; LIN, linearity index
Medium
employed
VAP (mm s1) VSL (mm s1) AHL (mm) STR (%) LIN (%)
0 h 6 h 0 h 6 h 0 h 6 h 0 h 6 h 0 h 6 h
CM 141.5 4.8a 124.2 9.2bA 87.4 9.4a 67.6 5.3bA 6.1 0.2a 6.3 0.8bA 61.8 0.3a 54.0 0.5bA 34.3 0.3a 29.1 0.1bA
FF 167.3 13.8a 110.1 9.5bB 66.9 6.9a 40.5 4.1bB 7.6 0.4b 10.4 0.9bB 40.0 0.7a 36.7 0.4bB 19.7 0.1a 17.2 0.2bB
CM þ P 161.1 5.6a 113.4 4.3bB 63.2 5.3a 42.3 4.0bB 7.4 0.6b 9.4 0.8bB 39.2 1.3a 38.2 1.5aB 21.3 0.7a 19.4 0.2bB
CM þ OB 135.0 6.2a 115.6 10.1bB 85 5.8a 47.7 3.8bB 8.0 0.5b 9.9 0.5bB 63.0 0.2a 41.2 0.2bB 31.0 0.2a 23.0 0.1bB
CM þ OBþP 164.2 4.2a 112.2 5.9bB 64.3 3.2a 43.4 4.2bB 7.2 0.6b 10.4 1.0bB 38.6 0.3a 37.7 0.8aB 22.5 0.5a 18.9 0.5bB
Fig. 3. Acteo–orcein stain showing presence of two pronuclei. The arrow
at the left indicates the female pronucleus and the arrow at the right the male
pronucleus.
Table 4. Fluorescent staining (FITC–PNA) for acrosome reaction (AR) in different capacitation media
Data are expressed as mean  s.e.m. Different small letter superscripts (a,b,c) indicate statistically significant differences (P, 0.05)
between rows. Different capital letter superscripts (A,B,C,D) indicate statistically significant differences (P, 0.05) between columns.
CM, capacitating medium; FF, follicular fluid; P, progesterone; OB, leptin
Type of spermatozoa Time of exposure (h) CM CM þ FF CM þ P CM þ OB CM þ OBþP
Viable 0 66.1 3.5aA 61.6 4.3aA 60.3 3.4aA 61.1 4.2aA 60.8 2.9aA
2 62.1 4.7aAC 52.7 3.6bA 54.6 2.9bA 49.4 3.6bB 51.7 3.7bA
4 54.2 4.6aBC 26.9 3.2bB 28.3 3.1bB 34.3 2.8bC 27.4 4.1bB
6 48.8 2.7aB 26.3 5.6bB 29.7 3.7bB 14.3 1.7bD 25.5 3.5bB
Viable with AR 0 10.7 2.0aA 11.4 1.2aA 10.7 1.6aA 9.2 2.1aA 12.7 1.8aA
2 14.6 2.6aA 15.4 2.6aA 18.5 3.6aB 15.9 1.7aB 16.7 1.4aB
4 16.0 4.1aA 48.4 1.7bB 47.4 1.8bcC 25.3 2.9dC 35.6 1.5eC
6 15.8 5.0aA 44.6 2.6bB 46.4 2.0bC 35.0 3.0 cD 44.8 1.9bD
Dead 0 10.7 1.7aA 13.6 3.0aA 12.7 1.6aA 12.5 1.9aA 13.0 1.0aA
2 9.2 0. 8aA 17.3 1.7bcA 13.5 1.6bA 16.3 2.1bcA 17.9 1.9cB
4 12.2 1.0aAC 12.9 1.4aA 13.7 1.7abA 16.0 1.7abA 17.0 1.7bB
6 15.3 2.9aBC 14.3 3.7aA 11.6 1.0aA 27.0 2.9bB 16.1 1.9aAB
Dead with AR 0 12.4 2.1aA 13.4 1.3abA 16.4 1.9abA 17.1 1.6bA 13.5 1.2abA
2 14.0 2.0aAC 14.7 2.8aA 13.4 1.0aAC 18.4 2.9aA 13.6 0.7aA
4 17.6 2.3aBC 11.8 1.5bA 10.7 2.0bBC 24.3 2.9cB 20.0 1.8aB
6 20.1 1.4aB 14.8 3.0bA 10.6 1.7bBC 23.7 2.0cB 13.5 1.1bA
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Capacitation is not only associated with hyperactivation, but
also with the acquired capability of spermatozoa to undergo the
acrosome reaction after binding to the zona pellucida. Following
incubation in FF, in CM supplemented with OB, P or OBþP, the
number of capacitated spermatozoa (expressed as live acrosome-
reacted) increased significantly (P, 0.05). After 6 h of incuba-
tion, these percentages reached 44.6% for FF, 35.3% for OB,
46.1% for P and 44.8% for OBþP. Conversely, in CM alone, the
rate of AR spermatozoa remained constant over time. According
to Cheng et al. (1998), P alone or combined with OB increased
the proportion of physiologicalAR spermatozoa to the same level
as FF, in contrast to the effects ofOBalone.Moreover, our results
showed that spermatozoa pre-incubated in CM for 6 h and then
exposed to fertilisingmedium supplementedwith FF, P orOBþP
for 18 h, were able to fertilise oocytes, leading to eight-cell stage
embryo development at the rate of 18.7%, 17.1% and 16.7%,
respectively. On the other hand, spermatozoa in medium supple-
mented with OB did not fertilise any oocytes.
Table 5. Development to eight-cell stage embryos
Data are expressed as mean s.e.m. Values labelled with different letters are statistically different (P, 0.05). CM, capacitating medium; FF, follicular fluid;
P, progesterone; OB, leptin; non-CM, non-capacitating medium
Replicate CM (%) CM þ FF
(%)
CM þ P
(%)
CM þ OB
(%)
CM þ OBþP
(%)
Non
CM þ FF (%)
Non
CM þ P (%)
Non
CM þ OB (%)
Non
CM þ OBþP (%)
1 0/10 (0.0) 4/19 (21.1) 3/18 (16.7) 0/22 (0.0) 5/29 (17.2) 0/11 (0.0) 0/12 (0.0) 0/13 (0.0) 0/11 (0.0)
2 0/12 (0.0) 4/24 (16.7) 5/27 (18.5) 0/25 (0.0) 4/25 (16.0) 0/10 (0.0) 0/14 (0.0) 0/10 (0.0) 0/12 (0.0)
3 0/13 (0.0) 4/21 (19.1) 3/19 (15.8) 0/18 (0.0) 4/24 (16.7) 0/10 (0.0) 0/12 (0.0) 0/11 (0.0) 0/13 (0.0)
4 0/13 (0.0) 3/17 (17.7) 4/23 (17.4) 0/20 (0.0) 3/18 (16.7) 0/12 (0.0) 0/9 (0.0) 0/10 (0.0) 0/11 (0.0)
Average 0.0 0.0 18.65 1.9a 17.1 1.2a 0.0 0.0 16.7 0.5a 0.0 0.0 0.0 0.0 0.0 0.0 0.0 (0.0)
(a) (b)
(c) (d)
Fig. 4. Representative in vitro fertilised mare oocytes. (a) Light microscopy of two-cell stage embryos (Day 1).
(b) Hoechst 33258 staining showing two pronuclei. (c) Light microscopy of eight-cell stage embryo (Day 3).
(d ) Hoechst 33258 staining showing eight pronuclei. Original magnification 20. Scale bars represent 20 mm.
Leptin in equine in vitro fertilisation Reproduction, Fertility and Development I
It can be argued that P facilitated IVF by promoting both
hyperactivation and the acrosome reaction. Many studies report
that this hormone, secreted by cumulus cells and contained in
FF, induces AR in human (Meizel and Turner 1991; Baldi et al.
1998), mouse (Roldan et al. 1994), boar (Melendrez et al. 1994),
stallion (Meyers et al. 1995; Cheng et al. 1998), golden hamster
(Llanos and Anabalo´n 1996), dog (Brewis et al. 2001) and
caprine (Somanath et al. 2000) spermatozoa. Progesterone also
affects human sperm capacitation (Foresta et al. 1992; Uhler
et al. 1992; Luconi et al. 1995) and increases the ability ofmouse
spermatozoa to respond to the zona pellucida (Roldan et al.
1994). Steroid effects are mediated by proteins acting as
receptors on the cell surface (Meizel and Turner 1991). The
acrosome reactions produced by the exposure of capacitated
spermatozoa to P could explain the rate of penetration in our IVF
setting. Thus, because neither incubation of spermatozoa in
capacitation conditions alone nor the treatment of non-
capacitated spermatozoa with P supported IVF in our experi-
ments, these results additionally support the hypothesis that the
pre-incubation step in capacitation medium is required for the
activation of functional receptors evoked by P binding. As
reported by McPartlin et al. (2009), these results support the
hypothesis that capacitation and hyperactivation are separate
and independent events. Regarding OB, our results are in
agreement with those reported for capacitation and acrosome
reaction in pig spermatozoa (Aquila et al. 2008), although the
rate of AR spermatozoa was lower compared with that obtained
with P. The AR rate was calculated on live spermatozoa after
OB treatment, highlighting the effect of OB compared with the
control. In any case, after IVF no sperm penetration occurred
and, therefore, no embryo was obtained.
It has been demonstrated that pig seminal plasma contains a
significant amount of OB and that this amount is lower in FF
(Lackey et al. 2002). As spermatozoa leave seminal plasma
during transit in the female reproductive tract, they are exposed
to decreased OB concentrations. Aquila et al. (2008) speculated
that the high OB concentrations in seminal plasma might
contribute to maintenance of spermatozoa in a quiescent meta-
bolic condition. Conversely, the low OB concentrations in the
secretions of the female pig reproductive tract (Gregoraszczuk
et al. 2004) could induce sperm activation by facilitating their
capacitation and acquisition of fertilising ability. Previous
results from our laboratory indicate that supplementation with
OB in the range between 10 and 1000 ngmL1 increases the
maturation rate of equine oocytes and enhances the fertilisation
rate after intracytoplasmic sperm injection (ICSI), thus confirm-
ing the stimulatory effect of OB on oocyte quality and fertilisa-
tion rate after ICSI (Lange-Consiglio et al. 2009). Based on this
information, OB supplementation would be expected to have a
positive influence in standard equine IVF. Since no embryos
were obtained, this hypothesis remains open to question. It is
possible to speculate that although previous experiments sug-
gested an optimal concentration of 10 ngmL1 (data not
shown), this dosage was not able to support oocyte fertilisation
in the co-culture system. Recently, we evaluated OB levels in
mare preovulatory FF (Lange-Consiglio et al. 2013) and, in that
case, concentrations ranged between 3.36 and 5.72 ngmL1 in
adult Standardbred and draft mares, respectively, but, by the dose
response in this study, the same concentrations did not activate
equine spermatozoa in vitro. It remains to be seen whether
interaction between the OB-R on spermatozoa and the OB
produced by the female genital tract drives fertilisation in vivo.
In conclusion, in this study we induced hyperactivation and
acrosome reaction in equine spermatozoa by FF, OB, P and
OBþP. We obtained eight-cell stage embryos by using FF, P or
OBþP. Interestingly, the supplementation of CMwithOB in our
IVF conditions did not help oocyte fertilisation. Based on these
results, we can speculate that P, but not OB, is the key factor in
FF to achieve IVF.
This finding may indicate that equine OB is specifically
involved in the improvement of ooplasmic maturity (Lange-
Consiglio et al. 2009), even though during co-culture with
spermatozoa no effects were seen on the external layers of the
oocyte (corona radiata, intercellular matrix, zona pellucida and
oolemma), which are involved in sperm penetration, nor were
effects seen on spermatozoa. This observation is a significant
finding, as OB produced no toxic effects as demonstrated in our
previous study of apoptosis. Nevertheless, it is important not to
rule out the potential action of OB, nor its possible involvement
in sperm functions other than those studied, such as sperm–zona
pellucida binding and zona pellucida-induced acrosome reaction.
This study confirms the difficulties in achieving appropriate
capacitation and hyperactivation of stallion spermatozoa
in vitro. It supports the hypothesis that capacitation and hyper-
activation are required for successful IVF in horses and, for the
first time, it demonstrates the presence of Ob and Ob-R mRNA
and their proteins in equine spermatozoa. Further studies are
required to determine the role of these molecules.
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Platelet concentrate in bovine reproduction:
effects on in vitro embryo production and after
intrauterine administration in repeat breeder cows
Anna Lange-Consiglio1, Nadia Cazzaniga1, Rosangela Garlappi2, Chiara Spelta3, Claudia Pollera4,
Claudia Perrini1 and Fausto Cremonesi1,5*
Abstract
Background: A repeat breeder cow (RBC) can be defined as an animal that after 3 or more inseminations cannot
get pregnant because of fertilization failure or early embryonic death. If no cause is identified precisely, inadequate
uterine receptivity is responsible for implantation failures. Since a large number of identified molecular mediators,
such as cytokines, growth factors and lipids have been postulated to be involved in early feto-maternal interaction,
in this study a different approach to the treatment of RBC syndrome has been employed using a platelet concentrate
(PC) that contains a significant amount of growth factors accumulated in its α-granules.
Methods: Three explorative studies were performed. Initially, PC was supplemented in the in vitro embryo culture
medium to study its effect on embryo-development. After the pilot study, 4 RBCs were treated with intrauterine
administration of PC to evaluate proliferative potential of endometrium by immunohistochemical expression of
the antigen Ki-67. Lastly, the effect of intrauterine administration of PC at 48 hrs after artificial insemination in RBCs
was evaluated.
Results: The in vitro results show that 5 % of PC and 5 % of fetal calf serum (FCS) increase the rate of blastocysts
compared with the control containing 10 % FCS only (43.04 % vs 35.00 % respectively). The immunohistochemical
study shows more proliferating nuclei in the treated uterine horn compared to the control one. After intrauterine
insemination in RBCs, the percentage of pregnant cows in the control group was 33.33 % compared to 70 % of the
treated animals.
Conclusion: We suppose that when embryo descends in uterus could find a more appropriate environment for
nesting and subsequent pregnancy.
Keywords: Repeat breeder cows, Embryos, Platelet concentrate, Intrauterine administration
Background
Unexplained infertility, the so called repeat breeder cow
(RBC) syndrome, involves a heterogeneous group of
sub-fertile cows, with no anatomical abnormalities and
infections of the reproductive tracts, nor estrous cycle
alterations. A repeat breeder is defined as a cow that
fails to become pregnant after 3 or more inseminations
as a consequence of either fertilization failure or early
embryonic death [1].
The etiology of RBC syndrome is multi-factorial and un-
clear. The normal uterine environment promotes normal
embryonic development but subclinical disorders com-
promise the survival of the embryo resulting in RBC
syndrome. The RBCs are characterized by early embry-
onic loss [2], that decreases the conception rates [3, 4].
In some cases, the transfer of non-RBC donated em-
bryos into RBC surrogates increased RBC pregnancy
rate, indicating that the lower conception rate of RBCs
is determined at early stages of embryo development
[3]. The problem could be the embryo but also the
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oviductal and/or uterine environment. Ferreira et al.
[5] provided evidence that RBC syndrome is associated
with oocyte quality and that this negative effect is en-
hanced during summer heat stress, but it is general
opinion that the successful implantation requires also a
complex sequence of signaling events that are crucial
to the establishment of pregnancy. In human medicine
there is a proportion of women with ‘unexplained’
infertility in whom pregnancies fail before they are
clinically recognized. Koot et al. [6] underline that this
infertility could occur as a result of a malfunction of
the endometrial-embryo ‘dialogue’ after the early phases of
implantation. Indeed, the uterus is responsible for two-
thirds of failures whilst the embryo for only one-third
[7, 8]. A large number of molecular mediators, under the
influence of ovarian hormones, have been postulated to be
involved in this early embryo-maternal interaction. These
mediators embrace a large number of inter-related mole-
cules including adhesion molecules, cytokines, growth fac-
tors, lipids and others [9, 10]. Many treatments have been
proposed for prevention of RBC syndrome at both herd
and individual level. These include, for example, nutri-
tional supplements and assisted reproductive techniques,
such as in vitro embryo production and embryo transfer.
Commonly, therapies in use include hormonal treatments
with progestins, GnRH, exogenous gonadotrophins and
prostaglandins [1]. However, in view of the embryo-
maternal interaction a different approach to the treatment
of RBC syndrome could be found using platelet concen-
trate (PC). Platelets contain significant quantities of
growth factors (accumulated in their α-granules), chemo-
kines and cytokines and also active metabolites [11], that
act in a paracrine manner on different cell types like myo-
cytes [12], mesenchymal stem cells of different sources
[13], condrocytes [14, 15], osteoblasts [16], fibroblasts
[17]. Moreover, several in vitro studies have shown a direct
dose–response influence of many growth factors on cell
migration, cell proliferation, and matrix synthesis [18–20].
Transforming growth factor β1 (TGF-β1) and TGF-β2,
platelet derived growth factors (PDGF-AA, PDGF-BB,
PDGF-AB), insulin-like growth factor 1 (IGF-I), epidermal
growth factor (EGF), vascular endothelial growth factor
(VEGF), fibroblast growth factor (FGF) and hepatocyte
growth factor (HGF) are very important for regeneration
processes. Indeed, these growth factors act synergistically
to increase the infiltration of neutrophils and macro-
phages, to promote angiogenesis, fibroplasia, matrix de-
position and, ultimately, re-epithelialization, inducing
the consequent tissue regeneration [21]. Lastly, it is known
the anti-inflammatory property of PC by the presence of
anti-inflammatory agents including HGF [22].
In this context, the uterine administration of PC may
be useful in peri-implantation, or in the healing process
of clinically silent endometrial injuries because many
cytokines act as intermediary links in the materno-fetal
relationship including decidualization (in the women),
implantation, placentation, embryogenesis and fetal
growth [23]. Moreover, since pro-inflammatory factor
transcripts in bovine endometrial epithelial cells are ele-
vated in case of subclinical or clinical endometritis [24],
we hypothesized that an early administration of PC, after
artificial insemination (AI) and before the descent of the
blastocyst in the uterus, could improve the uterine
microenvironment for embryo implantation and coun-
teract eventual subclinical endometritis.
Methods
Materials
Chemicals were obtained from Sigma Chemical (Milan,
Italy) and tissue culture plastic dishes from Euroclone
(Milan, Italy) unless otherwise specified.
Experimental Design
This study was based on three experiments as summarized
in Table 1. The first experiment was to evaluate the effect
of PC on in vitro embryo production by replacing fetal calf
serum (FCS) with PC to establish whether this product is
able to support embryo development. The second experi-
ment evaluated the endometrium immunohistochemically,
after in vivo PC administration, using Ki-67 as a marker of
cell proliferation. The third in vivo experiment evaluated
embryo implantation and development in RBCs following
intrauterine administration of PC at 48 h after artificial
insemination (AI).
Animals and repeat breeder syndrome diagnosis
All procedures were performed according to approved
animal care and use protocols of the institutional ethics
committee and to good veterinary practice for animal
welfare as to European directive 2010/63/UE. Moreover,
written farmers’ consent was obtained at the beginning
of the study.
The study was performed between January and April to
reduce the influence of climate (i.e. a hot and humid cli-
mate, heavy rain, heat stress). Indeed, in the Italian envir-
onment late winter is probably the most stable period,
with a low rain rate and temperature between 0 and 10 °C.
A total of 64 animals Holstein Friesians in which preg-
nancy had not been achieved despite 3 or more insemina-
tions were enrolled in this study. Ultrasound examination
was performed in each cow to detect any reproductive
pathology (like ovarian cysts, pyometra, abscess…) that
would result in exclusion of cows from the experiment be-
cause not considered RBCs. For each cow, on the day of
the estrus, cervical mucus was tested and samples of cer-
vical mucus were collected aseptically by swab (Equi-Vet,
Kruuse, Marslev, Denmark). Bacteriological examinations
were performed as reported by Gani et al. [25].
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The RBCs were 385 ± 12.5 days in milking, had a
weekly milk production of 128.6 ± 0.7 kg, 6.05 ± 4.84
previous inseminations (minimum of 3 and maximum
of 23 inseminations per animal), and were on lactation
number 2.7 ± 0.2.
Preparation of Platelet Concentrate (PC)
Blood was obtained from 8 donor cows, at the forty days
in milking because in this period the circulating platelet
counts is higher than other periods (data not shown),
in good health, free from infection that had not re-
ceived medication during the previous two months.
The collection of blood and the preparation of PC, with
the method of double centrifugation, were performed
as reported by Lange-Consiglio et al. [26]. Briefly, after
surgical scrub preparation of a few centimetres of skin
around the subcutaneous mammary vein, 450 ml of
blood was collected in ad hoc Terumo blood bags (Terumo
Srl, Rome, Italy) containing CPDA-1 by using the 16 gauge
needle provided with the bags. The bags were transported
at +4 °C to the laboratory within 2 hrs of collection and
immediately processed. All separation steps to produce PC
were performed under a horizontal laminar flow hood in
aseptic conditions. To prepare the PC, the blood was
drawn into sterile Falcon tubes of 50 ml each. The tubes
were centrifuged at 100xg for 30 min. This caused separ-
ation of the blood into three components: red blood cells
at the lowest level, ‘buffy coat’ comprised in the middle
layer, and platelet-rich plasma (PRP) in the upper layer.
Afterward, the PRP was carefully aspirated and distributed
in new 50 ml tubes and centrifuged again at 1500xg for
10 min to obtain the platelet pellet and the poor platelet
plasma (PPP) at the upper layer. Afterwards, two thirds of
the volume of PPP was aspirated for later use and the pel-
let mixed in the residual PPP volume to allow for platelet
count before the final dilution with PPP to obtain PC at a
standard concentration of 1x109 platelet/ml. All platelet
counts on peripheral blood, PRP and PC were performed
by an automatic hematology analyser HeCo Vet SEAC
(Florence, Italy).
At the end of the process, PC was pooled and pre-
pared at a standard concentration of 1 × 109 platelet/ml.
The total volume of PC was aliquoted into 10 ml usage
doses that were stored in syringes. To release platelet
derived factors, three cycles of freezing at −80 °C and
thawing at 37 °C were performed [27]. Syringes containing
PC dose were kept frozen at −20 °C until use. The same
pool of PC obtained from donor cows was used in all
experiments and in all animals in an heterologous way
meaning that it was employed in cows different from
donor cows.
For supplementation in in vitro cultured embryos, to
prevent coagulation and clot formation, a fibrinogen free
PC was prepared as reported by Mojica-Henshaw et al.
[28]. Briefly, after thawing, pooled PC was centrifuged at
4000 g for 20 min, and the supernatant was collected
and was manufactured by adding calcium chloride
(20 % w/v) at a ratio of 1:100. After allowing the product
to form a clot overnight at 4 °C, the coagulated product
was centrifuged at 4000 g for 20 min, and the super-
natant was collected to obtain fibrinogen free PC.
Experiment 1: effect of PC on in vitro embryo production
The in vitro embryo production consisted of 3 steps:
in vitro maturation of oocytes (IVM), in vitro fertilization
(IVF) and in vitro culture of embryo (IVC) performed on a
monolayer of cumulus cells. These steps were carried out
as reported by Lange-Consiglio et al. [29]. Briefly, cumu-
lus–oocyte complexes (COCs) were collected from ovaries
obtained from an abattoir by aspirating follicles 2–8 mm
in diameter and washing them twice in preincubated
(38.5 °C, 5 % CO2 in air) TCM 199-HEPES buffered
culture medium supplemented with 10 % FCS.
IVM was performed for 24 h in TCM 199 Earl’s Salt
medium supplemented with 10 % FCS, 5 μg/ml LH
(Lutropin, Bioniche, Canada), 0.5 μg/ml FSH (Folltropin,
Bioniche, Canada), 0.2 mM sodium pyruvate, 10 μg/ml
gentamycin and 1 mg/ml estradiol 17β. Cultures were in
70 μl droplets (up to 20 oocytes/droplet) of the medium
under oil, at 38.5 °C in 5 % CO2.
IVF was performed in Tyrode’s-albumin-lactate-pyru-
vate (TALP) medium containing 2 mM penicillamine,
1 mM hypotaurine, 250 mM epinephrine and 20 μg/ml
heparin. Frozen–thawed semen was prepared by Percoll
gradient (Amersham Pharmacia Biotec, Upsala, Sweden).
In a 15 ml conic tube, 1 ml Percoll 90 % was added
followed by 1 ml Percoll 45 %. Semen was thawed at
37 ° C for 30 sec, placed on the top of the Percoll
Table 1 Experimental design
Experiments N° samples Parameter evaluated
1 In vitro: effect of different amounts of PC on embryo development 705 oocytes • Rate of embryos
• Total cell numbers per blastocyst
2 In vivo: evaluation of endometrial cell proliferation, after in vivo PC
administration
4 RBCs Microscopic nuclear count of cells
expressing Ki-67
3 In vivo: embryo implantation and development after intrauterine
administration of PC
30 Treated RBCs 30 Control
RBCs
Rate of pregnancy
Lange-Consiglio et al. Reproductive Biology and Endocrinology  (2015) 13:65 Page 3 of 9
gradient and centrifuged for 30 min at 300 xg. After re-
moval of the supernatant, 4 ml TALP medium were
added and the sample centrifuged again for 2 min at 200
xg to remove excess Percoll.
Semen (107 spermatozoa/ml) was co-incubated with
matured oocytes for 18 h at 38.5 °C in 5 % CO2. At the
end of gametes co-culture, the cumulus cells were com-
pletely removed and evaluation of segmentation was
carried out from the first day of embryo culture (con-
sidering as day zero the day of insemination) when em-
bryos were equally divided into three different embryo
culture media: 1) standard embryo culture medium
(TCM-199) with 10 % of FCS; 2) standard medium sup-
plemented with 5 % FCS and 5 % PC; 3) standard
medium supplemented with 10 % PC. The percentage
of embryos developing to blastocyst stage was evaluated
daily up to day 7 after fertilization. Some blastocysts, as
reported in Table 2, were stained with Hoechst 33342
(10 μg/ml) for 10 min, and total cell numbers were
counted under an epifluorescence microscope to esti-
mate embryo quality. Hoechst 33342 dye was excited at
353–365 nm while the emission wavelength was set at
460 nm.
Experiment 2: immunohistochemical analysis of
endometrium after in vivo PC administration
Four RBCs, belonging to the group previously described,
culled by owner decision were used to test the effect of
PC on endometrial cell proliferation. On the ninth day
of diestrous stage, 10 ml of PC were administered into
uterine horn ipsy-lateral (two cows) or contra-lateral
(two cows) to the corpus luteum, maintaining the op-
posite horn as a control. After PC administration, a
Foley catheter was inserted in the control horn and the
balloon was inflated to prevent passage of PC and create
the control environment. Our previous study (data not
shown) demonstrated that insertion of a Foley catheter
for 3 days does not alter the normal histological appear-
ance of endometrium. These cows were slaughtered
3 days after the treatment (on the twelfth day of diestrus
stage) and the 4 uteri were evaluated macroscopically for
differences between the treated and the control horns.
For each horn, samples of middle/cranial portion were
collected in formalin solution and were examined immu-
nohistochemically for expression of the nuclear antigen
Ki-67, a marker of cell proliferation, using the ABC-
peroxidase method as reported by Turner et al. [30].
Briefly, the tissue was fixed in 4 % buffered formalin,
dehydrated, and embedded in paraffin. Sections 4 μm
thick were mounted on aptes (3-aminopropyl triethoxy
silane, Sigma) coated slides, dewaxed, and rehydrated.
Sections were immunostained using the standard ABC
technique with the rabbit antihuman/horse polyclonal
antibody to Ki-67 (Dako Italia, S.p.A., Milan. Italy) used
at 1:50 dilution. Ki-67 antibody is directed against differ-
ent epitopes of the proliferation-related antigen and can
be used on fixed sections. Endogenous peroxidase activ-
ity was blocked using 3 % hydrogen peroxide. Pre-
treatment with microwaving in sodium citrate buffer,
pH 6, was used. Non-specific primary antibody binding
was blocked using fetal calf serum at a dilution of 1:20
for the ABC Ki-67. The primary antibody was applied
for 18 hrs at +4 °C and washed in buffered saline. An
antirabbit biotinylated secondary antibody (Insight Bio-
technology Limited, Wembley Middlesex, UK) was ap-
plied at 1:200 dilution for 30 min at room temperature,
followed by washes and then by application of the horse-
radish peroxidase streptavidin complex (Dako) at 1:400
dilution for 30 min. The anti-rabbit secondary antibody
is an affinity-purified polyclonal antibody with well-
characterized specificity for rabbit IgG. Colour develop-
ment was with metal enhanced diaminobenzidine (DAB)
(Pierce and Warriner Ltd, Chester, UK) applied for
15 min. The slides were lightly counterstained with
Mayer emallume. The sections were viewed under a
photomicroscope Olympus BX51 and nuclear count was
performed on each section, at the level of endometrial
epithelial cells, as number of positive cells to detect the
entity of cell proliferation. Three different sections per
cow and 4 microscopy fields for each section were
counted.
Experiment 3: in vivo effectiveness of intrauterine
administration of PC at 48 h after AI in RBCs
This experiment was carried out in 2 farms, managed in
a cubicle yard. Sixty RBCs were randomly allocated into
two groups: “treated group” (N = 30) that received intra-
uterine administration of PC 48 hrs after AI and “control
group” (N = 30), that received no treatment in addition
to AI. Treated group were characterized by 6.0 ± 5.19 in-
seminations prior to the enrollment in the study while
control cows showed 6.1 ± 4.49 inseminations.
Cows displaying estrus in either group were submitted
for insemination. The semen from the same bull was
Table 2 Number of blastocysts at 7 days in three different
culture media and total cell number per blastocysts
Medium N° of blastocysts
at 7 days (%)
N° of
embryos
observed
Total cell
numbers per
blastocyst
CTR (10 % FCS) 84/240 (35.00 ± 1.72)a 29 104.6 ± 10.5a
FCS 5 % + PC 5 % 99/230 (43.04 ± 1.42)b 31 123.4 ± 8.3b
PC 10 % 64/235 (27.23 ± 1.39)c 34 98.7 ± 6.4c
The number are expressed as mean ± standard deviation (SD)
Different small letters superscript (a, b) in the same column indicate statistically
different comparisons (P < 0.05)
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used for insemination in each group, eliminating the
“bull” effect in the results of fertility.
All the cows were blood sampled for progesterone
assay at day 0 (day of insemination), and then 4 and
8 days after insemination (respectively T0, T4 and T8).
At 48 hrs after insemination, 10 ml of PC at 1 x 109
platelet/ml were administered into the uterus in the
cows in the treated group. This time was supposed to
be ideal after AI not to disturb spermatozoa progres-
sion and before the embryo reaches the uterus. Ten ml
of PC were administrated following previous study
(data not shown) in which this volume proved to be
evenly distributed along the uterine horns without
signs of excessive distension allowing to reach the dee-
pest portion of the organ. Ultrasound examination for
pregnancy diagnosis was performed in all cows 32 days
after insemination and confirmed at 60 days.
Bacteriological examination of cervical mucus
Bacteriological investigations were performed to detect
aerobic and anaerobic microorganisms, such as True-
perella pyogenes, Haemophylus sommni, Staphylococcus
sp., Streptococcus sp., Enterobacteriaceae, Prevotella sp.,
Fusobacterium spp. Each sample was plated on blood
agar (agar with 5 % sheep blood, Sintak, Italy) for iso-
lated colonies. The plates were incubated for 24–48 hrs
in aerobic and anaerobic conditions at 37° ± 2 °C. Iden-
tification of bacteria was based on colonial morphology,
Gram staining, and biochemical tests such as catalase,
oxidase, coagulase according to the guidelines of the
Bergey’s manual of Systematic Bacteriology and the
standard bacterial procedure of CLSI (Clinical and
Laboratory Standards Institute) and confirmed by
API-System (bioMerieux, France).
Intrauterine administration of platelet concentrate
After thawing and warming at 38 °C, the syringes of
PC were connected to a sterile disposable intrauterine
cannula, so that samples could be delivered through
the vestibule, the vagina and the cervix to reach deep
into the uterine horn ipsi-lateral to the newly formed
corpus luteum. Plastic catheters with atraumatic ends
were used. Ten ml of PC were administrated to cows
in the treatment group 48 hrs after insemination.
Progesterone assay
Plasma samples were obtained by jugular venipuncture
(2-5 ml). Blood was collected in heparinized tubes and
centrifuged at 1000xg for 10 min. The plasma concen-
tration of progesterone was assessed using a quantitative
automated method based on the enzyme-linked fluores-
cent assay (ELFA) technique (Mini-Vidas; bioMérieux
Italia S.p.A., Florence, Italy.
Statistical analysis
The collection efficiency of platelets for each PC was
analyzed using the following formulas [31]:
efficiency for platelet collection
¼ platelet count=μl in PC x volume of PC
platelet count in whole
blood=μl x volume of whole blood
The statistical analysis of the data collected during the
study, except for bacteriological data, was conducted
using chi-square test. For all tests, differences were con-
sidered statistically significant when P ≤ 0.05. The data
were analyzed using the “Software GraphPad Instat 3.00
for Windows” (La Jolla, CA, USA).
Results
Platelet collection efficiency and product sterility test
The platelet collection efficiency for the PCs was 10.9 ±
2.3 %, indicating that 10.9 ± 2.3 ml of PC at the concentra-
tion of 1x109 platelet/ml were obtained from 100 ml of
blood.
The bacterial sterility test performed on the PC pro-
duced in the laboratory has always given negative results,
confirming that the experimentation has been performed
in accordance with the appropriate standards of laboratory
sterility.
Experiment 1: effect of PC on in vitro embryo production
During three experiments, 168 ovaries were processed,
705 oocytes were collected, with an average of 4.2 oo-
cytes collected per ovary. The results related to the
culture of embryos in the standard medium (CTR)
show that the rate of cleavage of three replicates is
66.80 ± 2.07.
Results related to embryo culture show that the rate of
blastocyst development was statistically significant differ-
ent (P < 0.001) among all the three media tested and the
best embryo production rate and quality was achieved in
the culture medium supplemented with 5 % PC and 5 %
FCS (Table 2).
Experiment 2: immunohistochemical analysis of
endometrium after in vivo PC administration
No macroscopic alterations were observed in any of the
uterine samples. Immunohistochemical examination for
the unmasking of the nuclear antigen Ki-67 showed that
in all animals there were statistically more proliferating
nuclei in the treated uterine horn compared to the con-
trol one (Table 3 and Fig. 1).
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Experiment 3: in vivo effectiveness of intrauterine
administration of PC at 48 hrs after AI in RBCs
The clinical aspect of the uterus in all animals during the
clinical examination at the estrous stage appeared normal
in size, without presence of drains and with adequate,
clear and stringy estrous mucus.
Progesterone values did not differ from those expected
in a normal estrous cycle. Indeed, these values were
lower than 1 ng/ml during peri-estrus and then in-
creased gradually at day +4 as a result of ovulation and
further increased at day +8 post insemination (Table 4).
The percentage of pregnant cows in the control group
was of 33.33 % (10/30) compared to 70 % (21/30) of the
treated animals. The difference in pregnancy rates be-
tween the treated group and the control group was sta-
tistically significant (P < 0.05; Table 4). There was no
correlation between treatment results and number of
past inseminations before this study and characterizing
the status of the enrolled RBCs (P = 0.62). All treated
and control RBCs diagnosed as pregnant gave birth to
normal offsprings.
Microbiological results
No significant bacterial growth was observed in any of
the cervical mucus samples obtained from cows of both
experimental groups. The microorganism Aerococcus
viridans was isolate only from one cow.
Discussion
Studies in humans and in other mammals have shown
that cytokines and growth factors are produced by the
pre-implantation embryo and cells of the reproductive
tract, even if the exact combinations required for suc-
cessful implantation are not yet fully understood [23].
Based on the current knowledge of the regenerative ef-
fect of PC due to its high growth factor and cytokine
content [22], this study proposes a novel therapeutic ap-
proach. Autologous PC is known to accelerate the heal-
ing process in human medicine, and has been used in
maxillofacial surgery, muscle and/or tendon repair, and
reversal of skin ulcers [21]. In veterinary medicine there
are few clinical reports of the use of PC. It has been
mainly used for promoting equine tendon repair [32],
but there are some reports of its use in intestinal wound
healing in pigs [33], in a large cutaneous lesion in a dog
[34] and in bovine mastitis in which it was used in heter-
ologous way [26]. In all cases PC or platelet rich plasma
showed a clear regenerative potential.
For this reason, in this preliminary investigation, we per-
formed three explorative studies in vitro and in vivo. Only
one paper [35] described the effects of platelet rich plasma
on morula and blastocysts in vitro production. In our
study and in our experimental conditions (i.e. platelet con-
centration at 1x 109/ml), at first we studied the effect of
PC on in vitro embryo development using two different
percentages (respectively 5 % and 10 %) of PC as a partial
or complete replacement of FCS. The rate of blastocyst
production and the total cells number of the blastocysts
were statistically increased in the medium with 5 % PC
and 5 % FCS when compared to both the control and
medium with 10 % PC. Platelets release many growth fac-
tors, including FGF, TGF-6, PDGF and EGF [36, 37] that
can stimulate bovine embryo development [38, 39]. In-
deed, Munson et al. [40] demonstrated that TGF-6 and
PDGF act synergistically to promote proliferation of both
bovine trophoblastic cells and endometrial epithelial cells
during in vitro culture. Moreover, EGF in vivo is produced
by endometrial cells and its receptors have been detected
in the embryo itself, where EGF acts through the phos-
phorylation of membrane proteins as a mitogen, promot-
ing DNA and RNA synthesis. As pregnancy progresses,
the increased production of EGF enhances trophoblast dif-
ferentiation [41], promoting cell attachment and embryo
Table 3 Microscopic nuclear count of cells expressing nuclear antigen Ki-67 protein in control (CTR) and treated (TRT) uterine horns
of 4 cows in different sections and different microscopic fields
1 2 3 4
Uterine horn Uterine horn Uterine horn Uterine horn
CTR TRT CTR TRT CTR TRT CTR TRT
2 ± 0.7a 12 ± 0.2b 1 ± 0.2a 10 ± 0.6b 5 ± 2.9a 18 ± 2.3b 14 ± 3.8a 40 ± 4.2b
Legend: CTR Control; TRT Treated. The number are expressed as mean ± standard deviation (SD)
Different small letters superscript (a, b) in the same line indicate statistically different comparisons (P < 0.05)
Fig. 1 Immunohystochemical analysis. Nuclear positivity to Ki-67
protein. Magnification 100x
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development [23]. Fibronectin and other glycoproteins are
also released from platelets after aggregation, and Larson
et al. [42] discovered that a serum-free medium supple-
mented with fibronectin provides the extracellular matrix
required by the embryo to develop to the blastocyst stage
during in vitro culture. In a speculative interpretation, the
embryo culture systems supplemented with PC may have
provided TGF-6, PDGF and the matrix of extracellular fi-
bronectin necessary to support the development of em-
bryo during in vitro culture, thus replicating the uterine
microenvironment appropriate for embryo growth, viabil-
ity, and for cytokine secretion [23]. It is possible that the
low rate of embryos obtained in the medium with 10 %
PC, compared to control, results from an excess of factors
that may have had an inhibitory effect on the embryo
development.
This in vitro study provided a useful starting point for
the pre-clinical investigation in order to use PC in in vivo
trials. Immunohistochemical examination of uterine sam-
ples from animals slaughtered 3 days after PC treatment
showed that there was more expression of the nuclear anti-
gen Ki-67 in samples from treated uterine horns compared
to the controls. Cell proliferation is not enough indicative
for uterine health but Ki-67 is expressed in the nuclei of
proliferating cells. In tissues with a high proliferative rate it
is expressed in all cell cycle phases except for the resting or
G0 phases [43, 44] and reaches a maximum level during
G2 and M [45]. Since Ki-67 is significantly more expressed
in samples from treated uterine horns, it may be supposed
that the growth factors released by platelets in the PC may
have an effect on endometrial cell proliferation.
After these preliminary studies, the in vivo administra-
tion of PC into the uterus of RBCs at 48 hrs after insem-
ination was performed.
The gynecological clinical status and the progesterone
analysis performed in this study ensured that pregnancy
losses in enrolled animals were not caused by abnormal
ovarian cycles, an important condition for classification
of cows as RBC, as reported by Gustafsson et al. [46].
The progesterone analysis also allowed us to exclude
hypoluteinism as a possible cause of repeat breeding. In
fact, all animals showed progesterone values exceeding
the 2 ng/ml threshold both at day +4 and +8 post-
insemination [47]. Moreover, bacteriological examination
performed on cervical mucus confirmed the absence of
bacterial infections in the genital tract, as the only
isolated microorganism was Aerococcus viridans, a bac-
terium not recognized as a uterine pathogen.
In the in vivo study, there were more pregnant cows in
the treated group compared to the control group. This
suggests that the in vivo intrauterine administration of PC
48 hrs after insemination, time supposed to be ideal after
AI not to disturb spermatozoa progression and before the
embryo reaches the uterus, could make the uterine envir-
onment favorable to embryo implantation. This may be
the effect of platelet growth factors on regeneration and/
or the healing of clinically silent endometrial abnormal-
ities. Furthermore, PC should enrich the uterine environ-
ment with factors necessary for embryo development.
Uterine glands produce a glycoprotein-rich secretion,
which is believed to support the embryo during the
pre-implantation period [48]. In addition to providing
nutrition for the conceptus, this secretion contains a
complex array of growth factors and cytokines. Katagiri
and Takahashi [49] reported that RBCs show abnormalities
in the growth factor-cytokine network - specifically in
endometrial EGF concentrations. Cyclic cows have two
peaks of EGF concentrations on days 2–4 and 13–14 of the
oestrous cycle, but these peaks are lost or diminished in
about 70 % of RBCs [49]. The EGF family could act on the
trophectoderm promoting cell attachment and embryo de-
velopment [23]. Since PC contains EGF, treatments target-
ing the endometrial growth factor regulatory network may
be an effective way to deal with RBCs when uterine prob-
lems limit the production of this or other growth factors.
Conclusions
The preliminary data regarding the administration of PC
into the uterus of animals at 48 hrs after insemination
produced very encouraging results in RBCs. From our
data, we hypothesize that PC, whose content is known,
enriches the uterine environment with factors necessary
for embryo development and counteracts eventual sub-
clinical endometritis by its anti-inflammatory properties.
The obtained results in our three different explorative
studies are very interesting. This research could offer a
new therapeutic strategy for RBC syndrome and also
open the possibility for using PC in future embryo-
transfer programs in both human and veterinary medi-
cine as a vehicle to transfer embryos at the time of
transplantation, with the aim of improving the uterine
environment for implantation.
Table 4 Results of in vivo effectiveness of intrauterine administration of PC 48 h after AI in RBCs
Progesterone value (ng/ml)
N°cows T0 T4 T8 Pregnant (%) Not Pregnant (%) Delivery (%)
Control 30 0.40 ± 0.21a 2.63 ± 0.96a 7.75 ± 2.21a 10 (33.33)a 20 (66.67)a 10 (100)
Treated 30 0.40 ± 0.17a 3.12 ± 0.85a 8.33 ± 2.14a 21 (70.00)b 9 (30.00)b 21 (100)
Different small letters superscript (a, b) in the same column indicate statistically different comparisons (P < 0.05)
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Abstract
The aim of this work was to provide, for the first time, a protocol for isolation and characterization of stem cells
from porcine amniotic membrane in view of their potential uses in regenerative medicine. From three samples
of allanto-amnion recovered at delivery, the amniotic membrane was stripped from overlying allantois and
digested with trypsin and collagenase to isolate epithelial (amniotic epithelial cells [AECs]) and mesenchymal
cells, respectively. Proliferation, differentiation, and characterization studies by molecular biology and flow
cytometry were performed. Histological examination revealed very few mesenchymal cells in the stromal layer,
and a cellular yield of AECs of 10· 106/gram of digested tissue was achieved. AECs readily attached to plastic
culture dishes displaying typical cuboidal morphology and, although their proliferative capacity decreased to
the fifth passage, AECs showed a mean doubling time of 24.77– 6 h and a mean frequency of one fibroblast
colony-forming unit (CFU-F) for every 116.75 plated cells. AECs expressed mesenchymal stem cell (MSC)
mRNA markers (CD29, CD166, CD90, CD73, CD117) and pluripotent markers (Nanog and Oct 4), whereas
they were negative for CD34 and MHCII. Mesodermic, ectodermic, and endodermic differentiation was con-
firmed by staining and expression of specific markers. We conclude that porcine amniotic membrane can
provide an attractive source of stem cells that may be a useful tool for biomedical research.
Introduction
Two essential factors are needed for successful stemcell therapy research—a good animal model and an ef-
fective and sustainable source of stem cells. The use of ani-
mals in science and research is well documented and
practiced (Doherty et al., 2008). However, the evolutionary
gap between humans and many of the applied animal models
(such as rodents) has always hampered direct application of
the knowledge gained from animals to human therapy (Vo-
dicka, et al., 2005). Ideally, preclinical animal model studies
replicate the pathogenesis of the relevant human disease so
that therapeutic intervention in the animal model mimics the
intended clinical application. In this regard, the pig offers
many advantages because it shows many similarities to hu-
mans in aspects of anatomy and physiology, nutrition and
metabolism, histology, immunology, and pharmacokinetics
(Swindle et al., 2012). Moreover, with the substantially im-
proved knowledge of the structure and function of the pig
genome in the last two decades, it has been shown that this
animal shares a high sequence and chromosomal structure
homology with humans (Lunney, 2007).
The similarities between pigs and humans make this an-
imal model a valuable tool for evaluation of the safety,
feasibility, dosage, engraftment, or toxicity of transferred
mesenchymal stem cells (MSCs) (Casal and Haskins, 2006).
For practical application of MSCs in regenerative medicine,
some aspects of the stem cell reservoir must be considered:
large numbers of cells must be harvested in an inexpensive
and noninvasive way, without risk to the donor, and these
cells must retain a high ability to proliferate and differen-
tiate in vitro (Carlin et al., 2006). The most used and best-
1Large Animal Hospital, Reproduction Unit, Universita` degli Studi di Milano, Lodi, Italy.
2Department of Life and Environmental Sciences, Universita` Politecnica delle Marche, Ancona, Italy.
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characterized source of adult MSCs is bone marrow (BM),
but collection of BM requires an invasive procedure.
Moreover, the proliferative and differentiation potential of
BM-MSCs is limited due to the donor age and the number of
in vitro passages (Digirolamo et al., 1999; Guillot et al.,
2007; Majors et al., 1997).
Placenta has been proposed as a more suitable candidate
for the derivation of MSCs both in human and in veterinary
medicine. It includes several tissues, such as umbilical cord
blood (Chang et al., 2006; Grewal et al., 2003; Kang et al.,
2013; Kern et al., 2006), Wharton jelly (Corradetti et al.,
2011; Cremonesi et al., 2008; Hoynowski et al., 2007; Ia-
cono et al., 2012; La Rocca et al., 2009; Lovati et al., 2011;
Passeri et al., 2009; Weiss et al., 2008), amniotic membrane
(Corradetti et al., 2013; Filioli Uranio et al., 2011; Lange
Consiglio et al., 2012; Miki and Strom, 2006; Muttini et al.,
2013; Parolini and Soncini, 2004; Rutigliano et al., 2013),
and amniotic fluid (Chen et al., 2011; Corradetti et al., 2013;
Dev et al., 2012; Gao et al., 2014; Iacono et al., 2012; Lovati
et al., 2011; Parolini et al., 2009; Steigman and Fauza,
2007). These tissues could provide a large number of cells
without risks to the donor in an inexpensive and noninvasive
way, because they are discarded at delivery.
In addition, it is known that human MSCs from extrafetal
tissues possess a higher proliferation ability and differ-
entiation potential and a longer telomere length compared to
cells derived from adult tissues (Kern et al., 2006; Ko¨gler
et al., 2004). Specifically, MSCs isolated from amnion are
thought to be in an intermediate stage between embryonic
and adult stem cells (De Coppi et al., 2007; Delo et al.,
2006; Gucciardo et al., 2009; In’t Anker et al., 2004) and
are known to prevent rejection of the fetus due to their low
immunogenicity and immunomodulatory characteristics (Evan-
gelista et al., 2008; Wang, et al. 2006).
In veterinary medicine, presumptive stem cells have been
identified in the epithelial and/or stromal portions of the
amnion in canine (Filioli Uranio et al., 2011), equine (Lange
Consiglio et al., 2012), bovine (Corradetti et al., 2013), ovine
(Muttini et al., 2013), and feline (Rutigliano et al., 2013)
species. In this regard, some studies have already demon-
strated the clinical relevance of amniotic stem cells. Lange-
Consiglio et al. (2012, 2013a, b) isolated equine MSCs from
the amniotic membrane as an alternative to BM-MSCs and
demonstrated their superior efficacy for the treatment of
spontaneous tendon injuries in horses, showing only 4% of
relapses of the tendon defect in comparison to BM-MSCs
(23.08%).
In swine, MSCs have been isolated from other extrafetal
tissues such as Wharton jelly (Carlin et al., 2006), umbilical
cord blood (Kumar et al., 2007), and amniotic fluid (Chen
et al., 2011). The authors of these studies worked with
placental tissues and, although the results confirmed that the
isolated cells had stem cell properties, the collection of
Wharton jelly and amniotic fluid was invasive, occurring, as
it did, from the embryonic disc or from early or mid stage of
gestation with sows under general anesthesia. In addition, it
was only possible to collect a small amount (2mL) of um-
bilical cord blood after delivery (Kumar et al., 2007).
The aim of the study reported here was to isolate, for the
first time, presumptive MSCs from porcine amniotic mem-
brane (a usually discarded tissue) at delivery and to char-
acterize these cells in terms of morphology, proliferative
and differentiation potential, colony-forming unit (CFU)
capability, and expression of stemness markers.
Materials and Methods
Materials
Chemicals were obtained from Sigma-Aldrich Chemical
(Milan, Italy) unless otherwise specified, and tissue culture
plastic dishes were purchased from Euroclone (Milan, Italy).
Tissue collection
In this study, after approval by the Ethical Committee of the
University of Milan and written owner’s consent, all proce-
dures were conducted following standard veterinary practice
and in accordance with 2010/63 EU directive on animal pro-
tection and Italian Law (D.L. No. 116/1992). Allanto-amniotic
membranes and mesamnions were collected at delivery from
three normal full-term pregnant sows. A mean of four allanto-
amniotic membranes and four mesamnions were collected
from each sow.Mesamnion, generally found just after delivery
adhering to the back of piglet, is where the two chorio-
amniotic folds meet and fuse, thus connecting the amniotic
membrane with the chorion, as shown in Figure 1A. In pigs, as
in cattle, the mesamnion persists until parturition in such a way
that offspring are generally born without covering membranes
(Hyttel et al., 2011).
Samples for histology were fixed immediately as described
in the following section. Other samples were kept at 4C
in calcium- and magnesium-free phosphate-buffered saline
(PBS-CMF) (Euroclone), supplemented with 100U/mL of
penicillin, 100lg/mL streptomycin (Sigma) and 1lg/mL am-
photericin B (Sigma), and processed within 12 h of harvesting.
Histology of allanto-amnion and mesamnion
Paraffin embedding and preparation of histologic sec-
tions. For each sow, fragments of the four allanto-amnions
and four mesamnions were fixed in 10% formalin for 48–
72 h at 4C. Tissues were dehydrated in a graded series of
ethanol and embedded in paraffin. Tissue blocks were cut at
5- to 7-lm thickness using a microtome (Microm Interna-
tional GmbH, Walldorf), and sections were dewaxed and
stained for general morphological purposes.
Hematoxylin & Eosin and Periodic Acid Schiff staining.
Serial sections were stained either using a routine Hema-
toxylin & Eosin method for precise anatomical information
or with Periodic Acid Schiff (PAS) staining technique to
describe better the major tissue types in the specimens.
PAS-positive structures stain magenta. Sections were ex-
amined under an Olympus BX51 photomicroscope con-
nected to a digital camera and DP-soft (Olympus, Italy) for
computer-assisted image acquisition and processing.
Isolation of amniotic mesenchymal
and epithelial stem cells
The allanto-amniotic membranes collected were stripped
mechanically from the overlying allantois to obtain the thin,
transparent amniotic membranes. Then, pools of the amniotic
membranes and pools of the mesamnions of each sow (4–5
grams of tissue for every type of membrane) were made.
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Membranes of each pool were cut into small pieces and digested
enzymatically for 9min at 37C in a PBS solution containing
2.4U/mL dispase (Becton Dickinson and Company, Italy).
Cell isolation was performed as previously reported (Lange
Consiglio et al., 2012). Briefly, after a resting period of 5–
10min at room temperature in High-Glucose Dulbecco’s
Modified Eagle Medium (HG-DMEM; Celbio-Corning)
supplemented with 10% heat-inactivated fetal bovine serum
(FBS; Sigma) and 2mM l-glutamine (Sigma), fragments
were digested with 0.93mg/mL collagenase type I (Sigma)
and 20lg/mL DNase (Roche, Mannheim, Germany) for
&3 h at 37C. The amniotic fragments were then removed,
and cells were filtered using a 100-lm cell strainer (Sigma)
before being collected by centrifugation at 200· g for 10min.
In this way, amniotic mesenchymal cells (AMCs) were ob-
tained. Meanwhile, the amnion fragments not digested by
collagenase were collected in the strainer and further incu-
bated twice with 0.05% trypsin (Sigma) at 37C for 45min to
isolate amniotic epithelial cells (AECs). AECs were collected
by filtration and centrifugation, as described above.
Culture, expansion, and cell count
Soon after isolation, the number of viable cells was
counted using the Trypan Blue dye exclusion method
(Sigma). Cells were plated at a density of 1· 105 cell/cm2 in
T75 flasks (Euroclone). Cultures were established in HG-
DMEM supplemented with 10% FBS, 10 ng/mL epidermal
growth factor (EGF; Sigma), 1% penicillin (100UI/mL) and
streptomycin 100lg/mL, 0.25 lg/mL amphotericin B, and
2mM l-glutamine. Cell cultures were maintained in an in-
cubator (SANYO CO2 Incubator, MCO-15AC), at 38.5C,
FIG. 1. Histology of swine fetal adnexa, PAS reaction. (A) Schematic drawing of the extraembryonic membranes in the
early pig embryo, indicating how the mesamnion (arrow) forms (redrawn from Vejlsted, 2010). (B) Within the allanto-
amnion, it is possible to appreciate four layers: (a) Amniotic epithelial layer of cuboidal cells; (b) amniotic mesenchymal
layer; (c) allantois mesenchymal layer; (d) allantois epithelial layer of flattened cells. (C) Higher magnification of the
allanto-amnion to demonstrate epithelial and stromal layers of amnion. (D) Mesamnion. The modified amniotic epithelium
(arrows) is lying above the amniotic mesenchymal layer (asterisks). Observe the paucity of cells present in the mesenchymal
components both of allanto-amnion and of the mesamnion. Scale bars: B, 200lm; C, 100lm; D, 40lm. (E) Morphology of
monolayer amnion-derived epithelial cells. (F) Clusters of AECs. Scale bar, 20lm.
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in a humidified atmosphere (90%) with 5% CO2. The me-
dium was replaced after 72 h to eliminate nonadherent cells.
Cell cultures were maintained changing the medium twice a
week. After reaching confluence, corresponding to approx-
imately 80% of the flask surface [passage 0 (P0)], the pri-
mary culture was detached from the bottom of the flask with
0.05% trypsin and 0.02% EDTA in phosphate buffer
(Celbio-Corning) at 37C for 2–3min and seeded for sub-
culture at 1 · 104 cell/cm2.
Immunocytoscreen
AECs and AMCs were tested for immunoreactivity
against Vimentin (mouse monoclonal, clone Vim V9; Dako,
Glostrup, Denmark) and PanCytokeratin (mouse monoclo-
nal, clone A1E; Santa Cruz Biotechnology, Santa Cruz, CA,
USA). Cultured AECs and AMCs were fixed in Cytoscreen
solution (Hospitex Diagnostics, Milan, Italy) for 48 h and
then cytocentrifuged on Superfrost Plus slides (Thermo Sci-
entific, Menzel GmbH & Co., KG, Braunshweig, Germany)
and air-dried.
Briefly, for the immunocytochemistry procedure, primary
antibodies (anti-Vimentin: 1/100; anti-PanCytokeratin: 1/
200) diluted in Tris-buffered saline with Tween 20 (TBST)
were applied and incubated overnight at 4C. Secondary
antibodies, conjugated with horseradish peroxidase (HRP),
were added and incubated for 30min at room temperature.
The peroxidase reaction was developed for 10min using
diaminobenzidine (DAB), following the manufacturer’s in-
structions (ImpactDAB, Vector Labs Inc., Burlingame, CA,
USA) and blocked with deionized water. Cells were con-
sidered positive for Vimentin and PanCytokeratin when the
presence of intracytoplasmic stain was observed. Negative
controls for the target antigens were performed by replacing
the primary antibodies with irrelevant antibodies from the
host species in which the immunoglobulins were developed
[rabbit immunoglobulin (Ig) fraction normal X093 and
mouse IgG1 X0931; Dako]. Negative controls in which the
primary antibody was replaced with a buffer solution
(TBST) alone were also performed.
Proliferation rate and CFU assay
Proliferation rate and CFU assay were determined as
previously reported (Lange-Consiglio et al., 2012). Dou-
bling time (DT) was assessed from P1 to P5, CFU assays
were performed at P0 plating cells at different densities
(100, 250, 500, and 1000 cells/cm2). Colonies formed by
16–20 nucleated cells were counted under a BX71 inverted
microscope (Olympus).
Flow cytometry
AECs were analyzed by flow cytometry to determine the
percentage of pluripotent- (Oct-4) and mesenchymal-
(CD73) associated markers after isolation (P0). Primary
antibodies were purchased from Abcam (Cambridge, UK;
goat polyclonal antibody Oct-4) and Santa Cruz Bio-
technology Inc. (Texas, USA; rabbit polyclonal CD73).
Secondary antibodies included donkey anti-goat IgG-
AlexaFluor-488 and goat anti-rabbit IgG- AlexaFluor-488
(Abcam, Cambridge, UK). Staining procedure was per-
formed as previously reported (Corradetti et al., 2011). Cells
(1· 106 cells / mL) were labeled with anti-CD73 in PBS
with 3% of bovine serum albumin (BSA) (BDH; VWR In-
ternational Ltd, Poole, UK) for 45min at room temperature
in the dark, followed by washing in cold PBS and final
incubation with the secondary antibodies (1:250) for 30min
at room temperature in the dark.
For evaluation of Oct-4, cells (2· 106 cells / mL) were
fixed in 0.01% paraformaldehyde (in PBS) at 4C for
15min, washed in 3% BSA (in PBS), and then treated to
promote permeability for 10min at room temperature in 1%
Triton-X 100 (in PBS). After incubation, cells were washed
twice in ice-cold PBS and analyzed using a Millipore Guava
easyCyte Single Sample Flow Cytometer. A minimum of
10,000 cells was acquired for each sample and analyzed in
the FL1 channel. All analyses were based on control cells
incubated with isotype-specific IgGs to establish back-
ground signal. Off-line analyses of the flow cytometry
standard (FCS) files were performed using Weasel software
v.2.5 (http://en.bio-soft.net/other/weasel.html).
In vitro differentiation
To assess their potential to undergo mesodermic (osteo-
genic and adipogenic), ectodermic (neurogenic), and en-
dodermic (pancreatic) differentiation, AECs were expanded
up to P3 and then seeded at a density of 3 · 103 cell/cm2.
Cells plated at the density of 1.5 · 103 cells/cm2 were used
as control (noninduced cells). When 80% confluence was
achieved, the differentiation procedure began. Controls (or
the uninduced cells) were cultured for the same time as the
differentiation protocol in growth medium.
Osteogenic differentiation. To induce osteogenic differ-
entiation, cells were incubated in HG-DMEM supplemented
with 10% FBS, 100U/mL penicillin, 100lg/mL streptomy-
cin, 0.25lg/mL amphotericin B, 2mM l-glutamine, 10mM
b-glycerophosphate (Sigma), 0.1lM dexamethasone (Sig-
ma), and 250lM ascorbic acid (Sigma). Osteogenic differ-
entiation was performed by incubating cells for 3 weeks at
38.5C and 5% CO2. The medium was changed twice a week
for 3 weeks. Bone was used as positive control.
Adipogenic differentiation. Adipogenic differentiation
was performed by stimulating cells with three cycles of in-
duction/maintenance for a 21-day period. The adipogenesis
induction medium was composed of HG-DMEM supple-
mented with 10% FBS, 100U/mL penicillin, 100lg/mL
streptomycin, 0.25lg/mL amphotericin B, 2mM l-glutamine,
10lg/mL insulin (Sigma), 150lM indomethacin (Sigma),
1lM dexamethasone, and 500lM 3-isobutyl-methylxanthine
(IBMX; Sigma). The adipogenesis maintenance medium was
composed of HG-DMEM supplemented with 10% FBS and
10lg/mL insulin. Adipose tissue was used as positive control.
Neurogenic differentiation. Neurogenic differentiation
was performed with a 24-h preinduction in a medium
composed of HG-DMEM supplemented with 20% FBS and
1mM b-mercaptoethanol (Sigma) (Mitchell et al., 2003).
Then, neurogenic induction was performed with a medium
composed of HG-DMEM supplemented with 2% FBS,
2% dimethyl sulfoxide (Sigma), and 200lM butylated hy-
droxyanisole (Sigma). Cells were maintained in this medium
for 3 days. Spinal cord was used as positive control.
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Pancreatic differentiation. Expanded AECs at P3 were
induced to differentiate by a three-step protocol (Gao et al.,
2008). In step 1, the cell monolayer was treated for 24 h with
HG-DMEM supplemented with 10% FBS and 10-6 M re-
tinoic acid (Sigma); then the medium was changed with HG-
DMEM with only 10% FBS for 2 days. In step 2, the cells
were detached with 0.25% trypsin–EDTA and seeded in
extracellular matrix (ECM) gel- (Euroclone) coated 60-mm
plates. The medium was switched to Low-DMEM, supple-
mented with 10% FBS, 10mmol/L nicotinamide (Sigma),
and 20 ng/mL EGF (Sigma) for 6 days. In step 3, to mature
the insulin-producing cells, the low-glucose medium was
supplemented with 10% FBS and 10 nmol/L exendin-4
(Sigma) for 6 days. As a control group, the cells were cul-
tured in Low-DMEM containing only 10% FBS.
To confirm differentiation toward the osteogenic, adipo-
genic, and neurogenic lineages, conventional von Kossa, Oil
Red O, and Nissl stainings were performed, respectively,
whereas pancreatic differentiation was monitored by ob-
servation of three-dimensional, islet-like cell cluster for-
mation. Gene expression of specific differentiation markers
was evaluated.
Gene expression analysis (RT-PCR)
Qualitative PCR analysis was performed to evaluate the
expression of specific MSC-, pluripotent-, histocompatibility-,
and hematopoiesis -associated markers at P0, P1, P3, and P5
and to confirm differentiation. Total RNA was isolated from
cells using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA)
Table 1. Oligonucleotide Sequences Used for PCR Analysis and Their Description
Gene Forward (F) and reverse (R) primers Annealing temperature Size cDNA
Housekeeping gene GAPDH F, GCAAAGTGGACATTGTCGCCATCA 62C 124 bp
R, AGCTTCCCATTCTCAGCCTTGACT
Pluripotent markers Oct-4 F, GTTCAGCCAAACGACCATCTG 62C 140 bp
R, TCTCTGCCTTGCATATCTCCTG
Nanog F, AACTTCACCAATGCCTGAG 58C 234 bp
R, CTGATCTTCTGCTTCTTGACTG
Sox2 F, CAGCCCAGACCGAGTTAAGC 63C 214 bp
R, ATCCGGGTGCTCCTTCATGT
Mesenchymal markers CD117 F, GGACCGAAGGAGGCACTTAC 59C 206 bp
R, AACGGAACATCTCTGCTCGG
CD166 F, TGGTCACAGAGGACAACGT 58C 167 bp
R, CCACGTGATGTTGCCATCTG
CD29 F, TAAGAGTGCCGTGACAACCG 64C 154 bp
R: TTCAGAACCTGCCCATAGCG
CD90 F: GCTAACAGTCTTGCAGGTGG 64C 212 bp
R, AGAAGTTGGTTCGAGAGCGG
CD73 F, ATTCGAGCAAGTGCGTCAAC 64C 193 bp
R, TCGTAACCCAAGGCGTTCAT
Hematopoietic marker CD34 F, ACCAGAGCTACTCCCGAAAG 58C 139 bp
R, TAAGGGTCTTCGCCCAGC
Immunological markers MHC I F, TGGAGAGGAGCAGAGCTACAC 65C 225 bp
R, CTGTCACTGCCTGCAGCCT
MHC II F, CCTGCTCCCCTTACACACTG 62C 209 bp
R, TGCAATAACCTCACCCGCTC
Osteogenic markers BGLAP F, TCAACCCCGACTGCGACG 63C 204 bp
R, TTGGAGCAGCTGGGATGATGG
OPN F, TTGCTAAAGCCTGACCCATCT 58C 145 bp
R, CGTCGTCCACATCGTCTGT
Adipogenic markers ADIPQ F, TATGATGTCACCACTGGCAAATT 60C 185 bp
R, TAGAGGAGCACAGAGCCAGAG
LEP F, AGCCTTTCGACCATCAAGCA 63C 100 bp
R, CAACTTGTGTTGCGTGGGAG
Neurogenic markers GFAP F, ATCGAGATCGCCACCTACAG 58C 102 bp
R: CAGGCTGGTTTCTCGGATCT
NES F, CAGGAGAAACAGGGCCTACA 58C 193 bp
R, GCTCCAACTTAGGGTCCAAGA
Pancreatic markers INS F, AGGCCTTCGTGAACCAGCAC 62C 233 bp
R, GAGGGAACAGATGCTGGTGC
PDX-1 F, AAGGCTCACGCGTGGAAAAGG 62C 229 bp
R, CATGCGGCGGTTTTGGAACC
F, forward; R, reverse; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; BGLAP, osteocalcin; OPN, osteopontin; ADIPQ,
adiponectin; LEP, leptin; GFAP, glial fibrillary acidic protein; NES, nestin; INS, insulin; PDX-1, pancreatic and duodenal homeobox 1.
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according to manufacturer’s instructions. RNA concentration
and purity were measured using a NanoDrop Spectro-
photometer (NanoDrop ND1000, Wilmington, DE, USA).
The cDNA was synthesized from 1lg of total RNA using the
iScript retrotranscription kit (Bio-Rad Laboratories), and a
qualitative PCR reaction was performed using the Taq DNA
Polymerase recombinant commercial kit (Invitrogen Life
Technologies). All amplification reactions were performed
using a T1 Thermocycler (Biometra). The conditions of the
amplification reaction were: 94C for 2min (initial denatur-
ation); 94C for 30 sec (denaturation); 58–65C (temperature
depending on the melting temperature of primers) for 30 sec
(annealing); 72C for 30 sec (extension); 72C for 10min
(final elongation). Denaturation, annealing, and extension
steps were repeated 32 times.
Primer design. Swine-specific oligonucleotide primers
were designed using open source PerlPrimer software v.
1.1.17, based on available NCBI Sus scrofa sequences or
on mammalian multialigned sequences. Primers were de-
signed across an exon–exon junction to avoid DNA am-
plification. Table 1 lists the primers used to characterize
AECs and confirm their multidifferentiation potential.
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was
used as a reference gene.
Statistical analysis
Statistical analysis was performed using GraphPad Instat
3.00 for Windows (GraphPad Software, La Jolla, CA, USA).
Three replicates for each experiment (growth curve, DT, and
CFU) were performed and the results are reported as mean –
standard deviation (SD). One-way analysis of variance
(ANOVA) for multiple comparisons by Student–Newman–
Keuls multiple comparison tests was used. CFU compari-
sons among different cell plating densities inside each group
were analyzed. Differences were considered statistically
significant for p values <0.05.
Results
Histological analysis, cell collection, and morphology
Figure 1, B and C, shows that different contiguous tissues
can be distinguished within the allanto-amnion—amniotic
epithelial layer, amniotic mesenchymal layer, allantoic
mesenchymal layer, and allantoic epithelial layer. The am-
nion consisted of cuboidal epithelial cells in the epithelial
layer (Fig. 1B, Ca) and of stromal cells in the underlying
mesenchymal layer (Fig. 1B, Cb). The adjacent allantoic
membrane was composed of mesenchymal tissue (Fig. 1B,
Cc) covered by the flattened allantoic epithelium (Fig. 1B,
Cd). The amniotic and allantoic counterparts were separated
mechanically for further analyses. At the time of membrane
collection, a thin membrane was harvested from the backs of
piglets. On the basis of histologic analysis and of its posi-
tioning, this membrane was thought to be the mesamnion
(Fig. 1D). Both the allanto-amnion and the mesamnion
showed a paucity of cells in their mesenchymal components.
Actually, no cells were obtained from the stromal layer of
the amnion or the mesamnion, and only the amnion epi-
thelial layer proved to be an efficient source of cells to be
plated and maintained in culture (AECs). A concentration of
10· 106 cells/gram of digested tissue was obtained after
digestion and viability of the isolated cells was higher than
95%. AECs showed a typical polygonal morphology (Fig.
1E). Cell colonies, observed since the first culture steps,
demonstrated an ability to organize into three-dimensional
structures and to form clusters (Fig. 1F).
Immunocytoscreen
AECs were strongly positive for PanCytokeratin and
negative for Vimentin (Fig. 2A, B).
Proliferation analysis
Figure 3A shows the growth curve for AECs at P1, P3,
and P5. AECs showed a growth curve, with an initial lag
phase of few hours and a further intense log phase of 2–12
days at P1 and P3. At P5, AECs showed a slow lag phase
(about 4 days) and a less intensive log phase. Statistically
significant differences ( p< 0.05) in DT were identified be-
tween the passages studied (see asterisks in Fig. 3B). After
P1, the proliferation rate increased; indeed, the values de-
creased at P2 and remained constant until P3. The mean DT
value was 24.77– 6 h. A statistically significant increase
( p< 0.05) in fibroblast CFUs (CFU-F) frequency was ob-
served, reflecting the increase of plating density (Table 2).
FIG. 2. Immunocytoscreen results. Immunolocalization of
cytokeratins (CYT) and vimentin (VIM) in AECs (A, B).
Scale bars, 15 lm.
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Flow cytometry analysis
Flow cytometry analysis was assessed to evaluate the
homogeneity of the cell population and to identify the subset
of pluripotent or mesenchymal cells. The cell population
tested resulted homogeneously composed of CD73- and
Oct-4–positive cells, as reported in Figure 4.
In vitro differentiation
At P3, AECs were shown to be plastic and able to un-
dergo osteogenic, adipogenic, neurogenic, and pancreatic
differentiation. After 21 days of induction, the osteogenic
differentiation of AECs was confirmed by Von Kossa
staining, which highlighted calcium precipitates. Moreover,
cells modified their morphology and increased their size.
The control sample did not stain and did not develop a
mineralized matrix. The osteogenic induction was further
verified through RT-PCR analysis of osteogenesis-
associated markers expression—osteocalcin (BGLAP) and
osteopontin (OPN). Induced cells expressed OPN and
BGLAP, whereas control cells did not. Bone was used as
positive control for the expression of osteogenic markers
(Fig. 5A).
After 3 weeks of induction, AECs demonstrated differ-
entiation ability. Indeed, after adipogenic induction, the Red
Oil O staining showed intracellular lipid vacuoles that were
not present in control AECs maintained in standard medium.
RT-PCR for the expression of adipogenic markers such as
adiponectin (ADIPQ) and leptin (LEP) confirmed adipo-
genic induction. Adipose tissue was used as positive control
(Fig. 5B).
After 3 days of neurogenic induction, stimulated cells
acquired a typical neuronal morphology and stained posi-
tively for Nissl, whereas uninduced cells did not. The
analysis of neurogenic expression markers, such as the glial
fibrillary acidic protein (GFAP) and nestin (NES) confirmed
the neurogenic induction. Spinal cord was used as positive
control (Fig. 5C).
After 15 days of induction, AECs changed their typical
epithelial shape and gradually organized large three-
dimensional colonies (Fig. 5D), reminiscent of typical
FIG. 3. Proliferative potential. (A) Growth
curve of AECs at P1, P3, and P5. (B) Dou-
bling time of AECs at different passages
during cell culture. Statistically significant
differences were observed in doubling time
means between the passages studied
(*p < 0.05).
Table 2. Colony-Forming Unit Assay of
Amniotic Epithelial Cells at Passage 0
Density cells/cm2 Total cells CFU-F 1 CFU-F each
100 950 54– 0 17.59a
250 2375 218– 1.53 10.89b
500 4750 Confluence
1000 9500 Confluence
Different superscripts (a, b) indicate statistically different com-
parisons ( p < 0.05) between cell densities in each group.
CFU-F, fibroblast colony-forming units.
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FIG. 4. Flow cytometry analysis of
antigen expression with Alexafluor-488
labeled antibodies: Oct-4 and CD73.
Histograms represent relative number of
cells vs. fluorescence intensity (FL1).
Black histograms indicate background
fluorescence intensity of cells labeled
with isotype control antibodies only; grey
histograms show positivity to the studied
antibodies.
FIG. 5. Differentiation potential. (A) Osteogenic differentiation: Von Kossa staining on induced and control (CTR) AECs, and
osteogenesis-associated marker expression. (B) Adipogenic differentiation: Oil Red O staining in induced and CTR AECs, and
adipogenesis-associated marker expression. (C) Neurogenic differentiation: Nissl staining in induced and CTR AECs, and neuro-
genic marker expression. (D) Pancreatic differentiation: AECs organized large three-dimensional colonies reminiscent of typical
pancreatic islets in vitro and pancreatic marker expression Scale bars, 20lm. See text for acronyms of the different markers.
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pancreatic islets in vitro. Expression of insulin and pancre-
atic and duodenal homeobox 1 (PDX-1) mRNA transcripts
were detected by RT-PCR.
Evaluation of marker expression by RT-PCR
To characterize amniotic stem cells, RT-PCR analysis
was performed on cells at different passages (P0, P1, P3,
P5). As shown in Figure 6, cells expressed mesenchymal-
associated markers (CD166, CD117, CD29, CD90, CD73),
embryonic-associated markers (Nanog, Oct-4, Sox2), and
the immunological marker MHC-I. They did not express
MHC-II nor the hematopoietic marker CD34 from P0 to P5.
Of particular interest is the CD117 expression that decreased
from P0 to P5,
Discussion
The advantage of using amniotic membrane for produc-
tion of stem/progenitor cells in human and animal species is
the availability of the large amount of these tissues and the
noninvasive collection procedure at birth. Because the am-
niotic membrane is an extrafetal tissue, we conjectured that
amniotic cells with the potential to be primitive mesen-
chymal cell types might also exist in full-term porcine
amnion. Moreover, considering the similarity between pigs
and humans, the chance to characterize porcine stem cells
from this source could be helpful in experimental cell-based
therapies.
The aim of this study was to isolate and characterize
presumptive stem cells from the porcine amniotic mem-
brane, suggested in several studies to be an optimal source
of pluripotent/multipotent stem cells in a variety of veteri-
nary species (Corradetti et al., 2013; Filioli Uranio et al.,
2011; Lange Consiglio et al., 2012; Muttini et al., 2013;
Rutigliano et al., 2013). Usually, two cell types are harvested
from this tissue—amniotic epithelial and mesenchymal cells.
In contrast to findings in other species, in the present study
we were able to isolate only AECs from the amniotic
membrane; the mesenchymal layer of amniotic membrane
contained few stromal cells. Concerning the mesamnion, few
epithelial cells and no stromal cells could be retrieved. For
this reason, only amniotic AECs were expanded, character-
ized, and differentiated. After digestion, large numbers of
AECs with greater than 95% viability (optimal value in
terms of plating efficiency and cellular growth) were ob-
tained. Positivity to cytokeratin and negativity to vimentin
confirmed that isolated cells were epithelial cells.
When cultured, AECs demonstrated strong adherence to
plastic dishes and developed epithelial polygonal morphol-
ogy over time. Adherence is a fundamental property of
cultured stem cells (Dominici et al., 2006). When AECs
were kept in culture, small cell clusters or spheroid struc-
tures developed, showing that these cells lacked contact-
inhibited cell growth and continued to proliferate after
reaching 100% surface confluence, forming aggregates
overlying the monolayer of confluent cells. Other investi-
gators have reported that the monolayer of amniotic cells
may support the growth and lack of differentiation in am-
niotic cells forming the spheroid structures, possibly playing
the role of an autologous feeder layer and providing secreted
factors (Miki et al., 2010).
The proliferation study showed that AECs reached high
plating efficiency and had a high proliferation rate in vitro
until P3, when AECs showed a growth curve with a lag
phase of few hours and an intensive log phase of 12 days.
Moreover, the DT value at P3 was 19 h. These data are in
agreement with those obtained by other researchers who
reported a high proliferation rate of human (Miki et al.,
2010; Soncini et al., 2007), equine (Lange-Consiglio et al.,
2012), bovine (Corradetti et al., 2013), and feline (Ru-
tigliano et al., 2013) amniotic cells. After this period, the
proliferation rate decreased.
During the different subcultures, the time required to re-
move adherent cells from a culture surface using trypsin
increased reaching a maximum of about 20min. It is likely
that prolonged treatment with trypsin degrades membrane
proteins, causing alterations in the cells’ ability to adhere to
the plate. Indeed, at P5 the lag phase was 4 days. For this
reason, in this preliminary study, cell expansion could not be
continued beyond P5. This problem, which can be cir-
cumvented by use of other techniques for cell detachment
(for example using scrapers), does not affect the potential
therapeutic use of these cells because in regenerative med-
icine cells are usually used at P3. Indeed, this passage is
considered the best passage to obtain homogeneity of cells
and to prevent aging in the plate that would lead to epige-
netic changes in gene expression related to in vitro culture
(Lange-Consiglio et al., 2012).
Swine AECs also showed the ability to produce clones
and revealed the typical expression pattern expected for
FIG. 6. RT-PCR analysis. Specific gene expression inAECs
fromP0 to P5 ofmesenchymal (CD166,CD117, CD29, CD90,
CD73), pluripotent (Nanog, Oct-4, Sox2), hematopoietic
(CD34) and histocompatibility (MHC-I and MHC-II) mRNA
markers. GAPDH was used as reference gene.
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cultured stem cells (Dominici et al., 2006) when analyzed by
RT-PCR and flow cytometry. It has been demonstrated in
both human (Manuelpillai et al., 2011; Marongiu et al.,
2010; Miki et al., 2010; Soncini et al., 2007) and animal
MSCs (Chen et al., 2011; Corradetti et al., 2013; Lange-
Consiglio et al., 2012; Lovati et al., 2011; Iacono et al.,
2012) that pluripotent- and mesenchymal-associated mark-
ers are expressed. In our results, the same expression pattern
occurred, with the exception of CD117, which decreased
substantially from P0 to P5, as reported in some other
studies (Meirelles et al., 2003, 2006). The isolated cells are
epithelial cells, but they expressed MSC markers. Bilic et al.
(2008) reported that human AECs had an antigenic ex-
pression profile characteristic of culture-expanded MSCs
and could co-express epithelial and mesenchymal cell
markers (Sakuragawa et al., 2004).
In fact, it has been reported that the amnion-derived cells
have not completely differentiated into the epithelial or
mesenchymal phenotype; another explanation is that the ep-
ithelial–mesenchymal transition may occur in the amniotic
membrane (Bilic et al., 2008; Sakuragawa et al., 2004). Ex-
pression of the hematopoietic marker CD34 was not found at
any passage. This result was expected, and it confirmed that
isolated cells do not belong to a hematopoietic lineage.
To assess the usefulness of porcine AECs for cell therapy,
expression of markers related to cell immunogenicity, in-
cluding MHC-I and MHC-II, was also evaluated. At each
passage studied, AECs were negative for MHC-II and pos-
itive for MHC-I, consistent with previous reports (Corradetti
et al., 2013; Lange-Consiglio et al., 2012), thus reinforcing
the role of the amniotic membrane as an allogenic source for
cell-based therapies in pigs.
Differentiation data confirmed the high plasticity of these
cells that can differentiate into mesodermic (osteogenic and
adipogenic), ectodermic (neurogenic), and endodermic lin-
eages. After 21 days of induction, mineral deposits were
confirmed by Von Kossa staining and by the expression of
BGLAP and OPN. These results suggest that these cells
reached a mature osteogenic differentiation, as BGLAP and
OPN genes are associated to the matrix maturation and
mineralization phases (Raouf and Seth, 2000). Stimulated
AECs were also able to undergo adipogenic differentiation
confirmed by expression of LEP and ADIPQ (regarded as
intermediate and late markers of adipocyte differentiation).
Moreover, AECs acquired a neuron-like morphology and
expressed specific neuronal markers expression (GFAP and
NES) after in vitro induction. The morphological changes
and the marker expression confirmed that the cell population
comprised neuronal precursor stem cells (Lendahl et al.,
1990), as observed for amniotic-fluid derived MSCs in the
same species (Zheng et al., 2010). Regarding the pancreatic
differentiation, morphological and molecular studies suggest
that the differentiation occurred, but further study will be
needed to confirm the ability of these induced cells to se-
crete insulin.
This work allowed the isolation, characterization, and
differentiation of stem cells derived from the epithelial layer
of the amniotic membrane in pigs. Altogether, our findings
suggest that porcine amniotic membrane is a reliable source
of presumptive AECs, displaying intermediate features be-
tween adult and embryonic stem cells, and could have a
wide clinical application because of their low immunoge-
nicity and high differentiation potential. Only epithelial cells
were isolated here, but the amniotic epithelium layer, while
originating from the trophectoderm as with other parts of
fetal membranes, has the peculiarity of being continuous
with the epiblast (Vejlsted, 2010). For this reason, it may
probably preserve some of the characteristics of the epiblast
(Miki et al., 2006), such as Nanog and Oct4 expression.
Conclusion
The advantages of this study are the source of cells (am-
niotic membrane) and the pig as an animal model. Collection
of the amnion, in comparison to embryonic and adult tissues,
does not pose ethical issues, and its retrieval at term is a
noninvasive procedure. One of the most important criteria
when choosing an animal model is its relevance to human
conditions. Over the years, a huge amount of information,
mostly conducted on standard laboratory animals such as
rodents, has been generated. When new therapies for human
use are designed using this data, they often fail, particularly if
the metabolism of xenobiotics of interest is different.
Aside from nonhuman primates, the pig is the species that
shares the closest evolutionary resemblance to humans
(Verma et al., 2011); thus, its human-like physiology means
that data obtained in this species are highly relevant for
human-related therapeutic research. In addition to the po-
tential use of porcine amniotic cells as candidates in auto/
allo/xenogenic transplantation, these AECs are widely
available and could also be used to evaluate the safety and
efficacy of cell therapies.
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Abstract
Recent studies have revealed the presence of a mesenchymal stem cell (MSC) population in human and in gilt
granulosa cells (GCs), thus increasing the interest in identifying the same population in the bovine species. We
first isolated GCs by scraping from bovine preovulatory follicles and then tested several different media to
define the ideal conditions to select granulosa-derived stem cells. Although expressing MSC-associated
markers, none of the media tested proven to be efficient in selecting MSC-like cells that were able to differ-
entiate into mesodermic or ectodermic lineages. We performed another experimental approach exposing cells to
a chemical stress, such as lowering of pH, as a system to select a more plastic population. Following the
treatment, granulosa-specific granulose markers [follicle-stimulating hormone receptor (FSHR), follistatin
(FST), and leukemia inhibitory factor receptor (LIFR)] were lost in bovine GCs, whereas an increase in multi-
(CD29, CD44, CD73) and pluripotent (Oct-4 and c-Myc) genes was noticed. The stress allowed up-regulation of
tumor necrosis factor-a and interleukin-1b expression and the dedifferentiation of GCs, which was demon-
strated by differentiation studies. Indeed, pH-treated cells were able to differentiate into the mesodermic and
ectodermic lineages, thus suggesting that the chemical stress allows for the selection of cells that are more prone
to adjust and respond to the environmental changes.
Introduction
As in humans, mesenchymal stem cells (MSCs) havealso been harvested successfully in veterinary medicine
from adult tissues, such as bone marrow (Arnhold et al., 2007;
Fortier et al., 1998; Kern et al., 2006; Mitchell et al., 2003;
Ringe et al., 2002; Smith et al., 2003; Vidal et al., 2006, 2008)
and adipose tissue (Kern et al., 2006, Vidal et al., 2008). MSCs
have been derived mainly from bone marrow in cattle, as de-
scribed by Bosnakovski et al. (2005, 2006). Adult stem cells
currently are the most used stem cell type for clinical appli-
cations (Trounson et al., 2011), but their isolation usually re-
quires invasive techniques for sampling that are not devoid of
complications. Moreover, their culture and expansion in vitro
are time consuming, and the cells obtained display an ability to
proliferate and differentiate that is inversely proportional to the
age of the donor and to the number of in vitro passages (Vidal
et al., 2011). Adult tissues are not satisfactory because of the
low yield of stem cells that can be obtained, thus representing a
strong limitation for the therapeutic application of these cells
in veterinary and human medicine.
On the basis of these considerations, the interest of cli-
nicians in finding alternative sources of multipotent cells has
increased over the past years. MSCs from the fetal adnexa
have been reported as a potential tool to overcome some of
these limitations, opening up new prospects for the devel-
opment of regenerative medicine (Lange-Consiglio et al.,
2012). Also in bovine species, MSCs have been obtained
from umbilical cord blood (Raoufi et al. 2011) and amnion
and amniotic fluid (Corradetti et al., 2013). Recently, other
research groups have suggested granulosa cells (GCs) as a
promising adult source of MSCs in humans (Kossowska-
Tomaszczuk et al., 2009) and in gilts (Mattioli et al., 2012).
The investigation of Kossowska-Tomaszczuk et al. (2009)
refers to luteinizing GCs recovered from preovulatory fol-
licles of patients treated for oocyte retrieval. Mattioli et al.
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2Department of Life and Environmental Sciences, Universita` Politecnica delle Marche, Ancona, Italy.
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(2012) compared GCs retrieved from growing follicles be-
fore the preovulatory gonadotropin surge, and hence before
luteinization (e.g., in a condition of active proliferation
and before the final differentiation) with those obtained
from preovulatory follicles. In both studies, cells expressed
MSC-associated markers and were able to differentiate into
different cell types not present within the follicles, thus
suggesting their potential use in cell-based therapy. More-
over, Mattioli et al. (2012) demonstrated that luteinizing
GCs have more efficient osteogenic potential compared to
GCs isolated from growing follicles.
GCs represent a readily available source from which to
isolate cells easily, relying on the well-established tech-
niques for oocyte retrieval used in assisted reproduction.
This has increased our interest in identifying a MSC-like
population in the bovine species, considering that ovaries
can be easily collected in slaughterhouses due to the absence
of their commercial value. In this context, the present study
was designed to define a suitable protocol to select GCs with
MSC-associated features in terms of morphology, specific
markers, and differentiative potential from bovine preovu-
latory follicles.
Material and Methods
Sampleswere collected frombovine species slaughtered in a
slaughterhouse (INALCA,OspedalettoLodigiano, Lodi, Italy)
under legal regulations. Chemicals were obtained fromSigma-
Aldrich Chemical (Milan, Italy) unless otherwise specified,
and tissue culture plastic dishes were purchased from Euro-
clone (Milan, Italy).
Collection of ovaries and cells isolation
Bovine GCs employed in this study were isolated from
ovaries collected from slaughterhouses. The age, genealogy,
physiological status, and race were unknown for the animals.
The transport of the gonads to the laboratory occurred in a
portable thermos maintained at a temperature of 30C in
physiological saline solution (0.9%NaCl) supplemented with
kanamycin (150mg/liter). This temperature was maintained
at a constant level from the beginning of ovary collection and
during the time needed to reach the laboratory. In the labo-
ratory, the ovaries were washed repeatedly in physiological
saline solution supplemented with antibiotics; they were
maintained in a thermos for the period of sampling to avoid
thermal shock.
GCs were isolated from the bovine ovaries by scraping
(Mattioli et al., 2012). Briefly, follicles with a diameter be-
tween 0.8 and 1.2 cm were opened using a scalpel blade, and
GCs were gently scraped away from the internal face of the
follicle wall. The material collected by scraping was depos-
ited into 50-mL tubes containing Tissue Culture Medium
(TCM)-HEPES (Sigma) supplemented with 1mM pyruvic
acidic (Sigma), 2.2 grams/liter of sodium bicarbonate (Sig-
ma), 100· penicillin/streptomycin (Sigma), and 10% fetal
calf serum (FCS; Sigma). The tubes were left at room tem-
perature until the oocytes sedimented under gravity to the
bottom of the tubes. The deposited portion was aspirated and
plated on a gridded Petri plate (100· 15mm) to select and
discharge oocytes. This procedure was performed using a
stereomicroscope (model SZX-ILLK200, Olympus) with a
40· enlargement equipped with a heating plate set at 38C.
The GCs were pooled, washed in TCM-HEPES through two
successive centrifugations (200· g for 5min at room tem-
perature), counted in a Burker chamber, and used in the fol-
lowing experiments.
Experimental design
GCs were collected from bovine preovulatory follicles by
scraping, cultured in different media or exposed to acid con-
ditions (pH 5.7), induced to differentiate to mesodermic and
ectodermic lineages, and analyzed by qualitative and quanti-
tative PCR. All experiments were performed in triplicate.
GC isolation and culture
At first, GCs isolated by scraping were randomly allo-
cated to five different culture media with the basic medium
(MB) consisting of High-Glucose Dulbecco’s Modified
Eagle Medium (HG-DMEM) supplemented with 10% FCS,
100 IU/mL penicillin, 100 lg/mL streptomycin, 0.25 lg/mL
amphotericin B, and 2mM l-glutamine. This medium was
chosen because it is the most commonly used for the iso-
lation of MSCs (Wang et al., 2004). The other conditions
included MB supplemented with 0.1% epidermal growth
factor (MB +EGF) (Mattioli et al., 2012), MB supple-
mented with 0.02% leukemia inhibitory factor (MB +LIF)
(Kossowska-Tomaszczuk et al., 2009), and MB supple-
mented with only 2% FCS (2%-MB), as reported by Sol-
mesky et al. (2009), to perform in vitro isolation of stem
cells, and MB supplemented with 0.02% LIF (MB +LIF)
and 0.014 lL/mL b-mercaptoethanol (MB +LIF+BME), as
reported by Marshall et al. (2001) for culturing in vitro
embryonic stem cells.
This protocol was modified in our study because BME
was maintained only for passage 1 (P1) and then removed
from the culture medium. For each condition, cells cultures
were established in an atmosphere of 5% CO2 and 90%
humidity and at a temperature of 38.5C. Medium was re-
placed 72 h after isolation to remove nonadherent cells.
Adherent cells were detached with 0.05% trypsin-EDTA
(EuroClone) just prior to reaching confluence (80%) and
then reseeded for culture maintenance. Cells were expanded
for three passages, at which point they were analyzed for the
expression of specific markers by qualitative and quantita-
tive PCR and were tested for multidifferentiative potential.
In a second step, GCs isolated by scraping were divided
into two portions: One was cryopreserved and used as a
control [day 0 (d0)] and the second one was exposed to
acidic conditions (pH 5.7) and was observed constantly for
7 days to assess the viability and morphological changes
(d7). The acidic treatment was performed for 25min at pH
5.7 and at 37C (Hjelmeland et al., 2011). After that, cells
were centrifuged and the pellet was resuspended in DMEM/
F12 medium supplemented with LIF and B27. The cellular
suspension was seeded at a density of 1 · 105 cell/cm2 in
T25 flasks.
In vitro differentiation
GCs from each condition were seeded at the density of
3 · 103 cells/cm2 for differentiation in adipogenic, osteogenic,
and neurogenic lineages. Cells plated at a density of 1.5 · 103
cells/cm2 were used as control. For the first 3–4 days, the cells
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were incubated with basic medium to allow adhesion; at 60–
70% of confluence, they were induced to differentiate.
Osteogenic differentiation. This was assessed by incu-
bating cells for up to 3 weeks at 38.5C under 5% CO2 in
medium composed ofHG-DMEMmedium supplementedwith
10% FBS, 100 IU/mL penicillin, 100mg/mL streptomycin,
0.25mg/mL amphotericin B, 2mM l-glutamine, 10mM b-
glycerophosphate, 0.1mM dexamethasone, and 250mM as-
corbic acidic. Noninduced control cells were cultured for the
same time period in standard control medium (HG-DMEM
supplemented with 10% FCS, 100 IU/mL penicillin, 100mg/
mL streptomycin, 0.25mg/mL amphotericin B, and 2mM
l-glutamine). Osteogenesis was assessed by conventional von
Kossa staining using 1% silver nitrate and 5% sodium thio-
sufate, which allowed detection of calcium deposits.
Adipogenic differentiation. Near-confluent cells were cul-
tured through three cycles of induction/maintenance to stimu-
late adipogenic differentiation. Each cycle consisted of feeding
the GCs for 3 days with supplemented adipogenesis induction
medium, followed by culture for another 3 days (38.5C, 5%
CO2) in supplemented adipogenic maintenance medium. The
inductionmedium consisted of HG-DMEMsupplemented with
10% FCS, 100 IU/mL penicillin, 100mg/mL streptomycin,
0.25mg/mL amphotericin B, 2mM l-glutamine, 10mg/mL
insulin, 150mM indomethacin, 1mM dexamethasone, and
500mM 3-isobuty-l-methylxanthine. The maintenance me-
dium consisted of HG-DMEM supplemented with 10% FCS
and 10mg/mL insulin. Noninduced control cells were cultured
for the same time period in standard control medium. Adipo-
genesis was assessed using conventional Oil Red O staining
(0.1% in 60% isopropanol) to detect lipid droplets.
Neurogenic induction. This was performed by culturing
cells for 24 h in preinduction medium consisting of HG-
DMEM, 20%FCS, and 1mMBME (Mitchell et al., 2003; Seo
et al., 2009). Neural induction was performed by switching to
a medium composed of DMEM plus 2% FCS, 2% di-
methylsulfoxide, and 200mM butylated hydroxyanisole for
3 days (Woodbury et al., 2000). Noninduced control cells
were cultured for the same time period in standard medium.
Neurogenic differentiation was demonstrated by conven-
tional Nissl staining (0.1% Cresyl Violet solution) to detect
increase of Nissl bodies.
Molecular biology study
Qualitative PCR analysis was performed to evaluate the
expression of specific granulosa-, MSC-, pluripotent-, his-
tocompatibility- and hematopoiesis-associated markers to
confirm the differentiation that occurred and the stress in-
duced by the acidic treatment. RNA was isolated using
TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) accord-
ing to the protocol indicated by the manufacturer. RNA
concentration and purity were measured using a NanoDrop
spectrophotometer (NanoDrop ND1000, Wilmington, DE,
USA). Complementary DNA (cDNA) was synthesized from
300 ng of total RNA using the PrimeScript RT reagent kit
(Takara Bio, Otsu-Shi, Japan). Gene expression evaluation
was performed using specific sequences. Bovine-specific
oligonucleotide primers were designed using open source
Table 1. Oligonucleotide Sequences Used for Molecular Analysis
Genes Forward Reverse
Annealing
temperature
Size
cDNA
(bp)
Markers of
pluripotency
Oct4 CACACTAGGATATACCCAGGC GGAGATATGCAAGGCAGAGA 60C 177
c-Myc GCGCCGCATTCGCGAAACTT TGAGGGGCATCGCTGCAAGC 58C 214
Markers of
multipotency
CD73 AAGGTTCCTGTGGTCCAGGCCT TGCATTCTCGAAAGCGGCAGGA 68C 260
CD29 GTTGGTTCTGCAGTTACGATCAG AACCAAACCCAATTCGGAAGTC 52C 203
CD44 AACAGTAGGAGAAGGTGTGG TCATGAACTGGTCTTGGGTC 61C 166
MHC I GATCTCACTGACCTGGCA CTGAGGAGGTTCCCATCTC 60C 199
MHC II CCTCGCTTGCCTGAATTTGC ACAGGTGCCGACTGATGC 53C 266
Hematopietic
marker
CD34 CCTGAAGCTAAATGAGACCT AACTTTCTGTCCTGTTGGTC 58C 173
Markers of
granulosa cells
FSHR TGGTCCTGTTCTACCCCATCA GAAGAAATCCCTGCGGAAGTT 58C 83
FST CTCTGCCAGTTCATGGAGGACC GGCCAATCCAATAGATCTGCCC 63C 651
LIFR TGGCAGTACACATTGTCCCC TCCCGCAAAAACAACCGTTC 60C 145
Markersof
differentiation
LEP CAATGACATCTCACACACGCAG CGGCCAGCAGGTGGAGAAG 55C 212
PPARc CGCACTGGAATTAGATGACAGC CACAATCTGTCTGAGGTCTGTC 55C 214
BGLAP TCGGGCAAAGGCGCAGCCTTC GCAGGGCTGCAAGCTCTAGACG 55C 231
SPP1 CGCCGATCTAACGTTCAGAGTC GACTCTCAATCAGATTGGAATGC 55C 199
SPARC CTGGTCACGCTGTACGAGAG CGGTGTGAGACAGGTACCCGT 55C 232
GFAP GGCACCTTGAGGCAGAAGCTC CTCCTGGAGCTCCCGCACCT 60C 195
Markers of
inflammation
TNF-a ACATACCCTGCCACAAGGC TGGGGACTGCTCTTCCCTCT 60C 259
IL-1b TGCAGCTGGAGGAAGTAGAC GTCGGGCATGGATCAGACAA 60C 338
Housekeeping
gene
GAPDH ATGAGATCAAGAAGGTGGTG CCAAATTCATTGTCGTACCAG 60C 190
MHC I, major histocompatibility complex class I; MHC II, major histocompatibility complex class II; FSHR, follicle-stimulating
hormone receptor; LIFR, leukemia inhibitory factor receptor; LEP, leptin; PPARc, peroxisome proliferator-activated receptor gamma;
BGLAP, bone gamma-carboxyglutamate protein; SPP1, osteopontin; SPARC, secreted protein acidic and rich in cysteine; GFAP, glial
fibrillary acidic protein; TNF-a, tumor necrosis factor-a; IL-1b, interleukin-1b; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
PROGENITOR GCS IN BOVINE FOLLICLE 3
PerlPrimer software (v. 1.1.17), based on available National
Center for Biotechnology Information (NCBI) Bos taurus
sequences or on mammalian multialigned sequences. Pri-
mers were designed across an exon–exon junction to avoid
DNA amplification. Primers sequences and characteristics
are reported in Table 1. The bovine glyceraldehyde 3-
phosphate dehydrogenase gene (GAPDH) was employed as
a reference gene in each sample to standardize the results by
eliminating variation in messenger RNA (mRNA) and
cDNA quantity and quality.
Conventional qualitative PCR was performed using 1lL of
the cDNA obtained in a 25-lL final volume with recombinant
Taq DNA polymerase (Invitrogen, Life Technologies, Mon-
za, Italy). Amplified PCR products were electrophoresed on a
1.8% agarose gel with ethidium bromide.
For quantitative PCR, one single representative gene per
set of markers (CD73, FSHR, and Oct-4) was chosen to
evaluate the selection efficiency of any culture condition used
in this study. In addition, the expression of tumor necrosis
factor-a (TNF-a) and interleukin-1b (IL-1b) was evaluated to
confirm cellular stress induced by acidic treatment. Analyses
were carried out with the SYBR (a fluorescent intercalating
agent, able to bind the DNA in double-stranded conforma-
tion) method, in the MyiQTM Single-Color Real-Time PCR
Detection System (BioRad, Hercules, CA, USA). Triplicate
PCR reactions were carried out for each analyzed sample.
Reactions were set on a strip in a final volume of 25 lL by
mixing, for each sample, 1 lL of cDNA, 12.5lL of 2· con-
centrated SYBR Select Master Mix (Applied Biosystems,
Foster City, CA, USA), 1 lMforward primer, 1 lMof reverse
primer, and Milli-Q water.
Immunocytochemical characterization of Oct-4
To test the expression of the Oct-4 marker, primary an-
tibody was purchased from Abcam (Cambridge, MA, USA),
whereas Alexa Fluor 488–conjugated secondary antibody
and goat serum were from Life Technologies (Carlsbad, CA,
USA). All products were used following the manufacturer’s
instructions.
For immunostaining, GCs after isolation (control cell) and
GCs cultured inMB+LIFwere fixed in 4%paraformaldehyde
(PFA) for 10min at room temperature and washed three times
in phosphate-buffered saline (PBS). After fixation, cells were
permeabilized for 15min at room temperature in 0.25%
Triton-X 100 diluted in PBS and washed three times in PBS.
After washing, cells were blocked using 10% goat serum in
PBS for 30min at room temperature. Cells were incubated
with primary antibodies (1:200 dilution) overnight at 4C.
After washing three times, cells were incubated with second-
ary antibodies conjugated to Alexa Fluor 488 (1:250 dilution)
for 1 h. Finally, for nuclear staining, cells were incubated for
15minwithHoechst 33342 (1mg/mL;Sigma) diluted 1:100 in
PBS. Images were captured on a BX51microscope (Olympus,
Japan). A negative control was performed without the primary
antibodies. The positive control was carried out on bovine
in vitro embryos produced routinely in our laboratory as de-
scribed by Lange-Consiglio et al. (2010).
Statistical analysis
For quantitative PCR data, nonparametric tests were used.
The Mann–Whitney U-test was employed to compare two
groups (treated vs. untreated). Results were considered sta-
tistically significant if p < 0.05.
Results
GCs yield and morphology
From each ovary, about 2 million GCs were isolated with
an 80% viability evaluated by Trypan Blue dye exclusion.
Cells were plated and selected on the basis of their ability to
adhere to plastic. Observation under microscopy revealed
the presence of cells with epithelial morphology when cul-
tured in MB (Fig. 1A), with atypical morphology in LIF+
BME (Fig. 1B), whereas they displayed fibroblast-like
morphology when cultured under other conditions (Fig. 1C–
E). After pH treatment, in the next 7 days of culture, cells
displayed morphological changes compared to initial epi-
thelial morphology and a progressive vacuolization (Fig. 2).
After acidic treatment, the number of viable cells immedi-
ately decreased 50%. During the following 7 days of culture,
the viability of the remaining cells was further reduced 40%.
Molecular analysis of GCs
Table 2 shows expression of GCs studied in different
culture conditions. These cells expressed mesenchymal
FIG. 1. Morphology of cells cultured in different culture
conditions: (A) MB; (B) MB with LIF and BME; (C) MB
with EGF; (D) MB with LIF; (E) BM with 2% of FCS. Scale
bars, 20 lm; magnification, 20·.
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(CD29, CD44, CD166, andCD73) and pluripotent (Oct-4 and
c-Myc) markers and lackedCD34marker expression. For these
markers, no differences induced by the culture conditions were
observed compared to P0, except forCD166, whose expression
was not detected at P0. On the other hand, changes in the
granulosa-associated markers were detected in the different
culture conditions. Specifically, follicle-stimulating hormone
receptor (FSHR) was expressed only at P1 when cells were
cultured in MB, MB+EGF, MB+LIF, and MB+LIF+BME.
Cells cultured in 2% MB expressed FSHR over the passages
studied. Follistatin (FST) expression was observed in all of the
conditions and passages, but disappeared at P3 in MB+LIF+
BME.
qPCR results highlighted differences in the expression of
FSHR between cells cultured in different conditions (Fig. 3).
In MB+LIF and MB+EGF, FSHR expression was found
about 10 times less compared to the baseline (P0). Oct-4
expression reached the maximum expression in MB+LIF
medium (157.8 – 65.07) and the minimum expression in 2%
MB and MB (0.83 – 0.38 and 1.73– 0.27, respectively). A
relatively high value was recorded also in MB+EGF and
MB+LIF+BME (4.1 – 1.1 and 39.7 – 13.6). The expression
level of CD73 was found higher in MB (49.7 – 23.19) and
MB+LIF+BME (29.75– 19.87). The lowest expression of
CD73 was registered in 2% MB, showing a 1.37- (– 0.44)
fold increase.
GCs before and after acidic treatment expressed Oct-4, C-
Myc, CD73, CD29, CD44, MHC I, MHC II, and granulosa-
associated markers (FST and LIFR), but not CD34. The
main difference found between d0 and d7 was the loss of
FSHR expression (Fig. 4A). Considerable differences in
gene expression were observed in GCs before and after
acidic treatment (Fig. 4B). In particular, FSHR expression
was found significantly decreased in treated cells at d7.
Further indications supporting the efficacy of the treatment
were provided by the loss of other granulosa markers (i.e.,
FST and LIFR) and the increase of Oct-4 and CD29 com-
pared to untreated cells (d0). Decreased expression of MHC
I and MHC II in d7 was also observed. In addition, as a
response to the acidic treatment, in bovine GCs expression
of inflammatory markers, such as TNF-a and IL-1b, was
found to be significantly upregulated at d7 compared to d0,
with a 7.02- (– 0.2) and 21.26- (– 0.25) fold increase (Fig. 5;
p < 0.05 and p < 0.001, respectively).
In vitro differentiation
GCs cultured in different conditions did not show any
ability to differentiate (data not shown). On the other hand,
GCs treated with an acidic pH were easily induced into
the adipogenic, osteogenic, and neurogenic lineages. After
18 days of induction, the presence of intracellular lipid vac-
uoles was determined by Oil Red O staining (Fig. 6A). After
21 days in osteogenic media, extracellular mineral deposits
were demonstrated by von Kossa staining (Fig. 6B). Inter-
estingly, cells induced to differentiate toward the neuro-
genic lineage acquired the typical neuronal morphology with
FIG. 2. Morphology of cells isolated from bovine pre-
ovulatory follicles and exposed to a chemical stress (d7)
display a progressive vacuolization. Scale bar, 20 lm;
magnification, 20·.
Table 2. Gene Expression Analysis Using RT-PCR in Granulosa Cells in Different Culture Conditions
Colture condition Passage GAPDH OCT4 C-MYC CD44 CD29 CD166 CD34 CD73 FSHR FST
Baseline P0 X X X X X 7 7 X X X
MB P1 X X X X X X 7 X X X
P3 X X X X X X 7 X 7 X
P5 X X X X X X 7 X 7 X
2%-MB P1 X X X X X X 7 X X X
P3 X X X X X X 7 X X X
P5 X X X X X X 7 X X X
MB +EGF P1 X X X X X X 7 X X X
P3 X X X X X X 7 X 7 X
P5 X X X X X X 7 X 7 X
MB +LIF P1 X X X X X X 7 X X X
P3 X X X X X X 7 X 7 X
P5 X X X X X X 7 X 7 X
MB +LIF+BME P1 X X X X X X 7 X X X
P3 X X X 7 X 7 7 X 7 7
190 bp 177 bp 214 bp 166 bp 203 bp 755 bp 173 bp 260 bp 83 bp 651 bp
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; FSHR, follicle-stimulating hormone receptor; FST, follistatin; MB, basic medium;
EGF, epidermal growth factor; LIF, leukemia inhibitory factor; BME, b-mercaptoethanol.
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axon- and dendrite-like processes and were positive for Nissl
staining of Nissl bodies (Fig. 6C). Uninduced cells were
maintained in culture for the same period of each differentia-
tion protocol time and used as a negative control. They were
negative for all of the staining performed. Differentiation was
confirmed by molecular analysis through the use of specific
markers, including leptin (LEP) and peroxisome proliferator-
activated receptor gamma (PPARc) for adipogenic differ-
entiation, bone gamma-carboxyglutamate protein (BGLAP),
osteopontin (SPP1), and secreted protein acidic and rich in
cysteine (SPARC) for osteogenic differentiation, and glial fi-
brillary acidic protein (GFAP) for neurogenic differentiation.
In cells induced to undergo adipogenesis the expression
of PPARc but not LEP was revealed in induced cells,
whereas control cells did not express the genes tested.
Following osteogenesis induction, BGLAP was not ex-
pressed in induced cells. Qualitative PCR did not allow for
the discrimination between induced and uninduced cells
when the expression of SSP1 and SPARC was assessed
(Fig. 6B). For this reason, qPCR was performed to deter-
mine the levels of expression of these two markers in in-
duced cells compared to their respective uninduced controls.
The expression of osteogenesis-associated genes quantita-
tively confirmed the induction. SPP1 expression increased
2.17- (–0.09) fold ( p< 0.05), whereas a slight but statisti-
cally significant ( p < 0.05) increase (1.45 – 0.085) in SPARC
expression was found compared to the uninduced counter-
parts (Fig. 7). The expression of GFAP confirmed the neu-
rogenic differentiation.
FIG. 3. Quantitative RT-PCR analysis for the expression of multipotent (CD73), pluripotent (Oct-4), and granulosa-specific
(FSHR) markers in cells cultured under different conditions (MB, 2% MB, MB+EGF, MB+LIF, MB+LIF+BME) at P3.
Expression levelswere normalized to the reference gene (GAPDH). Data are represented as fold change comparedwith expression
observed in P0. Values are mean – standard deviation (SD) (n= 3). Asterisks depict highly significant (**p< 0.01) differences.
FIG. 4. Qualitative (A) and quantitative (B) RT-PCR
analysis for the expression of specific granulosa (LIF-R,
FSHR, FST)-, MSC (CD73, CD29, CD44)-, pluripotent (Oct-
4, c-Myc)-, histocompatibility (MHC I and MHC II)-, and
hematopoiesis (CD34)-associated markers in cells before (d0)
and after (d7) acidic treatment. (B) Quantitative data are re-
organized in a heat map. Representing the intensity of the
gene expression: black refers to the higher level of expression
and white refers to the lowest level of expression.
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Immunocytochemical characterization of Oct-4
Immunopositivity to Oct-4 was detected in GCs cultured
in MB+LIF and in bovine embryos used as a positive
control. GCs after collection, used as a control, were neg-
ative (Fig. 8).
Discussion
The purpose of this study was to identify a new source of
stem cells that were easy to collect and able to comply with
the requirements of regenerative medicine on a large scale.
On the basis of recently published studies in humans
(Kossowska-Tomaszczuk et al., 2009) and gilts (Mattioli
et al., 2012), GCs represent an alternative source of MSCs.
To reach our goal, we tested different culture conditions
and evaluated their efficacy in selecting MSCs from a cell
population obtained from the follicle. Once isolated, GCs
have been characterized on the basis of the minimal criteria
defined by the International Society for Stem Cell Therapy
to define MSCs (Dominici et al., 2006). According to results
obtained in humans (Kossowska-Tomaszczuk et al., 2009)
and gilts (Mattioli et al., 2012), cells adhered to a plastic
dish and expressed a pattern of mesenchymal (CD44, CD29,
CD166, CD73) and pluripotency (Oct-4, c-Myc) genes, with
FIG. 5. Quantitative RT-PCR analysis for the expression of inflammatory markers such as TNF-a and IL-1b in GCs before
(d0) and after acidic treatment (d7). Expression levels were normalized to the reference gene (GAPDH). Values are mean –
standard deviation (SD) (n = 3). Asterisks depict highly significant (**p< 0.01) and significant (*p< 0.05) differences
compared to d0.
FIG. 6. Differentiative potential. (A) Adipogenic differentiation: Oil Red O staining in induced and control cells at d7 and
adipogenesis-associated marker expression. (B) Osteogenic differentiation: Von Kossa staining on induced and control cells
d7 and osteogenesis-associated markers expression. (C) Neurogenic differentiation: Nissl staining in induced and control
cells d7 and neurogenic marker expression. Scale bars, 20lm. Magnification, 20·. (Right panel) Specific gene expression in
induced and control cells. BGLAP, SPP1, and SPARC mRNA were investigated for osteogenesis; PPARY and LEP for
adipogenesis; and NES and GFAP for neurogenesis. GAPDH was employed as reference gene. Bone, adipose tissue, and
spinal cord were used as positive controls.
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no expression of the hematopoietic CD34 and the functional
marker FSHR. The levels of expression of CD73, Oct-4, and
FSHR were also confirmed quantitatively, showing the re-
duction of specific granulosa markers and the upregulation
of MSC-associated genes.
In addition to molecular characterization by RT-PCR, the
high level of Oct-4 in GCs cultured in MB+LIF was also
detected by immunocytochemistry. Contrary to data reported
for humans (Kossowska-Tomaszczuk et al., 2009) and gilts
(Mattioli et al., 2012), however, despite inducing a MSC-like
phenotype in bovine GCs, none of the culture conditions tested
was efficient in selecting a plastic cell population. In fact, cells
exposed to each condition were not able to differentiate into
adipogenic, osteogenic, and neurogenic lineages. To date, the
expression of FST, a protein broadly secreted by GCs in the
ovary, was never found to be downregulated, as we would
expect it to be for cells retaining/acquiring a stem cell–as-
sociated phenotype. The FST gene continued to be switched
FIG. 7. Quantitative RT–PCR analysis for the expression of osteogenesis-associated genes such as SPP1 (A) and SPARC
(B). Data are represented as fold change compared with expression observed in P0. Values are mean – standard deviation
(SD) (n = 3). Asterisks depict highly significant (**p< 0.01) or significant (*P < 0.05) differences compared to uninduced
cells.
FIG. 8. Photomicrographs of immunostaining of bovine GCs labeled with antibodies against antigens for Oct-4. Mag-
nification, 40·; scale bar, 20lm. Magnification for embryos: 20·; scale bar, 40lm. CTR, control.
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‘‘on’’ in the genetic pattern of GCs, even if they were grown
under different culture conditions. Its expression probably
indicates an incomplete dedifferentiation to mesenchymal
cells and the maintenance of a strong epigenetic imprinting
that prevented GCs from differentiating. This epigenetic im-
printing could be the reason of failed differentiation.
On the basis of our findings, it is reasonable to assume
that GCs isolated in our study and maintained in different
conditions can be considered progenitors of GCs; the only
exception was those kept in MB +LIF+BME that lost ex-
pression of CD44 and CD166. The discrepancy in the dif-
ferentiation outcome observed between the present study
and that reported by Mattioli et al. (2012) and Kossowska-
Tomaszczuk et al. (2009) is difficult to explain considering
that GCs were isolated from the internal side of the pre-
ovulatory follicle and, thus, from the periantral layer, as
reported by Mattioli et al. (2012). Erickson (2000) postu-
lated that stem cells could be located in the periantral layer
of granulosa. As such, this method could be the most ap-
propriate for the collection of multipotent stem cells from
granulosa compared to the aspiration protocol performed by
Kossowska-Tomaszczuk et al. (2009).
On the basis of our negative results to detect stem cells in
preovulatory follicles, we decided to expose GCs to che-
mical stress by lowering the pH in culture to elucidate
whether acidic stress could influence the phenotype and,
eventually, help with the selection of more plastic cells. In
plants, drastic environmental changes have been reported to
convert mature somatic cells (for example, dissociated car-
rot cells) into immature blastema cells, from which a whole
plant structure, including stalks and roots, develops in the
presence of auxins (Thorpe, 2007). In our study, molecular
analysis revealed significant differences between the cells
before and after the acidic treatment. In particular, 7d cells
showed a significant decrease of expression of granulosa-
specific markers (FSHR, FST, LIF-R), with a concomitant
increase in the pluripotency-associated marker Oct-4. Chiou
et al. (2008) also reported the upregulation of Oct-4 in these
conditions. The loss of FSHR could be explained with the
lack of its ligand (FSH) in the culture media, which is in
agreement with the findings obtained by Kossowska-
Tomaszczuk et al. (2009), focusing on human GCs isolated
from the ovarian follicles of infertile patients and cultured in
the presence of LIF.
Changes in gene expression can be further justified
by hypothesizing that the chemical stress is able to induce
either a cell dedifferentiation or a strong selection of pro-
genitor cells. Changes in the external environment (includ-
ing the pH reduction) have been previously associated with
a specific phenotype acquired by cells exposed to them, as in
the case of ovary cells and cancer cells (Tannock and Rotin,
1989). Moreover, when cultured in acidic conditions, cells
lose the expression of the immunogenic markers (MHC I
and MHC II), confirming their more undifferentiated state.
MSCs have been reported to be immuno-privileged cells,
with no or low expression of those markers (Hass et al.,
2011).
Differentiation studies further corroborated such observa-
tions. pH-treated cells were induced toward the mesodermic
(adipogenic and osteogenic) and ectodermic (neurogenic)
lineages. Oil Red O, von Kossa, and Nissl staining, re-
spectively, demonstrated differentiation, which was further
confirmed by molecular analysis. For adipogenesis, we in-
vestigated the expression of PPARcand LEP; however, only
the first one was expressed in differentiated cells. The ex-
pression of PPARc suggests a preadipocytic commitment of
cells (Corradetti et al., 2013), which is further confirmed by the
lack of LEP, a marker regarded as an intermediate and late
marker. The expression ofGFAP in induced cells suggests that
astrocyte differentiation occurred, as previously reported for
bovine and equine amniotic-derived cells (Corradetti et al.,
2011, 2013; Lange-Consiglio et al., 2012).
Osteogenesis was assessed investigating the osteogenic-
specific markers BGLAP, SPP1, and SPARC. All of these
markers were expressed in induced cells, with the exception
of only BGLAP. This might be explained considering that
BGLAP is expressed in terminally differentiated osteoblasts
(Wagner et al., 2011). Surprisingly, the expression of SPP1
and SPARC was detected also in the negative controls (7d
uninduced cells), although with a lower expression level
compared to induced cells. We hypothesized that the ex-
pression of these markers (SPP1 and SPARC) in negative
controls can be due to the role they play in inflammation.
Indeed, these markers are mainly involved in the immune
response to an inflamed environment (Lund et al., 2009; Xu
et al., 2013), as is the case of the acidic treatment. The
upregulation of TNF-a and IL-1b expression confirmed our
hypothesis. In particular, SPARC levels are significantly
correlated with inflammation (Xu et al., 2013) and SPP1 is
strikingly upregulated at sites of inflammation and tissue
remodeling, because it promotes the migration of inflam-
matory cells to the wound site and functions as a proin-
flammatory cytokine (Lee et al., 2012).
Conclusions
Results obtained from this work demonstrated that none
of the culture conditions employed in this study allowed for
the selection of the stem cell population within GCs isolated
by scraping. The stress induced by the acidic treatment on
bovine GCs endorsed the selection of the more plastic cells,
which were the only ones able to respond to stimuli and
adjust to a more rigid environment. Thus, compared to the
freshly isolated cells, selected cells showed an increased
expression of the pluripotent marker Oct-4 and were able to
differentiate into mesodermic and ectodermic lineages. The
acquired phenotype of those cells can be also explained as a
consequence of the activation of an inflammatory process,
able to determine de-differentiation or nuclear reprogram-
ming in GCs (Lee et al., 2012). Further studies are required
to understand better the effect of the acidic treatment and the
consequent stress induced by it at molecular level. More-
over, different approaches will be required to discover a
possible stem cell niche in bovine pre-ovulatory follicle.
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Effects of platelet-rich plasma in a model of
bovine endometrial inflammation in vitro
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Abstract
Background: Endometritis reduces fertility and is responsible for major economic losses in beef and dairy
industries. The aim of this study was to evaluate an alternative therapy using platelet-rich plasma (PRP). PRP
was tested in vivo, after bovine intrauterine administration, and in vitro on endometrial cells.
Methods: Bovine endometrial cells were cultured until passage (P) 10 with 5 % or 10 % PRP. Effect of PRP on
endometrial cell proliferation and on the expression of genes [prostaglandin-endoperoxide synthase 2 (COX2), tumor
protein p53 (TP53), oestrogen receptors (ER-α and ER-β), progesterone receptor (PR) and c-Myc] involved in the regulation
of oestrus cycle and fetal-maternal interaction were evaluated. Moreover, to evaluate the ability of PRP to counteract
inflammation, 10 and 100 ng/ml of bacterial endotoxin lipopolysaccharide (LPS) were used to inflame endometrial cells in
vitro for 1, 6, 12, 24 and 48 h. The expression of genes such as interleukin 1β (IL-1β), interleukin-8 (IL-8), inducible nitric
oxide synthase (iNOS), prostaglandin-endoperoxide synthase 2 (COX2/PTGS2), and the release of PGE-2, IL-1β
and IL-8 were evaluated.
Results: In vivo treatment with PRP increased the detection of PR. In vitro, 5 % PRP at passage 5 increased
proliferation rate and induced a significant increase in the expression of all studied genes. Furthermore, the
results revealed that 10 ng/ml of LPS is the most effective dose to obtain an inflammatory response, and that
PRP treatment significantly down regulated the expression of pro-inflammatory genes.
Conclusion: This study lays the foundations for the potential treatment of endometritis with PRP in vivo.
Keywords: Cattle, Endometrial cells, Platelet-rich plasma, LPS, gene expression
Background
The wall of the uterus consists of endometrium, myome-
trium and perimetrium (tunica serosa). The bovine
endometrium is a complex tissue that comprises the
tunica mucosa (lamina epithelialis and lamina propria
consisting of loose connective tissue) and the tunica sub-
mucosa of the uterus. In the lamina propria, neutrophils
and lymphocytes are commonly detectable. The endo-
metritis is characterized by an increase number of
inflammatory cells associated to epithelial erosion and/
or necrosis and diffuse oedema of endometrium [1].
Meta-analysis studies show that endometritis reduces
pregnancy rate by 16 % [2]. The economic losses related
to this disease are substantial and associated with a great
impact on the economy to drop in milk yield and calves,
and treatment costs [3]. Approximately, 80 % to 100 %
of cows have intrauterine bacterial contamination in the
first two weeks postpartum. In most cases, clinical dis-
ease does not develop, as the normal uterus is able to
clear a bacterial infection efficiently [4]. In 10 %-20 % of
cows, however, the infection is not controlled and may
lead to chronic uterine inflammation [1, 5]. It is com-
monly accepted that the development of uterine infec-
tion depends on the immune response of the cow, as
well as species and number of bacteria [1]. Economically,
important uterine diseases in cattle are commonly
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associated with bacterial infection by Escherichia coli,
Trueperella pyogenes, Fusobacterium necrophorum or Pre-
votella species [1, 5–8]. The most significant pathogenic
bacteria responsible for uterine infection are E. coli, which
produce an endotoxin lipopolysaccharide (LPS) that is
present in their cell wall.
Establishment of uterine bacterial infection may also
depend on metabolic disease, although the specific
mechanisms are still not clear or by endocrine envir-
onment, that affects the likelihood of bacteria elimin-
ation [9–11].
The inflammatory response is a complex process in-
volving many signalling cascades. In the genital tract, the
initial response of the endometrium against infection is
dependent on innate immunity and mucosal defence
systems [3, 12]. The uterine immune response is pro-
vided at the cellular level, by uterine leukocytes and
polymorphonuclear cells that are the cells phagocytizing
and clearing bacteria [13]. In horse, at the molecular
level, cytokines have a significant role in the recruitment
of inflammatory cells [14]. In cattle, interleukin-6 and
TNF-α stimulate the production of antimicrobial pep-
tides that assist in the elimination of pathogenic bacteria
[15, 16]. Moreover, bovine endometrial epithelial and
stromal cells can respond to bacterial LPS through the
Toll-like receptor (TLRs) [17]. Activated TLRs subse-
quently stimulate the production of pro-inflammatory
cytokines and chemokines [18].
Literature on the treatment of endometritis in cattle
is extensive and at times inconsistent. Specifically, uter-
ine disease treatments aim at reverting inflammatory
changes that impair fertility, whilst enhancing uterine
defence and repair [19]. In cows, many therapeutic
agents and procedures have been developed to treat
endometritis, including systemic or intrauterine admin-
istration of antibiotics [20–22], or administration of
PGF2α and its analogue [20–24]. The intrauterine infu-
sion of antiseptics (e.i. Lugol’s solution) has been tested
although side-effects on future fertility of the cows have
been reported [23, 25]. Furthermore, approaches using
proteolytic enzymes [21], administration of estradiol
[26, 27] or GnRH [28] have also been described. Even if
all these treatments show some effects on uterine heal-
ing, no definitive results can be extrapolated from pub-
lished clinical trials.
Platelet-rich plasma (PRP) is an emerging therapeutic
application in tissue regeneration and engineering due to
its enrichment in growth factors with mitogenic and
anti-inflammatory potential [29, 30]. In particular, PRP is
a concentration of platelets (3-5 fold the plasma baseline
level) containing transforming growth factor β1 (TGF-
β1) and TGF-β2, platelet derived growth factors (PDGF-
AA, PDGF-BB, PDGF-AB), insulin-like growth factor 1
(IGF-I), epidermal growth factor (EGF), vascular
endothelial growth factor (VEGF), fibroblast growth fac-
tor (FGF) and hepatocyte growth factor (HGF) that are
very important for regeneration processes. Indeed, these
growth factors act synergistically to increase the infil-
tration of neutrophils and macrophages, to promote
angiogenesis, fibroplasia, matrix deposition and, ultim-
ately, re-epithelialization, inducing the consequent
tissue regeneration [29]. Lastly, the presence of anti-
inflammatory molecules, including HGF [31] also
confers on PRP the ability to suppress inflammatory
process.
In this context, the specific aim of this study was to in-
vestigate the effect of PRP in vivo and in vitro, on a model
of healthy or LPS stressed bovine endometrial cells. In
vivo, the progesterone receptor (PR) expression was de-
tected immunohistochemically. The steroid hormone pro-
gesterone (P4) plays a key role in reproductive events
associated with establishment and maintenance of preg-
nancy. Conceptus growth and development require the
action of P4 on the uterus to regulate endometrial
function, including conceptus-maternal interactions,
pregnancy recognition, and uterine receptivity to im-
plantation [32]. Indeed, low P4 concentrations have
been implicated as a causative factor in the low preg-
nancy rates observed in high-yielding dairy cows [33].
In vitro, genes involved in the regulation of oestrous
cycle, in pro-inflammatory process and the release of
some cytokines were evaluated.
Methods
Experimental design
This study was based on three experiments. The first ex-
periment evaluated the endometrium histologically and
immunohistochemically, after in vivo PRP administra-
tion, using PR receptor as a marker of cell receptivity.
The second experiment evaluated the effect of a 5 % and
10 % concentration of PRP in culture medium, on in
vitro endometrial cell proliferation and on the expres-
sion of some genes involved in the regulation of oestrous
cycle and fetal-maternal interaction, to establish whether
it is able to improve the functions of this cell line. The
genes included prostaglandin-endoperoxide synthase 2
(COX2 or PTGS2), tumor protein p53 (TP53), oestrogen
receptors (ER-α and ER-β), progesterone receptor (PR)
and v-myc avian myelocytomatosis viral oncogene homo-
log (c-Myc). The third in vitro experiment evaluated the
ability of PRP to counteract an in vitro model of inflam-
mation by stressing endometrial cells with LPS at different
times and concentrations. Expression of pro-inflammatory
genes and release of some cytokines were evaluated.
Materials
Chemicals were obtained from Sigma-Aldrich Chemical
(Milan, Italy) unless otherwise specified. LPS was
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purchase by Sigma-Aldrich Chemical (E. coli 0:111B4;
L2630 catalog number). Tissue culture plastic dishes
were purchased from Euroclone (Milan, Italy).
Animals
All procedures were performed according to approved ani-
mal care and use protocols of the institutional ethics com-
mittee and to good veterinary practice for animal welfare as
to European directive 2010/63/UE. Written farmers’ con-
sent was obtained at the beginning of the study.
From a group of Holstein Friesian, animals at 150-180
days in milking belonging to a 180 cows dairy farm lo-
cated in North Italy, 14 cows bearing a well-developed
corpus luteum (CL) diagnosed by B-mode ultrasound
evaluation of the ovaries, were selected. They received
an i.m. luteolytic dose of PGF2α to synchronize the es-
trous cycle. All animals (n = 10) showed estrous signs in
the following 96 hours and at that time bacteriological
and cytological analyses, trans rectal and vaginal palpa-
tion, and sonography of the reproductive tract were con-
ducted to exclude genital diseases. These animals were
enrolled for the first study.
Endometrial samples for in vitro study were collected
from slaughtered bovines under legal regulations
Preparation of platelet-rich plasma
Collection of blood
Blood was obtained from two donor cows at forty days
in milking, as this is the period the circulating platelet
count is higher than other periods (data not shown).
These animals were in good health, free from infectious
diseases and they did not receive medication during the
previous two months. The collection of blood and the
preparation of PRP, with the method of double centrifu-
gation, were performed as reported by Lange-Consiglio
et al. [34]. After surgical scrub preparation of a few cen-
timeters of skin around the subcutaneous mammary
vein, 450 ml of blood was collected in ad hoc Terumo
blood bags (Terumo Srl, Rome, Italy) containing citrate-
phosphate-dextrose-adenine (CPDA-1) using the 16-
gauge needle provided with the bags. The bags were
transported at 4 °C to the laboratory within 2 h of
collection and immediately processed.
Double centrifugation method
All separation steps were performed under a horizontal
laminar flow hood in aseptic conditions. To prepare the
PRP, the blood was drawn into sterile Falcon tubes of
50 mL each (EuroClone SpA, Milan, Italy). The tubes
were centrifuged at 100 x g for 30 min at 4 °C. This
caused separation of the blood into three components:
red blood cells at the lowest level, “buffy coat” in the
middle layer, and platelet rich plasma (PRP) in the upper
layer. Afterward, the PRP was carefully aspirated and
distributed in new 50-ml tubes and centrifuged again at
1,500 x g for 10 min at 4 °C to obtain the platelet pellet
and the poor platelet plasma (PPP) on the upper layer.
Afterward, two-thirds of the volume of PPP was aspi-
rated for later use and the pellet mixed in the residual
PPP volume to allow for platelet count before the final
dilution with PPP to obtain PRP at a standard concen-
tration of 1 × 109 platelets/ml [34]. All platelet counts on
peripheral blood and PRP were performed using a HeCo
Vet automatic hematology analyzer (SEAC, Florence,
Italy). The total amount of PRP obtained for each donor
was aliquoted in 10 ml ready-to-use doses that were
stored in syringes. The syringes were then frozen at
−80 °C and thawed at 37 °C three times [35] to allow the
release of platelet-derived factors. The PRP was sub-
jected to aerobic and anaerobic bacteriological examin-
ation to verify its sterility. Syringes containing the PRP
dose were kept frozen at −20 °C until use.
Experiment 1: in vivo effect of intrauterine administration
of PRP
At day 4 post estrus, all previously selected animals were
checked by ultrasound for the presence of a newly
formed CL and were randomly divided in two groups.
Seven cows were treated with PRP while the other seven
animals were enrolled as control (CTR). Physiological
solution (0.9 % NaCl) was used as placebo for these lat-
ter. Ten ml of PRP or ten ml of physiological solution
were aseptically infused into the uterus by a disposable
sterile catheter included in a protective sheath guided
into the cervix by manipulation per rectum. To prevent
transfer of vaginal flora into the uterine lumen, the pro-
tective sheath was removed just after cervix penetration
and the catheter was hence introduced into corpus uteri
where PRP was infused.
Endometrial biopsy
Endometrial biopsies were collected using a stainless
steel Hauptner equine endometrial biopsy instrument as
previously described by Chapwanya et al. [15] and Katagiri
and Takahashi [36]. Samples were obtained just before
treatment at day 4 post estrus (T0) and 7-day post treat-
ment, that is at day 11 post estrus (T1). Briefly, after clean-
ing the base of tail, perineum and external genitalia,
animals were given caudal epidural anesthesia (4–5 ml
2 % of lidocaine). Afterwards, the biopsy instrument in-
cluded in a protective sheath was introduced into the
uterus through the cervix by manipulation per rectum.
Once the cervix was passed, and the protective sheath
ruptured, the tip of the biopsy instrument inside the
uterus was identified using the hand per rectum. Then,
with the help of the hand in the rectum, the medial uter-
ine wall was gently pressed into the instrument jaws and
biopsies were taken from the dorsomedial aspect of one
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horn just anterior to the bifurcation. Biopsies for histology
were gently removed from the biopsy instrument with a
fine gauge needle and transferred to a vial of fixation solu-
tion. All biopsies were processed by the same operator.
The samples were performed for histological and im-
munocytochemical studies.
Histological and immunohistochemical examinations
Samples were routinely formalin-fixed (10 % buffered
formalin) for 48-72 hours and paraffin-wax embedded.
Four-micrometer thick sections were stained with
hematoxylin and eosin (HE), while others were prepared
on poly-L-lysine–coated glass slides for immunohisto-
chemistry to detect the presence of PR.
The immunohistochemical staining of all samples was
performed using the avidin–biotin–peroxidase complex
procedure with a commercial immunoperoxidase kit
(Vectastain Standard Elite; Vector Laboratories, Inc.,
Burlingame, CA, USA).
Tissue sections were immersed in a pre-heated solu-
tion at 94 °C of Dewax and HIER Buffer H (Thermo
Fischer Scientific, Lab Vision Corporation, Fremont, CA,
USA) diluted 1:15 with deionized water for 40 minutes.
This solution is designed to simultaneously dewax and
perform heat induced epitope retrieval.
Endogenous peroxidase was blocked using 1 % hydro-
gen peroxide in Tris buffer for 45 min.
Sections were incubated for 18 hours at 4 °C with anti-
PR (Thermo Fischer Scientific, Lab Vision Corporation,
Fremont, CA, USA) mouse monoclonal antibodies di-
luted 1:400. After incubation with the secondary bio-
tinylated anti-mouse immunoglobulin (diluted 1:200;
Vector Laboratories, Inc.) for 30 min, the avidin–bio-
tin–peroxidase complex method (Vector Laboratories,
Inc.) was performed. Positive staining was visualized
with 3.3-diaminobenzidine-4 HCl (Vectastain, Vector
Laboratories, SK-4100) and nuclei were counterstained
with Mayer’s hematoxylin. Diluent negative control sec-
tions were produced by omission of the primary antibody.
Evaluation of histological and immunohistochemical data
Tissue samples were evaluated in order to assess the ab-
sence of pathological lesions.
The immunohistochemically stained tissue slides were
examined using standard light microscopy. Three ran-
domly selected areas were evaluated per section. The
staining results were independently scored semi quantita-
tively by different blinded operators at 400X magnifica-
tion. The results of PR protein expression were assessed
by categorizing immunoreaction of epithelial cells, muscu-
lar layer and glandular cells into five groups according to
the percentage of positive cells. These group were: 0) no
positive cells; 1) <1 % of positive cells; 2) from 1 % to
10 %; 3) from 11 % to 33 %; 4) from 34 % to 66 % and 5)
from 67 % to 100 % [37]. The intensity of labeling was
graded as: weak positive staining (W); moderate positive
staining (M); intense positive staining (I) and scored as
follows: W = 1, M = 2, I = 3. A total score was conferred
adding together the positive cells percentage score and the
intensity of immunolabeling score [37].
Experiment 2: effect of different concentrations of PRP on
in vitro endometrial cells proliferation and gene
expression
Tissue collection and cell isolation
Fresh bovine uteri were collected from three different
cows at the slaughterhouse intended for human con-
sumption and unrelated to our experiments. Samples
were obtained from healty normal-cycling cows at dies-
trus stage (middle-late luteal phase). Only uteri belong-
ing to cows with an obvious corpus luteum on the ovary
were used for endometrial fragment collection and ensu-
ing cell culture.
Endometrial samples were kept at 4 °C in saline
solution supplemented with 4 μg/ml amphotericin B,
100 IU/ml penicillin-100 μg/ml streptomycin and proc-
essed within 2 h. Endometrial stromal cells were ob-
tained according to the protocol described by Donofrio
et al., [38]. Briefly, the endometrium was digested in
25 ml of sterile filtered Hanks’ buffered salt solution
supplemented with 50 mg collagenase II, 100 mg bovine
serum albumin, and 10 mg DNase I for 90 minutes at
38.5 °C in a shaking bath. Then, cells were filtered with
an 80-μm filter, centrifuged at 300 x g for 10 minutes,
and washed twice in PBS. Before seeding, the total num-
ber of viable cells was evaluated by the exclusion
method staining with trypan blue and using a Bürker
chamber.
Cells expansion
A pool of endometrial stromal cells cultures from three
different cows was established in Dulbecco's Modified
Eagle's Medium high glucose (HG-DMEM) supple-
mented with 10 % FBS, 100 UI/ml penicillin–100 μg/ml
streptomycin, 0.25 mg/ml amphotericin B and 2 mM L-
glutamine (standard complete medium). For mainten-
ance of cultures, cells were plated in 75 cm2 flasks (SPL
Cell culture flask 70025) at up to 1x105 cells/cm2 and in-
cubated at 38.5 °C with 5 % CO2 in a humidified atmos-
phere. To remove non-adherent cells, the medium was
replaced for the first time after 48 h. Adherent cells were
detached with 0.05 % trypsin-EDTA just prior to reach-
ing confluence (80 %) and then reseeded for culture
maintenance at the density of 1x104 cells/cm2.
Proliferation studies
All data are representative of three independent
experiments.
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Doubling time (DT) DT for passages 1–10 (P1 and
P10) was assessed plating 9x103 cells into six-well tissue
culture plates. Every 4 days cells were trypsinized,
counted and reseeded at the same density. Mean DT
was calculated from day 0 to day 4. The DT value was
obtained for each passage according to the formula DT
= CT/CD, where CT represents the culture time and
CD = log (Nc/No)/log2 represents the number of cell
generations (Nc represents the number of cells at con-
fluence, No represents the number of seeded cells).
Growth curves To obtain growth curves at P1, P5 and
P10 endometrial cells were plated at the density of 9x103
cells into six-well tissue culture plates. Every two days,
over the 12 days of culture, cells from one well of each
plate were detached and counted.
In vitro effect of PRP on endometrial gene expression
In this study, culture medium was replaced for the first
time after 48 h to remove non-adherent cells and chan-
ged with complete standard medium supplemented with
two different concentrations of PRP, 5 % and 10 %, as a
FBS substitute. Control cells were grown in complete
standard medium supplemented with 10 % FBS. The
cells were expanded for 10 passages, which was the last
time point included in our study. Cells from each well
were then collected to evaluate mRNA expression of
genes involved in the regulation of oestrous cycle and
fetal-maternal interaction by quantitative real-time PCR.
The genes evaluated were prostaglandin-endoperoxide
synthase 2 (COX2), tumor protein p53 (TP53), oestrogen
receptors (ER-α and ER-β) and progesterone receptor
(PR). The expression of c-Myc was also evaluated.
Molecular characterization of endometrial cells was
performed at passages 1, 3, 5 and 10 by qualitative PCR.
Data were obtained from three replicates.
Experiment 3: In vitro effect of PRP after LPS treatment
on gene expression
P5 endometrial cells were plated in six well plates at a
density of 50,000 cells/well in DMEM standard complete
medium containing two different concentration of LPS,
10 ng/ml and 100 ng/ml. Evaluation of the expression of
genes involved in inflammation was performed at 1, 6,
12, 24 and 48 h. The LPS concentrations were chosen
on the base of results of Herath et al. [39] that demon-
strated level of LPS around 100 ng/ml in cows with clin-
ical endometritis. Supernatants were collected and
stored at -20 °C until being used for ELISA to measure
PGE-2, IL-1β and IL-8.
To study the in vitro effect of PRP in cells inflammed
with LPS, endometrial cells were treated with 10 ng/ml
LPS and 5 % PRP for 1, 6, 12, 24 and 48 h. At each time
point, the expression of same genes was analyzed. Data
were obtained from three replicates.
Molecular characterization
Total RNA was extracted from endometrial cells using
TRI Reagent Solution (Life Technologies, Monza, Italy).
Samples were then treated with DNase in order to elim-
inate DNA contamination. RNA concentration and pur-
ity were measured by Nanodrop Spectrophotometry
(NanodropH ND1000). The quality and integrity of the
total RNA extracted were verified by electrophoresis on
a 1.5 % (w/v) agarose gel. The cDNA was synthesized
from total RNA (200 ng) using the PrimeScript RT re-
agent Kit (Takara Bio). Gene expression evaluation was
performed using bovine specific sequences. Oligonucleo-
tide primers were designed using open source PerlPri-
mer software v. 1.1.17 based on available NCBI Bos
taurus sequences or on mammal multi-aligned se-
quences. Primers were designed across an exon–exon
junction in order to eliminate genomic DNA amplifica-
tion and their sequence conditions and the references
used are shown in Table 1.
Qualitative PCR analysis was performed in a 25 μl
final volume with Taq DNA Polymerase recombinant
commercial kit (Invitrogen Life Technologies) under
the following conditions: initial denaturation at 94 °C
for 2 minutes, 32 cycles at 94 °C for 30 seconds
(denaturation), 55–60 °C for 30 seconds (annealing),
72 °C for 30 seconds (elongation) and final elongation
at 72 °C for 10 minutes. For conventional PCR,
primers were used at 200 nM final concentrations.
Quantitative PCRs were performed with SYBR green
method in a MyiQ iCycler thermal cycler (Biorad).
PCR reactions were carried out in triplicate for each
sample. The reactions were set on a strip in a final
volume of 25 μl by mixing, for each sample, 1 μl of
cDNA, 12.5 μl of 2X concentrated SYBR Premix Ex
Taq II (Takara Bio) containing SYBR Green as a
fluorescent intercalating agent, 0.2 μg forward primer,
0.2 μg of reverse primer and MQ water. PCR efficien-
cies were tested and found to be close to 1. The ther-
mal profile for all reactions was 30 seconds at 95 °C
and then 40 cycles of 5 seconds at 95 °C, 30 seconds
at 60 °C. Fluorescence monitoring occurred at the
end of each cycle. Efficiency of amplification for each
primer was monitored through the analysis of serial
dilution. Additional dissociation curve analysis was
performed and in all cases showed a single peak. The
data thus obtained were analyzed using the iQ5 op-
tical system software version 2.0 (BioRad). The
expression of each gene was normalized to the refer-
ence gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (internal control) in order to standardize
the results by eliminating variation in cDNA quantity.
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Such gene was identified among others used as
endogenous control genes based on previous studies
focusing on endometrial gene expression [40]. Relative
gene expressions were presented with the 2−ΔΔCt
method [41].
Protein release by ELISA
Protein release (PGE-2, IL-1β and IL-8) was measured in
cell-free supernatants obtained by centrifugation at 250
x g for 5 min and stored at −80 °C until measurement.
Protein production was assessed according to the man-
ufacturers’ instructions (Bovine PGE-2 MBS737103,
MyBioSource; Bovine IL-1β Screening Set ESS0027,
Thermo Fisher Scientific; CXCL8/IL-8 DuoSet DY208,
R&D Systems). The Human CXCL8/IL-8 DuoSet was
previously validated for measurement of bovine IL-8
[42]. The limits of detection for PGE-2, IL-ß and IL-8
were 1.0, 20.1 and 14.3 pg/ml, respectively.
Results are expressed in pg/ml.
Statistical analysis
Statistical analysis was performed using GraphPad Instat
Software version 3.00 for Windows (La Jolla, CA, US).
For proliferation data, three replicates for each experiment
were performed. Results are reported as mean ± standard
deviation (SD). One-way analysis of variance (ANOVA)
for multiple comparisons by Student-Newman-Keuls mul-
tiple comparison tests was used.
Immunohistochemical data were analyzed by unpaired
Student's t-test.
For cytokines, statistical differences were determined
using ANOVA followed by Dunnett's multiple compari-
son test, the Tukey–Kramer multiple comparisons test
or unpaired t test.
Differences were considered statistically significant for
P values < 0.05.
For quantitative PCR data, non-parametric tests were
used. The Mann-Whitney U-test was employed to com-
pare two groups (treated vs untreated). Results were
considered significant if the value of P was < 0.01.
Results
Experiment 1: in vivo effectiveness of intrauterine
administration of PRP
Histological examination
No pathological alterations were detected in any of the
examined biopsies. All the samples were covered by a
columnar simple epithelial monolayer. A moderately
large amount of uterine glands was dispersed in the
stroma. Scattered rare lymphocytes were also detectable
in the stroma. Neither fibrosis nor hemorrhages were
present.
Immunohistochemical evaluation
Positive nuclei to PR were brown-stained, while negative
nuclei were blue stained by hematoxylin counterstain.
Diluent negative controls showed no immunoreaction.
The PR immunoreactivity was evaluated separately in
the surface epithelial cells, glandular epithelium and
smooth muscle cells. The total scores are listed in Table 2.
Table 1 Oligonucleotide sequences used for RT-PCR analysis
Marker Forward 5'-3' Reverse 5'-3' T annealing bp
Interleukin-1β
(IL-1β)
TGCAGCTGGAGGAAGTAGAC GTCGGGCATGGATCAGACAA 60 338
Interleukin 8
(IL-8)
ACATACCCTGCCACAAGGC TGGGGACTGCTCTTCCCTCT 57 146
Inducible nitric oxide synthase (iNOS) GGACCTCAACAAAGCCCTGA CCTTGACCCAATAGCTGCCA 60 293
Prostaglandin-endoperoxide synthase 2
(COX2)
CATGGGTGTGAAAGGGAGGAA AAAGACGTCAGGCAGAAGGG 60 700
Tumor protein p53
(TP53)
CCTAGGAGCACTAAGCGAGC GCCCCTCTCTCTTGAGCATT 55 268
Oestrogen receptor alpha
(ERα)
AGGGAAGCTCCTATTTGCTCC CGGTGGATGTGGTCCTTCTCT 55 234
Oestrogen receptor beta
(ERβ)
GCTTCGTGGAGCTCAGCCTG AGGATCATGGCCTTGACACAG 55 262
Progesterone receptor
(PR)
GAGAGCTCATCAAGGCAATTGG CACCATCCCTGCCAATATCTTG 55 227
v-myc avian myelocytomatosis viral oncogene homolog
(c-Myc)
GCGCCGCATTCGCGAAACTT TGAGGGGCATCGCTGCAAGC 58 °C 214
Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)
ATGAGATCAAGAAGGTGGTG CCAAATTCATTGTCGTACCAG 60 190
Marini et al. Reproductive Biology and Endocrinology  (2016) 14:58 Page 6 of 17
PR expression has been detected in all these uterine
compartments (Fig. 1). Treated animals in T1 showed
the highest PR receptor score in glandular epithelium
and smooth muscle cells compared to T0 (P < 0.05). In
T1 control animals, glandular epithelium and smooth
muscle cells obtained the same high average score that
is not statistically different compared to T0 (P > 0.05).
Experiment 2: effect of different percentages of PRP on in
vitro endometrial cells proliferation and gene expression
Cells isolation and expansion
Cells were selected on their ability to adhere to plastic.
For endometrial cells, initial viability was >80 %. Cells
displayed the typical fibroblast-like morphology (Fig. 2a).
The molecular biology study on the isolated cells con-
firmed their endometrial nature due to the expression of
ER-α, ER-β, PR and TP53 (Fig. 2b).
Proliferation studies
The DT value at P1 and P2 were similar between the
cells grown in presence of 5 % PRP, 10 % PRP and 10 %
FBS. After P2, for endometrial cells grown in presence
of 5 % PRP, the proliferative ability increased until P5
while for cells grown in presence of 10 % PRP, the prolif-
erative ability decreased and then remained constant
until P10. No difference in the DT value for endometrial
cells grown in presence of 10 % FBS were found over
the passages studied (Fig. 3a). The mean DT value for
endometrial cells grown in presence of 5 % PRP was
1.96 ± 0.31 days, while it was 4.64 ± 1.52 and 2.20 ±
0.22 days for endometrial cells grown with 10 % PRP
and FBS 10 %, respectively.
Endometrial cells cultured with 5 % of PRP, at P1
showed a growth curve with an initial lag phase of 2 days
and a subsequent long log phase of 8 days. At P5, endo-
metrial cells demonstrated a growth curve with an initial
lag phase similar to that observed for P1, continues with
a log phase of 4 days followed by a stationary phase of
4 days. Finally, after 10 days in culture, a death phase
was observed. At P10, endometrial cells showed a
growth curve with an initial lag phase longer than that
registered for endometrial cells at P5 (2-8 days) and sub-
sequent log phase shorter than that observed for P5
(2 days) (Fig. 3b).
In vitro effect of PRP on endometrial gene expression
Endometrial cells were cultured in presence of two dif-
ferent concentrations of PRP (5 % and 10 %) until pas-
sage 10, and mRNA expression of genes involved in the
regulation of oestrous cycle and fetal-maternal inter-
action was measured by quantitative PCR. PRP 5 % at
P5 had a significant effect on the expression of endo-
metrial genes when compared to the expression levels
of untreated cells (Fig. 4a-f ). The results showed a
statistically significant increase (P < 0.01) in the ex-
pression of all studied genes at P5 in cells cultured in
Table 2 Total score for PGR expression in bovine according to the surface epithelial cells, glandular epithelium and smooth muscle
cells
Surface epithelium Glandular epithelium Smooth muscle
Subject T0 T1 T0 T1 T0 T1
SALINE CTR 2 5 3.5 8 5 3 4.5
4 8 4 8 8 6.5 6.5
8 3 4 3 8 4 7.5
9 8 7.5 7.5 8 5.5 7.5
10 3 2 4 4 4 7
11 4 4 5 4 5 4.5
14 4 4 6 7 6 4
Average score 5.0±2.2a 4.1±1.7a 5.9±2.0a 6.3±1.9a 4.4±1.1a 5.8±1.66a
PRP 1 5 3.5 5.5 6.5 4 7.5
3 3.5 0 4.5 7 2.5 6.5
5 2 6.5 3.5 8 2.5 7
6 8 8 7.5 8 8 7.5
7 7.5 8 8 8 6 6.5
12 5 5 6 7 3 7
13 4 6 5 7 5 6.5
Average score 5.0±2.1a 5.3±2.8a 5.7±1.6a 7.4±0.6b 4.4±2a 6.9±0.4b
Legend: average score represent mean ± standard deviation. Different small letters superscripts (a,b) indicate statistically different comparisons (P<0.05) between
T0 and T1
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presence of 5 % PRP compared to 10 % PRP or 10 %
FBS. In particular, ER-α expression increased 9-fold
(±0.66), ER-β expression increased 260-fold (±6.8), PR
expression increased 5.44-fold (±0.85), TP53 expres-
sion increased 5.56-fold (±0.52) and COX2 expression
increased 15.74-fold (±0.78). The expression of c-Myc
increased of 22-fold (±0.24). At P10, a decrease in the
expression of all the evaluated genes was observed,
with the only exception on TP53, whose expression
remains constant.
Experiment 3: in vitro effect of PRP after LPS treatment on
gene expression
Endometrial cells at P5 were cultured with or without
10 ng/ml or 100 ng/ml LPS for 1, 6, 12, 24, and 48 h,
and mRNA expression of pro-inflammatory genes was
evaluated by qPCR. The results are summarized in
Fig. 5a,c,e,g for 10 ng/ml and Fig. 5b,d,f,h for 100 ng/ml.
Treatment with PRP did not alter GAPDH mRNA ex-
pression, which was included as a reference gene. The
results revealed that the 10 ng/ml concentration of LPS
between 1 h and 12 h is the most effective dose to in-
duce an over-expression of pro-inflammatory genes in
bovine endometrial cells.
A significant increased (P < 0.01) expression of IL-1β
(18.65 ± 0.32), iNOS (208.17 ± 0.18) and COX2 (99.84 ±
0.31) was observed immediately (1 h) after LPS treat-
ment compared to untreated cells. Expression of IL-8
was significantly higher (P < 0.01) at 6 h and 12 h (10.55
± 0.29 and 10.22 ± 0.12 respectively) after LPS treatment
compared to untreated cells. Within 48 h, all genes
returned nearly to baseline.
The PRP treatment had a significant effect (P < 0.01)
on the endometrial gene expression of these genes when
Fig. 1 Immunohistochemical PR expression in uterine biopsies (20x, Haematoxylin counterstain). Figures in the left column are of PRP group treated at T0
while in the right column are of PRP group treated at T1. Arrows show the following results. Uterine surface epithelium showing: (a) weak positivity
involving scattered cells (score W1); (b) and marked positivity in the majority of the epithelial cells (score I5). Glandular epithelium with (c)
weak and diffuse immunostaining (score W4); (d) intense and diffuse imunostaining scored as I5. Smooth muscle cells with (e) moderate and
diffuse immunolabeling (score M5). The same score is detectable in the close glandular epithelium. (f) Intense and diffuse
immunohistochemical expression in smooth muscle cells (score I5)
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compared to the levels of expression found in the LPS
(10 ng/ml) treated cells (Fig. 6a-d). The mRNA expres-
sion of the pro-inflammatory cytokine IL-1β was found
significantly lower compared to untreated cells, passing
from 18.65 ± 0.32 to 0.59 ± 0.16 (P < 0.01), immediately
1 h after PRP treatment. The mRNA expression of the
pro-inflammatory chemokine IL-8 was significantly lower
(P < 0.01) with values decreasing at 1 h, 6 h and 12 h after
PRP treatment to 0.33 ± 0.14, 1.37 ± 0.31 and 2.23 ± 0.16,
respectively, compared to untreated cells. A significant re-
duction (P < 0.01) in the expression levels of iNOS (from
208.17 ± 0.18 it fell to 1.66 ± 0.04) and COX2 (from 99.84
± 0.31 it fell to 7 ± 0.07) was found compared to untreated
cells 1 h after treatment with PRP.
Protein release
The results of the release of PGE-2 for endometrial cells
treated by PRP at P5 are shown graphically in Fig. 7a.
The release of PGE-2, IL-1β and IL-8 by endometrial
cells stimulated with 10 ng/ml of LPS and treated with
5 % PRP at different time (1, 6, 12, 24 and 48 h) are
shown graphically in Fig. 7 b,c,d). In endometrial cells
(CTR), the concentrations of IL-1β and IL-8 were below
the limits of detection of the assay. The endometrial cells
responded to 5 % of PRP with release of 5000 ± 480 pg/ml
of PGE-2 that is statistically different (P < 0.05) compared
to CTR (330 ± 30 pg/ml). The treatment with 10 ng/ml of
LPS induced release of PGE-2 and IL-1β at 1 h (30000 ±
2490 and 2500 ± 220 pg/ml, respectively). The greater
release of IL-8 was at 6 h (150 ± 13 ng/ml).
The PRP was able to counteract the action of LPS and
significantly (P < 0.05) decreased the production of PGE-
2, IL-1β and IL-8 mainly between the first and the 24a h.
Discussion
In the present study, the effect of PRP has been investi-
gated in vivo on healthy animals (without endometrial
infection) and in an in vitro model where bovine endo-
metrial cells were stressed with LPS. After in vivo appli-
cation, our results delineate a trend showing that, in
vivo, PR expression was detected with a similar average
score in all the animals at T0. At T1 in epithelial cells,
PR average scores in control and PRP animals remain
unchanged. In glandular epithelium and smooth muscle
cells, at T1, PR expression increases in PRP animals.
These results have to be further explored but may indi-
cate that PRP might be helpful in maintaining and/or in-
creasing the number of progesterone receptors in
uterine tissues. In our in vitro experiment, bovine endo-
metrial cells were cultured with two different concentra-
tions of PRP (5 % and 10 %) and mRNA levels of
different genes were quantified and compared to control
cells, cultured with 10 % FBS only. Various research
groups have studied the use of PRP as a supplement of
cell culture [43–45] demonstrating that PRP increases
cell proliferation. PRP confirmed this effect also on endo-
metrial cells, mainly at the concentration of 5 %. This con-
centration of PRP sustained the shortest population
doubling time at P5 while the highest concentration
(10 %) inhibited proliferation rate, leading to speculate
that this effect may be due to an excess of growth factors.
This data was confirmed by growth curve study with 5 %
of PRP at different passages. According to this, at P5, 5 %
of PRP induced an intensive endometrial cells prolifera-
tion. Regarding gene expression, the presence of 5 % of
PRP at P5 induced also an up-regulation of the expression
of COX2, TP53, ER-α, ER-β and PR. To test the release of
Fig. 2 (a) Cell morphology. Monolayer of endometrial cells. Scale bar: 20 μM. Magnification 20X. (b) Molecular characterization of endometrial cells at
diestrus stage. Qualitative PCR analysis for the expression of genes that influencing pre-implantation conceptus development (ERα, ERβ and PR)
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some proteins, we evaluated the secretion of prostaglandin
E2 (PGE2). Indeed, it is known that in the bovine uterus,
COX2 converts arachidonic acid to prostaglandin H2,
which is then converted, by PGE synthase and PGF syn-
thase, to PGE-2 [46]. In these cells, PGE-2 production was
modulated in parallel with COX2 expression in all condi-
tions. This is the first study reporting the effects of PRP
on the proliferation and gene expression of bovine endo-
metrial cells in vitro and further studies are required to
elucidate the mechanisms through which the PRP up-
regulates these genes. Although, the molecular mecha-
nisms involved in this up-regulation are not clear, is con-
ceivable that PRP-derived growth factors play an
important role. Indeed, the expression of c-Myc, that was
up-regulated in this study and which is involved in cell
proliferation and growth, is activated by EGF that is a
component of PRP [29].
In our study, we even further tested the hypothesis
that PRP has anti-inflammatory properties and is able to
influence gene expression of pro-inflammatory factors in
an in vitro model of inflammation. To develop an in
vitro cell culture system with stressed cells and to study
gene response, endometrial cells were exposed to the
bacterial endotoxin LPS before and after the treatment
with PRP. Exposure of endometrial cells to 10 ng/ml LPS
resulted in marked changes in the expression of pro-
inflammatory genes that was reduced by the addition of
5 % of PRP. The presence of PRP ameliorated the LPS-
induced molecular changes in endometrial cells as
they increased the levels of gene expression of IL-1β,
IL-8, iNOS and COX2 expression. In parallel with
gene expression, the release of some proteins was
studied confirming the observations regarding gene
regulations. LPS demonstrates to be capable of
Fig. 3 Proliferation studies. (a) Doubling time at different passages during cell culture in different culture conditions (5 % PRP and 10 % FBS). (b)
Growth curve at P1, P5 and P10 for endometrial cells cultured with 5 % PRP
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inducing the release of PGE-2, IL-1β and IL-8 whose
pick were obtained 1 h and 12-24 h, after stimulation
with LPS. PRP reduce the release of these proteins-
and the maximum modulatory activity was observed
immediately after 1 h for PGE-2 and IL-1β, and be-
tween 12 h and 24 h for IL-8. Therefore, our results
indicated consistent anti-inflammatory effect of PRP.
How can we explain these results? Recent literature
demonstrates the healing potential of autologous
platelet-rich plasma in human medicine, including max-
illofacial surgery, dental implant surgery, orthopedic sur-
gery, bone reconstruction, muscle and tendon repair,
reversal of skin ulcers, retinal hole repair in eye surgery,
and cosmetic surgery [29]. In veterinary medicine, little
Fig. 4 Quantitative PCR analysis for the expression of genes involved in the regulation of oestrus cycle and fetal-maternal interaction like: (a, b)
oestrogen receptors (ERα and ERβ), (c) c-Myc, (d) progesterone receptor (PR), (e) tumor protein p53 (TP53), and (f) prostaglandin-endoperoxide
synthase 2 (COX2) in cells cultured in presence of 5 % PRP. Also the expression of is reported. Expression levels normalized to the reference gene.
Data are represented as fold-change compared with expression observed in cells cultured in presence of 10 % FBS. Values are mean ± SD (n = 3).
Asterisk depict highly significant (*, P < 0.01) differences compared to cells cultured in presence of 10 % FBS
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Fig. 5 Quantitative PCR analysis for the expression of pro-inflammatory markers such as IL-1β, IL-8, iNOS and COX2 in cells cultured in presence of 10
(a, c, e, g) or 100 ng/ml LPS (b, d, f, h). Expression levels normalized to the reference gene GAPDH. Data are represented as fold-change compared with
expression observed in untreated cells. Values are mean ± SD (n = 3). Asterisk depict highly significant (*, P< 0.01) differences compared to untreated cells
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clinical information exists about its application. PRP is
mainly used for equine tendon repair [47] although its
application has also been reported for intestinal wound
healing in pigs [48] and for the treatment of a large cuta-
neous lesion in a dog [49]. Recently, our group has
proposed its use as an alternative therapy for bovine
mastitis and for repeat breeder cows syndrome, showing
promising results [32, 50]. Indeed, in acute mastitis, the
treatment with only PRP did not show statistically
significant differences compared to antibiotic alone or
treatment with PRP combined to antibiotic, but it was
better than the use of only antibiotic for chronic mastitis
[32]. In repeat breeder treatment, after intrauterine ad-
ministration of PRP the percentage of pregnant cows
was 70 % compared to control group, treated with
physiological solution, where the rate was 33.33 %.
Moreover, immunohistochemical study, by the nuclear
antigen Ki-67, a marker of cell proliferation, showed
more proliferating nuclei in the treated uterine horn,
after three days of administration, compared to the
control one [50]. In tissues with a high proliferative rate,
Ki-67 is expressed in all cell cycle phases except for the
resting or G0 phases [51, 52] and reaches a maximum
level during G2 and M [53]. Since Ki-67 was significantly
more expressed in uterine horns treated with PRP,
Lange-Consiglio et al. [50] supposed that the growth
factors released by platelets in the PRP might have
had an effect on endometrial cell proliferation. In-
deed, in all treated horns there were statistically more
proliferating nuclei compared to the controls. Also in
our in vitro study, PRP induce cell proliferation con-
firming these previous results [50], but a longer in
vitro culture time (P5) is necessary to stimulate a
good proliferation rate. It is difficult to explain the
different times of PRP efficacy between in vivo and in
vitro study, probably they are mainly due to the dif-
ferent doses used.
After the study with PRP on repeat breeder cows, our
group tried to test the effect of PRP on in vitro endomet-
rial stressed cells by LPS. Results showed that LPS
Fig. 6 Quantitative PCR analysis for the expression of pro-inflammatory markers such as IL-1β, IL-8, iNOS and COX2 in cells cultured in presence of 10
ng/ml of LPS and 5 % PRP. Expression levels normalized to the reference gene GAPDH. Data are represented as fold-change compared with expression
observed in untreated cells (CTR). Values are mean ± SD (n= 3). Asterisk depict highly significant (*, P < 0.01) differences compared to untreated cells
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provoked a rapid increase in endometrial mRNA expres-
sion and release of IL-1β and IL-8. Previous studies have
shown that bovine endometrium expresses the TLR-4/
CD14/MD-2 receptor complex in both epithelial and
stromal cells [17, 18, 54]. This is a key component of the
innate immune system, which is necessary to detect LPS.
Subsequent activation of TLR4 triggers the production
of cytokines, particularly IL-1β and chemokine IL-8 in
bovine endometrium. Accordingly, after LPS treatment,
we found an immediate rapid rise in IL-1β expression,
which had already peaked by 1 h, and had been followed
by a rise in IL-8 expression, with a significant up-
regulation at 6 h and 12 h. These waves of cytokine gene
activation, short for IL-1β and prolonged for IL-8 until
12 h, are supported by data of DeForge and Remick [55]
that studied the kinetics of these cytokines in LPS-
stimulated human whole blood as an ex vivo model of
sepsis. LPS also induces an inflammatory response char-
acterized by the increased expression of iNOS and
COX2 and stimulates the secretion of PGE, as demon-
strated also by Herath et al. [56]. Prostaglandins, pro-
duced by the uterine endometrium, have multiple roles
in endometrial function [46]. Indeed, they are key regu-
lators of several reproductive events, including estrous
cycle, implantation, pregnancy maintenance and
parturition. The release of PGE-2 induced by 5 % of PRP
could support these events. In addition, PGE has an im-
portant role in the mammalian immune response, acting
through prostaglandin E receptors 2 and 4 (PTGER2
and PTGER4) to control inflammation [3]. Instead, the
intensive LPS-induced PGE secretion by endometrial
cells may impair fertility. In fact, this has been suggested
as a pathogenic mechanism after uterine bacterial infec-
tion, which could result in an extended luteal phase and
thus contribute to an impaired reproductive perform-
ance. According to this, COX2 was greatly up-regulated
in the present study by LPS. Regarding the inducible
iNOS, it is the main isoenzyme governing the produc-
tion of NO, and it is considered an important mediator
of cellular interactions and a potent regulator of many
local processes [57]. iNOS is typically expressed at the
sites of inflammation, produces large amounts of NO for
a prolonged time and is usually related to the activation
of pro-inflammatory macrophages [58]. In this context,
our findings showed a significantly higher expression of
iNOS in cells cultured in presence of LPS. This gene
returned nearly to baseline within 48 h, supporting the
idea that the inflammatory process is controlled by nega-
tive feedback regulation in order to eliminate excessive
tissue inflammation and damage [59].
Fig. 7 Effect of 5 % PRP at P5 on release of PGE-2 (a) and effect of LPS and PRP on release of PGE-2 (b), IL-1β (c) and IL-8 (d) in endometrial cells. Each
value represents the mean ± SD of three samples. Values labeled with asterisk are statistically different (P < 0.05) compared to untreated cells (CTR)
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The treatment with 5 % of PRP, after LPS action, down-
regulated the expression of all pro-inflammatory genes.
The inhibition of NF-kB (nuclear factor kappa-light-
chain-enhancer of activated B cells) activation could be a
possible mechanism through which PRP exerted these
anti-inflammatory effects. Within mammalian cells, in-
cluding endometrial cells, NF-kB is present in an inactive
status [60]. It regulates more than 150 genes, including
those involved in inflammation and other immune re-
sponses [61]. Upon phosphorylation, it translocates into
the nucleus [62] by the interaction of specific receptors on
the surface of a cell, and it triggers the inflammatory cas-
cade. In particular, LPS is reported to bind the surface
antigen CD44 and induce the translocation of the phos-
phorylated Nf-kB to the nuclei leading to the increase
of pro-inflammatory gene levels [63]. Numerous stud-
ies demonstrated that PRP inhibited the translocation
of NF-kB to the nucleus [31, 64]. Between different
growth factors, indeed, the HGF is described to dis-
rupt the transactivacting activity of NF-kB, with its
retention in the cytosol [31].
Based on these results, it would be interesting to ex-
plore the mechanisms through which the PRP induces
up-regulation of COX2, TP53, ER-α, ER-β and PR genes
and to perform in vivo investigation on the potential ap-
plication of PRP in the treatment of bovine endometritis.
Indeed, considering the results obtained in our in vivo
and in vitro studies, it might be possible to envisage
treatment of endometritis with PRP combined with ad-
ministration of exogenous P4. This combination, using
intravaginal P4 devices, may improve the fertility in
bovine with inadequate circulating P4 concentrations. In
this way, at the same time, it would be possible to in-
crease circulating P4 concentration and endometrial PR.
Conclusions
Although this study is performed on an in vitro model, our
data indicates that PRP have strong effects on endometrial
cells determining high proliferation rate and up-regulation
of genes that play an important role in reproduction. The
mechanisms through which the PRP up-regulates these
genes is not yet clear, but it is conceivable that its growth
factors are involved in these mechanisms. The results of
the current investigation demonstrated that PRP is capable
of effectively decrease gene expression of pro-inflammatory
factors IL-1β, I-L8, COX2 and iNOS after stimulation by
LPS, prospecting its possible use in regenerative therapy in
in vivo endometritis.
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a b s t r a c t
Extrafetal tissues are a noncontroversial and inexhaustible source of mesenchymal stem
cells that can be harvested noninvasively at low cost. In the veterinary ﬁeld, as in man,
stem cells derived from extrafetal tissues express plasticity, reduced immunogenicity, and
have high anti-inﬂammatory potential making them promising candidates for treatment of
many diseases. Umbilical cord mesenchymal cells have been isolated and characterized in
different species and have recently been investigated as potential candidates in regener-
ative medicine. In this study, cells derived from bovine Wharton jelly (WJ) were isolated
for the ﬁrst time by enzymatic methods, frozen/thawed, cultivated for at least 10 passages,
and characterized. Wharton jelly–derived cells readily attached to plastic culture dishes
displaying typical ﬁbroblast-like morphology and, although their proliferative capacity
decreased to the seventh passage, these cells showed a mean doubling time of
34.55  6.33 hours and a mean frequency of one colony-forming unit ﬁbroblast like for
every 221.68 plated cells. The results of molecular biology studies and ﬂow cytometry
analyses revealed that WJ-derived cells showed the typical antigen proﬁle of mesenchymal
stem cells and were positive for CD29, CD44, CD105, CD166, Oct-4, and c-Myc. They were
negative for CD34 and CD14. Remarkably, WJ-derived cells showed differentiation ability.
After culture in induced media, WJ-derived cells were able to differentiate into osteogenic,
adipogenic, chondrogenic, and neurogenic lines as shown by positive staining and
expression of speciﬁc markers. On polymerase chain reaction analysis, these cells were
negative for MHC-II and positive for MHC-I, thus reinforcing the role of extrafetal tissue as
an allogenic source for bovine cell–based therapies. These results provide evidence that
bovine WJ-derived cells may have the potential to differentiate to repair damaged tissues
and reinforce the importance of extrafetal tissues as stem cell sources in veterinary
regenerative medicine. A more detailed evaluation of their immunologic properties is
necessary to better understand their potential role in cellular therapy.
 2016 Elsevier Inc. All rights reserved.
1. Introduction
Increasing interest in veterinary stem cell therapy has
led to research into new stem cell sources that can supply
sufﬁcient numbers of cells while minimizing risks to
donors and recipients [1]. Extrafetal stem cells are being
investigated for this purpose in large animals [2]. Extrafetal
stem cells have been isolated from umbilical cord blood,
amniotic ﬂuid, amniotic membrane, umbilical cord matrix,
yolk sac, and placenta [3–9]. It has been shown that they
possess properties of mesenchymal stem cells (MSCs), and
their application in regenerative medicine has increased
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over the past few years [10]. These studies show that um-
bilical cord, previously considered as a biomedical waste, is
a source of stem cells with promising therapeutic applica-
tions in man and in livestock species.
The umbilical cord provides an inexhaustible source of
stem cells and presents few, if any, ethical concerns. Indeed,
umbilical cord can be collected after parturition because it
is considered a waste tissue. In addition, the process of
obtaining the cord tissue is relatively simple and noninva-
sive. Mesenchymal stem cells have been isolated from
different compartments of the umbilical cord in different
species. In particular, they were obtained invasively, by a
surgical intrauterine approach, from umbilical cord blood
of sheep [11,12]; noninvasively at the time of birth in the
horse [13]; in cattle, after caesarean section delivery [14];
and from canine and feline fetuses at birth [15,16]. In 2006,
for the ﬁrst time in veterinary medicine, MSCs from cordon
matrix, called Wharton jelly (WJ), were obtained from
porcine umbilical cord [17]. Wharton jelly is the embryonic
mucous connective tissue lying between the amniotic
epithelium and the umbilical vessels [18]. It encloses the
yolk sac, which is the source of primordial germ cells and
the ﬁrst hematopoietic stem cells [18]. Extraembryonic
tissues, which originate from the hypoblast and the tro-
phectoderm, do not participate in gastrulation; therefore,
they are less differentiated than adult somatic tissues such
as bonemarrowor adipose tissue [2].Wharton jelly is a rich
source of MSCs [19–21]. Recently, primitive MSCs were
isolated from the umbilical cord matrix in caprine [22,23],
canine [24], and equine species [4,13,25]. These cells show
speciﬁc markers of pluripotency and MSCs markers and are
able to differentiate into adipogenic, chondrogenic, osteo-
genic, and neurogenic tissues [2]. The similarities in growth
kinetics and expression of markers of pluripotency indicate
their close resemblance to embryonic stem cells [26]. These
markers, found in mouse and human embryonic stem cells,
include the POU (Pit/Oct/Unc) domain-containing protein
Oct-4, Sox-2, and Nanog. Some authors have shown that
human umbilical cord matrix expresses low levels of
transcription factors that play a central role in the regula-
tion of pluripotency and self-renewal [18]. In contrast,
however, Carlin et al. [17] showed that cells derived from
porcine umbilical cord matrix express markers of embry-
onic lineage Oct-3/4, Sox-2, and Nanog. Contrary to obser-
vations in adult MSCs, WJ MSCs share properties unique to
fetal-derived MSCs, such as more rapid proliferation and
greater ex vivo expansion capabilities [18,27]. Moreover,
they have high potential to be differentiated in vitro [28],
they express human leukocyte antigen-class I surface
markers but do not express human leukocyte antigen-class
II markers [29], and they are immunosuppressive in mixed
lymphocyte assays by inhibition of T-cell proliferation
[30,31]. For these reasons, these cells have raised interest
for their potential uses in cell and gene therapy, cloning,
virological, and biotechnological studies [32].
Despite the importance of bovine species as models for
in vivo studies, little is known about bovine MSCs. So far,
they have been derived from umbilical cord blood [14],
bone marrow [33,34], and amniotic membrane or amniotic
ﬂuid [8]. To date, only one article on isolation and charac-
terization of MSCs from bovine umbilical cord matrix [32]
has been published, but these cells were isolated by
migration techniques and not by classical enzymatic
digestion. The mechanical and enzymatic disaggregation of
the tissue avoids problems of selection by migration, but
perhaps more importantly, yields a higher number of cells
more representative of the whole tissue in a shorter time.
However, as well as the primary explant technique select-
ing on the basis of cell migration, the dissociation tech-
nique selects cells resistant to disaggregation but still
capable of attachment [35].
The isolation of bovine MSCs from fetal adnexa is an
interesting prospect because of the potential for these cells
to be used for biotechnological applications. For the ﬁrst
time, we isolated, by enzymatic methods, presumptive
MSCs from bovine WJ and were able to characterize them
in terms of morphology, speciﬁc mesenchymal or pluripo-
tent markers, proliferative and differentiation potential.
2. Materials and methods
2.1. Materials
Chemicals were obtained from Sigma Chemical (Milan,
Italy) and tissue culture plastic dishes from Euroclone
(Milan, Italy) unless otherwise speciﬁed.
2.2. Tissue collection
This studywas approved by the Ethical Committee of the
University of Milan, and written owner consent was given.
All procedures were conducted following standard veteri-
nary practice and in accordance with 2010/63 EU directive
on animal protection and Italian Law (D.L. No. 116/1992).
Fresh bovine umbilical cords were obtained after full-
term births.
Bovine umbilical cords (n¼ 3) were obtained from three
cows after normal-term pregnancies with spontaneous
parturition in accordance with veterinary practice stan-
dard. Before the cows stood up breaking the cord, a surgical
tape was placed at the calf junction, and a second tie was
tightened at approximately 30 or 40 cm from the ﬁrst. The
tie-limited cord portion was cut away with scissors. The
harvested segment of the cord was washed twice in sterile
saline solution and kept at 4 C in saline solution supple-
mented with 4 mg/mL amphotericin, 100 UI/mL penicillin,
and 100 mg/mL streptomycin and processed within
12 hours of collection.
2.3. Isolation and culture of WJ-derived cells
At the laboratory, the loose amnion was removed from
the exterior of the cords, and the cords were incised
longitudinally to expose and remove umbilical vessels
(arteries and veins). The remaining WJ-containing tissue
was minced into small pieces using scissors. The tissue was
digested in high glucose-Dulbecco’s Modiﬁed Eagle me-
dium (HG-DMEM) supplemented with 1 mg/mL collage-
nase type I at 38.5 C for 8 hours. After incubation,
collagenasewas inactivated by diluting 1:1with HG-DMEM
supplemented with 10% fetal calf serum (FCS). The digested
suspension was ﬁltered on an 80-mm strainer, centrifuged
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at 300g for 10 minutes, and washed twice in PBS. Before
seeding, cells were counted using a Burker chamber with
the trypan blue dye exclusion assay. WJ cell cultures were
established in HG-DMEM standard medium composed of
10% FCS, penicillin (100 UI/mL)–streptomycin (100 mg/mL),
0.25 mg/mL amphotericin B, 2 mM L-glutamine, and 10 ng/
mL EGF. Cultures were established at a density of 1 
105 cells/cm2 in T75 culture ﬂasks. The ﬂasks were incu-
bated at 38.5 C with 5% CO2 and 90% humidity. The
medium was replaced after 72 hours to remove non-
adherent cells and then replaced twice weekly until cells
reached approximately 80% conﬂuence. Cells were then
detached with 0.05% trypsin-EDTA, counted, and redis-
tributed into new culture ﬂasks at a density of 1104 cells/
cm2 to maintain and expand the culture for 10 passages (P).
2.4. Cryopreservation and thawing
Cells at P3 were cryopreserved. Brieﬂy, the conﬂuent
cultures were treated with 0.05% trypsin-EDTA and washed
by centrifugation (200g at 4 C, for 5 minutes) with cell
culture medium supplemented with 10% FCS to neutralize
trypsin-EDTA. The cell pellet obtained was resuspended in
precooled (4 C) cryopreservation media in 1-mL cryovials.
The cryopreservation medium was 90% (v:v) FCS and 10%
DMSO. The cryovials were maintained at 80 C overnight
and then plunged into liquid nitrogen (196 C). After a
minimum of 1 month of cryopreservation, the cells were
thawed in a water bath at 37 C. The cells were diluted in
culture medium and centrifuged twice at 200g for
10 minutes. The cell pellet was resuspended in culture
medium and plated in T25 culture ﬂasks. Aliquots of these
cells were kept to evaluate the cell viability using Burker
hemocytometer chamber and the trypan blue dye exclu-
sion method, under phase-contrast microscopy (Nikon
Eclipse Ti, Tokyo, Japan). After thawing, other aliquots were
used for population doubling studies or expanded until P3
to evaluate speciﬁc MSC marker expression and multi-
potent differentiation capacity in comparison to freshly
isolated cells.
2.5. Proliferation rate and colony-forming unit assay
Proliferation of MSCs was determined as previously re-
ported [6].Doubling time (DT) fromP1 to10wasassessedby
plating 9103 cells into six-well tissue culture plates. Every
4 days, cells were trypsinized, counted, and reseeded at the
same density. Mean DTwas calculated fromDays 0 to 4. The
DT value was obtained for each P according to the formula
DT¼ CT/CD, where CT represents the culture time and CD¼
log(Nc/No)/log2 represents the number of cell generations
(Nc represents the number of cells at conﬂuence, No repre-
sents the number of seeded cells). Data representative of
three independent experiments are reported.
To obtain the cell proliferation growth curve, cells at P0,
P3, and P5 were seeded into six-well tissue culture dishes
at a density of 1 103 cells/cm2. Every 2 days, until 14 days
of culture, one of the six wells was trypsinized, and cells
were counted using the trypan blue dye exclusion method
with a Burker chamber.
Colony-forming unit (CFU) assays were performed at P0
on freshly isolated cells at different densities (100, 250,
500, and 1000 cells/cm2). Cells were plated in six-well
plates for 2 weeks in HG-DMEM standard medium. Then,
colonies were ﬁxed for 1 hour with 4% formalin and stained
with 1% methylene blue for 15 minutes in 10 mM borate
buffer at room temperature. Colonies formed by 16 to 20
nucleated cells were counted under a BX71 microscope
(Olympus Italia, Srl, Milano, Italy).
2.6. Osteogenic, adipogenic, chondrogenic, and neurogenic
cell differentiation
All the differentiation tests were performed when cells
reached P3.
For osteogenic differentiation, cells were placed in
plastic six-well plates at a density of 28  103 cells/well.
After the cells had adhered to the plastic, the inducer me-
dium was added to the plate for 21 days and refreshed
every 3 days. The medium was composed of HG-DMEM,
10% FCS, penicillin (100 UI/mL)–streptomycin (100 mg/
mL), 0.25 mg/mL amphotericin B, 200 mM L-glutamine,
0.25 mM ascorbic acid, 10 mM b-glycerophosphate, and 0.1
mM dexamethasone [36]. Osteogenic differentiation was
conﬁrmed by positive staining of the extracellular calcium
matrix using Von Kossa staining.
For adipogenic differentiation, cells were placed in
plastic six-well plates at a density of 28  103 cells/well.
After the cells had adhered to the plastic, the inducer
medium and the maintaining medium were added alter-
nately, every 3 days for a total of 21 days. The inducer
medium was composed of HG-DMEM, 10% FCS, penicillin
(100 UI/mL)–streptomycin (100 mg/mL), 0.25 mg/mL
amphotericin B, 200 mM L-glutamine, 0.1% insulin, 0.1 mM
dexamethasone, and 1% indomethacin. The maintaining
medium was composed of HG-DMEM, 10% FCS, penicillin
(100 UI/mL)–streptomycin (100 mg/mL), 0.25 mg/mL
amphotericin B, and 0.1% insulin [36]. Adipogenic differ-
entiation was conﬁrmed by positive staining of the lipid
structures using Oil Red O staining.
For chondrogenic differentiation, cells were cultured in
DMEM low glucose, containing 100 U/mL penicillin, 100 mg/
mL streptomycin, 0.25 mg/mL amphotericin B, 2 mM/L
L-glutamine, 100 nM dexamethasone, 50 mg/mL L-ascorbic
acid 2-phosphate, 1 mM sodium pyruvate (BDH, Atlanta,
USA), 40 mg/mL proline, ITS (insulin 5 mg/mL, transferrin
5 mg/mL, selenous acid 5 ng/mL), and 5 ng/mL transforming
growth factor-b3 (Peprovet, DBA Italia, 100-36E). Chon-
drogenic differentiation was assessed after incubating cells
for up to 3 weeks [37]. Differentiation was evaluated by
Alcian blue staining.
For neurogenic differentiation, cells were placed in
plastic six-well plates at a density of 28  103 cells/well.
After the cells had adhered to the plastic, the preinducer
mediumwas administrated to the plates for 1 day, followed
by administration of inducer medium for 7 days. The pre-
inducer medium was composed of HG-DMEM, 20% FCS,
penicillin (100 UI/mL)–streptomycin (100 mg/mL), 0.25 mg/
mL amphotericin B, and 0.0007% b-mercaptoethanol
[15,38]. The inducer mediumwas composed of HG-DMEM,
2% FCS, penicillin (100 UI/mL)–streptomycin (100 mg/mL),
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0.25 mg/mL amphotericin B, 1% DMSO, and 0.36 mg/mL
butylated hydroxyanisole [39]. Neurogenic differentiation
was conﬁrmed by positive staining of the Nissl substance
and granules, using Nissl staining.
For each differentiation experiment, a control groupwas
performed by seeding cells at lower density (9.5103 cells/
well) and feeding with HG-DMEM standardmedium. These
cells were stained using the same protocol as the treated
cells. At the end of the differentiations, aliquots of non-
stained cells were harvested and stored at 80 C for
further molecular analysis.
2.7. RNA extraction and reverse transcription polymerase
chain reaction analysis
Expression of speciﬁc MSC (CD29, CD44, CD105, CD166),
pluripotent (Oct-4 and c-Myc), and hematopoietic (CD34,
CD14, CD45) markers was investigated by reverse
transcription polymerase chain reaction (RT-PCR) analysis
on fresh and thawed undifferentiated cells at P3. To eval-
uate whether cells could be well tolerated by the host once
transplanted, expression of the major histocompatibility
complex class I (MHC-I) and II (MHC-II) was assessed. Total
RNA was extracted from bovine WJ-derived cells
using Trizol reagent (Invitrogen, Monza, Italy), followed by
DNase treatment according to the manufacturer’s speciﬁ-
cations. RNA concentration and purity were measured
using a NanoDrop ND1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA). cDNA was synthe-
sized from 500 ng total RNA, using the iScript retro-
transcription kit (Bio-Rad Laboratories, Hercules, CA, USA).
Conventional PCR was performed in a 25-mL ﬁnal volume
with DreamTaq DNA Polymerase (Fermentas, St. Leon Rot,
Germany) under the following conditions: initial denatur-
ation at 95 C for 2 minutes, 32 cycles at 95 C for 30 sec-
onds (denaturation), 55 C to 63 C for 30 seconds
(annealing), 72 C for 30 seconds (elongation), and ﬁnal
elongation at 72 C for 10 minutes.
For differentiation experiments, total RNAwas extracted
from undifferentiated (control cells) and from induced WJ-
derived cells, and RT-PCR analysis was performed as
described previously. Bovine adult tissues (bone, adipose
tissue, cartilage, and spinal cord) were used as positive
controls for assessing the expression of BGLAP, SPP1, and
SPARC for osteogenic differentiation; peroxisome
proliferator-activated receptor-gamma (PPAR-g) and leptin
(LEP) for adipogenesis; collagen type 2a1 (COL2A1) and
aggrecan (ACAN) for chondrogenesis; and glial ﬁbrillary
acidic protein (GFAP) and nestin (NES) for neurogenesis.
Bovine-speciﬁc oligonucleotide primers were designed
using open-source PerlPrimer software version 1.1.17, based
on available NCBI Bos taurus sequences or on mammal
multialigned sequences. Primers were designed across an
exon–exon junction to avoid DNA ampliﬁcation. Primers
were used at 300 nM ﬁnal concentrations. Their sequences
and the conditions used to amplify each gene are presented
in Table 1. GAPDH was used as a reference gene.
2.8. Flow cytometry
WJ-derived cells were analyzed by ﬂow cytometry to
determine the percentage of mesenchymal (CD105,
CD166), hematopoietic (CD34), and immunogenic (MHC-
II) markers after isolation (P0). For CD105, CD166, and
CD34, primary mouse monoclonal antibodies and sec-
ondary antibodies rabbit antimouse ﬂuorescein isothio-
cyanate were used. For MHC-II, primary rat monoclonal
antibody and secondary rabbit antirat ﬂuorescein iso-
thiocyanate were used. Staining was performed as
previously reported [40]. Cells (1  106 cells/mL) were
labeled with primary antibodies in PBS with 3% of BSA
(BDH; VWR International Ltd, Poole, UK) for 45 minutes
Table 1
Oligonucleotide sequences used for reverse transcription polymerase chain reaction analysis.
Markers Forward (50/30) Reverse (50/30) Annealing T Product
length
Integrin b-1 (CD29) GTTGGTTCTGCAGTTACGATCAG AACCAAACCCAATTCGGAAGTC 52 C 203
CD44 antigen (CD44) AACAGTAGGAGAAGGTGTGG TCATGAACTGGTCTTGGGTC 61 C 166
Endoglin (CD105) ACAAGTCTTGCAGAAACAGTC GATGTCTGGAGAGTCAGCTC 61 C 182
ALCAM (CD166) GTATTTATTGCCTTCAGGTCCT TCTACCAGGGAGCATTTATAGTC 59 C 755
Octamer-binding transcription factor 4 (Oct-4) CACACTAGGATATACCCAGGC GGAGATATGCAAGGCAGAGA 60 C 177
v-myc avian myelocytomatosis viral
oncogene homolog (c-Myc)
GCGCCGCATTCGCGAAACTT TGAGGGGCATCGCTGCAAGC 58 C 214
CD34 molecule (CD34) CCTGAAGCTAAATGAGACCT AACTTTCTGTCCTGTTGGTC 58 C 173
CD14 molecule (CD14) TCCGAAGCCTGACTGGTCTA TGTCGGCTCCCTTGAGAAAC 56 C 104
Major histocompatibility complex I (MHC-I) GATCTCACTGACCTGGCA CTGAGGAGGTTCCCATCTC 60 C 199
Major histocompatibility complex II (MHC-II) CCTCGCTTGCCTGAATTTGC ACAGGTGCCGACTGATGC 53 C 299
Bone gamma-carboxyglutamate (Gla) protein (BGLAP) TCGGGCAAAGGCGCAGCCTTC GCAGGGCTGCAAGCTCTAGACG 55 C 231
Secreted phosphoprotein 1 (SPP1) CGCCGATCTAACGTTCAGAGTC GACTCTCAATCAGATTGGAATGC 55 C 199
Secreted protein acidic and rich in cysteine (SPARC) CTGGTCACGCTGTACGAGAG CGGTGTGAGACAGGTACCCGT 55 C 232
Leptin (LEP) CAATGACATCTCACACACGCAG CGGCCAGCAGGTGGAGAAG 55 C 212
Peroxisome proliferator-activated receptor (PPAR-g) CGCACTGGAATTAGATGACAGC CACAATCTGTCTGAGGTCTGTC 55 C 199
Collagen type 1, alpha I (COL1A1) CGCGGATTTGTTGCTGCTTGC AGGTCCCATCAGCCCCATTGGT 55 C 269
Aggrecan (ACAN) CGCTGTCTCGCCAAGTGTATGG CGGTTCAGGGATGCTGACACTC 60 C 175
Glial ﬁbrillary acidic protein (GFAP) GGCACCTTGAGGCAGAAGCTC CTCCTGGAGCTCCCGCACCT 60 C 195
Nestin (NES) ACCACTGAGCAGTTCCAGCTGG TTGCAGGTGTCTGCAGCCGT 55 C 187
Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH)
ATGAGATCAAGAAGGTGGTG CCAAATTCATTGTCGTACCAG 60 C 190
Abbreviation: T, temperature.
A. Lange-Consiglio et al. / Theriogenology xxx (2016) 1–104
at room temperature in the dark, followed by washing
in cold PBS and a ﬁnal incubation with secondary an-
tibodies (1:50) for 30 minutes at room temperature in
the dark. After incubation, cells were washed twice in
ice-cold PBS and analyzed using a Millipore Guava
easyCyte Single Sample Flow Cytometer. A minimum of
10,000 cells was acquired for each sample and analyzed
in the FL1 channel.
The negative pattern was examined by applying the
same cell suspension with the ﬁrst incubation, and the
result was included on the global compensation, to exclude
autoﬂuorescence. A 488-nm ﬁlter was used in each
analysis.
Ofﬂine analyses of the ﬂow cytometry standard ﬁles
were performed using Weasel software version 2.5 (http://
en.bio-soft.net/other/WEASEL.htmL).
2.9. Statistical analysis
Statistical analysis was performed using GraphPad
Instat 3.00 for Windows (GraphPad Software, La Jolla, CA,
USA). Three replicates were performed for each experi-
ment (DT and CFU) and the results reported as
mean  standard deviation (SD). One-way ANOVA for
multiple comparisons by Student-Newman-Keuls multi-
ple comparison tests was used. P < 0.05 was considered
as signiﬁcant.
3. Results
3.1. Cell morphology
The cellular yield was approximately 3  106 cells/g of
minced WJ. The initial viability was greater than 95%.
Cells were selected purely on their ability to adhere to
plastic. Isolated cells readily attached to plastic culture
dishes. Colonies started to appear within the ﬁrst 2 days,
reaching conﬂuence after 5 days. Wharton jelly–derived
cells were a morphologically homogeneous population of
ﬁbroblast-like cells in all passages of cell culture (Fig. 1A).
After thawing (at P3), viability was 80%. Wharton jelly–
derived cells conserved their ﬁbroblast-like shape.
3.2. Proliferation studies
Wharton jelly–derived cells were able to proliferate,
reaching conﬂuence up to 10 passages.
At P1, the growth curve showed an initial lag phase of
3 to 4 days longer than that seen in the other passages and a
subsequent log phase until 14 days. The WJ-derived cells
showed more extensive proliferation at P5, but the
intensity of proliferation was similar in all passages in the
ﬁnal culture days (Fig. 1B).
DT remained constant until the seventh passage, then
decreased signiﬁcantly (P < 0.05) until P10. The mean DT
was 1.44  0.24 days or 34.55  6.33 hours (Fig. 1C).
After thawing, the mean DT was 1.59  0.06 days or
38.21  1.68 hours (Fig. 1C) with no statistical difference
compared to fresh cells.
The number of cell colonies formed was counted at P0
on fresh cells. These cells were able to form an average of
1 CFU-F (Fig. 1D) for 221.68 3.86 seeded cells. The highest
number of colonies was found at the greatest density of
seeding (Table 2).
Fig. 1. Cell characteristics. (A) Monolayer of Wharton jelly (WJ)-derived cells; magniﬁcation  20; scale bar ¼ 20 mm. (B) Growth curve at P1, P5 and P10. (C)
Doubling times for both fresh and thawed cells. (D) Colony of WJ-derived cells for CFU study; magniﬁcation  20; scale bar ¼ 20 mm.
Table 2
Colony-forming unit (CFU) assay.
Density cells/cm2 Total cells CFU One CFU each
100 950 1.5  0.71a 633.33
250 2375 22.33  5.17b 106.36
500 4750 57.92  4.31c 82.01
1000 9500 146.15  2.78c 65.00
Different small letter superscripts (a, b, c) indicate statistically different
comparisons (P < 0.05) between cell densities in the WJ group.
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3.3. Molecular characterization
As shown by RT-PCR, WJ-derived cells expressed MSC
markers (CD29, CD44, CD105, CD166) and lacked hemato-
poietic ones (CD34 and CD14) from P0 to P10. MHC-I
expression was present, whereas MHC-II was not. More-
over, undifferentiated MSCs were found to express Oct-4
and c-Myc, essential transcription factors for maintaining
the primitive pluripotent state of embryonic stem cells.
After thawing, cells studied at P3 expressed the same MSC-
mRNA markers such as CD29, CD44, CD105, CD166, Oct-4,
c-Myc, and MHC-I, as freshly isolated cells, but not CD34,
CD14, and MHC-II (Fig. 2A).
3.4. Flow cytometry analysis
Flow cytometry was used to evaluate the homogeneity
of the cell population and to identify the subset of
mesenchymal, hematopoietic, and immunogenic cells. The
cell populations tested were all CD105þ and CD166þ, but
negative for CD34 and MHC-II, as shown in Figure 2B.
3.5. Differentiation assay
The results of all differentiation assays are shown in
Figure 3.
3.5.1. Osteogenic differentiation potential
After 21 days of induction, osteogenic differentiation
was conﬁrmed by von Kossa staining. The control (non-
induced cells) was negative for von Kossa staining. RT-PCR
analysis of SPP1 and SPARC mRNA expression conﬁrmed
osteogenic induction, but BGLAP was not expressed in
induced cells.
3.5.2. Adipogenic differentiation potential
Cells were able to undergo adipogenic differentiation, as
demonstrated by the development of positive staining for
Oil Red O after 3 weeks of culture in adipogenic induction
medium. Control cells, maintained in regular control me-
dium, showed no lipid deposits. RT-PCR analysis of PPAR-g
and LEPmRNA expression conﬁrmed adipogenic induction.
3.5.3. Chondrogenic differentiation potential
Differentiation was identiﬁed by marked deposition of
glycosaminoglycans in thematrix, stained with Alcian blue.
The presence of COL2A1 and ACAN mRNA conﬁrmed
chondrogenic induction for this cell population.
3.5.4. Neurogenic differentiation potential
After 3 days of induction, neurogenic differentiationwas
conﬁrmed by the morphology of the cells. The WJ-derived
cells adopted the typical morphology of neural cells with
dendrite-like processes. The presence of GFAP mRNA
Fig. 2. (A) Reverse transcription polymerase chain reaction analysis of mesenchymal (CD29, CD44, CD105, and CD166), pluripotent (Oct-4 and c-Myc), hemato-
poietic (CD34 and CD14) speciﬁc gene expression on WJ–derived fresh and thawed cells. Major histocompatibility complex (MHC) I and II gene expression is also
reported. GAPDH was used as the reference gene. (B) Flow cytometry analysis of the expression of mesenchymal (CD105 and CD166), hematopoietic (CD34) and
immunogenic (MHCII) markers. Histograms represent relative number of cells versus ﬂuorescence intensity (FL1). Black histograms indicate background ﬂuo-
rescence intensity of cells labeled with isotype control antibodies only gray histograms show positivity to the studied antibodies.
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suggested that under these culture conditions, WJ-derived
cells were induced to differentiate into glial cells. RT-PCR
analysis of bovine adult tissues (bone, adipose tissue, carti-
lage, and spinal cord) showed expression of the speciﬁc
studied genes.
The frozen-thawed cells were able to differentiate
toward the same lineages as freshly isolated cells (data not
shown).
4. Discussion
This work allowed the isolation, characterization, and
differentiation of bovine stem cells derived from WJ. Our
ﬁndings suggest that this tissue is a reliable source of pre-
sumptive stem cells, displaying intermediate features be-
tween adult and embryonic stem cells. These cells have
wide potential clinical applications because of their low
immunogenicity and high differentiation potential. After
digestion, large numbers of WJ-derived cells with greater
than 95% viability (optimal value in terms of plating efﬁ-
ciency and cellular growth) were obtained. When cultured,
these cells demonstrated strong adherence to plastic dishes
and developed ﬁbroblast-like morphology over time.
Adherence is a fundamental property for the culture of stem
cells [41]. The proliferation studies showed thatWJ-derived
cells reached high plating efﬁciency and had a high prolif-
eration rate in vitro until P10, demonstrating a growth curve
with a lag phase of few hours and an intensive log phase of
12 days.Moreover, themeanvalue of DT for 10 passageswas
34.55 hours. During this intensive proliferation, the cells
maintained their morphological characteristics. These data
are in agreement with those obtained by other researchers
who reported a high proliferation rate of human [37,42],
equine [6], bovine [8], and feline [43] extrafetal derived
cells. It is very difﬁcult to compare these data with those
obtained from Cardoso et al. [32] because that study only
reported the number of cells permilliliter found at different
passages and the DT value was not calculated.
Fig. 3. Staining of differentiated and control (CTR) (un-differentiated) WJ–derived cells and respective molecular expression. Osteogenic induced cells were
evaluated for von Kossa staining and reverse transcription polymerase chain reaction (RT-PCR) analysis of SPP1, SPARC, and BGLAP. Adipogenic induced cells were
evaluated for Oil Red O–stained cytoplasmic neutral lipids and RT-PCR of PPAR-g and LEP. Chondrogenic induced cells were evaluated for Alcian blue staining and
RT-PCR of COL2A1 and ACAN. Neurogenic induced cells were evaluated for Nissl staining and RT-PCR of NES and GFAP; magniﬁcation:  20; scale bar ¼ 20 mm.
GAPDH was employed as reference gene. Bone, adipose tissue, cartilage, and spinal cord were used as positive controls.
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Bovine WJ-derived cells also showed the ability to
produce clones. When seeded at different densities, they
were able to form clones with a frequency that increased
with the cell-seeding density, suggesting paracrine
signaling between cells at P0 [44]. Moreover, WJ-derived
cells showed a typical expression pattern expected for
cultured stem cells [41] when analyzed by RT-PCR. Indeed,
these cells expressed a pattern of mesenchymal (CD29,
CD44, CD105, CD73, CD166) and pluripotency (Oct-4, c-Myc)
genes with no expression of the hematopoietic CD34. The
pluripotency genes are essential transcription factors for
maintaining the primitive pluripotent state of embryonic
stem cells. These data conﬁrm the results obtained in
equine, canine, and bovine WJ [6,8,24,32,45–47] where
pluripotent- and mesenchymal-associated markers were
expressed.
For the ﬁrst time, the expression of MHC-I and MHC-II,
related to cell immunogenicity, was also evaluated to assess
the usefulness of bovine WJ-derived cells for cell therapy.
At each passage, these cells were negative for MHC-II and
positive for MHC-I, consistent with ﬁndings of previous
publications [6,8]. These ﬁndings reinforce the role of the
extrafetal tissue as an allogenic source for cell-based ther-
apies in cattle. It is important to underline that RT-PCR
alone is not useful for characterizing WJ-derived cells and
that quantitative analyses are needed to make meaningful
statements about their gene expression. Flow cytometry
provides useful quantitative data on the percentage of cell
reactivity. Indeed, we showed that greater than 90% cells
were positive for CD105 and CD73, whereas less than 10%
were positive for CD34 and MHC-II. These data conﬁrm the
mesenchymal nature of isolated cells and the lack of
immunogenicity and underline the homogeneity of this cell
line.
The capacity of MSCs to differentiate into a variety of cell
types (adipocytes, osteocytes, and chondrocytes) [48,49]
has aroused interest in cell and gene therapy. Bovine WJ-
derived cells, obtained by enzymatic digestion, were able
to differentiate into osteocytes, adipocytes, chondrocytes,
and neuron-like cells in the same way as cells obtained by
nonenzymatic digestion [32]. This suggests that these cells
are capable of differentiation into multiple germ layers, an
essential characteristic also observed in the pig [17], dog
[24], horse [4], and chicken [50]. After 21 days of induction,
mineral deposits were conﬁrmed by von Kossa staining and
by the expression of SPP1 and SPARC but not of BGLAP. This
might be because BGLAP is expressed in terminally differ-
entiated osteoblasts [51]. When stimulated to differentiate
toward the adipogenic lineage, bovine WJ-derived cells
were positive for Oil Red O staining and expressed genes
involved in lipid biosynthesis and storage. mRNAs for PPAR-
g, crucial for the preadipocyte commitment [52], and LEP, as
late marker of adipocyte differentiation, were detected. The
potential of bovine WJ-derived cells to undergo chondro-
genesis was conﬁrmed by positive Alcian blue staining and
identiﬁcation of markers commonly associated with the
chondrocyte phenotype such as collagen type II and
aggrecan, the most essential cartilage proteoglycan and key
markers of chondrocyte differentiation [53]. ACAN expres-
sion was demonstrated, whereas a basal level of COL2A1
was detected. The low expression of COL2A1 might be
related to the culture conditions in this study because
chondrogenic differentiation of MSCs in monolayer culture
appears to be dose dependent and time dependent in
relation to the bioactive factors used [32,33]. GFAP and
nestin, markers expressed in neuronal precursor stem cells,
have been detected in WJ-derived cells. The expression of
both markers is probably related to the ability of these cells
to differentiate either toward the glial cell lineage, as pre-
viously shown by Miki et al. [54] for 95% of cells isolated
from human amnion, or toward neurogenic line as previ-
ously observed in pigs [55].
Whatever the reason, this cell line converted into a
typical neuron-like morphology when appropriately
induced.
Our ﬁndings suggest that, in agreement with reports of
other researchers in several species [6,45–47,56], bovine
WJ represents an alternative source of progenitor cells that
can be obtained by enzymatic methods for use in cell-based
therapies. In our study, the digestion of tissue did not result
in a reduced cellular viability or degradation of cellular
surface receptors or alteration of cellular function as
reported by Jeschke et al. [57].
Moreover, after thawing, the cryopreserved cells had a
high level of viability (80%) and could be successfully
expanded and differentiated. This demonstrates that
bovine umbilical cord matrix cells can tolerate freezing
without loss of functional integrity in terms of morphology,
presence of speciﬁc stemness markers, and differentiation
potential, although renewal capacity was slightly lower
than that observed in freshly isolated cells.
In conclusion, these data conﬁrm that bovine WJ
contains a niche of MSCs. However, further investigation,
including preclinical studies and further study of immu-
nologic properties, is needed to better understand their
role in cellular therapy before in vivo applications of
WJ-derived cells are considered. To date, there is only a
single literature report of transplantation of caprine
WJ-derived cells for wound healing, which showed prom-
ising effects [23]. The ﬁndings of this study reinforce the
emerging importance of extraembryonic tissues for
derivation of cells that may be ideal tools in veterinary
regenerative medicine.
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ABSTRACT 
Ovarian follicle encloses oocytes in a microenvironment throughout its growth and 
competence acquisition. MicroRNAs were identified in follicular cells and shown to 
be active during intra-follicular communication regulating cellular processes. To 
determine cellular origin of follicular miRNAs we screened 348 miRNAs in granulosa 
cells and cumulus-oocyte complexes (COCs) and their derived extracellular vesicles 
(EVs). Bioinformatics analyses revealed that PI3K-Akt pathway was highly regulated 
by exclusive microRNAs. To investigate whether miRNAs could influence oocyte 
quality, we individualized follicles and recovered follicular cells (FCs) and COCs, 
that were individually cultured in order to pool follicular cells based on oocyte 
competence to reach the blastocyst stage. We found levels of PI3K-Akt signalling 
pathway components in FCs correlating with oocyte competence. This miRNA-
modulated pathway was downregulated in FCs of lower quality oocytes, indicated by 
increased levels of PTEN and decreased levels of PTEN regulators bta-miR-494 and 
bta-miR-20a. Using PI3K-Akt responsive genes we showed decreased FOXO3a levels 
in lower quality groups inferring changes in cell cycle progression and oxidative 
response. MicroRNA expression profiles were used as tool to identify molecular 
pathways involved in oocyte competence. The distinct levels of PI3K-Akt pathway 
components in FCs from follicles carrying oocytes with distinct developmental 
competences validated this strategy. 
 
INTRODUCTION 
 The success of in vitro production of bovine embryos is closely associated 
with oocyte quality
1,2
 . The oocyte’s competence to reach the blastocyst stage is 
progressively acquired during follicle growth
3
, and is the result of interactions 
between external factors and the follicular microenvironment
4
. The ovarian follicle is 
composed of three cell types besides the oocyte; theca, granulosa, and cumulus cells, 
along with a basement membrane and follicular fluid. Each one of these cell types 
plays an active role in oocyte differentiation and regulation
5
. Due to its complexity, 
currently there is no reliable method to measure oocyte competence prior to 
phenotype analysis following fertilization. 
 Several morphological, ultrastructural, and metabolic criteria have been used 
to predict oocyte competence. These morphological criteria remain subjective and in 
some cases invasive and/or poorly correlated with oocyte competence. Identification 
of other relevant biomarkers to accurately predict oocyte quality is of primary 
interest
6
. The appropriate interplay between oocyte and follicular cells (FCs) is 
indispensable for proper folliculogenesis, oocyte development, and progression to 
ovulation, as well as subsequent embryo development
7
. Hence, understanding the 
different signalling pathways in FCs that modulate the oocyte competence is 
important for unravelling the key intracellular events driving oocyte competence 
acquisition. 
The mechanisms governing cellular communication within ovarian follicles 
were first studied and described using paracrine agents (oocytes-secreted factors)
8
 and 
observing the exchange of small molecules through gap junctions
9
. Recently, it was 
demonstrated that exchanges of bioactive molecules across FCs may occur within the 
follicular environment, potentially influencing the oocyte, via cell-secreted vesicles
10
 
or through transzonal projections
11
. As a result, such mechanisms, among others, 
allow the intra-follicular flow of molecules such as proteins, mRNAs, and miRNAs. 
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MicroRNAs are naturally occurring small non-coding RNAs that act as key 
posttranscriptional regulators of gene expression following base pair interactions with 
the 3’-untranslated region (3’UTR) of target protein-coding genes12. miRNAs have 
been linked to the regulation of genes involved in tissue development and 
differentiation. In mammals, miRNAs are predicted to control the activity of more 
than 60% of all protein-coding genes and participate in the regulation of many cellular 
processes
13
. Recently, miRNAs were reported as regulators of different genes 
associated with follicle selection in sheep and oocyte developmental competence in 
bovines and equines
14,15,10
. Therefore, the determination of miRNA expression 
profiles in models including ovarian follicles and cellular communication within this 
microenvironment may lead to the discovery of molecular pathways involved in the 
acquisition of oocyte competence. 
The phosphatidylinositol-3-kinase/protein kinase B (PI3K-Akt) pathway plays 
a key role in cellular responses to cell proliferation, apoptosis, DNA repair, and 
protein synthesis. Accumulating evidence suggests that PI3K-Akt is associated with 
ovarian function, including recruitment of primordial follicles, granulosa 
proliferation, corpus luteum survival, and oocyte maturation
16,17,18
. There are several 
functions of PI3K-Akt regulators, including the upregulation of Akt activity by its 
phosphorylation as a result of PI3K upregulation and downregulation by PTEN 
(phosphatase homologous to tensin). Additionally, there are experimental indications 
that miRNAs are also involved in the regulation of PI3K-Akt, representing an 
additional layer of complexity in the regulating system of this pathway
19
. Specifically, 
some miRNAs, such as miR-494 and miR-20a, have been shown to have modulatory 
effects on PTEN levels and thus, on downstream genes of the PI3K-Akt pathway
20,21
. 
Here, we investigated the levels of miRNAs in FCs following isolation and 
culture. Granulosa cells (GCs) and cumulus-oocyte-complexes (COCs) were cultured 
in order to allow the identification of miRNAs in individual cell types as well as in 
their secreted extracellular vesicles (EVs). Bioinformatics analyses of miRNAs 
identified in different follicular cell types and EVs indicate that the PI3K-Akt 
pathway to be regulated by miRNAs uniquely expressed in GCs, COCs and in their 
respective EVs. Therefore, we tested the hypothesis that oocyte competence is 
associated with alterations in levels of PI3K-Akt pathway components and their 
regulatory miRNAs during follicle development. For this,, we dissected ovarian 
follicles and retrieved FCs and COCs. We placed the COCs in individual droplets and 
tracked maturation and parthenogenetic development until the blastocyst stage was 
reached. Then we further determined the levels of PI3K-Akt components in 
previously collected FCs from the originated follicles, relating them to the oocyte’s 
competence to mature and support early development. We determined the levels of 
PI3K-Akt downstream genes related to different cellular processes (i.e. protein 
synthesis, DNA repair, cell cycle progression, and apoptosis), as well as the levels of 
PTEN-regulators bta-miR-494 and bta-miR-20a. Our results demonstrated that the 
PI3K-Akt pathway is regulated by different miRNAs detected in FCs,  and as a result, 
potentially driving oocyte competence. 
 
RESULTS 
To find new pathways involved in oocyte competence acquisition without 
disrupting the oocyte, we used FCs and EVs to perform miRNA profiling after 
stimulating with FSH. FCs from immature follicles (3-6 mm in diameter) were 
exposed to physiological levels of FSH in culture in order to mimic follicle 
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development, and the cells were subsequently used to determine miRNA profiles. As 
a result, we identified different miRNAs present in GCs and COCs. Interestingly, 
these specific miRNAs were found to regulate similar pathways. EVs derived from 
FCs in culture media were equally used to determine miRNA profiles and identify 
specifically regulated pathways. In both the FCs and their EVs, the PI3K-Akt pathway 
appeared to be highly regulated by miRNAs. Based on that observation, we 
investigated the levels of PI3K-Akt family members in a retrospective model, with 
respect to oocyte competence. In order to do so, we used FCs collected from 
immature follicles (3-6 mm in diameter). PI3K-Akt levels of the selected members 
were altered in FCs and were correlated with oocyte competence. 
 
miRNA profiles of FCs 
A total of 326 miRNAs were detected (<37 Ct, in at least 2 out of 3 samples of 
each group), of which 302 were detected in both GCs and COCs (Supplementary 
Table S1.A). Ten of these miRNAs showed increased levels (p < 0.05) in COCs, 
let7a-3p, miR-128, miR-15b, miR-196b, miR-342, miR-411a, miR-497, miR-502b, 
miR-542-5p, and miR-592, and one showed increased levels (p > 0.05) in GCs: miR-
454. Additionally, specific miRNA signatures were identified in GCs and COCs. 
Eight out of 326 miRNAs were specifically present in GCs while 16 only appeared in 
COCs (Table 1). 
 
Cell type miRNA Ct value miRNA Ct value 
GCs 
bta-miR-367 35.43 bta-miR-543 34.69 
bta-miR-449a 33.13 bta-miR-653 35.33 
bta-miR-451 28.47 bta-miR-759 35.18 
bta-miR-539 35.43 bta-miR-875 36.60 
COCs 
bta-miR-105a 30.58 bta-miR-329b 35.32 
bta-miR-126-3p 30.35 bta-miR-365-5p 30.41 
bta-miR-137 35.15 bta-miR-369-5p 31.30 
bta-miR-142-3p 34.70 bta-miR-371 34.57 
bta-miR-200a 35.04 bta-miR-374b 28.44 
bta-miR-218 35.96 bta-miR-495 35.89 
bta-miR-219-5p 35.83 bta-miR-544b 32.18 
bta-miR-329a 36.06 bta-miR-562 33.65 
   EVs origin miRNA 
 
Ct value miRNA Ct value 
GCs 
bta-miR-125b 34.84 bta-miR-370 35.66 
bta-miR-130b 34.92 bta-miR-502b  36.14 
bta-miR-132  36.45 bta-miR-760-3p 33.40 
bta-miR-154b 34.08 bta-miR-885  34.97 
bta-miR-155 35.06 bta-miR-143  34.95 
bta-miR-27a-5p 27.27 bta-miR-197 34.26 
bta-miR-29d-5p 34.36    
COCs 
bta-let-7e 32.83 bta-miR-16b 33.10 
bta-let-7f 34.45 bta-miR-187 34.26 
bta-let-7i 34.61 bta-miR-210 33.86 
bta-miR-1 35.61 bta-miR-25    35.07 
bta-miR-100 34.27 bta-miR-26a  33.81 
bta-miR-101    35.30 bta-miR-30c 36.50 
bta-miR-106a 34.41 bta-miR-339b 35.12 
bta-miR-124b 34.84 bta-miR-346  33.54 
bta-miR-125a  34.18 bta-miR-378b 34.98 
bta-miR-129  34.66 bta-miR-425-3p 29.46 
bta-miR-133a 32.78 bta-miR-453 34.95 
bta-miR-145  33.29 bta-miR-665   31.20 
bta-miR-149-3p  30.64 bta-miR-874  33.87 
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bta-miR-149-5p 33.14 bta-miR-877     32.88 
bta-miR-15a 33.60 bta-miR-940   28.43 
       Ct value represents the group average. 
 
MiRNA profiles of follicular EVs isolated from culture media 
EVs recovered from GCs and COCs culture media were used for RNA 
isolations and subsequent real-time PCR amplifications of 348 mature bovine 
miRNAs was performed. Real-time PCR analysis revealed 67 detectable miRNAs 
(<37 Ct and detected in at least 2 samples of each group), of which 24 were common 
between EVs from the two FC types (Supplementary Table S1.B). Two miRNAs 
(miR-127 and miR-433) showed higher levels (p < 0.05) in GC-EVs and other two 
miRNAs (miR-631 and miR-323) higher levels (p < 0.05) in COC-EVs. Specific 
miRNA signatures were identified in GCs and COCs EVs. Thirteen out of 67 
miRNAs in EVs were specifically detected in GCs, while 30 only appeared in COCs 
(Table 1). 
 
Bioinformatics analyses of miRNAs 
Bioinformatics analyses were performed to identify the pathways regulated by 
miRNAs and potentially involved in follicle development and acquisition of oocyte 
competence. MicroRNAs that were specific to each cell type or EV origin were used 
to determine cellular pathways. We performed a bioinformatics analysis on bovine 
miRNAs using human miRNA sequences that are homologous to bovine miRNAs 
(Supplementary Table S2), and the great homology between miRNAs and 3’UTR of 
the target genes (Supplementary Table S3). Additionally, we grouped miRNAs 
according to their cellular origin and, using the mirpath analysis package from 
DIANA tools (http://diana.imis.athena-innovation.gr/DianaTools), we identified the 
regulated pathways. The analysis of 8 miRNAs, specifically detected in GCs, showed 
their role in the regulation of 69 pathways. The analysis of 16 miRNAs, specifically 
identified in COC cells, showed their role in the regulation of 94 pathways. Regarding 
the differences in miRNA expressions between the two cell types, the ones showing 
increased expression levels in GC cells play a role in the regulation of 19 pathways, 
while the ten showing increased expression levels in COC cells play a role in the 
regulation of 68 pathways. In addition, 13 specific EV miRNAs from GCs were 
shown to regulate 58 pathways. Moreover, 30 specific COC-EV miRNAs were shown 
to be involved in the regulation of 102 pathways. Finally, regarding miRNAs 
differently expressed depending on the EVs types, those with increased expression 
levels in GC-EVs were shown to regulate 14 pathways, while those found in COC-
EVs, play a role in the regulation of 13 pathways. 
We selected the most relevant pathways regulated by exclusive miRNAs of both 
the different FCs and EV types, which are shown in Figure 1. Different genes were 
shown to be regulated by specific miRNAs in the different cells and EV types. 
Therefore, specific miRNAs are modulating important cellular processes, including 
many signalling pathways such as the PI3K-Akt pathway. Interestingly, the PI3K-Akt 
signalling pathway appears to be controlled by miRNAs from different origins. There 
are 70 and 111 genes belonging to the PI3K-Akt shown to be regulated by specific 
miRNAs from GC and COCs, respectively.  
  
6 
0 5 10 15 20 25
PI3K-Akt signaling pathway
MAPK signaling pathway
Endocytosis
Wnt signaling pathway
RNA transport
Cell cycle
Oocyte meiosis
ErbB signaling pathway
TGF-beta signaling pathway
GnRH signaling pathway
p value log-10
Predicted pathways in COC cells
0 5 10 15
PI3K-Akt signaling pathway
MAPK signaling pathway
Endocytosis
Wnt signaling pathway
TGF-beta signaling pathway
Insulin signaling pathway
ErbB signaling pathway
Gap-junction
GnRH signaling pathway
Progesterone-mediated oocyte maturation
p value log-10
Predicted pathways in GC cells
0 25 50 75 100 125
PI3K-Akt signaling pathway
MAPK signaling pathway
Endocytosis
Wnt signaling pathway
RNA transport
Cell cycle
Oocyte meiosis
ErbB signaling pathway
TGF-beta signaling pathway
GnRH signaling pathway
number of genes
Predicted pathways in COC cells
0 20 40 60 80
PI3K-Akt signaling pathway
MAPK signaling pathway
Endocytosis
Wnt signaling pathway
TGF-beta signaling pathway
Insulin signaling pathway
ErbB signaling pathway
Gap-junction
GnRH signaling pathway
Progesterone-mediated oocyte maturation
Predicted pathways in GC cells
number of genes
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
p value log-10
Predicted pathways in COC-EVs
0 50 100 150 200
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
number of genes
Predicted pathways in COC-EVs
0 20 40 60 80
PI3K-Akt signaling pathway
MAPK signaling pathway
Wnt signaling pathway
Insulin signaling pathway
TGF-beta signaling pathway
ErbB signaling pathway
GnRH signaling pathway
Gap junction
p53 signaling pathway
mTOR signaling pathway
number of genes
Predicted pathways in CG-EVs
0 5 10 15
PI3K-Akt signaling pathway
MAPK signaling pathway
Wnt signaling pathway
Insulin signaling pathway
TGF-beta signaling pathway
ErbB signaling pathway
GnRH signaling pathway
Gap junction
p53 signaling pathway
mTOR signaling pathway
p value log-10
Predicted pathways in GC-EVs
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
- log-10 (p value)
Predicted pathways regulated by miRNAs from COC-EVs
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
- log-10 (p value)
Predicted pathways regulated by miRNAs from GC-EVs
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
- log-10 (p value)
Predicted pathways regulated by miRNAs from GC-Cell
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
- log-10 (p value)
Predicted pathways regulated by miRNAs from COC-Cell
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
(- log 10 [ p value ])
Predicted pathways regulated by miRNAs from COC-Cell
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
(- log 10 [ p value ])
Predicted pathways regulated by miRNAs from COC-Cell
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
(- log 10 [ p value ])
Predicted pathways regulated by miRNAs from COC-Cell
0 20 40 60
PI3K-Akt signaling pathway
MAPK signaling pathway
Focal adhesion 
Regulation actin cytoskeleton
Endocytosis
Wnt signaling pathway
Insulin signaling pathway
ErbB signaling pathway
TGF-beta signaling pathway 
mRNA surveillance pathway
(- log 10 [ p value ])
Predicted pathways regulated by miRNAs from COC-Cell
 
Similarly, different miRNAs from EVs also target PI3K-Akt pathway 
components with GC- and COC-derived EVs carrying 13 and 30 specific miRNAs 
that are known to regulate 76 and 178 genes, respectively, showing the relevance of 
this signalling pathway during follicular development. After determining the 
regulation of the PI3K-Akt pathway using bioinformatics analyses, we identified 
which of the 67 specific miRNAs in each of the groups showed strong evidence of 
targeting genes from the PI3K-Akt pathway using the miRTarBase tool. The results 
were as follows: CG (8 miRNAs), COC (16 miRNAs), GC-EV (13 miRNAs), and 
COC-LV (30 miRNAs). A total of 23 miRNAs, out of the 67 specifically identified in 
both FCs and EVs, showed strong evidence (after experimental validation) of 
interaction with PI3K-Akt pathway components (Figure 2). 
  
7 
PI3K	
PTEN	
PIP2	 PIP3	
EIF4e	
EIF4b	
BRCA	
CDK6	
FOXO3a	
YWHAZ	
BCL-2	
BAX	
BAD	
Protein  
synthesis 
Cell cycle 
progression 
Apoptosis 
Mul ple	
targets	
mir-449a 
mir-126-3p 
mir-125b 
mir-143 
mir-15a mir-16b 
mir-1 
mir-449a 
mir-105-5p 
mir-16b 
mir-200a 
mir-26a 
mir-124b 
mir-129 mir-145 
mir-15a mir-16b 
mir-106a 
mir-145 mir-125b 
mir-1 mir-155 
mir-105-5p mir-197 
mir-126-3p 
mir-451 
mir-105-5p 
mir-27a-5p 
mir-143 
mir-15a mir-149-3p 
mir-100 mir-125b 
mir-126-3p 
mir-125b 
mir-1 
mir-124b 
mir-26a mir-130b 
mir-25 
mir-106a 
mir-200a 
mir-132 
+p 
p-AKT	
+p 
+p 
+p 
DNA 
Repair 
Cell 
Survival 
Cell 
Death 
 
 
Individual oocyte competence and developmental rates 
A total of 174 oocytes were collected and activated. Among these oocytes, 
63.79% cleaved and 29.31% reached the blastocyst stage (Supplementary Table S4). 
Only routines with blastocyst/cleaved rates both higher than 35% were used in the 
following experiments. 
 
Analysis of PTEN and PI3K transcripts and p-Akt protein levels in FCs in relation 
to oocyte competence 
Since miRNAs present in GCs, COCs, and their respective EVs are predicted to 
be involved in the regulation of genes within the PI3K-Akt signalling pathway, we 
decided to investigate the mRNA levels corresponding to the main molecules within 
this pathway. mRNA levels of PTEN (a negative effector of the PI3K-Akt pathway) 
and PI3K (a positive effector) were determined in FCs of NC, CNB, and BL groups. 
Relative abundance of PTEN was significantly lower (p < 0.05) in FCs originated 
from follicles containing oocytes capable of generating blastocysts in vitro compared 
to those observed in FCs originated from follicles containing oocytes which could not 
reach this stage (Figure 3A). PTEN is responsible for converting PIP3 to PIP2 and 
maintaining low levels of PIP3, an Akt activator. Although PI3K levels appear to be 
increased in CNB and BL samples, no statistical differences among the oocyte quality 
groups were detected (Figure 3B). PI3K is responsible for converting PIP2 to PIP3 
and therefore, is an important activator of this pathway. 
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 PI3K-Akt signalling pathway is modulated by the levels of PTEN and PI3K, 
which are responsible for Akt activation. In order to understand how the PI3K-Akt 
pathway influences oocyte competence, we evaluated the levels of phosphorylated 
Akt protein (p-Akt) in FCs within the distinct oocyte quality groups. Western blot 
analysis revealed increased levels of p-Akt (p < 0.06) in FCs originated from follicles 
that generated blastocysts (Figure 3C and 3D). 
 
miRNA-494 and miR-20a analysis in FCs in relation to oocyte competence 
 We investigated the levels of bta-miR-494 and bta-miR-20a, two validated 
regulators of PTEN in humans and bovine, respectively
22,21
.  The miR-494 presents a 
validated and conserved binding site across mammalian species, including bovine, 
using TargetScan (http://www.targetscan.org/). Additionally, bta-miR-20a was 
recently validated as a regulator of PTEN in bovine granulosa cells 
21
. Relative levels 
of bta-miR-494 and bta-miR-20a were significantly higher (p < 0.05) in FCs derived 
from follicles in which the oocytes cleaved, regardless of subsequent blastocyst 
generation (CNB and BL), than in follicles in which the oocytes did not cleave (NC) 
(Figure 4A and 4B). Additionally, we performed a luciferase assay to demonstrate 
that miR-494 can regulate the PTEN by binding to its 3’UTR. Our results 
demonstrated that granulosa cells containing the vector with the wild copy of the 
PTEN 3’UTR have decreased firefly luciferase activity after transfection of the miR-
494 mimic compared to the control and mutant construct, suggesting that miR-494 is 
a validated regulator of PTEN (Figure 4C).  
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Analysis of PI3K-Akt regulated genes in FCs according to oocyte competence 
 The PI3K-Akt signalling pathway can lead to different cellular effects, 
including changes in protein synthesis, DNA repair, cell cycle progression, apoptotic 
signalling etc.. In order to identify the mechanisms by which PI3K-Akt regulation is 
influencing oocyte competence, we chose to analyse downstream genes related to 
different cellular effects using RT-PCR. 
We analysed the mRNA levels of 8 genes (BAX, BCL2, BRCA, CDK6, EIF4b, 
EIF4e, FOXO3a, and YWHAZ) in FCs of different oocyte competence groups (Figure 
5). Among these genes, only BAX and FOXO3a showed statistical differences 
between the competence groups. BAX levels were increased (p < 0.05) in the BL 
group although the ratio between BAX/BCL-2 transcript levels did not differ among 
the groups. Similarly, FOXO3a mRNA levels were significantly increased (p < 0.05) 
in the BL and CNB groups compared to NC, inferring a possible FOXO3a-dependent 
cell cycle progression response. 
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DISCUSSION 
 Ovarian follicle development and oocyte competence acquisition are complex 
events that result from the interaction between FCs,  such as theca, granulosa, and 
cumulus, and the oocyte. MiRNA-controlled pathways related to oocyte meiosis and 
to the Wnt, TGF-beta, ErbB, Insulin, PI3K-Akt, and MAPK signalling pathways have 
been identified in bovine FCs (theca cells and GCs) and have been associated with 
follicular development
23
. Exosomal and non-exosomal miRNAs present in follicular 
fluid can control important pathways involved in oocyte quality
15
. Recently, miRNAs 
controlling the proliferation and cell cycle of GCs were identified in metabolic 
pathways downstream of the PI3K-Akt pathway
24
. Herein, we utilised a novel 
approach to identify pathways associated with oocyte competence. Initially, we 
determined the levels of miRNAs in GCs and COCs as well as in their respective 
EVs, 48 h after in vitro exposure to physiological levels of FSH in order to mimic the 
follicle environment. Functional analysis of the identified miRNAs indicate the 
modulation of the PI3K-Akt signalling pathway regardless of follicle compartment 
(GCs, COCs or its EVs) that originated the miRNAs.  
In order to test if the components of this pathway can serve as predictors of 
oocyte quality, we dissected ovarian follicles, stored FCs, and individually activated 
oocytes to evaluate their developmental competences. In vitro parthenogenetic 
development allowed us to pool FCs in different groups using retrospective method, 
depending on oocyte competences, for subsequent RNA and protein experiments. Our 
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results demonstrated that the main members of the PI3K-Akt signalling family 
displayed different levels of expression or amounts of protein depending on oocyte 
quality. In addition, we investigated genes regulated by PI3K-Akt and observed an 
increase in FOXO3a levels suggesting the existence of mechanisms governing the 
modulation of cell-cycle progression, protection to oxidative stress, and anti-apoptotic 
response. 
Regarding miRNAs differently expressed among cell and EV types, according 
to miRTarBase (http://mirtarbase.mbc.nctu.edu.tw/index.php), only one that was 
found to increase in COC cells, miR-15b, has strongly been validated in previous 
bovine studies. In mouse GCs, miR-15b is negatively controlled by FSH
25
. Some of 
these miRNAs, such as miR-342 or miR-542-5p, which showed increased levels in 
COCs in this study, were recently identified in EVs from bovine follicular fluid by 
Navakanitworakul and collaborators
26
, displaying increased levels of expression in 
large follicles compared to small follicles. Additionally, miR-433 was increased in 
GC-EVs in our study, was linked to induction of senescence in ovarian cancer cells. 
Moreover, cells with high miR-433 expression level release this miRNA into growth 
media via exosomes, promoting a bystander effect
27
. 
Several miRNAs detected in the present study are exclusively found in GCs 
and COCs cells or their respective EVs (Tables 2 and 3) and have been described as 
key molecules for the regulation of the PI3K-Akt signalling pathway
20,19
. Examples of 
specific GC miRNAs related to PI3K-Akt signalling are miR-105
28
, miR-126
29
, and 
miR-200a
30
. Similarly, COC miRNAs associated with this pathway are miR-449
31
 and 
miR-451
32,33
. Although most studies have been done in humans and are related to 
reproductive diseases, it has been unequivocally demonstrated that miRNA-dependent 
regulation of the PI3K-Akt signalling pathway is necessary for the correct gene 
balance governing this pathway, and eventually, reproductive success. 
Oocyte growth and follicle development rely on the regulation of pathways involved 
in cell proliferation and survival, such as the PI3K-Akt signalling pathway
34
. 
Stimulation of PI3K promotes phosphorylation of Akt, resulting in follicle survival 
and activation of growth. Alternatively, this pathway is suppressed under the action of 
PTEN
35
. PTEN is involved in converting PIP3 to PIP2, and high levels of PTEN are 
responsible for decreasing the Akt pathway activity, consequently reducing cell 
proliferation
34,36
. In the present study, we detected high levels of PTEN mRNA and 
low levels of p-Akt protein in FCs from poor oocyte quality groups, suggesting that 
the PI3K-Akt signalling pathway is less active in these follicles. In addition, we 
observed decreased levels of bta-miR-494 and bta-miR-20a, two validated modulators 
of PTEN, in FCs of poor oocyte quality groups. The inhibition of PTEN in human 
ovary in vitro results in the increased activation of primordial follicles, but 
compromises the development of growing follicles
35
. In murine ovary, the deletion of 
PTEN in mouse oocytes resulted in pan-ovarian follicle activation and premature 
oocyte depletion, whereas disruption of granulosa cell-specific PTEN did not affect 
the initiation of follicle growth but increased GC proliferation and enhanced 
ovulation
37,17
. Down-regulation of PTEN was also caused by the up-regulation of 
miR-494 (a conserved miRNA among mammals) in human bronchial cells, 
demonstrating the importance of this mechanism in controlling PTEN levels
22
. 
Furthermore, we validate the interaction between miR-494 and the PTEN using the 
luciferase assay for the wild-type or the mutant 3’UTR. As predicted by 
bioinformatics analysis the presence of bta-miR-494 and the wild-type 3’UTR 
sequence reduced the levels of luciferase activity compared to control and the PTEN 
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mutant sequence. Therefore, these results demonstrate that bta-miR-494 is regulating 
the levels of PTEN in follicular cells. Similar analysis were performed for bta-miR-
20a, which was validated as a regulator of PTEN in granulosa cells
21
. Thus, our 
results demonstrated that PTEN levels are regulated by the increase in miR-494 and 
miR-20a in follicles harbouring competent oocytes. Additionally, these results suggest 
that multiple miRNAs regulating the same mRNA target are necessary to induce a 
physiological response such as upregulation of AKT, which was observed in cells 
obtained from follicles associated with higher quality oocytes.  
Thus, our data demonstrated that the components of the PI3K-Akt pathway 
such as PTEN, bta-miR-494, bta-miR-20a and p-Akt are associated, in the follicular 
environment, with the developmental potential and oocyte quality. The experimental 
model adopted in this study allowed us to evaluate the molecular profile of the PI3K-
Akt pathway in follicular cells of low oocyte competence follicles (LCO, i.e., Non-
Cleaved or Cleaved Non Blastocyst groups) and high oocyte competence (HCO; i.e. 
Bastocyst group). LCO follicular cells have a molecular profile marked by an increase 
in PTEN expression, lower expression of bta-miR-494, and decreased amounts of p-
Akt, which indicates lower activity of the PI3K-Akt pathway. On the contrary, the 
HCO group has different indicator levels, confirming the increased activity of the 
PI3K-Akt pathway in this group. These two molecular profiles were associated with 
extreme oocyte competence, and based on previously described functions of the 
PI3K-Akt pathway in follicular environments, we can assume that these oocyte 
competence extremes are related to the regulation of cell proliferation, protection 
from oxidative stress, and apoptosis blockage in the FCs, as discussed below. 
The PI3K-Akt signalling pathway, besides being involved in cell proliferation 
and survival, plays a role in apoptosis, protein synthesis, cell cycle, angiogenesis, 
DNA repair, and metabolic pathways etc., as reviewed by Lai and colaborators
38
. In 
the present study, we analysed the mRNA levels of genes related to different cellular 
processes, such as BAX and BCL-2 (apoptosis), BRCA (DNA repair), EIF4b and 
EIF4e (protein synthesis), FOXO3a and YWHAZ (cell cycle progression), and CDK6 
(FOXO-independent cell cycle progression) in order to find, which intracellular 
events mediate the relation between the PI3K-Akt signalling pathway and oocyte 
ability to develop. We observed differences in the transcript levels of FOXO3a and 
BAX between FC groups, associated with different oocyte capacities of development. 
Here, we found that FOXO3a levels are increased in FCs of higher quality 
oocytes. Transcription factor FOXO3a plays an important role in ovarian activity
39
, 
and when activated, has broad anti-proliferative and pro-apoptotic cellular effects. 
Besides these effects, FOXO3a protects quiescent cells from oxidative stress
40
. In 
addition, FOXO3a has been reported to also protect mouse oocytes against oxidative 
stress
41
. The effects induced by FOXO3a elevations may also vary depending on the 
signal integration and associated factors, and may differ from triggering cell death to 
promoting survival by expression of oxidative stress resistance factors
42
. Since this 
study does not include the testing of other factors involved in FOXO3a regulation 
levels, apart from the p-Akt protein and the levels of FOXO3a, we cannot specify the 
final effects associated with FOXO3a in the FCs. However, since different levels of 
FOXO3a were found in FCs associated with oocyte competence, we can consider that 
the Akt-FOXO3a interaction acts in such cases by adjusting the regulation of 
oxidative stress response, cell proliferation, and leads to apoptosis by either favouring 
(in HCO) or preventing (in LCO) the acquisition of competence. We also assume that 
in the HCO group, the Akt-FOXO3a interaction promotes the transcription of 
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FOXO3a (since it acts as an enhancer for its own transcription), which could 
contribute to the regulation of ROS scavengers, and that Akt, being able to inhibit 
FOXO3a, allows a final proliferative and anti-apoptotic response in high competence 
follicles. 
Another gene that displayed differences in expression levels among the 
developmental competence groups was BAX, which increased in the higher quality 
group. BCL2 and BAX are anti-apoptotic and pro-apoptotic genes, respectively, which 
serve as markers for apoptosis identification in ovarian tissues
43
. Oocyte competence 
may be related to events linked to apoptosis, and it has been suggested that early 
apoptosis signals in the oocyte
44
 or in GCs
45
 are positively correlated with oocyte 
competence, suggesting the involvement of apoptotic processes in follicular and 
oocyte development. The pro-apoptotic or anti-apoptotic effects of BCL-2 and BAX 
genes depend on protein-protein interactions. The BAX protein can form homodimers 
or heterodimers with BCL-2. The increase in the proportion of BAX homodimers in 
relation to BAX-BCL-2 heterodimers determines the triggering of cell death through 
apoptosis. So, the ratio BAX/BCL-2 is the main indicator of the apoptotic process
46,47
. 
In this study, the BAX/BCL-2 ratios showed no statistical differences among oocyte 
quality groups, and therefore, there is no clear evidence in our results that this ratio 
regulates the acquisition of oocyte competence, as previously suggested by Yang et 
al
48
. The homodimerisation of BAX and its translocation to the mitochondria to 
trigger apoptosis is under the direct influence of the p-Akt protein
49
. The p-Akt 
phosphorylates the BAX protein and regulates its activity, so phosphorylation of BAX 
prevents its translocation to mitochondria and induces its maintenance in the 
cytoplasm as an heterodimer through its association with BCL-2, preventing 
apoptosis. In the results described in this study, the BL group, besides displaying 
higher BAX levels, also has elevated p-Akt. Therefore, there is evidence that, in these 
cells, the elevation of BAX did not lead to higher incidence of apoptosis due to its low 
activity resulting from the phosphorylation induced by p-Akt. Furthermore, in the 
CNB group, BAX is elevated in the FCs, but not p-Akt, which may suggest a higher 
probability of apoptosis, even if the BAX/BCL-2 ratio does not increase. Finally, the p-
Akt also has effects on the control of apoptosis through the regulation of BCL-2 
availability. BCL-2 and its associated death promoter (BAD) form heterodimers, 
precluding BCL-2 to be available to form heterodimers with BAX. Phosphorylation of 
BAD by p-Akt leads to the isolation of BAD per 14-3-3 proteins family, and the 
consequential anti-apoptotic effect
50
. Therefore, p-Akt, acting by either 
phosphorylation and sequestration of BAD or by phosphorylation of BAX, and its 
maintenance in the cytoplasm triggers the anti-apoptotic response within cells. 
The mechanisms involved in the acquisition of oocyte competence have not 
yet been completely elucidated. The acquisition of oocyte competence is a 
multifactorial process, and while some basic processes are well known, such as the 
progression of meiosis and migration of cortical granules, some intracellular 
processes related to molecular events that lead to the formation of an oocyte capable 
of supporting development are still unclear. Several factors influence oocyte quality 
and regulate competence acquisition. However, an adequate follicular 
microenvironment is a key factor towards successful follicle growth, oocyte 
maturation and fertilisation, early embryo development, and even full-term 
development, allowing the generation of a healthy product
4
. In conclusion, our study 
demonstrated that miRNAs expressed in different compartments of the ovarian 
follicle microenvironment potentially regulate the PI3K-Akt signalling pathway. 
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Using a retrospective developmental competence model, we investigated whether the 
PI3K-Akt pathway could be associated with oocyte quality. This model allowed to 
compare the molecular profile of the PI3K-Akt signalling pathway members in FCs 
associated with LCO (i.e. in the FCs of the NC or CNB groups) and HCO (i.e. in FCs 
of the BL group). We were able to identify a molecular landscape formed by the 
PI3K-Akt pathway in FCs consisting of lower PTEN levels, higher p-Akt, FOXO3a, 
bta-miR-494, bta-miR-20a, and BAX levels, leading to high oocyte developmental 
potential (Figure 6). This molecular landscape is compatible with cellular responses 
related to oxidative stress protection, cell proliferation, and blockage of apoptosis, 
suggesting that these PI3K-Akt-induced cellular responses contribute to oocyte 
competence acquisition during oogenesis. 
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MATERIAL AND METHODS 
This study was approved by the University of São Paulo Research Ethics 
Committee (Protocol number 14.1.674.74.0). Experiments were conducted in 
accordance with International Guiding Principles for Biomedical Research Involving 
Animals (Society for the Study of Reproduction). Unless otherwise stated, the 
reagents and culture media used were purchased from Sigma-Aldrich Chemical 
Company (St. Louis, MO, USA). 
This study consists of two experiments (Figure 7). In the first experiment, we 
determined the miRNA profiles in GCs and COCs as well as in their respective EVs 
(GC-EVs and COC-EVs) and identified the pathways regulated by miRNAs 
exclusively expressed in each group. In the second experiment, ovarian follicles were 
dissected and loose FCs were stored, while COCs were subjected to in vitro 
maturation (IVM) and embryo development after parthenogenetic activation. The 
oocyte's ability to mature and sustain development until reaching the blastocyst stage 
after parthenogenetic activation was evaluated and used as the criteria to group FCs 
according to oocyte competence, retrospectively. FCs were used to investigate the 
PI3K-Akt components levels. 
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Experiment 1: Granulosa and cumulus-oocyte complex culture to identify miRNAs 
origin inside follicular environment 
In order to identify the miRNAs present in different compartments of the 
ovarian follicles, as well as the contribution of miRNAs transiting within the follicular 
environment in EVs, three routines of bovine ovarian follicles were dissected and the 
follicular components were separated. Following follicle rupture, we identified and 
separated COCs and loose GCs before placing them in independent culture plates. 
After culturing the cells, the culture media were collected and RNAs were isolated 
from both the cells and respective EVs. Bioinformatics analyses were performed to 
identify metabolic pathways regulated by miRNAs in the different cell types and 
respective EVs. Additional and detailed information related to material and methods 
for experiment 1 can be found in the Supplementary material and methods. 
 
Follicular dissection and cellular recovery 
Ovaries were recovered from slaughterhouses. Follicles, ranging between 3 
and 6 mm in diameter, were dissected and ruptured with 18G needles under a 
stereomicroscope. After rupture, COCs and loose GCs were collected for further 
experiments. 
 
GC and COC cultures 
After the follicle rupture, loose GCs and COCs were collected under the 
stereomicroscope using pipettes. The cell culture system was based on the protocol 
developed by Portela et al.
51
 adapted from Gutiérrez et al
52
. At the end of the culture 
period our aim was to obtain cells similar to growing follicle cells. Both the cells and 
medium were collected 48 h after the FSH treatment and stored at -80 ˚C until RNA 
extraction. 
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EV isolation 
EVs were isolated from GCs and COCs culture media using differential 
centrifugation and ultracentrifugation steps (modified from Crescitelli
53
). In order to 
determine the EVs size, 6 pellets (3 from GC-EVs and 3 from COC-EVs) were 
analysed using the Nanosight (Malvern, UK) instrument (Supplementary Figure S1). 
A second set of pellets was diluted in TRI-reagent BD (Molecular Research Center, 
Inc.) before storage at -80 
o
C. 
 
RNA extraction 
Total RNA (mRNAs and miRNAs) was extracted from three of each sample 
using a TRI-reagent or TRI-reagent BD (Molecular Research Center, Inc.) according 
to the manufacturer’s instructions with some modifications. 
 
GC, COC, and EV screening for miRNAs by RT-PCR 
Briefly, the reverse transcription reaction was carried out with 100 ng of total 
RNA using the miScript PCR Starter Kit (Qiagen, Venlo & Limburg, the Netherlands) 
according to the manufacturer's instructions. The levels of 348 miRNAs and 3 
housekeeping genes (miR-99b, RNU1, and RNU43) were investigated by RT-PCR 
using miScript SYBR Green PCR Kit (Qiagen, Venlo & Limburg, the Netherlands) 
with specific primers to miRNAs (Supplementary Table S5). Samples were analysed 
in triplicates and only miRNAs with Ct value under 37 and detected in at least 2 out 
of 3 samples in each group were considered as present. 
 
Bioinformatics analyses of miRNAs according to cellular origin 
Bioinformatics analyses were performed to identify miRNA-controlled 
pathways in FCs. As bioinformatics tools are based on human sequences the 
homology between bovine and human miRNA sequences were determined using 
miRBase, the homology of miRNA-gene interactions was identified using 
TargetScan. Additionally, pathway identification was performed using DIANA tools. 
The validation of target genes was accomplished using miRTarBase. 
 
Experiment 2: Retrospective oocyte development competence model 
In order to determine the levels of PI3K-Akt members in FCs of follicles 
containing oocytes with distinct development capacities, we developed an 
experimental model based on individual maturation of oocytes and culture of 
embryos. After maturation and embryo development, FCs were grouped according to 
oocyte competence. Prior to oocyte maturation, ovarian follicles were dissected, FCs 
(regardless of cell types) were obtained after centrifugation of follicular fluid and 
stored for further use, and COCs collected for individual IVM and embryo culture 
after parthenogenetic activation. At the end of the IVM, oocytes were denuded and 
classified depending on the presence or absence of first polar body in mature (IVM+) 
or non-mature (IVM-) ones, respectively. Regardless of the maturation status, 
denuded oocytes were individually activated parthenogenetically and placed in a 
droplet for embryo development in vitro. Embryos (zygotes) from the IVM+ group 
without signs of embryonic cleavages were classified as 'non-cleaved' (NC group). 
Embryos that started development (cleaved) but stopped before reaching the 
blastocyst stage were classified as 'cleaved non-blastocyst' (CNB group), while those 
who had reached the blastocyst stage composed the 'blastocyst' group (BL group). 
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FCs from NC, CNB, and BL groups were used to determine the levels of PI3K-Akt 
members in samples from follicles containing oocytes with different developmental 
capacities. Additional and detailed information related to material and methods for 
experiment 2 can be found in Supplementary material and methods. 
 
Oocyte maturation, parthenogenetic activation, and single embryo culture 
 After follicle rupture, COCs were collected for single embryo culture as 
described in supplementary materials and methods and FCs were collected, washed by 
centrifugation (600 x g) to remove the follicular fluid, and immediately placed in 
liquid nitrogen for future analyses of the PI3K-Akt pathway components to 
retrospectively determine the follicle of origin. The oocyte maturation, 
parthenogenetic activation and single embryo culture procedure allowed us to classify 
oocytes and their respective FCs, according to their development competence. 
 
RNA and protein extractions 
Total RNA, including small RNA molecules, and proteins were extracted 
using either TRI-reagent or TRI-reagent BD (Molecular Research Center, Inc.) 
according to the manufacturer’s instructions with some modifications. RNA 
concentrations were measured using a NanoDrop 2000 (Thermo Scientific) according 
to the manufacturer’s protocol. Proteins were precipitated from the organic phase left 
from TRI reagent lysis and dissolved in 20 µL of 8 M urea. 
 
Determination of mRNA and miRNA expressions by RT-PCR 
Briefly, the reverse transcription reaction was carried out with 30 ng of total 
RNA per gene using a High Capacity cDNA reverse transcription kit (Life 
Technologies) according to the manufacturer's instructions. PCR amplification was 
performed with the resulting cDNA using sequence-specific forward and reverse 
oligonucleotide primers in custom-prepared plates for the indicated genes 
(Supplementary Table S6). Relative quantification of transcripts was determined by 
qPCR using ABI-7500 (Applied Biosystems). 
For the miRNA-494 and miR-20a study, RT-PCR was performed with using 
miScript SYBR Green PCR Kit (Qiagen, Venlo & Limburg, the Netherlands), primer 
specific to miRNA target (Supplementary Table S5), and 0.1 µL cDNA. Real-time 
PCRs were performed using ABI-7500 (Applied Biosystems). The assays were 
analysed in quadruplicates and only the Ct values under 35 were considered. 
 
Target gene validation using luciferase reporter assay  
To experimentally validate the miRNA-mRNA interaction between bta-miR-
494 and the PTEN gene, we constructed a plasmid vector with a fragment of the 3´-
UTR harboring the conserved binding sites of bta-miR-494 (wild type construct) or 
fragment with mutant variants of the miRNA binding sequences (Mutant construct) 
inserted between the SacI and XhoI restriction sites downstream of pmirGLO Dual-
Luciferase miRNA Target Expression Vector (Promega, Madison, USA). Plasmids 
were amplified and sequenced to verify the presence and absence of miRNA binding 
sites in the wild type and mutant constructs, respectively. Sub-confluent cells were co-
transfected with either the wild type construct or the mutant construct in the presence 
or absence of bta-miR-494 mimic using lipofectamine 2000 transfection reagent 
(Invitrogen, Darmstadt, Germany). After 24 h, treated cells were lysed and shaking 
for 15 min. The activity of firefly luciferase and renilla was determined using Dual-
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Glo luciferase assay kit (Promega, Madison, WI, USA) followed by luciferase assay 
reagent (LAR) and Stop & Glo reagent. Data was calculated as the ratio of firefly 
luciferase to renilla activity and compared with the group transfected with only empty 
vector. 
 
Akt protein detection and quantitation by western blotting 
Samples were separated on 12% SDS-polyacrylamide gels. The antibodies 
used was p-Akt1/2/3 antibody (Ser 473), a rabbit polyclonal IgG from Santa Cruz 
Biotechnology, at a 1:200 dilution (catalogue number SC-101629), a HRP-labelled 
anti-rabbit IgG (catalogue number #7074S - Cell Signaling) in TBST containing 1% 
BSA and a HRP labelled mouse monoclonal anti-beta-actin (ACTB) antibody 
(catalogue number A3854 - Sigma-Aldrich) to normalize the data. Blots treated with 
Clarity
TM 
Western ECL substrate (Bio-Rad) to visualise the proteins. 
 
Statistical analyses 
Data are displayed as means ± SEM of replicate samples. Statistical analyses 
were performed using the SAS 9.3 Software (SAS Institute). To assess statistical 
differences, ANOVA was performed respecting normality and homoscedasticity 
premises. Means were compared by Duncan test. When ANOVA premises were not 
satisfied, data were compared by Kruskal-Wallis test. Unless differently stated, a level 
of 5% was considered significant. 
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FIGURE LEGENDS 
Figure 1. Most relevant pathways regulated by exclusive miRNAs of granulosa cells 
and cumulus-oocyte complexes and respective extracellular vesicles. Represented by 
graphics of number of genes and enrichment factor in granulosa cells (GCs), cumulus-
oocyte complexes (COCs), and extracellular vesicles (GC-EVs and COC-EVs). 
Figure 2. Schematic representation of the PI3K-Akt pathway. Solid lines indicate 
direct interactions, dashed lines indicate multiple step interactions, lines ending with 
arrowheads indicate stimulation, lines ending in bar indicate blockage, and the symbol 
'p' indicates phosphorylation. Except for BAD, genes (enclosed in white boxes), other 
genes had their mRNA levels (PI3K, PTEN, FOXO3a, YWHAZ, BCL-2, BAX, CDK6, 
BRCA, EIF4e, or EIF4b) or protein levels (p-Akt) determined in ovarian follicular 
cells associated with different oocyte competences. Pentagons indicate bovine 
miRNAs exclusively identified in granulosa cells (GC; black) and in cumulus-oocyte 
complexes (COC; blue); or identified in GC-derived EVs (red) and in COC-derived 
EVs (green). Only miRNAs validated with strong evidence of interaction with the 
target gene are depicted.  
Figure 3. PI3K-Akt components levels in oocyte quality groups. Relative expression 
of (A) PTEN and (B) PI3K mRNAs and (C, D) levels of phosphorylated Akt protein 
(p-Akt) in follicular cells of non-cleaved (NC), cleaved non-blastocyst (CNB), and 
blastocyst (BL) groups of oocyte quality. C. Normalized levels of p-Akt obtained 
from western blotting analyses. D. Representative protein bands of p-Akt (~ 60 kDa) 
and Actin B (ACTB; 42 kDa) from western blotting analyses. Bars depict means and 
error bars depict standard errors of the means. Differences were statistically 
significant when p < 0.05. 
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Figure 4. Relative levels of bta-miR-494 and bta-miR-20a in follicular cells. (A) 
Relative levels of bta-miR-494 in non-cleaved (NC), cleaved non-blastocyst (CNB), 
and blastocyst (BL) groups. Bovine miRNA-494 and its validated target PTEN. 
Bioinformatics analysis of the 3'UTR of PTEN indicated two conserved target sites 
among mammals. (B) Relative levels of bta-miR-20a in non-cleaved (NC), cleaved 
non-blastocyst (CNB), and blastocyst (BL) groups. (C) Luciferase assay of the bovine 
PTEN 3’UTR in granulosa cells. The firefly luciferase activity was evaluated in cells 
transfected the empty pmirGLO vector, the vector with the wild type PTEN 3’UTR 
insert, the vector with the mutated construct insert  and evaluated by the transfection 
of the bta-miR-494 mimic.  Different letters indicate p<0.05. ** indicate p<0.01. 
Figure 5. Relative expression of mRNAs of genes responsible for the PI3K-Akt 
downstream cellular effects in non-cleaved (NC), cleaved non-blastocyst (CNB) and 
blastocyst (BL) groups. Bars depict means and error bars depict standard errors of the 
means. Different superscripts (a, b) indicate significant differences (p < 0.05). 
Figure 6. Schematic representation of the PI3K-Akt signalling pathway model and 
cellular responses in ovarian follicular cells (FCs) associated with high (HCO) or low 
(LCO) competent oocytes. In this study, HCO were represented by FCs from the BL 
group while LCO were represented by FCs from either the CNB or the NC group or a 
combination of both. Pentagons indicate if a given component of the pathway was 
upregulated (upward arrow) or downregulated (downward arrow) in FCs of LCO and 
HCO. Lines ending with arrowheads indicate stimulation, whereas lines ending with 
bars indicate blockage. 
Figure 7. Flowchart of the experiments 1 and 2 showing the formation of 
experimental groups and subsequent analysis. COC - cumulus-oocyte complex; GC - 
granulosa cells; EVs - extracellular vesicles; FCs follicular cells (granulosa and 
cumulus may be included); IVM - oocytes after IVM that did not showed the 
presence of the first polar body (1.CP); IVM - oocytes after IVM that showed the 
presence of the 1.CP; NC - embryos (or zygotes) derived through IVM, oocytes that 
did not undergo cleavage after parthenogenetic activation; CNB - embryos that 
underwent cleavage after parthenogenetic activation but did not reach the blastocyst 
stage; BL - blastocyst; p-Akt - phosphorylated Akt protein. 
 
 
SUPPLEMENTARY FIGURE LEGENDS 
Supplementary Fig. S1. Extracellular vesicle (EV) characterization by nanoparticle 
tracking analysis (NTA) and western blot. EV size was validated using Nanosight 
equipment (Malvern) and analysed with the NanoSight NTA Software v3.1. Videos 
were acquired at camera level 14 and room temperature (25 °C) using 50 nm, 100 nm, 
and 150 nm calibration beads (Malvern) in order to check size accuracy. Samples 
were introduced manually. Samples were analysed by recording between three and 
five 30 s videos. EVs were diluted at 1:500 in PBS. Vesicles size was defined as the 
mode and the mean determined from the acquired videos. A. EV size mode with 
standard deviation bars; B. Nanosight analysis showing EV concentration. C. NTA 
results of one representative COC-EVs sample showing concentration and size D. 
NTA results of one representative GC-EVs sample showing concentration and size. In 
order to investigate the EVs contents, we performed a western blotting analysis using 
the same methods than those described in Materials and Methods but with Alix (SC-
49267) and CD63 (SC-15363) as primary antibodies. Western blot analysis 
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demonstrated the presence of ALIX and CD63 in EVs isolated from COC and GC 
culture media. Protein detection in EVs originated from COCs is low due to the low 
amount of EVs isolated from these cells. E. Western blotting demonstrating the 
detected bands for ALIX and; F. for CD63. 
 
SUPPLEMENTARY TABLES  
Supplementary Table S1. A complete list of miRNAs identified in bovine granulosa 
cells (GCs) and cumulus-oocyte complexes (COCs) with their respective Ct values 
and standard deviations.  
Supplementary Table S2. Homology between bovine and human miRNA sequences 
(5'-3'). Bold letters indicate a mismatch. 
Supplementary Table S3. Homology of interaction between miRNAs and 3’UTR of 
the target genes in bovines and humans. 
Supplementary Table S4. Routines of individual parthenogenetic bovine embryo 
development displaying blastocyst/cleaved rates higher than 35%. 
Supplementary Table S5. Mature bovine miRNA sequences present in the profiler 
plate. 
Supplementary Table S6. Bovine primer sequences used in the RT-PCR 
amplification. 
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